{"doc_id": "PMID-10473104", "wnd_id": "PMID-10473104_0", "text": "UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.\n\nUFT, an anticancer agent that is composed of tegafur (FT) and uracil at a molar ratio of 1:4, is widely used in clinical practice in Japan to treat cancer patients requiring a long-term chemotherapy, and it is associated with few side effects, if any. In this study, we have evaluated the inhibitory effect of UFT against RENCA cell-induced angiogenesis by a dorsal air sac assay. Marked angiogenesis is induced by implantation of a chamber containing RENCA cells into mice. In this model, UFT showed a strong angiogenesis-inhibitory effect, whereas 5-fluorouracil (5-FU) and doxifluridine were less effective. Additional experiments revealed FT to be effective component of UFT; uracil remained ineffective in the inhibition of angiogenesis. Moreover, we have found that gamma-hydroxybutyric acid and gamma-butyrolactone, the metabolites of FT, possess a potent angiogenesis inhibitory effect that is amplified when the compounds are administered by a continuous infusion. This may reflect a transition in blood concentration of each metabolite resulting from the administration of UFT. Similar results were also obtained with respect to 5-FU. It was suggested that UFT has a stronger angiogenesis-inhibitory effect than did other fluorinated pyrimidines, partly due to its pharmacokinetic properties characterized by maintaining of higher and long-lasting blood levels of 5-FU and partly due the inhibitory effects derived from gamma-hydroxybutyric acid and gamma-butyrolactone, UFT-specific metabolites.", "tokens": ["UFT", "and", "its", "metabolites", "inhibit", "the", "angiogenesis", "induced", "by", "murine", "renal", "cell", "carcinoma", ",", "as", "determined", "by", "a", "dorsal", "air", "sac", "assay", "in", "mice", ".", "UFT", ",", "an", "anticancer", "agent", "that", "is", "composed", "of", "tegafur", "(", "FT", ")", "and", "uracil", "at", "a", "molar", "ratio", "of", "1:4", ",", "is", "widely", "used", "in", "clinical", "practice", "in", "Japan", "to", "treat", "cancer", "patients", "requiring", "a", "long", "-", "term", "chemotherapy", ",", "and", "it", "is", "associated", "with", "few", "side", "effects", ",", "if", "any", ".", "In", "this", "study", ",", "we", "have", "evaluated", "the", "inhibitory", "effect", "of", "UFT", "against", "RENCA", "cell", "-", "induced", "angiogenesis", "by", "a", "dorsal", "air", "sac", "assay", ".", "Marked", "angiogenesis", "is", "induced", "by", "implantation", "of", "a", "chamber", "containing", "RENCA", "cells", "into", "mice", ".", "In", "this", "model", ",", "UFT", "showed", "a", "strong", "angiogenesis", "-", "inhibitory", "effect", ",", "whereas", "5", "-", "fluorouracil", "(", "5", "-", "FU", ")", "and", "doxifluridine", "were", "less", "effective", ".", "Additional", "experiments", "revealed", "FT", "to", "be", "effective", "component", "of", "UFT", ";", "uracil", "remained", "ineffective", "in", "the", "inhibition", "of", "angiogenesis", ".", "Moreover", ",", "we", "have", "found", "that", "gamma", "-", "hydroxybutyric", "acid", "and", "gamma", "-", "butyrolactone", ",", "the", "metabolites", "of", "FT", ",", "possess", "a", "potent", "angiogenesis", "inhibitory", "effect", "that", "is", "amplified", "when", "the", "compounds", "are", "administered", "by", "a", "continuous", "infusion", ".", "This", "may", "reflect", "a", "transition", "in", "blood", "concentration", "of", "each", "metabolite", "resulting", "from", "the", "administration", "of", "UFT", ".", "Similar", "results", "were", "also", "obtained", "with", "respect", "to", "5", "-", "FU", ".", "It", "was", "suggested", "that", "UFT", "has", "a", "stronger", "angiogenesis", "-", "inhibitory", "effect", "than", "did", "other", "fluorinated", "pyrimidines", ",", "partly", "due", "to", "its", "pharmacokinetic", "properties", "characterized", "by", "maintaining", "of", "higher", "and", "long", "-", "lasting", "blood", "levels", "of", "5", "-", "FU", "and", "partly", "due", "the", "inhibitory", "effects", "derived", "from", "gamma", "-", "hydroxybutyric", "acid", "and", "gamma", "-", "butyrolactone", ",", "UFT", "-", "specific", "metabolites", "."], "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 4, "end": 5}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "UFT", "start": 0, "end": 1}]}, {"id": "E21", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 6, "end": 7}, "arguments": []}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 7, "end": 8}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "renal cell carcinoma", "start": 10, "end": 13}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "treat", "start": 56, "end": 57}, "arguments": [{"entity_id": "T4", "role": "Instrument", "text": "UFT", "start": 25, "end": 26}, {"entity_id": "T1002", "role": "Theme", "text": "patients", "start": 58, "end": 59}]}, {"id": "E29", "event_type": "Planned_process", "trigger": {"text": "chemotherapy", "start": 64, "end": 65}, "arguments": [{"entity_id": "T1002", "role": "Theme", "text": "patients", "start": 58, "end": 59}]}, {"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "inhibitory effect", "start": 86, "end": 88}, "arguments": [{"entity_id": "T9", "role": "Cause", "text": "UFT", "start": 89, "end": 90}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 94, "end": 95}, "arguments": [{"entity_id": "T10", "role": "Cause", "text": "RENCA cell", "start": 91, "end": 93}]}, {"id": "E22", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 95, "end": 96}, "arguments": []}, {"id": "E23", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 104, "end": 105}, "arguments": []}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 106, "end": 107}, "arguments": []}, {"id": "E7", "event_type": "Planned_process", "trigger": {"text": "implantation", "start": 108, "end": 109}, "arguments": [{"entity_id": "T13", "role": "Instrument", "text": "RENCA cells", "start": 113, "end": 115}, {"entity_id": "T1003", "role": "Theme", "text": "mice", "start": 116, "end": 117}]}, {"id": "E24", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 126, "end": 127}, "arguments": []}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "inhibitory effect", "start": 128, "end": 130}, "arguments": [{"entity_id": "T14", "role": "Cause", "text": "UFT", "start": 122, "end": 123}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "effective", "start": 144, "end": 145}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "doxifluridine", "start": 141, "end": 142}]}, {"id": "E10", "event_type": "Negative_regulation", "trigger": {"text": "effective", "start": 144, "end": 145}, "arguments": [{"entity_id": "T17", "role": "Cause", "text": "5-fluorouracil", "start": 132, "end": 135}, {"entity_id": "T18", "role": "Cause", "text": "5-FU", "start": 136, "end": 139}]}, {"id": "E11", "event_type": "Regulation", "trigger": {"text": "ineffective", "start": 159, "end": 160}, "arguments": [{"entity_id": "T22", "role": "Cause", "text": "uracil", "start": 157, "end": 158}]}, {"id": "E28", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 162, "end": 163}, "arguments": []}, {"id": "E25", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 164, "end": 165}, "arguments": []}, {"id": "E26", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 189, "end": 190}, "arguments": []}, {"id": "E12", "event_type": "Negative_regulation", "trigger": {"text": "inhibitory effect", "start": 190, "end": 192}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "gamma-butyrolactone", "start": 177, "end": 180}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "inhibitory effect", "start": 190, "end": 192}, "arguments": [{"entity_id": "T24", "role": "Cause", "text": "gamma-hydroxybutyric acid", "start": 172, "end": 176}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "amplified", "start": 194, "end": 195}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "gamma-butyrolactone", "start": 177, "end": 180}]}, {"id": "E16", "event_type": "Positive_regulation", "trigger": {"text": "amplified", "start": 194, "end": 195}, "arguments": [{"entity_id": "T24", "role": "Theme", "text": "gamma-hydroxybutyric acid", "start": 172, "end": 176}]}, {"id": "E15", "event_type": "Planned_process", "trigger": {"text": "administered", "start": 199, "end": 200}, "arguments": [{"entity_id": "T25", "role": "Instrument", "text": "gamma-butyrolactone", "start": 177, "end": 180}]}, {"id": "E17", "event_type": "Planned_process", "trigger": {"text": "administered", "start": 199, "end": 200}, "arguments": [{"entity_id": "T24", "role": "Instrument", "text": "gamma-hydroxybutyric acid", "start": 172, "end": 176}]}, {"id": "E18", "event_type": "Planned_process", "trigger": {"text": "administration", "start": 219, "end": 220}, "arguments": [{"entity_id": "T29", "role": "Instrument", "text": "UFT", "start": 221, "end": 222}]}, {"id": "E27", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 243, "end": 244}, "arguments": []}, {"id": "E19", "event_type": "Negative_regulation", "trigger": {"text": "inhibitory effect", "start": 245, "end": 247}, "arguments": [{"entity_id": "T31", "role": "Cause", "text": "UFT", "start": 239, "end": 240}]}, {"id": "E20", "event_type": "Negative_regulation", "trigger": {"text": "inhibitory effect", "start": 245, "end": 247}, "arguments": [{"entity_id": "T8", "role": "Cause", "text": "fluorinated pyrimidines", "start": 250, "end": 252}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "UFT", "entity_type": "Drug_or_compound", "start": 0, "end": 1}, {"id": "T34", "text": "inhibit", "entity_type": "Negative_regulation", "start": 4, "end": 5}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 6, "end": 7}, {"id": "T39", "text": "induced", "entity_type": "Positive_regulation", "start": 7, "end": 8}, {"id": "T1000", "text": "murine", "entity_type": "Organism", "start": 9, "end": 10}, {"id": "T2", "text": "renal cell carcinoma", "entity_type": "Pathological_formation", "start": 10, "end": 13}, {"id": "T1001", "text": "mice", "entity_type": "Organism", "start": 23, "end": 24}, {"id": "T4", "text": "UFT", "entity_type": "Drug_or_compound", "start": 25, "end": 26}, {"id": "T5", "text": "tegafur", "entity_type": "Drug_or_compound", "start": 34, "end": 35}, {"id": "T6", "text": "FT", "entity_type": "Drug_or_compound", "start": 36, "end": 37}, {"id": "T7", "text": "uracil", "entity_type": "Drug_or_compound", "start": 39, "end": 40}, {"id": "T40", "text": "treat", "entity_type": "Planned_process", "start": 56, "end": 57}, {"id": "T16", "text": "cancer", "entity_type": "Pathological_formation", "start": 57, "end": 58}, {"id": "T1002", "text": "patients", "entity_type": "Organism", "start": 58, "end": 59}, {"id": "T54", "text": "chemotherapy", "entity_type": "Planned_process", "start": 64, "end": 65}, {"id": "T41", "text": "inhibitory effect", "entity_type": "Negative_regulation", "start": 86, "end": 88}, {"id": "T9", "text": "UFT", "entity_type": "Drug_or_compound", "start": 89, "end": 90}, {"id": "T10", "text": "RENCA cell", "entity_type": "Cell", "start": 91, "end": 93}, {"id": "T42", "text": "induced", "entity_type": "Positive_regulation", "start": 94, "end": 95}, {"id": "T11", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 95, "end": 96}, {"id": "T12", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 104, "end": 105}, {"id": "T43", "text": "induced", "entity_type": "Positive_regulation", "start": 106, "end": 107}, {"id": "T44", "text": "implantation", "entity_type": "Planned_process", "start": 108, "end": 109}, {"id": "T13", "text": "RENCA cells", "entity_type": "Cell", "start": 113, "end": 115}, {"id": "T1003", "text": "mice", "entity_type": "Organism", "start": 116, "end": 117}, {"id": "T14", "text": "UFT", "entity_type": "Drug_or_compound", "start": 122, "end": 123}, {"id": "T15", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 126, "end": 127}, {"id": "T45", "text": "inhibitory effect", "entity_type": "Negative_regulation", "start": 128, "end": 130}, {"id": "T17", "text": "5-fluorouracil", "entity_type": "Drug_or_compound", "start": 132, "end": 135}, {"id": "T18", "text": "5-FU", "entity_type": "Drug_or_compound", "start": 136, "end": 139}, {"id": "T19", "text": "doxifluridine", "entity_type": "Drug_or_compound", "start": 141, "end": 142}, {"id": "T46", "text": "effective", "entity_type": "Negative_regulation", "start": 144, "end": 145}, {"id": "T20", "text": "FT", "entity_type": "Drug_or_compound", "start": 149, "end": 150}, {"id": "T21", "text": "UFT", "entity_type": "Drug_or_compound", "start": 155, "end": 156}, {"id": "T22", "text": "uracil", "entity_type": "Drug_or_compound", "start": 157, "end": 158}, {"id": "T47", "text": "ineffective", "entity_type": "Regulation", "start": 159, "end": 160}, {"id": "T53", "text": "inhibition", "entity_type": "Negative_regulation", "start": 162, "end": 163}, {"id": "T23", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 164, "end": 165}, {"id": "T24", "text": "gamma-hydroxybutyric acid", "entity_type": "Drug_or_compound", "start": 172, "end": 176}, {"id": "T25", "text": "gamma-butyrolactone", "entity_type": "Drug_or_compound", "start": 177, "end": 180}, {"id": "T26", "text": "FT", "entity_type": "Drug_or_compound", "start": 184, "end": 185}, {"id": "T27", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 189, "end": 190}, {"id": "T48", "text": "inhibitory effect", "entity_type": "Negative_regulation", "start": 190, "end": 192}, {"id": "T49", "text": "amplified", "entity_type": "Positive_regulation", "start": 194, "end": 195}, {"id": "T50", "text": "administered", "entity_type": "Planned_process", "start": 199, "end": 200}, {"id": "T28", "text": "blood", "entity_type": "Organism_substance", "start": 211, "end": 212}, {"id": "T51", "text": "administration", "entity_type": "Planned_process", "start": 219, "end": 220}, {"id": "T29", "text": "UFT", "entity_type": "Drug_or_compound", "start": 221, "end": 222}, {"id": "T30", "text": "5-FU", "entity_type": "Drug_or_compound", "start": 231, "end": 234}, {"id": "T31", "text": "UFT", "entity_type": "Drug_or_compound", "start": 239, "end": 240}, {"id": "T33", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 243, "end": 244}, {"id": "T52", "text": "inhibitory effect", "entity_type": "Negative_regulation", "start": 245, "end": 247}, {"id": "T8", "text": "fluorinated pyrimidines", "entity_type": "Drug_or_compound", "start": 250, "end": 252}, {"id": "T32", "text": "blood", "entity_type": "Organism_substance", "start": 268, "end": 269}, {"id": "T35", "text": "5-FU", "entity_type": "Drug_or_compound", "start": 271, "end": 274}, {"id": "T36", "text": "gamma-hydroxybutyric acid", "entity_type": "Drug_or_compound", "start": 282, "end": 286}, {"id": "T37", "text": "gamma-butyrolactone", "entity_type": "Drug_or_compound", "start": 287, "end": 290}, {"id": "T38", "text": "UFT", "entity_type": "Drug_or_compound", "start": 291, "end": 292}], "lang": "en"}
{"doc_id": "PMID-10978248", "wnd_id": "PMID-10978248_0", "text": "Vasodilator-stimulated phosphoprotein is involved in stress-fiber and membrane ruffle formation in endothelial cells.\n\nVasodilator-stimulated phosphoprotein (VASP) is highly expressed in vascular endothelial cells, where it has been implicated in cellular reorganization during angiogenesis, as well as in endothelial retraction and changes in vessel permeability. However, the cellular functions of VASP are not known. In this study, we have expressed wild-type and mutant forms of VASP in endothelial cells to determine in what aspects of cytoskeletal behavior this protein participates. Expression of wild-type VASP induces marked membrane ruffling and formation of prominent stress fibers in bovine aortic endothelial cells. Deletion of the proline-rich domain of VASP abolishes its ability to bind profilin but does not affect ruffling or stress fiber formation. Further deletions reveal a sequence within the carboxy-terminal domain that is responsible for in vivo bundle formation. Ruffling occurs only on the expression of forms of VASP that possess bundling activity and the capacity to bind zyxin/vinculin-derived peptide. The ability of distinct subdomains within VASP to bind adhesion proteins and induce F-actin bundling in vivo suggests that this protein could function in the aggregation and tethering of actin filaments during the formation of endothelial cell-substrate and cell-cell contacts. These data provide a mechanism whereby VASP can influence endothelial migration and organization during capillary formation and modulate vascular permeability via effects on endothelial cell contractility.", "tokens": ["Vasodilator", "-", "stimulated", "phosphoprotein", "is", "involved", "in", "stress", "-", "fiber", "and", "membrane", "ruffle", "formation", "in", "endothelial", "cells", ".", "Vasodilator", "-", "stimulated", "phosphoprotein", "(", "VASP", ")", "is", "highly", "expressed", "in", "vascular", "endothelial", "cells", ",", "where", "it", "has", "been", "implicated", "in", "cellular", "reorganization", "during", "angiogenesis", ",", "as", "well", "as", "in", "endothelial", "retraction", "and", "changes", "in", "vessel", "permeability", ".", "However", ",", "the", "cellular", "functions", "of", "VASP", "are", "not", "known", ".", "In", "this", "study", ",", "we", "have", "expressed", "wild", "-", "type", "and", "mutant", "forms", "of", "VASP", "in", "endothelial", "cells", "to", "determine", "in", "what", "aspects", "of", "cytoskeletal", "behavior", "this", "protein", "participates", ".", "Expression", "of", "wild", "-", "type", "VASP", "induces", "marked", "membrane", "ruffling", "and", "formation", "of", "prominent", "stress", "fibers", "in", "bovine", "aortic", "endothelial", "cells", ".", "Deletion", "of", "the", "proline", "-", "rich", "domain", "of", "VASP", "abolishes", "its", "ability", "to", "bind", "profilin", "but", "does", "not", "affect", "ruffling", "or", "stress", "fiber", "formation", ".", "Further", "deletions", "reveal", "a", "sequence", "within", "the", "carboxy", "-", "terminal", "domain", "that", "is", "responsible", "for", "in", "vivo", "bundle", "formation", ".", "Ruffling", "occurs", "only", "on", "the", "expression", "of", "forms", "of", "VASP", "that", "possess", "bundling", "activity", "and", "the", "capacity", "to", "bind", "zyxin", "/", "vinculin", "-", "derived", "peptide", ".", "The", "ability", "of", "distinct", "subdomains", "within", "VASP", "to", "bind", "adhesion", "proteins", "and", "induce", "F", "-", "actin", "bundling", "in", "vivo", "suggests", "that", "this", "protein", "could", "function", "in", "the", "aggregation", "and", "tethering", "of", "actin", "filaments", "during", "the", "formation", "of", "endothelial", "cell", "-", "substrate", "and", "cell", "-", "cell", "contacts", ".", "These", "data", "provide", "a", "mechanism", "whereby", "VASP", "can", "influence", "endothelial", "migration", "and", "organization", "during", "capillary", "formation", "and", "modulate", "vascular", "permeability", "via", "effects", "on", "endothelial", "cell", "contractility", "."], "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "involved", "start": 5, "end": 6}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "Vasodilator-stimulated phosphoprotein", "start": 0, "end": 4}]}, {"id": "E4", "event_type": "Regulation", "trigger": {"text": "involved", "start": 5, "end": 6}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "Vasodilator-stimulated phosphoprotein", "start": 0, "end": 4}]}, {"id": "E2", "event_type": "Development", "trigger": {"text": "formation", "start": 13, "end": 14}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "membrane ruffle", "start": 11, "end": 13}]}, {"id": "E3", "event_type": "Development", "trigger": {"text": "formation", "start": 13, "end": 14}, "arguments": [{"entity_id": "T3", "role": "Theme", "text": "stress-fiber", "start": 7, "end": 10}]}, {"id": "E5", "event_type": "Gene_expression", "trigger": {"text": "expressed", "start": 27, "end": 28}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "Vasodilator-stimulated phosphoprotein", "start": 18, "end": 22}, {"entity_id": "T7", "role": "Theme", "text": "VASP", "start": 23, "end": 24}]}, {"id": "E23", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 42, "end": 43}, "arguments": []}, {"id": "E26", "event_type": "Regulation", "trigger": {"text": "changes", "start": 51, "end": 52}, "arguments": [{"entity_id": "T12", "role": "Theme", "text": "vessel", "start": 53, "end": 54}]}, {"id": "E6", "event_type": "Planned_process", "trigger": {"text": "expressed", "start": 73, "end": 74}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "VASP", "start": 81, "end": 82}]}, {"id": "E7", "event_type": "Gene_expression", "trigger": {"text": "Expression", "start": 97, "end": 98}, "arguments": [{"entity_id": "T16", "role": "Theme", "text": "VASP", "start": 102, "end": 103}]}, {"id": "E8", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 103, "end": 104}, "arguments": []}, {"id": "E9", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 103, "end": 104}, "arguments": []}, {"id": "E17", "event_type": "Regulation", "trigger": {"text": "ruffling", "start": 106, "end": 107}, "arguments": [{"entity_id": "T47", "role": "Theme", "text": "membrane", "start": 105, "end": 106}]}, {"id": "E18", "event_type": "Development", "trigger": {"text": "formation", "start": 108, "end": 109}, "arguments": [{"entity_id": "T19", "role": "Theme", "text": "stress fibers", "start": 111, "end": 113}]}, {"id": "E24", "event_type": "Negative_regulation", "trigger": {"text": "abolishes", "start": 128, "end": 129}, "arguments": []}, {"id": "E25", "event_type": "Binding", "trigger": {"text": "bind", "start": 132, "end": 133}, "arguments": [{"entity_id": "T23", "role": "Theme", "text": "VASP", "start": 127, "end": 128}, {"entity_id": "T26", "role": "Theme", "text": "profilin", "start": 133, "end": 134}]}, {"id": "E10", "event_type": "Regulation", "trigger": {"text": "affect", "start": 137, "end": 138}, "arguments": []}, {"id": "E27", "event_type": "Development", "trigger": {"text": "formation", "start": 142, "end": 143}, "arguments": [{"entity_id": "T29", "role": "Theme", "text": "stress fiber", "start": 140, "end": 142}]}, {"id": "E30", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 169, "end": 170}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "VASP", "start": 173, "end": 174}]}, {"id": "E32", "event_type": "Binding", "trigger": {"text": "bind", "start": 182, "end": 183}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "VASP", "start": 173, "end": 174}, {"entity_id": "T34", "role": "Theme", "text": "zyxin", "start": 183, "end": 184}, {"entity_id": "T35", "role": "Theme2", "text": "vinculin", "start": 185, "end": 186}]}, {"id": "E11", "event_type": "Binding", "trigger": {"text": "bind", "start": 198, "end": 199}, "arguments": [{"entity_id": "T36", "role": "Site", "text": "subdomains", "start": 194, "end": 195}, {"entity_id": "T37", "role": "Theme", "text": "VASP", "start": 196, "end": 197}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "induce", "start": 202, "end": 203}, "arguments": [{"entity_id": "T37", "role": "Cause", "text": "VASP", "start": 196, "end": 197}, {"entity_id": "T38", "role": "Theme", "text": "F-actin", "start": 203, "end": 206}]}, {"id": "E44", "event_type": "Development", "trigger": {"text": "formation", "start": 225, "end": 226}, "arguments": [{"entity_id": "T45", "role": "Theme", "text": "endothelial cell-substrate", "start": 227, "end": 231}]}, {"id": "E19", "event_type": "Development", "trigger": {"text": "formation", "start": 225, "end": 226}, "arguments": [{"entity_id": "T41", "role": "Theme", "text": "cell-cell contacts", "start": 232, "end": 236}]}, {"id": "E20", "event_type": "Negative_regulation", "trigger": {"text": "influence", "start": 245, "end": 246}, "arguments": [{"entity_id": "T46", "role": "Cause", "text": "VASP", "start": 243, "end": 244}]}, {"id": "E21", "event_type": "Negative_regulation", "trigger": {"text": "influence", "start": 245, "end": 246}, "arguments": [{"entity_id": "T46", "role": "Cause", "text": "VASP", "start": 243, "end": 244}]}, {"id": "E50", "event_type": "Localization", "trigger": {"text": "migration", "start": 247, "end": 248}, "arguments": [{"entity_id": "T51", "role": "Theme", "text": "endothelial", "start": 246, "end": 247}]}, {"id": "E49", "event_type": "Development", "trigger": {"text": "organization", "start": 249, "end": 250}, "arguments": [{"entity_id": "T51", "role": "Theme", "text": "endothelial", "start": 246, "end": 247}]}, {"id": "E53", "event_type": "Development", "trigger": {"text": "formation", "start": 252, "end": 253}, "arguments": [{"entity_id": "T54", "role": "Theme", "text": "capillary", "start": 251, "end": 252}]}, {"id": "E55", "event_type": "Regulation", "trigger": {"text": "modulate", "start": 254, "end": 255}, "arguments": [{"entity_id": "T57", "role": "Theme", "text": "vascular", "start": 255, "end": 256}]}, {"id": "E22", "event_type": "Regulation", "trigger": {"text": "effects", "start": 258, "end": 259}, "arguments": [{"entity_id": "T46", "role": "Cause", "text": "VASP", "start": 243, "end": 244}, {"entity_id": "T58", "role": "Theme", "text": "endothelial cell", "start": 260, "end": 262}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T45", "role": "Arg1", "text": "endothelial cell-substrate", "start": 227, "end": 231}, {"entity_id": "T45", "role": "Arg1", "text": "endothelial cell-substrate", "start": 227, "end": 231}]}], "entity_mentions": [{"id": "T1", "text": "Vasodilator-stimulated phosphoprotein", "entity_type": "Gene_or_gene_product", "start": 0, "end": 4}, {"id": "T9", "text": "involved", "entity_type": "Regulation", "start": 5, "end": 6}, {"id": "T3", "text": "stress-fiber", "entity_type": "Cellular_component", "start": 7, "end": 10}, {"id": "T4", "text": "membrane ruffle", "entity_type": "Cellular_component", "start": 11, "end": 13}, {"id": "T2", "text": "formation", "entity_type": "Development", "start": 13, "end": 14}, {"id": "T5", "text": "endothelial cells", "entity_type": "Cell", "start": 15, "end": 17}, {"id": "T6", "text": "Vasodilator-stimulated phosphoprotein", "entity_type": "Gene_or_gene_product", "start": 18, "end": 22}, {"id": "T7", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 23, "end": 24}, {"id": "T10", "text": "expressed", "entity_type": "Gene_expression", "start": 27, "end": 28}, {"id": "T8", "text": "vascular endothelial cells", "entity_type": "Cell", "start": 29, "end": 32}, {"id": "T11", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 42, "end": 43}, {"id": "T28", "text": "changes", "entity_type": "Regulation", "start": 51, "end": 52}, {"id": "T12", "text": "vessel", "entity_type": "Multi-tissue_structure", "start": 53, "end": 54}, {"id": "T13", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 62, "end": 63}, {"id": "T21", "text": "expressed", "entity_type": "Planned_process", "start": 73, "end": 74}, {"id": "T14", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 81, "end": 82}, {"id": "T15", "text": "endothelial cells", "entity_type": "Cell", "start": 83, "end": 85}, {"id": "T33", "text": "Expression", "entity_type": "Gene_expression", "start": 97, "end": 98}, {"id": "T16", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 102, "end": 103}, {"id": "T39", "text": "induces", "entity_type": "Positive_regulation", "start": 103, "end": 104}, {"id": "T47", "text": "membrane", "entity_type": "Cellular_component", "start": 105, "end": 106}, {"id": "T17", "text": "ruffling", "entity_type": "Regulation", "start": 106, "end": 107}, {"id": "T18", "text": "formation", "entity_type": "Development", "start": 108, "end": 109}, {"id": "T19", "text": "stress fibers", "entity_type": "Cellular_component", "start": 111, "end": 113}, {"id": "T1000", "text": "bovine", "entity_type": "Organism", "start": 114, "end": 115}, {"id": "T20", "text": "aortic endothelial cells", "entity_type": "Cell", "start": 115, "end": 118}, {"id": "T22", "text": "proline-rich domain", "entity_type": "Protein_domain_or_region", "start": 122, "end": 126}, {"id": "T23", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 127, "end": 128}, {"id": "T24", "text": "abolishes", "entity_type": "Negative_regulation", "start": 128, "end": 129}, {"id": "T25", "text": "bind", "entity_type": "Binding", "start": 132, "end": 133}, {"id": "T26", "text": "profilin", "entity_type": "Gene_or_gene_product", "start": 133, "end": 134}, {"id": "T59", "text": "affect", "entity_type": "Regulation", "start": 137, "end": 138}, {"id": "T29", "text": "stress fiber", "entity_type": "Cellular_component", "start": 140, "end": 142}, {"id": "T27", "text": "formation", "entity_type": "Development", "start": 142, "end": 143}, {"id": "T30", "text": "expression", "entity_type": "Gene_expression", "start": 169, "end": 170}, {"id": "T31", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 173, "end": 174}, {"id": "T32", "text": "bind", "entity_type": "Binding", "start": 182, "end": 183}, {"id": "T34", "text": "zyxin", "entity_type": "Gene_or_gene_product", "start": 183, "end": 184}, {"id": "T35", "text": "vinculin", "entity_type": "Gene_or_gene_product", "start": 185, "end": 186}, {"id": "T36", "text": "subdomains", "entity_type": "Protein_domain_or_region", "start": 194, "end": 195}, {"id": "T37", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 196, "end": 197}, {"id": "T61", "text": "bind", "entity_type": "Binding", "start": 198, "end": 199}, {"id": "T64", "text": "induce", "entity_type": "Positive_regulation", "start": 202, "end": 203}, {"id": "T38", "text": "F-actin", "entity_type": "Gene_or_gene_product", "start": 203, "end": 206}, {"id": "T40", "text": "actin", "entity_type": "Gene_or_gene_product", "start": 221, "end": 222}, {"id": "T44", "text": "formation", "entity_type": "Development", "start": 225, "end": 226}, {"id": "T45", "text": "endothelial cell-substrate", "entity_type": "Cellular_component", "start": 227, "end": 231}, {"id": "T41", "text": "cell-cell contacts", "entity_type": "Cellular_component", "start": 232, "end": 236}, {"id": "T46", "text": "VASP", "entity_type": "Gene_or_gene_product", "start": 243, "end": 244}, {"id": "T66", "text": "influence", "entity_type": "Negative_regulation", "start": 245, "end": 246}, {"id": "T51", "text": "endothelial", "entity_type": "Cell", "start": 246, "end": 247}, {"id": "T50", "text": "migration", "entity_type": "Localization", "start": 247, "end": 248}, {"id": "T49", "text": "organization", "entity_type": "Development", "start": 249, "end": 250}, {"id": "T54", "text": "capillary", "entity_type": "Tissue", "start": 251, "end": 252}, {"id": "T53", "text": "formation", "entity_type": "Development", "start": 252, "end": 253}, {"id": "T55", "text": "modulate", "entity_type": "Regulation", "start": 254, "end": 255}, {"id": "T57", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 255, "end": 256}, {"id": "T67", "text": "effects", "entity_type": "Regulation", "start": 258, "end": 259}, {"id": "T58", "text": "endothelial cell", "entity_type": "Cell", "start": 260, "end": 262}], "lang": "en"}
{"doc_id": "PMID-11306510", "wnd_id": "PMID-11306510_0", "text": "Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.\n\nAngiogenesis is essential for tumor growth and metastasis. It is regulated by numerous angiogenic factors, one of the most important being vascular endothelial growth factor (VEGF). Recently VEGF-B and VEGF-C, two new VEGF family members, have been identified that bind to the tyrosine kinase receptors flt-1 (VEGFR1), KDR (VEGFR2), and flt-4 (VEGFR3). Although the importance of VEGF-A has been shown in renal carcinomas, the contribution of these new ligands in kidney tumors is not clear. We have, therefore, measured the mRNA level of VEGF-B and VEGF-C together with their receptors by RNase protection assay (RPA) in 26 normal kidney samples and 45 renal cell cancers. We observed a significant up-regulation of VEGF-B (P = 0.002) but not VEGF-C (P = 0.3) in neoplastic kidney compared with normal tissues. In addition, although VEGF receptors were higher in tumors than normal kidney, there was a significant up-regulation of only flt-1 (P = 0.003) but not KDR (P = 0.12) or flt-4 (P = 0.09). There was also a significant correlation between VEGF-C and both of its receptors flt-4 (P = 0.006) and KDR (P = 0.03) but no association between VEGF-B and its receptor flt-1 (P = 0.23). A significant increase was observed in flt-1 (P  less than  0.001), KDR (P = 0.02), and flt-4 (P = 0.01) but not VEGF-B (P = 0.82) or VEGF-C (P = 0.52) expression in clear cell compared with chromophil (papillary) carcinomas.", "tokens": ["Vascular", "endothelial", "growth", "factor", "-", "B", "and", "vascular", "endothelial", "growth", "factor", "-", "C", "expression", "in", "renal", "cell", "carcinomas", ":", "regulation", "by", "the", "von", "Hippel", "-", "Lindau", "gene", "and", "hypoxia", ".", "Angiogenesis", "is", "essential", "for", "tumor", "growth", "and", "metastasis", ".", "It", "is", "regulated", "by", "numerous", "angiogenic", "factors", ",", "one", "of", "the", "most", "important", "being", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", ".", "Recently", "VEGF", "-B", "and", "VEGF", "-C", ",", "two", "new", "VEGF", "family", "members", ",", "have", "been", "identified", "that", "bind", "to", "the", "tyrosine", "kinase", "receptors", "flt", "-", "1", "(", "VEGFR1", ")", ",", "KDR", "(", "VEGFR2", ")", ",", "and", "flt", "-", "4", "(", "VEGFR3", ")", ".", "Although", "the", "importance", "of", "VEGF", "-", "A", "has", "been", "shown", "in", "renal", "carcinomas", ",", "the", "contribution", "of", "these", "new", "ligands", "in", "kidney", "tumors", "is", "not", "clear", ".", "We", "have", ",", "therefore", ",", "measured", "the", "mRNA", "level", "of", "VEGF", "-", "B", "and", "VEGF", "-C", "together", "with", "their", "receptors", "by", "RNase", "protection", "assay", "(", "RPA", ")", "in", "26", "normal", "kidney", "samples", "and", "45", "renal", "cell", "cancers", ".", "We", "observed", "a", "significant", "up", "-", "regulation", "of", "VEGF", "-", "B", "(", "P", "=", "0.002", ")", "but", "not", "VEGF", "-", "C", "(", "P", "=", "0.3", ")", "in", "neoplastic", "kidney", "compared", "with", "normal", "tissues", ".", "In", "addition", ",", "although", "VEGF", "receptors", "were", "higher", "in", "tumors", "than", "normal", "kidney", ",", "there", "was", "a", "significant", "up", "-", "regulation", "of", "only", "flt", "-", "1", "(", "P", "=", "0.003", ")", "but", "not", "KDR", "(", "P", "=", "0.12", ")", "or", "flt", "-", "4", "(", "P", "=", "0.09", ")", ".", "There", "was", "also", "a", "significant", "correlation", "between", "VEGF", "-C", "and", "both", "of", "its", "receptors", "flt", "-", "4", "(", "P", "=", "0.006", ")", "and", "KDR", "(", "P", "=", "0.03", ")", "but", "no", "association", "between", "VEGF", "-", "B", "and", "its", "receptor", "flt", "-", "1", "(", "P", "=", "0.23", ")", ".", "A", "significant", "increase", "was", "observed", "in", "flt", "-", "1", "(", "P", "less", "than", "0.001", ")", ",", "KDR", "(", "P", "=", "0.02", ")", ",", "and", "flt", "-", "4", "(", "P", "=", "0.01", ")", "but", "not", "VEGF", "-", "B", "(", "P", "=", "0.82", ")", "or", "VEGF", "-C", "(", "P", "=", "0.52", ")", "expression", "in", "clear", "cell", "compared", "with", "chromophil", "(", "papillary", ")", "carcinomas", "."], "event_mentions": [{"id": "E1", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 13, "end": 14}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "vascular endothelial growth factor-C", "start": 7, "end": 13}]}, {"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 13, "end": 14}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "Vascular endothelial growth factor-B", "start": 0, "end": 6}]}, {"id": "E34", "event_type": "Blood_vessel_development", "trigger": {"text": "Angiogenesis", "start": 30, "end": 31}, "arguments": []}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "essential", "start": 32, "end": 33}, "arguments": []}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "essential", "start": 32, "end": 33}, "arguments": []}, {"id": "E8", "event_type": "Growth", "trigger": {"text": "growth", "start": 35, "end": 36}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "tumor", "start": 34, "end": 35}]}, {"id": "E4", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 37, "end": 38}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "tumor", "start": 34, "end": 35}]}, {"id": "E35", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 44, "end": 45}, "arguments": []}, {"id": "E19", "event_type": "Binding", "trigger": {"text": "bind", "start": 78, "end": 79}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "VEGF-C", "start": 65, "end": 67}, {"entity_id": "T29", "role": "Theme", "text": "flt-1", "start": 84, "end": 87}, {"entity_id": "T30", "role": "Theme", "text": "VEGFR1", "start": 88, "end": 89}]}, {"id": "E6", "event_type": "Binding", "trigger": {"text": "bind", "start": 78, "end": 79}, "arguments": [{"entity_id": "T20", "role": "Theme", "text": "VEGF-B", "start": 62, "end": 64}, {"entity_id": "T29", "role": "Theme", "text": "flt-1", "start": 84, "end": 87}, {"entity_id": "T30", "role": "Theme", "text": "VEGFR1", "start": 88, "end": 89}]}, {"id": "E7", "event_type": "Binding", "trigger": {"text": "bind", "start": 78, "end": 79}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "VEGF-C", "start": 65, "end": 67}, {"entity_id": "T31", "role": "Theme", "text": "KDR", "start": 91, "end": 92}, {"entity_id": "T32", "role": "Theme", "text": "VEGFR2", "start": 93, "end": 94}]}, {"id": "E9", "event_type": "Binding", "trigger": {"text": "bind", "start": 78, "end": 79}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "VEGF-C", "start": 65, "end": 67}, {"entity_id": "T33", "role": "Theme", "text": "flt-4", "start": 97, "end": 100}, {"entity_id": "T34", "role": "Theme", "text": "VEGFR3", "start": 101, "end": 102}]}, {"id": "E10", "event_type": "Binding", "trigger": {"text": "bind", "start": 78, "end": 79}, "arguments": [{"entity_id": "T20", "role": "Theme", "text": "VEGF-B", "start": 62, "end": 64}, {"entity_id": "T31", "role": "Theme", "text": "KDR", "start": 91, "end": 92}, {"entity_id": "T32", "role": "Theme", "text": "VEGFR2", "start": 93, "end": 94}]}, {"id": "E11", "event_type": "Binding", "trigger": {"text": "bind", "start": 78, "end": 79}, "arguments": [{"entity_id": "T20", "role": "Theme", "text": "VEGF-B", "start": 62, "end": 64}, {"entity_id": "T33", "role": "Theme", "text": "flt-4", "start": 97, "end": 100}, {"entity_id": "T34", "role": "Theme", "text": "VEGFR3", "start": 101, "end": 102}]}, {"id": "E42", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 173, "end": 176}, "arguments": [{"entity_id": "T43", "role": "Theme", "text": "VEGF-B", "start": 177, "end": 180}]}, {"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 173, "end": 176}, "arguments": [{"entity_id": "T44", "role": "Theme", "text": "VEGF-C", "start": 187, "end": 190}]}, {"id": "E49", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 221, "end": 224}, "arguments": [{"entity_id": "T50", "role": "Theme", "text": "flt-1", "start": 226, "end": 229}]}, {"id": "E13", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 221, "end": 224}, "arguments": [{"entity_id": "T51", "role": "Theme", "text": "KDR", "start": 236, "end": 237}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 221, "end": 224}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "flt-4", "start": 243, "end": 246}]}, {"id": "E58", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 302, "end": 303}, "arguments": []}, {"id": "E20", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 302, "end": 303}, "arguments": []}, {"id": "E21", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 302, "end": 303}, "arguments": []}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 302, "end": 303}, "arguments": []}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "increase", "start": 302, "end": 303}, "arguments": []}, {"id": "E59", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 350, "end": 351}, "arguments": [{"entity_id": "T64", "role": "Theme", "text": "VEGF-C", "start": 343, "end": 345}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 350, "end": 351}, "arguments": [{"entity_id": "T63", "role": "Theme", "text": "VEGF-B", "start": 334, "end": 337}]}, {"id": "E16", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 350, "end": 351}, "arguments": [{"entity_id": "T62", "role": "Theme", "text": "flt-4", "start": 324, "end": 327}]}, {"id": "E17", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 350, "end": 351}, "arguments": [{"entity_id": "T61", "role": "Theme", "text": "KDR", "start": 316, "end": 317}]}, {"id": "E18", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 350, "end": 351}, "arguments": [{"entity_id": "T60", "role": "Theme", "text": "flt-1", "start": 306, "end": 309}]}], "relation_mentions": [], "entity_mentions": [{"id": "T2", "text": "Vascular endothelial growth factor-B", "entity_type": "Gene_or_gene_product", "start": 0, "end": 6}, {"id": "T4", "text": "vascular endothelial growth factor-C", "entity_type": "Gene_or_gene_product", "start": 7, "end": 13}, {"id": "T1", "text": "expression", "entity_type": "Gene_expression", "start": 13, "end": 14}, {"id": "T5", "text": "renal cell carcinomas", "entity_type": "Pathological_formation", "start": 15, "end": 18}, {"id": "T6", "text": "von Hippel-Lindau", "entity_type": "Gene_or_gene_product", "start": 22, "end": 26}, {"id": "T7", "text": "Angiogenesis", "entity_type": "Blood_vessel_development", "start": 30, "end": 31}, {"id": "T3", "text": "essential", "entity_type": "Positive_regulation", "start": 32, "end": 33}, {"id": "T9", "text": "tumor", "entity_type": "Pathological_formation", "start": 34, "end": 35}, {"id": "T8", "text": "growth", "entity_type": "Growth", "start": 35, "end": 36}, {"id": "T89", "text": "metastasis", "entity_type": "Localization", "start": 37, "end": 38}, {"id": "T10", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 44, "end": 45}, {"id": "T12", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 53, "end": 57}, {"id": "T13", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 58, "end": 59}, {"id": "T20", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 62, "end": 64}, {"id": "T27", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 65, "end": 67}, {"id": "T28", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 70, "end": 71}, {"id": "T19", "text": "bind", "entity_type": "Binding", "start": 78, "end": 79}, {"id": "T29", "text": "flt-1", "entity_type": "Gene_or_gene_product", "start": 84, "end": 87}, {"id": "T30", "text": "VEGFR1", "entity_type": "Gene_or_gene_product", "start": 88, "end": 89}, {"id": "T31", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 91, "end": 92}, {"id": "T32", "text": "VEGFR2", "entity_type": "Gene_or_gene_product", "start": 93, "end": 94}, {"id": "T33", "text": "flt-4", "entity_type": "Gene_or_gene_product", "start": 97, "end": 100}, {"id": "T34", "text": "VEGFR3", "entity_type": "Gene_or_gene_product", "start": 101, "end": 102}, {"id": "T35", "text": "VEGF-A", "entity_type": "Gene_or_gene_product", "start": 108, "end": 111}, {"id": "T36", "text": "renal carcinomas", "entity_type": "Pathological_formation", "start": 115, "end": 117}, {"id": "T37", "text": "kidney tumors", "entity_type": "Pathological_formation", "start": 125, "end": 127}, {"id": "T38", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 141, "end": 144}, {"id": "T39", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 145, "end": 147}, {"id": "T80", "text": "RNase", "entity_type": "Gene_or_gene_product", "start": 152, "end": 153}, {"id": "T40", "text": "normal kidney samples", "entity_type": "Multi-tissue_structure", "start": 160, "end": 163}, {"id": "T41", "text": "renal cell cancers", "entity_type": "Pathological_formation", "start": 165, "end": 168}, {"id": "T42", "text": "up-regulation", "entity_type": "Positive_regulation", "start": 173, "end": 176}, {"id": "T43", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 177, "end": 180}, {"id": "T44", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 187, "end": 190}, {"id": "T45", "text": "neoplastic kidney", "entity_type": "Organ", "start": 196, "end": 198}, {"id": "T11", "text": "normal tissues", "entity_type": "Tissue", "start": 200, "end": 202}, {"id": "T46", "text": "VEGF receptors", "entity_type": "Gene_or_gene_product", "start": 207, "end": 209}, {"id": "T47", "text": "tumors", "entity_type": "Pathological_formation", "start": 212, "end": 213}, {"id": "T48", "text": "kidney", "entity_type": "Organ", "start": 215, "end": 216}, {"id": "T49", "text": "up-regulation", "entity_type": "Positive_regulation", "start": 221, "end": 224}, {"id": "T50", "text": "flt-1", "entity_type": "Gene_or_gene_product", "start": 226, "end": 229}, {"id": "T51", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 236, "end": 237}, {"id": "T52", "text": "flt-4", "entity_type": "Gene_or_gene_product", "start": 243, "end": 246}, {"id": "T53", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 259, "end": 261}, {"id": "T54", "text": "flt-4", "entity_type": "Gene_or_gene_product", "start": 266, "end": 269}, {"id": "T55", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 275, "end": 276}, {"id": "T56", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 285, "end": 288}, {"id": "T57", "text": "flt-1", "entity_type": "Gene_or_gene_product", "start": 291, "end": 294}, {"id": "T58", "text": "increase", "entity_type": "Positive_regulation", "start": 302, "end": 303}, {"id": "T60", "text": "flt-1", "entity_type": "Gene_or_gene_product", "start": 306, "end": 309}, {"id": "T61", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 316, "end": 317}, {"id": "T62", "text": "flt-4", "entity_type": "Gene_or_gene_product", "start": 324, "end": 327}, {"id": "T63", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 334, "end": 337}, {"id": "T64", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 343, "end": 345}, {"id": "T59", "text": "expression", "entity_type": "Gene_expression", "start": 350, "end": 351}, {"id": "T23", "text": "clear cell", "entity_type": "Cell", "start": 352, "end": 354}, {"id": "T65", "text": "chromophil (papillary) carcinomas", "entity_type": "Pathological_formation", "start": 356, "end": 361}], "lang": "en"}
{"doc_id": "PMID-11306510", "wnd_id": "PMID-11306510_1", "text": "No significant association was demonstrated between VEGF-B, VEGF-C, flt-1, KDR, and flt-4 with patient sex, patient age, or tumor size (P  greater than  0.05). The effect of von Hippel-Lindau (VHL) gene and hypoxia on VEGF-B and VEGF-C expression in the renal carcinoma cell line 786-0 transfected with wild-type and mutant VHL was determined by growing cells under 21% O2- and 0.1% O2. In wild-type VHL cells, whereas VEGF-A was significantly up-regulated under hypoxic compared with normoxic conditions (P  less than  0.001), expression of VEGF-C was reduced (P  less than  0.002). Nevertheless, the repression of VEGF-C was lost in mutant VHL cell lines under hypoxia. In contrast VEGF-B was not regulated by VHL despite clear up-regulation in vivo. These findings strongly support an enhanced role for this pathway in clear cell carcinomas by regulating angiogenesis and/or lymphangiogenesis. The study shows that clear cell tumors are able to up-regulate angiogenic growth factor receptors more efficiently than chromophil (papillary), that clear cell tumors can use pathways independent of VHL to regulate angiogenesis, and that this combined regulation may account for their more aggressive phenotype, which suggests that targeting VEGFR1 (flt-l) may be particularly effective in these tumor types.", "tokens": ["No", "significant", "association", "was", "demonstrated", "between", "VEGF", "-B", ",", "VEGF", "-C", ",", "flt", "-", "1", ",", "KDR", ",", "and", "flt", "-", "4", "with", "patient", "sex", ",", "patient", "age", ",", "or", "tumor", "size", "(", "P", "greater", "than", "0.05", ")", ".", "The", "effect", "of", "von", "Hippel", "-", "Lindau", "(", "VHL", ")", "gene", "and", "hypoxia", "on", "VEGF", "-", "B", "and", "VEGF", "-", "C", "expression", "in", "the", "renal", "carcinoma", "cell", "line", "786-", "0", "transfected", "with", "wild", "-", "type", "and", "mutant", "VHL", "was", "determined", "by", "growing", "cells", "under", "21", "%", "O2", "-", "and", "0.1", "%", "O2", ".", "In", "wild", "-", "type", "VHL", "cells", ",", "whereas", "VEGF", "-", "A", "was", "significantly", "up", "-", "regulated", "under", "hypoxic", "compared", "with", "normoxic", "conditions", "(", "P", "less", "than", "0.001", ")", ",", "expression", "of", "VEGF", "-C", "was", "reduced", "(", "P", "less", "than", "0.002", ")", ".", "Nevertheless", ",", "the", "repression", "of", "VEGF", "-", "C", "was", "lost", "in", "mutant", "VHL", "cell", "lines", "under", "hypoxia", ".", "In", "contrast", "VEGF", "-", "B", "was", "not", "regulated", "by", "VHL", "despite", "clear", "up", "-", "regulation", "in", "vivo", ".", "These", "findings", "strongly", "support", "an", "enhanced", "role", "for", "this", "pathway", "in", "clear", "cell", "carcinomas", "by", "regulating", "angiogenesis", "and", "/", "or", "lymphangiogenesis", ".", "The", "study", "shows", "that", "clear", "cell", "tumors", "are", "able", "to", "up", "-", "regulate", "angiogenic", "growth", "factor", "receptors", "more", "efficiently", "than", "chromophil", "(", "papillary", ")", ",", "that", "clear", "cell", "tumors", "can", "use", "pathways", "independent", "of", "VHL", "to", "regulate", "angiogenesis", ",", "and", "that", "this", "combined", "regulation", "may", "account", "for", "their", "more", "aggressive", "phenotype", ",", "which", "suggests", "that", "targeting", "VEGFR1", "(", "flt", "-", "l", ")", "may", "be", "particularly", "effective", "in", "these", "tumor", "types", "."], "event_mentions": [{"id": "E26", "event_type": "Regulation", "trigger": {"text": "effect", "start": 40, "end": 41}, "arguments": [{"entity_id": "T72", "role": "Cause", "text": "von Hippel-Lindau", "start": 42, "end": 46}, {"entity_id": "T73", "role": "Cause", "text": "VHL", "start": 47, "end": 48}]}, {"id": "E27", "event_type": "Regulation", "trigger": {"text": "effect", "start": 40, "end": 41}, "arguments": [{"entity_id": "T72", "role": "Cause", "text": "von Hippel-Lindau", "start": 42, "end": 46}, {"entity_id": "T73", "role": "Cause", "text": "VHL", "start": 47, "end": 48}]}, {"id": "E76", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 60, "end": 61}, "arguments": [{"entity_id": "T77", "role": "Theme", "text": "VEGF-C", "start": 57, "end": 60}]}, {"id": "E24", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 60, "end": 61}, "arguments": [{"entity_id": "T75", "role": "Theme", "text": "VEGF-B", "start": 53, "end": 56}]}, {"id": "E33", "event_type": "Planned_process", "trigger": {"text": "transfected", "start": 69, "end": 70}, "arguments": [{"entity_id": "T79", "role": "Theme", "text": "786-0", "start": 67, "end": 69}, {"entity_id": "T81", "role": "Instrument", "text": "VHL", "start": 76, "end": 77}]}, {"id": "E25", "event_type": "Cell_proliferation", "trigger": {"text": "growing", "start": 80, "end": 81}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "cells", "start": 81, "end": 82}]}, {"id": "E83", "event_type": "Positive_regulation", "trigger": {"text": "up-regulated", "start": 105, "end": 108}, "arguments": [{"entity_id": "T84", "role": "Theme", "text": "VEGF-A", "start": 100, "end": 103}]}, {"id": "E28", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 121, "end": 122}, "arguments": [{"entity_id": "T86", "role": "Theme", "text": "VEGF-C", "start": 123, "end": 125}]}, {"id": "E85", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 126, "end": 127}, "arguments": []}, {"id": "E87", "event_type": "Negative_regulation", "trigger": {"text": "repression", "start": 137, "end": 138}, "arguments": [{"entity_id": "T88", "role": "Theme", "text": "VEGF-C", "start": 139, "end": 142}]}, {"id": "E91", "event_type": "Regulation", "trigger": {"text": "regulated", "start": 159, "end": 160}, "arguments": [{"entity_id": "T92", "role": "Theme", "text": "VEGF-B", "start": 154, "end": 157}, {"entity_id": "T93", "role": "Cause", "text": "VHL", "start": 161, "end": 162}]}, {"id": "E29", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 164, "end": 167}, "arguments": [{"entity_id": "T92", "role": "Theme", "text": "VEGF-B", "start": 154, "end": 157}, {"entity_id": "T93", "role": "Cause", "text": "VHL", "start": 161, "end": 162}]}, {"id": "E30", "event_type": "Regulation", "trigger": {"text": "regulating", "start": 185, "end": 186}, "arguments": []}, {"id": "E31", "event_type": "Regulation", "trigger": {"text": "regulating", "start": 185, "end": 186}, "arguments": []}, {"id": "E36", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 186, "end": 187}, "arguments": []}, {"id": "E37", "event_type": "Blood_vessel_development", "trigger": {"text": "lymphangiogenesis", "start": 190, "end": 191}, "arguments": []}, {"id": "E38", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 205, "end": 206}, "arguments": []}, {"id": "E32", "event_type": "Regulation", "trigger": {"text": "regulate", "start": 228, "end": 229}, "arguments": [{"entity_id": "T102", "role": "Cause", "text": "VHL", "start": 226, "end": 227}]}, {"id": "E39", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 229, "end": 230}, "arguments": []}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T21", "role": "Arg1", "text": "chromophil", "start": 212, "end": 213}, {"entity_id": "T21", "role": "Arg1", "text": "chromophil", "start": 212, "end": 213}]}, {"id": "R2", "relation_type": "frag", "arguments": [{"entity_id": "T95", "role": "Arg1", "text": "papillary", "start": 214, "end": 215}, {"entity_id": "T95", "role": "Arg1", "text": "papillary", "start": 214, "end": 215}]}], "entity_mentions": [{"id": "T66", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 6, "end": 8}, {"id": "T67", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 9, "end": 11}, {"id": "T68", "text": "flt-1", "entity_type": "Gene_or_gene_product", "start": 12, "end": 15}, {"id": "T69", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 16, "end": 17}, {"id": "T70", "text": "flt-4", "entity_type": "Gene_or_gene_product", "start": 19, "end": 22}, {"id": "T1000", "text": "patient", "entity_type": "Organism", "start": 23, "end": 24}, {"id": "T1001", "text": "patient", "entity_type": "Organism", "start": 26, "end": 27}, {"id": "T71", "text": "tumor", "entity_type": "Pathological_formation", "start": 30, "end": 31}, {"id": "T15", "text": "effect", "entity_type": "Regulation", "start": 40, "end": 41}, {"id": "T72", "text": "von Hippel-Lindau", "entity_type": "Gene_or_gene_product", "start": 42, "end": 46}, {"id": "T73", "text": "VHL", "entity_type": "Gene_or_gene_product", "start": 47, "end": 48}, {"id": "T75", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 53, "end": 56}, {"id": "T77", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 57, "end": 60}, {"id": "T76", "text": "expression", "entity_type": "Gene_expression", "start": 60, "end": 61}, {"id": "T78", "text": "renal carcinoma", "entity_type": "Pathological_formation", "start": 63, "end": 65}, {"id": "T79", "text": "786-0", "entity_type": "Cell", "start": 67, "end": 69}, {"id": "T25", "text": "transfected", "entity_type": "Planned_process", "start": 69, "end": 70}, {"id": "T81", "text": "VHL", "entity_type": "Gene_or_gene_product", "start": 76, "end": 77}, {"id": "T14", "text": "growing", "entity_type": "Cell_proliferation", "start": 80, "end": 81}, {"id": "T26", "text": "cells", "entity_type": "Cell", "start": 81, "end": 82}, {"id": "T74", "text": "wild-type VHL cells", "entity_type": "Cell", "start": 93, "end": 98}, {"id": "T82", "text": "VHL", "entity_type": "Gene_or_gene_product", "start": 96, "end": 97}, {"id": "T84", "text": "VEGF-A", "entity_type": "Gene_or_gene_product", "start": 100, "end": 103}, {"id": "T83", "text": "up-regulated", "entity_type": "Positive_regulation", "start": 105, "end": 108}, {"id": "T16", "text": "expression", "entity_type": "Gene_expression", "start": 121, "end": 122}, {"id": "T86", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 123, "end": 125}, {"id": "T85", "text": "reduced", "entity_type": "Negative_regulation", "start": 126, "end": 127}, {"id": "T87", "text": "repression", "entity_type": "Negative_regulation", "start": 137, "end": 138}, {"id": "T88", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 139, "end": 142}, {"id": "T24", "text": "mutant VHL cell lines", "entity_type": "Cell", "start": 145, "end": 149}, {"id": "T90", "text": "VHL", "entity_type": "Gene_or_gene_product", "start": 146, "end": 147}, {"id": "T92", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 154, "end": 157}, {"id": "T91", "text": "regulated", "entity_type": "Regulation", "start": 159, "end": 160}, {"id": "T93", "text": "VHL", "entity_type": "Gene_or_gene_product", "start": 161, "end": 162}, {"id": "T17", "text": "up-regulation", "entity_type": "Positive_regulation", "start": 164, "end": 167}, {"id": "T94", "text": "clear cell carcinomas", "entity_type": "Pathological_formation", "start": 181, "end": 184}, {"id": "T18", "text": "regulating", "entity_type": "Regulation", "start": 185, "end": 186}, {"id": "T96", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 186, "end": 187}, {"id": "T97", "text": "lymphangiogenesis", "entity_type": "Blood_vessel_development", "start": 190, "end": 191}, {"id": "T98", "text": "clear cell tumors", "entity_type": "Pathological_formation", "start": 196, "end": 199}, {"id": "T100", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 205, "end": 206}, {"id": "T21", "text": "chromophil", "entity_type": "Pathological_formation", "start": 212, "end": 213}, {"id": "T95", "text": "papillary", "entity_type": "Pathological_formation", "start": 214, "end": 215}, {"id": "T101", "text": "clear cell tumors", "entity_type": "Pathological_formation", "start": 218, "end": 221}, {"id": "T102", "text": "VHL", "entity_type": "Gene_or_gene_product", "start": 226, "end": 227}, {"id": "T22", "text": "regulate", "entity_type": "Regulation", "start": 228, "end": 229}, {"id": "T104", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 229, "end": 230}, {"id": "T105", "text": "VEGFR1", "entity_type": "Gene_or_gene_product", "start": 248, "end": 249}, {"id": "T106", "text": "flt-l", "entity_type": "Gene_or_gene_product", "start": 250, "end": 253}, {"id": "T107", "text": "tumor", "entity_type": "Pathological_formation", "start": 260, "end": 261}], "lang": "en"}
{"doc_id": "PMID-11425277", "wnd_id": "PMID-11425277_0", "text": "Current prospects for controlling cancer growth with non-cytotoxic agents--nutrients, phytochemicals, herbal extracts, and available drugs.\n\nIn animal or cell culture studies, the growth and spread of cancer can be slowed by many nutrients, food factors, herbal extracts, and well-tolerated, available drugs that are still rarely used in the clinical management of cancer, in part because they seem unlikely to constitute definitive therapies in themselves. However, it is reasonable to expect that mechanistically complementary combinations of these measures could have a worthwhile impact on survival times and, when used as adjuvants, could improve the cure rates achievable with standard therapies. The therapeutic options available in this regard include measures that: down-regulate serum free IGF-I; suppress the synthesis of mevalonic acid and/or certain derivatives thereof; modulate arachidonate metabolism by inhibiting 5-lipoxygenase, 12-lipoxygenase, or COX-2; antagonize the activation of AP-1 transcription factors; promote the activation of PPAR-gamma transcription factors; and that suppress angiogenesis by additional mechanisms. Many of these measures appear suitable for use in cancer prevention.", "tokens": ["Current", "prospects", "for", "controlling", "cancer", "growth", "with", "non-cytotoxic", "agents", "--", "nutrients", ",", "phytochemicals", ",", "herbal", "extracts", ",", "and", "available", "drugs", ".", "In", "animal", "or", "cell", "culture", "studies", ",", "the", "growth", "and", "spread", "of", "cancer", "can", "be", "slowed", "by", "many", "nutrients", ",", "food", "factors", ",", "herbal", "extracts", ",", "and", "well", "-", "tolerated", ",", "available", "drugs", "that", "are", "still", "rarely", "used", "in", "the", "clinical", "management", "of", "cancer", ",", "in", "part", "because", "they", "seem", "unlikely", "to", "constitute", "definitive", "therapies", "in", "themselves", ".", "However", ",", "it", "is", "reasonable", "to", "expect", "that", "mechanistically", "complementary", "combinations", "of", "these", "measures", "could", "have", "a", "worthwhile", "impact", "on", "survival", "times", "and", ",", "when", "used", "as", "adjuvants", ",", "could", "improve", "the", "cure", "rates", "achievable", "with", "standard", "therapies", ".", "The", "therapeutic", "options", "available", "in", "this", "regard", "include", "measures", "that", ":", "down", "-", "regulate", "serum", "free", "IGF", "-", "I", ";", "suppress", "the", "synthesis", "of", "mevalonic", "acid", "and", "/", "or", "certain", "derivatives", "thereof", ";", "modulate", "arachidonate", "metabolism", "by", "inhibiting", "5", "-", "lipoxygenase", ",", "12", "-", "lipoxygenase", ",", "or", "COX", "-", "2", ";", "antagonize", "the", "activation", "of", "AP", "-", "1", "transcription", "factors", ";", "promote", "the", "activation", "of", "PPAR", "-", "gamma", "transcription", "factors", ";", "and", "that", "suppress", "angiogenesis", "by", "additional", "mechanisms", ".", "Many", "of", "these", "measures", "appear", "suitable", "for", "use", "in", "cancer", "prevention", "."], "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "controlling", "start": 3, "end": 4}, "arguments": []}, {"id": "E2", "event_type": "Growth", "trigger": {"text": "growth", "start": 5, "end": 6}, "arguments": [{"entity_id": "T3", "role": "Theme", "text": "cancer", "start": 4, "end": 5}]}, {"id": "E17", "event_type": "Planned_process", "trigger": {"text": "culture", "start": 25, "end": 26}, "arguments": [{"entity_id": "T32", "role": "Theme", "text": "cell", "start": 24, "end": 25}]}, {"id": "E5", "event_type": "Growth", "trigger": {"text": "growth", "start": 29, "end": 30}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "cancer", "start": 33, "end": 34}]}, {"id": "E4", "event_type": "Localization", "trigger": {"text": "spread", "start": 31, "end": 32}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "cancer", "start": 33, "end": 34}]}, {"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "slowed", "start": 36, "end": 37}, "arguments": []}, {"id": "E6", "event_type": "Negative_regulation", "trigger": {"text": "slowed", "start": 36, "end": 37}, "arguments": []}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "down-regulate", "start": 129, "end": 132}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "IGF-I", "start": 134, "end": 137}]}, {"id": "E10", "event_type": "Negative_regulation", "trigger": {"text": "suppress", "start": 138, "end": 139}, "arguments": []}, {"id": "E7", "event_type": "Synthesis", "trigger": {"text": "synthesis", "start": 140, "end": 141}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "mevalonic acid", "start": 142, "end": 144}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "modulate", "start": 151, "end": 152}, "arguments": []}, {"id": "E9", "event_type": "Metabolism", "trigger": {"text": "metabolism", "start": 153, "end": 154}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "arachidonate", "start": 152, "end": 153}]}, {"id": "E16", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 155, "end": 156}, "arguments": [{"entity_id": "T17", "role": "Theme", "text": "5-lipoxygenase", "start": 156, "end": 159}]}, {"id": "E11", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 155, "end": 156}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "12-lipoxygenase", "start": 160, "end": 163}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 155, "end": 156}, "arguments": [{"entity_id": "T19", "role": "Theme", "text": "COX-2", "start": 165, "end": 168}]}, {"id": "E20", "event_type": "Negative_regulation", "trigger": {"text": "antagonize", "start": 169, "end": 170}, "arguments": []}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 171, "end": 172}, "arguments": [{"entity_id": "T24", "role": "Theme", "text": "AP-1", "start": 173, "end": 176}]}, {"id": "E25", "event_type": "Positive_regulation", "trigger": {"text": "promote", "start": 179, "end": 180}, "arguments": []}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 181, "end": 182}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "PPAR-gamma", "start": 183, "end": 186}]}, {"id": "E15", "event_type": "Negative_regulation", "trigger": {"text": "suppress", "start": 191, "end": 192}, "arguments": []}, {"id": "E18", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 192, "end": 193}, "arguments": []}, {"id": "E30", "event_type": "Negative_regulation", "trigger": {"text": "prevention", "start": 207, "end": 208}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "cancer", "start": 206, "end": 207}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "controlling", "entity_type": "Regulation", "start": 3, "end": 4}, {"id": "T3", "text": "cancer", "entity_type": "Pathological_formation", "start": 4, "end": 5}, {"id": "T2", "text": "growth", "entity_type": "Growth", "start": 5, "end": 6}, {"id": "T32", "text": "cell", "entity_type": "Cell", "start": 24, "end": 25}, {"id": "T33", "text": "culture", "entity_type": "Planned_process", "start": 25, "end": 26}, {"id": "T5", "text": "growth", "entity_type": "Growth", "start": 29, "end": 30}, {"id": "T4", "text": "spread", "entity_type": "Localization", "start": 31, "end": 32}, {"id": "T6", "text": "cancer", "entity_type": "Pathological_formation", "start": 33, "end": 34}, {"id": "T21", "text": "slowed", "entity_type": "Negative_regulation", "start": 36, "end": 37}, {"id": "T7", "text": "cancer", "entity_type": "Pathological_formation", "start": 64, "end": 65}, {"id": "T8", "text": "down-regulate", "entity_type": "Negative_regulation", "start": 129, "end": 132}, {"id": "T9", "text": "IGF-I", "entity_type": "Gene_or_gene_product", "start": 134, "end": 137}, {"id": "T10", "text": "suppress", "entity_type": "Negative_regulation", "start": 138, "end": 139}, {"id": "T23", "text": "synthesis", "entity_type": "Synthesis", "start": 140, "end": 141}, {"id": "T11", "text": "mevalonic acid", "entity_type": "Drug_or_compound", "start": 142, "end": 144}, {"id": "T12", "text": "modulate", "entity_type": "Regulation", "start": 151, "end": 152}, {"id": "T26", "text": "arachidonate", "entity_type": "Drug_or_compound", "start": 152, "end": 153}, {"id": "T28", "text": "metabolism", "entity_type": "Metabolism", "start": 153, "end": 154}, {"id": "T16", "text": "inhibiting", "entity_type": "Negative_regulation", "start": 155, "end": 156}, {"id": "T17", "text": "5-lipoxygenase", "entity_type": "Gene_or_gene_product", "start": 156, "end": 159}, {"id": "T18", "text": "12-lipoxygenase", "entity_type": "Gene_or_gene_product", "start": 160, "end": 163}, {"id": "T19", "text": "COX-2", "entity_type": "Gene_or_gene_product", "start": 165, "end": 168}, {"id": "T20", "text": "antagonize", "entity_type": "Negative_regulation", "start": 169, "end": 170}, {"id": "T22", "text": "activation", "entity_type": "Positive_regulation", "start": 171, "end": 172}, {"id": "T24", "text": "AP-1", "entity_type": "Gene_or_gene_product", "start": 173, "end": 176}, {"id": "T25", "text": "promote", "entity_type": "Positive_regulation", "start": 179, "end": 180}, {"id": "T14", "text": "activation", "entity_type": "Positive_regulation", "start": 181, "end": 182}, {"id": "T27", "text": "PPAR-gamma", "entity_type": "Gene_or_gene_product", "start": 183, "end": 186}, {"id": "T15", "text": "suppress", "entity_type": "Negative_regulation", "start": 191, "end": 192}, {"id": "T29", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 192, "end": 193}, {"id": "T31", "text": "cancer", "entity_type": "Pathological_formation", "start": 206, "end": 207}, {"id": "T30", "text": "prevention", "entity_type": "Negative_regulation", "start": 207, "end": 208}], "lang": "en"}
{"doc_id": "PMID-11815955", "wnd_id": "PMID-11815955_0", "text": "Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.\n\nBACKGROUND: Endostatin, a C-terminal fragment of collagen XVIII, is an endogenous angiogenesis inhibitor. While endostatin is being investigated for its usefulness in treating solid tumors, its significance in hematologic malignancies is unknown. METHODS: The authors evaluated plasma endostatin (PE) levels using an enzyme linked immunoassay in 71 patients with acute myeloid leukemia (AML) and 43 patients with myelodysplastic syndrome (MDS), and correlated PE with various clinical parameters. RESULTS: There was no significant difference in the median PE level between AML/MDS patients and the normal controls. Nevertheless, patients who achieved complete remission (CR) had a significantly lower median PE level compared to those who did not. In multivariate analysis, PE was found to be a significant (P = 0.03) predictor of overall survival (OS) with adjustment of the other baseline covariates, including patient age, history of antecedent hematologic disorders, and the use of protective environments. The prognostic value of PE was also evaluated by dividing MDS/AML patients into high and low PE groups using the median PE level of normal controls as the cut-off. The authors found that patients in the high PE group survived for a significantly shorter time than those patients in the low PE group. CONCLUSIONS: PE is a useful prognostic predictor of CR and OS for AML/MDS patients. The mechanism underlying the association between high PE and poor clinical outcome is unclear, although it may be related to the possible PE reflection of tumor burden.", "tokens": ["Clinical", "significance", "of", "plasma", "endostatin", "in", "acute", "myeloid", "leukemia", "/", "myelodysplastic", "syndrome", ".", "BACKGROUND", ":", "Endostatin", ",", "a", "C-", "terminal", "fragment", "of", "collagen", "XVIII", ",", "is", "an", "endogenous", "angiogenesis", "inhibitor", ".", "While", "endostatin", "is", "being", "investigated", "for", "its", "usefulness", "in", "treating", "solid", "tumors", ",", "its", "significance", "in", "hematologic", "malignancies", "is", "unknown", ".", "METHODS", ":", "The", "authors", "evaluated", "plasma", "endostatin", "(", "PE", ")", "levels", "using", "an", "enzyme", "linked", "immunoassay", "in", "71", "patients", "with", "acute", "myeloid", "leukemia", "(", "AML", ")", "and", "43", "patients", "with", "myelodysplastic", "syndrome", "(", "MDS", ")", ",", "and", "correlated", "PE", "with", "various", "clinical", "parameters", ".", "RESULTS", ":", "There", "was", "no", "significant", "difference", "in", "the", "median", "PE", "level", "between", "AML", "/", "MDS", "patients", "and", "the", "normal", "controls", ".", "Nevertheless", ",", "patients", "who", "achieved", "complete", "remission", "(", "CR", ")", "had", "a", "significantly", "lower", "median", "PE", "level", "compared", "to", "those", "who", "did", "not", ".", "In", "multivariate", "analysis", ",", "PE", "was", "found", "to", "be", "a", "significant", "(", "P", "=", "0.03", ")", "predictor", "of", "overall", "survival", "(", "OS", ")", "with", "adjustment", "of", "the", "other", "baseline", "covariates", ",", "including", "patient", "age", ",", "history", "of", "antecedent", "hematologic", "disorders", ",", "and", "the", "use", "of", "protective", "environments", ".", "The", "prognostic", "value", "of", "PE", "was", "also", "evaluated", "by", "dividing", "MDS", "/", "AML", "patients", "into", "high", "and", "low", "PE", "groups", "using", "the", "median", "PE", "level", "of", "normal", "controls", "as", "the", "cut", "-", "off", ".", "The", "authors", "found", "that", "patients", "in", "the", "high", "PE", "group", "survived", "for", "a", "significantly", "shorter", "time", "than", "those", "patients", "in", "the", "low", "PE", "group", ".", "CONCLUSIONS", ":", "PE", "is", "a", "useful", "prognostic", "predictor", "of", "CR", "and", "OS", "for", "AML", "/", "MDS", "patients", ".", "The", "mechanism", "underlying", "the", "association", "between", "high", "PE", "and", "poor", "clinical", "outcome", "is", "unclear", ",", "although", "it", "may", "be", "related", "to", "the", "possible", "PE", "reflection", "of", "tumor", "burden", "."], "event_mentions": [{"id": "E5", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 28, "end": 29}, "arguments": []}, {"id": "E1", "event_type": "Planned_process", "trigger": {"text": "treating", "start": 40, "end": 41}, "arguments": [{"entity_id": "T6", "role": "Instrument", "text": "endostatin", "start": 32, "end": 33}, {"entity_id": "T7", "role": "Theme", "text": "solid tumors", "start": 41, "end": 43}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "enzyme linked immunoassay", "start": 65, "end": 68}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "plasma endostatin", "start": 57, "end": 59}, {"entity_id": "T10", "role": "Theme", "text": "PE", "start": 60, "end": 61}]}, {"id": "E4", "event_type": "Death", "trigger": {"text": "survived", "start": 234, "end": 235}, "arguments": [{"entity_id": "T1006", "role": "Theme", "text": "patients", "start": 228, "end": 229}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "plasma endostatin", "entity_type": "Gene_or_gene_product", "start": 3, "end": 5}, {"id": "T2", "text": "Endostatin", "entity_type": "Gene_or_gene_product", "start": 15, "end": 16}, {"id": "T3", "text": "collagen XVIII", "entity_type": "Gene_or_gene_product", "start": 22, "end": 24}, {"id": "T4", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 28, "end": 29}, {"id": "T6", "text": "endostatin", "entity_type": "Gene_or_gene_product", "start": 32, "end": 33}, {"id": "T5", "text": "treating", "entity_type": "Planned_process", "start": 40, "end": 41}, {"id": "T7", "text": "solid tumors", "entity_type": "Pathological_formation", "start": 41, "end": 43}, {"id": "T9", "text": "plasma endostatin", "entity_type": "Gene_or_gene_product", "start": 57, "end": 59}, {"id": "T10", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 60, "end": 61}, {"id": "T24", "text": "enzyme linked immunoassay", "entity_type": "Planned_process", "start": 65, "end": 68}, {"id": "T1000", "text": "patients", "entity_type": "Organism", "start": 70, "end": 71}, {"id": "T1001", "text": "patients", "entity_type": "Organism", "start": 80, "end": 81}, {"id": "T11", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 90, "end": 91}, {"id": "T12", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 106, "end": 107}, {"id": "T1002", "text": "patients", "entity_type": "Organism", "start": 112, "end": 113}, {"id": "T1003", "text": "patients", "entity_type": "Organism", "start": 120, "end": 121}, {"id": "T13", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 133, "end": 134}, {"id": "T14", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 146, "end": 147}, {"id": "T1004", "text": "patient", "entity_type": "Organism", "start": 174, "end": 175}, {"id": "T15", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 194, "end": 195}, {"id": "T1005", "text": "patients", "entity_type": "Organism", "start": 203, "end": 204}, {"id": "T16", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 208, "end": 209}, {"id": "T17", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 213, "end": 214}, {"id": "T1006", "text": "patients", "entity_type": "Organism", "start": 228, "end": 229}, {"id": "T18", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 232, "end": 233}, {"id": "T25", "text": "survived", "entity_type": "Death", "start": 234, "end": 235}, {"id": "T1007", "text": "patients", "entity_type": "Organism", "start": 242, "end": 243}, {"id": "T19", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 246, "end": 247}, {"id": "T20", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 251, "end": 252}, {"id": "T1008", "text": "patients", "entity_type": "Organism", "start": 265, "end": 266}, {"id": "T21", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 274, "end": 275}, {"id": "T22", "text": "PE", "entity_type": "Gene_or_gene_product", "start": 290, "end": 291}, {"id": "T23", "text": "tumor", "entity_type": "Pathological_formation", "start": 293, "end": 294}], "lang": "en"}
{"doc_id": "PMID-11912515", "wnd_id": "PMID-11912515_0", "text": "Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma.\n\nBACKGROUND: Angiogenesis is essential for tumor growth and relies on the production of angiogenic factors. Vascular endothelial growth factor (VEGF) is a major regulator of angiogenesis that binds to tyrosine kinase receptors Flt-1 and KDR. The interaction of VEGF and its receptors at gene and protein levels in neuroblastoma remains widely unknown. METHODS: Tumor biopsy specimens and serum were obtained from 37 neuroblastoma patients; adrenal biopsy sections and sera of 7 normal children served as controls. Biopsy specimens were examined by real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blotting; serum was analyzed by enzyme-linked immunosorbent assay (ELISA). VEGF-A(165), B, C, Flt-1, and KDR were analyzed. RESULTS: VEGF isoforms and its receptors' mRNA were expressed in neuroblastoma and control tissues. Whereas the ligands were increased in stages III and IV, the receptors were upregulated in stage III only. At protein level, VEGF-B and C, Flt-1, and KDR were not detectable in tissue lysates, whereas VEGF-A was increased in stages III and IV. Serum VEGF protein levels were upregulated in stage III. CONCLUSIONS: VEGF-A(165) is one of the major angiogenesis regulators among the ligands' family of VEGF, whereas its receptors KDR, and most probably Flt-1, may contribute to a poor prognosis (angiogenic) phenotype, as indicated by their upregulated MRNA levels in stage III neuroblastoma. VEGF-A(165) mainly contributes to increased serum VEGF levels and may serve as a diagnostic tool in advanced-stage neuroblastoma.", "tokens": ["Upregulation", "of", "vascular", "endothelial", "growth", "factor", "receptors", "is", "associated", "with", "advanced", "neuroblastoma", ".", "BACKGROUND", ":", "Angiogenesis", "is", "essential", "for", "tumor", "growth", "and", "relies", "on", "the", "production", "of", "angiogenic", "factors", ".", "Vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", "is", "a", "major", "regulator", "of", "angiogenesis", "that", "binds", "to", "tyrosine", "kinase", "receptors", "Flt", "-", "1", "and", "KDR", ".", "The", "interaction", "of", "VEGF", "and", "its", "receptors", "at", "gene", "and", "protein", "levels", "in", "neuroblastoma", "remains", "widely", "unknown", ".", "METHODS", ":", "Tumor", "biopsy", "specimens", "and", "serum", "were", "obtained", "from", "37", "neuroblastoma", "patients", ";", "adrenal", "biopsy", "sections", "and", "sera", "of", "7", "normal", "children", "served", "as", "controls", ".", "Biopsy", "specimens", "were", "examined", "by", "real", "-", "time", "reverse", "transcription", "polymerase", "chain", "reaction", "(", "RT", "-", "PCR", ")", "and", "Western", "blotting", ";", "serum", "was", "analyzed", "by", "enzyme", "-", "linked", "immunosorbent", "assay", "(", "ELISA", ")", ".", "VEGF", "-", "A", "(", "165", ")", ",", "B", ",", "C", ",", "Flt", "-", "1", ",", "and", "KDR", "were", "analyzed", ".", "RESULTS", ":", "VEGF", "isoforms", "and", "its", "receptors", "'", "mRNA", "were", "expressed", "in", "neuroblastoma", "and", "control", "tissues", ".", "Whereas", "the", "ligands", "were", "increased", "in", "stages", "III", "and", "IV", ",", "the", "receptors", "were", "upregulated", "in", "stage", "III", "only", ".", "At", "protein", "level", ",", "VEGF", "-", "B", "and", "C", ",", "Flt", "-", "1", ",", "and", "KDR", "were", "not", "detectable", "in", "tissue", "lysates", ",", "whereas", "VEGF", "-", "A", "was", "increased", "in", "stages", "III", "and", "IV", ".", "Serum", "VEGF", "protein", "levels", "were", "upregulated", "in", "stage", "III", ".", "CONCLUSIONS", ":", "VEGF", "-", "A", "(", "165", ")", "is", "one", "of", "the", "major", "angiogenesis", "regulators", "among", "the", "ligands", "'", "family", "of", "VEGF", ",", "whereas", "its", "receptors", "KDR", ",", "and", "most", "probably", "Flt", "-", "1", ",", "may", "contribute", "to", "a", "poor", "prognosis", "(", "angiogenic", ")", "phenotype", ",", "as", "indicated", "by", "their", "upregulated", "MRNA", "levels", "in", "stage", "III", "neuroblastoma", ".", "VEGF", "-", "A", "(", "165", ")", "mainly", "contributes", "to", "increased", "serum", "VEGF", "levels", "and", "may", "serve", "as", "a", "diagnostic", "tool", "in", "advanced", "-", "stage", "neuroblastoma", "."], "event_mentions": [{"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "Upregulation", "start": 0, "end": 1}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "vascular endothelial growth factor receptors", "start": 2, "end": 7}]}, {"id": "E7", "event_type": "Blood_vessel_development", "trigger": {"text": "Angiogenesis", "start": 15, "end": 16}, "arguments": []}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "essential", "start": 17, "end": 18}, "arguments": []}, {"id": "E4", "event_type": "Growth", "trigger": {"text": "growth", "start": 20, "end": 21}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "tumor", "start": 19, "end": 20}]}, {"id": "E6", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 27, "end": 28}, "arguments": []}, {"id": "E18", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 42, "end": 43}, "arguments": []}, {"id": "E3", "event_type": "Binding", "trigger": {"text": "binds", "start": 44, "end": 45}, "arguments": [{"entity_id": "T8", "role": "Theme", "text": "Vascular endothelial growth factor", "start": 30, "end": 34}, {"entity_id": "T9", "role": "Theme", "text": "VEGF", "start": 35, "end": 36}, {"entity_id": "T12", "role": "Theme", "text": "Flt-1", "start": 49, "end": 52}]}, {"id": "E5", "event_type": "Binding", "trigger": {"text": "binds", "start": 44, "end": 45}, "arguments": [{"entity_id": "T8", "role": "Theme", "text": "Vascular endothelial growth factor", "start": 30, "end": 34}, {"entity_id": "T9", "role": "Theme", "text": "VEGF", "start": 35, "end": 36}, {"entity_id": "T13", "role": "Theme", "text": "KDR", "start": 53, "end": 54}]}, {"id": "E14", "event_type": "Binding", "trigger": {"text": "interaction", "start": 56, "end": 57}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "VEGF", "start": 58, "end": 59}]}, {"id": "E8", "event_type": "Transcription", "trigger": {"text": "expressed", "start": 165, "end": 166}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "VEGF", "start": 157, "end": 158}]}, {"id": "E9", "event_type": "Gene_expression", "trigger": {"text": "detectable", "start": 210, "end": 211}, "arguments": [{"entity_id": "T32", "role": "Theme", "text": "KDR", "start": 207, "end": 208}]}, {"id": "E10", "event_type": "Gene_expression", "trigger": {"text": "detectable", "start": 210, "end": 211}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "Flt-1", "start": 202, "end": 205}]}, {"id": "E11", "event_type": "Gene_expression", "trigger": {"text": "detectable", "start": 210, "end": 211}, "arguments": [{"entity_id": "T29", "role": "Theme", "text": "C", "start": 200, "end": 201}]}, {"id": "E12", "event_type": "Gene_expression", "trigger": {"text": "detectable", "start": 210, "end": 211}, "arguments": [{"entity_id": "T30", "role": "Theme", "text": "VEGF-B", "start": 196, "end": 199}]}, {"id": "E15", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 220, "end": 221}, "arguments": [{"entity_id": "T33", "role": "Theme", "text": "VEGF-A", "start": 216, "end": 219}]}, {"id": "E13", "event_type": "Gene_expression", "trigger": {"text": "protein levels", "start": 229, "end": 231}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "VEGF", "start": 228, "end": 229}]}, {"id": "E34", "event_type": "Positive_regulation", "trigger": {"text": "upregulated", "start": 232, "end": 233}, "arguments": []}, {"id": "E20", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 250, "end": 251}, "arguments": []}, {"id": "E19", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 279, "end": 280}, "arguments": []}, {"id": "E17", "event_type": "Regulation", "trigger": {"text": "contributes", "start": 302, "end": 303}, "arguments": [{"entity_id": "T43", "role": "Cause", "text": "VEGF-A(165)", "start": 295, "end": 301}]}, {"id": "E16", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 304, "end": 305}, "arguments": [{"entity_id": "T45", "role": "Theme", "text": "VEGF", "start": 306, "end": 307}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T29", "role": "Arg1", "text": "C", "start": 200, "end": 201}, {"entity_id": "T29", "role": "Arg1", "text": "C", "start": 200, "end": 201}]}, {"id": "R2", "relation_type": "frag", "arguments": [{"entity_id": "T23", "role": "Arg1", "text": "B", "start": 142, "end": 143}, {"entity_id": "T23", "role": "Arg1", "text": "B", "start": 142, "end": 143}]}, {"id": "R3", "relation_type": "frag", "arguments": [{"entity_id": "T22", "role": "Arg1", "text": "C", "start": 144, "end": 145}, {"entity_id": "T22", "role": "Arg1", "text": "C", "start": 144, "end": 145}]}], "entity_mentions": [{"id": "T1", "text": "Upregulation", "entity_type": "Positive_regulation", "start": 0, "end": 1}, {"id": "T2", "text": "vascular endothelial growth factor receptors", "entity_type": "Gene_or_gene_product", "start": 2, "end": 7}, {"id": "T3", "text": "Angiogenesis", "entity_type": "Blood_vessel_development", "start": 15, "end": 16}, {"id": "T6", "text": "essential", "entity_type": "Positive_regulation", "start": 17, "end": 18}, {"id": "T5", "text": "tumor", "entity_type": "Pathological_formation", "start": 19, "end": 20}, {"id": "T4", "text": "growth", "entity_type": "Growth", "start": 20, "end": 21}, {"id": "T7", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 27, "end": 28}, {"id": "T8", "text": "Vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 30, "end": 34}, {"id": "T9", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 35, "end": 36}, {"id": "T10", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 42, "end": 43}, {"id": "T11", "text": "binds", "entity_type": "Binding", "start": 44, "end": 45}, {"id": "T12", "text": "Flt-1", "entity_type": "Gene_or_gene_product", "start": 49, "end": 52}, {"id": "T13", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 53, "end": 54}, {"id": "T14", "text": "interaction", "entity_type": "Binding", "start": 56, "end": 57}, {"id": "T15", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 58, "end": 59}, {"id": "T16", "text": "neuroblastoma", "entity_type": "Pathological_formation", "start": 68, "end": 69}, {"id": "T17", "text": "Tumor biopsy specimens", "entity_type": "Multi-tissue_structure", "start": 75, "end": 78}, {"id": "T18", "text": "serum", "entity_type": "Organism_substance", "start": 79, "end": 80}, {"id": "T42", "text": "neuroblastoma", "entity_type": "Pathological_formation", "start": 84, "end": 85}, {"id": "T1000", "text": "patients", "entity_type": "Organism", "start": 85, "end": 86}, {"id": "T19", "text": "adrenal biopsy sections", "entity_type": "Multi-tissue_structure", "start": 87, "end": 90}, {"id": "T20", "text": "sera", "entity_type": "Organism_substance", "start": 91, "end": 92}, {"id": "T1001", "text": "children", "entity_type": "Organism", "start": 95, "end": 96}, {"id": "T38", "text": "Biopsy specimens", "entity_type": "Multi-tissue_structure", "start": 100, "end": 102}, {"id": "T21", "text": "serum", "entity_type": "Organism_substance", "start": 122, "end": 123}, {"id": "T24", "text": "VEGF-A(165)", "entity_type": "Gene_or_gene_product", "start": 135, "end": 141}, {"id": "T23", "text": "B", "entity_type": "Gene_or_gene_product", "start": 142, "end": 143}, {"id": "T22", "text": "C", "entity_type": "Gene_or_gene_product", "start": 144, "end": 145}, {"id": "T25", "text": "Flt-1", "entity_type": "Gene_or_gene_product", "start": 146, "end": 149}, {"id": "T26", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 151, "end": 152}, {"id": "T28", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 157, "end": 158}, {"id": "T47", "text": "expressed", "entity_type": "Transcription", "start": 165, "end": 166}, {"id": "T57", "text": "neuroblastoma", "entity_type": "Pathological_formation", "start": 167, "end": 168}, {"id": "T58", "text": "tissues", "entity_type": "Tissue", "start": 170, "end": 171}, {"id": "T30", "text": "VEGF-B", "entity_type": "Gene_or_gene_product", "start": 196, "end": 199}, {"id": "T29", "text": "C", "entity_type": "Gene_or_gene_product", "start": 200, "end": 201}, {"id": "T31", "text": "Flt-1", "entity_type": "Gene_or_gene_product", "start": 202, "end": 205}, {"id": "T32", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 207, "end": 208}, {"id": "T49", "text": "detectable", "entity_type": "Gene_expression", "start": 210, "end": 211}, {"id": "T46", "text": "tissue lysates", "entity_type": "Organism_substance", "start": 212, "end": 214}, {"id": "T33", "text": "VEGF-A", "entity_type": "Gene_or_gene_product", "start": 216, "end": 219}, {"id": "T27", "text": "increased", "entity_type": "Positive_regulation", "start": 220, "end": 221}, {"id": "T35", "text": "Serum", "entity_type": "Organism_substance", "start": 227, "end": 228}, {"id": "T36", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 228, "end": 229}, {"id": "T48", "text": "protein levels", "entity_type": "Gene_expression", "start": 229, "end": 231}, {"id": "T34", "text": "upregulated", "entity_type": "Positive_regulation", "start": 232, "end": 233}, {"id": "T37", "text": "VEGF-A(165)", "entity_type": "Gene_or_gene_product", "start": 239, "end": 245}, {"id": "T56", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 250, "end": 251}, {"id": "T39", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 258, "end": 259}, {"id": "T40", "text": "KDR", "entity_type": "Gene_or_gene_product", "start": 263, "end": 264}, {"id": "T41", "text": "Flt-1", "entity_type": "Gene_or_gene_product", "start": 268, "end": 271}, {"id": "T52", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 279, "end": 280}, {"id": "T53", "text": "stage III neuroblastoma", "entity_type": "Pathological_formation", "start": 291, "end": 294}, {"id": "T43", "text": "VEGF-A(165)", "entity_type": "Gene_or_gene_product", "start": 295, "end": 301}, {"id": "T55", "text": "contributes", "entity_type": "Regulation", "start": 302, "end": 303}, {"id": "T54", "text": "increased", "entity_type": "Positive_regulation", "start": 304, "end": 305}, {"id": "T44", "text": "serum", "entity_type": "Organism_substance", "start": 305, "end": 306}, {"id": "T45", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 306, "end": 307}], "lang": "en"}
{"doc_id": "PMID-12567143", "wnd_id": "PMID-12567143_0", "text": "Postoperative progression of pulmonary metastasis in osteosarcoma.\n\nEarly relapse with distant metastasis often is observed in patients with cancer after resection of the primary tumor. It is considered that resection of the primary tumor induces activation of systemic angiogenesis and enhances progression of remote metastasis. The authors show that resection of the primary osteosarcoma tumor enhances progression of pulmonary metastasis in animal osteosarcoma models. Matrigel plug neovascularization assay revealed that systemic angiogenic activity was elevated after primary tumor removal (tumor intact group, 1.61 +/- 0.21 g/dL; tumor removed group, 4.92 +/- 0.35 g/dL). In addition, serum concentration of the angiogenesis inhibitor, endostatin, decreased significantly after primary tumor removal. Treatment with the antiangiogenic reagent TNP-470 suppressed postoperative progression of pulmonary metastasis. These results indicate the possibility that activation of angiogenic activity after resection of osteosarcoma tumors enhances progression of pulmonary metastasis. The current data also suggest that administration of antiangiogenic reagents can prevent progression of pulmonary metastasis in osteosarcoma postoperatively.", "tokens": ["Postoperative", "progression", "of", "pulmonary", "metastasis", "in", "osteosarcoma", ".", "Early", "relapse", "with", "distant", "metastasis", "often", "is", "observed", "in", "patients", "with", "cancer", "after", "resection", "of", "the", "primary", "tumor", ".", "It", "is", "considered", "that", "resection", "of", "the", "primary", "tumor", "induces", "activation", "of", "systemic", "angiogenesis", "and", "enhances", "progression", "of", "remote", "metastasis", ".", "The", "authors", "show", "that", "resection", "of", "the", "primary", "osteosarcoma", "tumor", "enhances", "progression", "of", "pulmonary", "metastasis", "in", "animal", "osteosarcoma", "models", ".", "Matrigel", "plug", "neovascularization", "assay", "revealed", "that", "systemic", "angiogenic", "activity", "was", "elevated", "after", "primary", "tumor", "removal", "(", "tumor", "intact", "group", ",", "1.61", "+/-", "0.21", "g/dL", ";", "tumor", "removed", "group", ",", "4.92", "+/-", "0.35", "g/dL", ")", ".", "In", "addition", ",", "serum", "concentration", "of", "the", "angiogenesis", "inhibitor", ",", "endostatin", ",", "decreased", "significantly", "after", "primary", "tumor", "removal", ".", "Treatment", "with", "the", "antiangiogenic", "reagent", "TNP", "-", "470", "suppressed", "postoperative", "progression", "of", "pulmonary", "metastasis", ".", "These", "results", "indicate", "the", "possibility", "that", "activation", "of", "angiogenic", "activity", "after", "resection", "of", "osteosarcoma", "tumors", "enhances", "progression", "of", "pulmonary", "metastasis", ".", "The", "current", "data", "also", "suggest", "that", "administration", "of", "antiangiogenic", "reagents", "can", "prevent", "progression", "of", "pulmonary", "metastasis", "in", "osteosarcoma", "postoperatively", "."], "event_mentions": [{"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "progression", "start": 1, "end": 2}, "arguments": []}, {"id": "E34", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 4, "end": 5}, "arguments": [{"entity_id": "T20", "role": "ToLoc", "text": "pulmonary", "start": 3, "end": 4}, {"entity_id": "T21", "role": "Theme", "text": "osteosarcoma", "start": 6, "end": 7}]}, {"id": "E35", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 12, "end": 13}, "arguments": [{"entity_id": "T1", "role": "Theme", "text": "tumor", "start": 25, "end": 26}]}, {"id": "E4", "event_type": "Planned_process", "trigger": {"text": "resection", "start": 21, "end": 22}, "arguments": [{"entity_id": "T1", "role": "Theme", "text": "tumor", "start": 25, "end": 26}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "resection", "start": 31, "end": 32}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "tumor", "start": 35, "end": 36}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 36, "end": 37}, "arguments": []}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 37, "end": 38}, "arguments": []}, {"id": "E23", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 40, "end": 41}, "arguments": []}, {"id": "E8", "event_type": "Positive_regulation", "trigger": {"text": "enhances", "start": 42, "end": 43}, "arguments": []}, {"id": "E7", "event_type": "Positive_regulation", "trigger": {"text": "progression", "start": 43, "end": 44}, "arguments": []}, {"id": "E36", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 46, "end": 47}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "tumor", "start": 35, "end": 36}]}, {"id": "E9", "event_type": "Planned_process", "trigger": {"text": "resection", "start": 52, "end": 53}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "osteosarcoma tumor", "start": 56, "end": 58}]}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "enhances", "start": 58, "end": 59}, "arguments": []}, {"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "progression", "start": 59, "end": 60}, "arguments": []}, {"id": "E37", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 62, "end": 63}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "osteosarcoma tumor", "start": 56, "end": 58}, {"entity_id": "T23", "role": "ToLoc", "text": "pulmonary", "start": 61, "end": 62}]}, {"id": "E24", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 70, "end": 71}, "arguments": []}, {"id": "E25", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 75, "end": 76}, "arguments": []}, {"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "elevated", "start": 78, "end": 79}, "arguments": []}, {"id": "E13", "event_type": "Planned_process", "trigger": {"text": "removal", "start": 82, "end": 83}, "arguments": [{"entity_id": "T7", "role": "Theme", "text": "tumor", "start": 81, "end": 82}]}, {"id": "E26", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 110, "end": 111}, "arguments": []}, {"id": "E10", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 115, "end": 116}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "endostatin", "start": 113, "end": 114}]}, {"id": "E14", "event_type": "Planned_process", "trigger": {"text": "removal", "start": 120, "end": 121}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "tumor", "start": 119, "end": 120}]}, {"id": "E15", "event_type": "Planned_process", "trigger": {"text": "Treatment", "start": 122, "end": 123}, "arguments": [{"entity_id": "T17", "role": "Instrument", "text": "TNP-470", "start": 127, "end": 130}]}, {"id": "E16", "event_type": "Negative_regulation", "trigger": {"text": "suppressed", "start": 130, "end": 131}, "arguments": []}, {"id": "E30", "event_type": "Positive_regulation", "trigger": {"text": "progression", "start": 132, "end": 133}, "arguments": []}, {"id": "E38", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 135, "end": 136}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "tumor", "start": 119, "end": 120}, {"entity_id": "T24", "role": "ToLoc", "text": "pulmonary", "start": 134, "end": 135}]}, {"id": "E17", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 143, "end": 144}, "arguments": []}, {"id": "E28", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 145, "end": 146}, "arguments": []}, {"id": "E18", "event_type": "Planned_process", "trigger": {"text": "resection", "start": 148, "end": 149}, "arguments": [{"entity_id": "T16", "role": "Theme", "text": "osteosarcoma tumors", "start": 150, "end": 152}]}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "enhances", "start": 152, "end": 153}, "arguments": []}, {"id": "E20", "event_type": "Positive_regulation", "trigger": {"text": "progression", "start": 153, "end": 154}, "arguments": []}, {"id": "E33", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 156, "end": 157}, "arguments": [{"entity_id": "T16", "role": "Theme", "text": "osteosarcoma tumors", "start": 150, "end": 152}, {"entity_id": "T47", "role": "ToLoc", "text": "pulmonary", "start": 155, "end": 156}]}, {"id": "E32", "event_type": "Planned_process", "trigger": {"text": "administration", "start": 164, "end": 165}, "arguments": [{"entity_id": "T50", "role": "Theme", "text": "osteosarcoma", "start": 175, "end": 176}]}, {"id": "E21", "event_type": "Negative_regulation", "trigger": {"text": "prevent", "start": 169, "end": 170}, "arguments": []}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "progression", "start": 170, "end": 171}, "arguments": []}, {"id": "E31", "event_type": "Localization", "trigger": {"text": "metastasis", "start": 173, "end": 174}, "arguments": [{"entity_id": "T22", "role": "ToLoc", "text": "pulmonary", "start": 172, "end": 173}, {"entity_id": "T50", "role": "Theme", "text": "osteosarcoma", "start": 175, "end": 176}]}], "relation_mentions": [], "entity_mentions": [{"id": "T26", "text": "progression", "entity_type": "Positive_regulation", "start": 1, "end": 2}, {"id": "T20", "text": "pulmonary", "entity_type": "Organ", "start": 3, "end": 4}, {"id": "T55", "text": "metastasis", "entity_type": "Localization", "start": 4, "end": 5}, {"id": "T21", "text": "osteosarcoma", "entity_type": "Pathological_formation", "start": 6, "end": 7}, {"id": "T56", "text": "metastasis", "entity_type": "Localization", "start": 12, "end": 13}, {"id": "T1000", "text": "patients", "entity_type": "Organism", "start": 17, "end": 18}, {"id": "T28", "text": "cancer", "entity_type": "Pathological_formation", "start": 19, "end": 20}, {"id": "T29", "text": "resection", "entity_type": "Planned_process", "start": 21, "end": 22}, {"id": "T1", "text": "tumor", "entity_type": "Pathological_formation", "start": 25, "end": 26}, {"id": "T27", "text": "resection", "entity_type": "Planned_process", "start": 31, "end": 32}, {"id": "T2", "text": "tumor", "entity_type": "Pathological_formation", "start": 35, "end": 36}, {"id": "T30", "text": "induces", "entity_type": "Positive_regulation", "start": 36, "end": 37}, {"id": "T31", "text": "activation", "entity_type": "Positive_regulation", "start": 37, "end": 38}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 40, "end": 41}, {"id": "T34", "text": "enhances", "entity_type": "Positive_regulation", "start": 42, "end": 43}, {"id": "T33", "text": "progression", "entity_type": "Positive_regulation", "start": 43, "end": 44}, {"id": "T32", "text": "metastasis", "entity_type": "Localization", "start": 46, "end": 47}, {"id": "T35", "text": "resection", "entity_type": "Planned_process", "start": 52, "end": 53}, {"id": "T4", "text": "osteosarcoma tumor", "entity_type": "Pathological_formation", "start": 56, "end": 58}, {"id": "T36", "text": "enhances", "entity_type": "Positive_regulation", "start": 58, "end": 59}, {"id": "T37", "text": "progression", "entity_type": "Positive_regulation", "start": 59, "end": 60}, {"id": "T23", "text": "pulmonary", "entity_type": "Organ", "start": 61, "end": 62}, {"id": "T57", "text": "metastasis", "entity_type": "Localization", "start": 62, "end": 63}, {"id": "T25", "text": "osteosarcoma", "entity_type": "Pathological_formation", "start": 65, "end": 66}, {"id": "T5", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 70, "end": 71}, {"id": "T6", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 75, "end": 76}, {"id": "T38", "text": "elevated", "entity_type": "Positive_regulation", "start": 78, "end": 79}, {"id": "T7", "text": "tumor", "entity_type": "Pathological_formation", "start": 81, "end": 82}, {"id": "T39", "text": "removal", "entity_type": "Planned_process", "start": 82, "end": 83}, {"id": "T8", "text": "tumor", "entity_type": "Pathological_formation", "start": 84, "end": 85}, {"id": "T9", "text": "tumor", "entity_type": "Pathological_formation", "start": 93, "end": 94}, {"id": "T11", "text": "serum", "entity_type": "Organism_substance", "start": 106, "end": 107}, {"id": "T12", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 110, "end": 111}, {"id": "T13", "text": "endostatin", "entity_type": "Gene_or_gene_product", "start": 113, "end": 114}, {"id": "T10", "text": "decreased", "entity_type": "Negative_regulation", "start": 115, "end": 116}, {"id": "T14", "text": "tumor", "entity_type": "Pathological_formation", "start": 119, "end": 120}, {"id": "T40", "text": "removal", "entity_type": "Planned_process", "start": 120, "end": 121}, {"id": "T41", "text": "Treatment", "entity_type": "Planned_process", "start": 122, "end": 123}, {"id": "T17", "text": "TNP-470", "entity_type": "Drug_or_compound", "start": 127, "end": 130}, {"id": "T42", "text": "suppressed", "entity_type": "Negative_regulation", "start": 130, "end": 131}, {"id": "T51", "text": "progression", "entity_type": "Positive_regulation", "start": 132, "end": 133}, {"id": "T24", "text": "pulmonary", "entity_type": "Organ", "start": 134, "end": 135}, {"id": "T58", "text": "metastasis", "entity_type": "Localization", "start": 135, "end": 136}, {"id": "T43", "text": "activation", "entity_type": "Positive_regulation", "start": 143, "end": 144}, {"id": "T18", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 145, "end": 146}, {"id": "T44", "text": "resection", "entity_type": "Planned_process", "start": 148, "end": 149}, {"id": "T16", "text": "osteosarcoma tumors", "entity_type": "Pathological_formation", "start": 150, "end": 152}, {"id": "T45", "text": "enhances", "entity_type": "Positive_regulation", "start": 152, "end": 153}, {"id": "T46", "text": "progression", "entity_type": "Positive_regulation", "start": 153, "end": 154}, {"id": "T47", "text": "pulmonary", "entity_type": "Organ", "start": 155, "end": 156}, {"id": "T54", "text": "metastasis", "entity_type": "Localization", "start": 156, "end": 157}, {"id": "T53", "text": "administration", "entity_type": "Planned_process", "start": 164, "end": 165}, {"id": "T48", "text": "prevent", "entity_type": "Negative_regulation", "start": 169, "end": 170}, {"id": "T49", "text": "progression", "entity_type": "Positive_regulation", "start": 170, "end": 171}, {"id": "T22", "text": "pulmonary", "entity_type": "Organ", "start": 172, "end": 173}, {"id": "T52", "text": "metastasis", "entity_type": "Localization", "start": 173, "end": 174}, {"id": "T50", "text": "osteosarcoma", "entity_type": "Pathological_formation", "start": 175, "end": 176}], "lang": "en"}
{"doc_id": "PMID-12727857", "wnd_id": "PMID-12727857_0", "text": "Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.\n\nThe expression of endothelial cell (EC) adhesion molecules involved in leukocyte-vessel wall interactions is suppressed in malignancies. In the present study, we investigated in vivo the regulation of leukocyte-vessel wall interactions by the presence of a tumor. By means of intravital microscopy, tumor necrosis factor alpha-stimulated leukocyte-vessel wall interactions were studied in ear skin microvessels of nude mice bearing small human LS174T colon carcinomas and in C57Bl/6 mice bearing murine B16F10 melanomas. Leukocyte-vessel wall interactions were studied both within and outside small tumors growing in the ear, and in ear microvessels of mice with a large tumor growing on their flank. Tumor-free mice were used as controls. Compared with values measured at the edge of the ear and in the contralateral ear, leukocyte adhesion was found to be diminished significantly in vessels inside the ear tumor in both mouse models. This reduction disappeared with increasing distance from the tumor. Surprisingly, the level of leukocyte adhesion in ear venules of mice with a large flank tumor was also reduced significantly. Leukocyte rolling, i.e., the step preceding adhesion, was not influenced by the presence of a tumor in nude mice, but was down-regulated in immune-competent C57Bl/6 mice. Treatment of mice bearing a small ear tumor with a humanized antivascular endothelial growth factor antibody prevented the down-regulation of leukocyte-vessel wall interactions inside the tumor vessels compared with the nontreated group. Fluorescence-activated cell sorter analysis showed that isolated tumor ECs have suppressed levels of intercellular adhesion molecule 1 as compared with ECs from normal mouse tissues. In cultured b.END5 cells the tumor necrosis factor alpha-induced up-regulation of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 was reduced in ECs that were preincubated with basic fibroblast growth factor or vascular endothelial growth factor.", "tokens": ["Tumor", "angiogenesis", "modulates", "leukocyte", "-", "vessel", "wall", "interactions", "in", "vivo", "by", "reducing", "endothelial", "adhesion", "molecule", "expression", ".", "The", "expression", "of", "endothelial", "cell", "(", "EC", ")", "adhesion", "molecules", "involved", "in", "leukocyte", "-", "vessel", "wall", "interactions", "is", "suppressed", "in", "malignancies", ".", "In", "the", "present", "study", ",", "we", "investigated", "in", "vivo", "the", "regulation", "of", "leukocyte", "-", "vessel", "wall", "interactions", "by", "the", "presence", "of", "a", "tumor", ".", "By", "means", "of", "intravital", "microscopy", ",", "tumor", "necrosis", "factor", "alpha-", "stimulated", "leukocyte", "-", "vessel", "wall", "interactions", "were", "studied", "in", "ear", "skin", "microvessels", "of", "nude", "mice", "bearing", "small", "human", "LS174T", "colon", "carcinomas", "and", "in", "C57", "B", "l", "/", "6", "mice", "bearing", "murine", "B16F10", "melanomas", ".", "Leukocyte", "-", "vessel", "wall", "interactions", "were", "studied", "both", "within", "and", "outside", "small", "tumors", "growing", "in", "the", "ear", ",", "and", "in", "ear", "microvessels", "of", "mice", "with", "a", "large", "tumor", "growing", "on", "their", "flank", ".", "Tumor", "-", "free", "mice", "were", "used", "as", "controls", ".", "Compared", "with", "values", "measured", "at", "the", "edge", "of", "the", "ear", "and", "in", "the", "contralateral", "ear", ",", "leukocyte", "adhesion", "was", "found", "to", "be", "diminished", "significantly", "in", "vessels", "inside", "the", "ear", "tumor", "in", "both", "mouse", "models", ".", "This", "reduction", "disappeared", "with", "increasing", "distance", "from", "the", "tumor", ".", "Surprisingly", ",", "the", "level", "of", "leukocyte", "adhesion", "in", "ear", "venules", "of", "mice", "with", "a", "large", "flank", "tumor", "was", "also", "reduced", "significantly", ".", "Leukocyte", "rolling", ",", "i.e.", ",", "the", "step", "preceding", "adhesion", ",", "was", "not", "influenced", "by", "the", "presence", "of", "a", "tumor", "in", "nude", "mice", ",", "but", "was", "down", "-", "regulated", "in", "immune", "-", "competent", "C57", "B", "l", "/", "6", "mice", ".", "Treatment", "of", "mice", "bearing", "a", "small", "ear", "tumor", "with", "a", "humanized", "antivascular", "endothelial", "growth", "factor", "antibody", "prevented", "the", "down", "-", "regulation", "of", "leukocyte", "-", "vessel", "wall", "interactions", "inside", "the", "tumor", "vessels", "compared", "with", "the", "nontreated", "group", ".", "Fluorescence", "-", "activated", "cell", "sorter", "analysis", "showed", "that", "isolated", "tumor", "ECs", "have", "suppressed", "levels", "of", "intercellular", "adhesion", "molecule", "1", "as", "compared", "with", "ECs", "from", "normal", "mouse", "tissues", ".", "In", "cultured", "b.END5", "cells", "the", "tumor", "necrosis", "factor", "alpha-", "induced", "up", "-", "regulation", "of", "intercellular", "adhesion", "molecule", "1", "and", "vascular", "cell", "adhesion", "molecule", "1", "was", "reduced", "in", "ECs", "that", "were", "preincubated", "with", "basic", "fibroblast", "growth", "factor", "or", "vascular", "endothelial", "growth", "factor", "."], "event_mentions": [{"id": "E33", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 1, "end": 2}, "arguments": [{"entity_id": "T1", "role": "AtLoc", "text": "Tumor", "start": 0, "end": 1}]}, {"id": "E3", "event_type": "Regulation", "trigger": {"text": "modulates", "start": 2, "end": 3}, "arguments": []}, {"id": "E4", "event_type": "Binding", "trigger": {"text": "interactions", "start": 7, "end": 8}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "leukocyte", "start": 3, "end": 4}, {"entity_id": "T6", "role": "Theme", "text": "vessel wall", "start": 5, "end": 7}]}, {"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "reducing", "start": 11, "end": 12}, "arguments": []}, {"id": "E8", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 15, "end": 16}, "arguments": [{"entity_id": "T7", "role": "Theme", "text": "endothelial adhesion molecule", "start": 12, "end": 15}]}, {"id": "E10", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 18, "end": 19}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "endothelial cell (EC) adhesion molecules", "start": 20, "end": 27}]}, {"id": "E5", "event_type": "Regulation", "trigger": {"text": "involved", "start": 27, "end": 28}, "arguments": []}, {"id": "E14", "event_type": "Binding", "trigger": {"text": "interactions", "start": 33, "end": 34}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "leukocyte", "start": 29, "end": 30}, {"entity_id": "T16", "role": "Theme", "text": "vessel wall", "start": 31, "end": 33}]}, {"id": "E17", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 49, "end": 50}, "arguments": [{"entity_id": "T21", "role": "Cause", "text": "tumor", "start": 61, "end": 62}]}, {"id": "E18", "event_type": "Binding", "trigger": {"text": "interactions", "start": 55, "end": 56}, "arguments": [{"entity_id": "T19", "role": "Theme", "text": "leukocyte", "start": 51, "end": 52}, {"entity_id": "T20", "role": "Theme", "text": "vessel wall", "start": 53, "end": 55}]}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "stimulated", "start": 73, "end": 74}, "arguments": []}, {"id": "E24", "event_type": "Binding", "trigger": {"text": "interactions", "start": 78, "end": 79}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "leukocyte", "start": 74, "end": 75}, {"entity_id": "T26", "role": "Theme", "text": "vessel wall", "start": 76, "end": 78}]}, {"id": "E34", "event_type": "Binding", "trigger": {"text": "interactions", "start": 111, "end": 112}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "Leukocyte", "start": 107, "end": 108}, {"entity_id": "T36", "role": "Theme", "text": "vessel wall", "start": 109, "end": 111}]}, {"id": "E6", "event_type": "Growth", "trigger": {"text": "growing", "start": 120, "end": 121}, "arguments": [{"entity_id": "T37", "role": "Theme", "text": "tumors", "start": 119, "end": 120}]}, {"id": "E7", "event_type": "Growth", "trigger": {"text": "growing", "start": 135, "end": 136}, "arguments": [{"entity_id": "T42", "role": "Theme", "text": "tumor", "start": 134, "end": 135}]}, {"id": "E1", "event_type": "Binding", "trigger": {"text": "adhesion", "start": 166, "end": 167}, "arguments": [{"entity_id": "T47", "role": "Theme", "text": "leukocyte", "start": 165, "end": 166}]}, {"id": "E11", "event_type": "Negative_regulation", "trigger": {"text": "diminished", "start": 171, "end": 172}, "arguments": []}, {"id": "E12", "event_type": "Negative_regulation", "trigger": {"text": "reduction", "start": 185, "end": 186}, "arguments": []}, {"id": "E52", "event_type": "Binding", "trigger": {"text": "adhesion", "start": 200, "end": 201}, "arguments": [{"entity_id": "T53", "role": "Theme", "text": "leukocyte", "start": 199, "end": 200}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 213, "end": 214}, "arguments": []}, {"id": "E15", "event_type": "Planned_process", "trigger": {"text": "Treatment", "start": 255, "end": 256}, "arguments": [{"entity_id": "T1010", "role": "Theme", "text": "mice", "start": 257, "end": 258}, {"entity_id": "T63", "role": "Instrument", "text": "humanized antivascular endothelial growth factor antibody", "start": 265, "end": 271}]}, {"id": "E16", "event_type": "Negative_regulation", "trigger": {"text": "prevented", "start": 271, "end": 272}, "arguments": []}, {"id": "E19", "event_type": "Negative_regulation", "trigger": {"text": "down-regulation", "start": 273, "end": 276}, "arguments": []}, {"id": "E64", "event_type": "Binding", "trigger": {"text": "interactions", "start": 281, "end": 282}, "arguments": [{"entity_id": "T65", "role": "Theme", "text": "leukocyte", "start": 277, "end": 278}, {"entity_id": "T66", "role": "Theme", "text": "vessel wall", "start": 279, "end": 281}]}, {"id": "E20", "event_type": "Planned_process", "trigger": {"text": "nontreated", "start": 289, "end": 290}, "arguments": [{"entity_id": "T1010", "role": "Theme", "text": "mice", "start": 257, "end": 258}]}, {"id": "E32", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 294, "end": 295}, "arguments": [{"entity_id": "T87", "role": "Theme", "text": "cell", "start": 295, "end": 296}]}, {"id": "E21", "event_type": "Negative_regulation", "trigger": {"text": "suppressed", "start": 304, "end": 305}, "arguments": [{"entity_id": "T70", "role": "Cause", "text": "tumor ECs", "start": 301, "end": 303}, {"entity_id": "T71", "role": "Theme", "text": "intercellular adhesion molecule 1", "start": 307, "end": 311}]}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 329, "end": 330}, "arguments": []}, {"id": "E27", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 329, "end": 330}, "arguments": []}, {"id": "E76", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 330, "end": 333}, "arguments": [{"entity_id": "T77", "role": "Theme", "text": "intercellular adhesion molecule 1", "start": 334, "end": 338}]}, {"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 330, "end": 333}, "arguments": [{"entity_id": "T78", "role": "Theme", "text": "vascular cell adhesion molecule 1", "start": 339, "end": 344}]}, {"id": "E25", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 345, "end": 346}, "arguments": []}, {"id": "E28", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 345, "end": 346}, "arguments": []}, {"id": "E29", "event_type": "Planned_process", "trigger": {"text": "preincubated", "start": 350, "end": 351}, "arguments": [{"entity_id": "T79", "role": "Theme", "text": "ECs", "start": 347, "end": 348}, {"entity_id": "T80", "role": "Instrument", "text": "basic fibroblast growth factor", "start": 352, "end": 356}]}, {"id": "E30", "event_type": "Planned_process", "trigger": {"text": "preincubated", "start": 350, "end": 351}, "arguments": [{"entity_id": "T79", "role": "Theme", "text": "ECs", "start": 347, "end": 348}, {"entity_id": "T81", "role": "Instrument", "text": "vascular endothelial growth factor", "start": 357, "end": 361}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "Tumor", "entity_type": "Pathological_formation", "start": 0, "end": 1}, {"id": "T2", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 1, "end": 2}, {"id": "T3", "text": "modulates", "entity_type": "Regulation", "start": 2, "end": 3}, {"id": "T5", "text": "leukocyte", "entity_type": "Cell", "start": 3, "end": 4}, {"id": "T6", "text": "vessel wall", "entity_type": "Multi-tissue_structure", "start": 5, "end": 7}, {"id": "T4", "text": "interactions", "entity_type": "Binding", "start": 7, "end": 8}, {"id": "T11", "text": "reducing", "entity_type": "Negative_regulation", "start": 11, "end": 12}, {"id": "T7", "text": "endothelial adhesion molecule", "entity_type": "Gene_or_gene_product", "start": 12, "end": 15}, {"id": "T8", "text": "expression", "entity_type": "Gene_expression", "start": 15, "end": 16}, {"id": "T10", "text": "expression", "entity_type": "Gene_expression", "start": 18, "end": 19}, {"id": "T9", "text": "endothelial cell (EC) adhesion molecules", "entity_type": "Gene_or_gene_product", "start": 20, "end": 27}, {"id": "T12", "text": "involved", "entity_type": "Regulation", "start": 27, "end": 28}, {"id": "T15", "text": "leukocyte", "entity_type": "Cell", "start": 29, "end": 30}, {"id": "T16", "text": "vessel wall", "entity_type": "Multi-tissue_structure", "start": 31, "end": 33}, {"id": "T14", "text": "interactions", "entity_type": "Binding", "start": 33, "end": 34}, {"id": "T17", "text": "regulation", "entity_type": "Regulation", "start": 49, "end": 50}, {"id": "T19", "text": "leukocyte", "entity_type": "Cell", "start": 51, "end": 52}, {"id": "T20", "text": "vessel wall", "entity_type": "Multi-tissue_structure", "start": 53, "end": 55}, {"id": "T18", "text": "interactions", "entity_type": "Binding", "start": 55, "end": 56}, {"id": "T21", "text": "tumor", "entity_type": "Pathological_formation", "start": 61, "end": 62}, {"id": "T22", "text": "stimulated", "entity_type": "Positive_regulation", "start": 73, "end": 74}, {"id": "T25", "text": "leukocyte", "entity_type": "Cell", "start": 74, "end": 75}, {"id": "T26", "text": "vessel wall", "entity_type": "Multi-tissue_structure", "start": 76, "end": 78}, {"id": "T24", "text": "interactions", "entity_type": "Binding", "start": 78, "end": 79}, {"id": "T27", "text": "ear skin microvessels", "entity_type": "Tissue", "start": 82, "end": 85}, {"id": "T1000", "text": "nude mice", "entity_type": "Organism", "start": 86, "end": 88}, {"id": "T1001", "text": "human", "entity_type": "Organism", "start": 90, "end": 91}, {"id": "T32", "text": "LS174T colon carcinomas", "entity_type": "Pathological_formation", "start": 91, "end": 94}, {"id": "T1002", "text": "C57Bl/6 mice", "entity_type": "Organism", "start": 96, "end": 102}, {"id": "T1003", "text": "murine", "entity_type": "Organism", "start": 103, "end": 104}, {"id": "T86", "text": "B16F10 melanomas", "entity_type": "Pathological_formation", "start": 104, "end": 106}, {"id": "T35", "text": "Leukocyte", "entity_type": "Cell", "start": 107, "end": 108}, {"id": "T36", "text": "vessel wall", "entity_type": "Multi-tissue_structure", "start": 109, "end": 111}, {"id": "T34", "text": "interactions", "entity_type": "Binding", "start": 111, "end": 112}, {"id": "T37", "text": "tumors", "entity_type": "Pathological_formation", "start": 119, "end": 120}, {"id": "T13", "text": "growing", "entity_type": "Growth", "start": 120, "end": 121}, {"id": "T38", "text": "ear", "entity_type": "Organ", "start": 123, "end": 124}, {"id": "T39", "text": "ear microvessels", "entity_type": "Tissue", "start": 127, "end": 129}, {"id": "T1004", "text": "mice", "entity_type": "Organism", "start": 130, "end": 131}, {"id": "T42", "text": "tumor", "entity_type": "Pathological_formation", "start": 134, "end": 135}, {"id": "T28", "text": "growing", "entity_type": "Growth", "start": 135, "end": 136}, {"id": "T43", "text": "flank", "entity_type": "Organism_subdivision", "start": 138, "end": 139}, {"id": "T44", "text": "Tumor", "entity_type": "Pathological_formation", "start": 140, "end": 141}, {"id": "T1005", "text": "mice", "entity_type": "Organism", "start": 143, "end": 144}, {"id": "T45", "text": "ear", "entity_type": "Organ", "start": 158, "end": 159}, {"id": "T46", "text": "ear", "entity_type": "Organ", "start": 163, "end": 164}, {"id": "T47", "text": "leukocyte", "entity_type": "Cell", "start": 165, "end": 166}, {"id": "T85", "text": "adhesion", "entity_type": "Binding", "start": 166, "end": 167}, {"id": "T30", "text": "diminished", "entity_type": "Negative_regulation", "start": 171, "end": 172}, {"id": "T48", "text": "vessels", "entity_type": "Tissue", "start": 174, "end": 175}, {"id": "T50", "text": "ear tumor", "entity_type": "Pathological_formation", "start": 177, "end": 179}, {"id": "T1006", "text": "mouse", "entity_type": "Organism", "start": 181, "end": 182}, {"id": "T31", "text": "reduction", "entity_type": "Negative_regulation", "start": 185, "end": 186}, {"id": "T51", "text": "tumor", "entity_type": "Pathological_formation", "start": 192, "end": 193}, {"id": "T53", "text": "leukocyte", "entity_type": "Cell", "start": 199, "end": 200}, {"id": "T52", "text": "adhesion", "entity_type": "Binding", "start": 200, "end": 201}, {"id": "T54", "text": "ear venules", "entity_type": "Multi-tissue_structure", "start": 202, "end": 204}, {"id": "T1007", "text": "mice", "entity_type": "Organism", "start": 205, "end": 206}, {"id": "T58", "text": "flank tumor", "entity_type": "Pathological_formation", "start": 209, "end": 211}, {"id": "T33", "text": "reduced", "entity_type": "Negative_regulation", "start": 213, "end": 214}, {"id": "T59", "text": "Leukocyte", "entity_type": "Cell", "start": 216, "end": 217}, {"id": "T60", "text": "tumor", "entity_type": "Pathological_formation", "start": 234, "end": 235}, {"id": "T1008", "text": "nude mice", "entity_type": "Organism", "start": 236, "end": 238}, {"id": "T1009", "text": "C57Bl/6 mice", "entity_type": "Organism", "start": 248, "end": 254}, {"id": "T40", "text": "Treatment", "entity_type": "Planned_process", "start": 255, "end": 256}, {"id": "T1010", "text": "mice", "entity_type": "Organism", "start": 257, "end": 258}, {"id": "T62", "text": "ear tumor", "entity_type": "Pathological_formation", "start": 261, "end": 263}, {"id": "T63", "text": "humanized antivascular endothelial growth factor antibody", "entity_type": "Gene_or_gene_product", "start": 265, "end": 271}, {"id": "T84", "text": "endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 267, "end": 270}, {"id": "T41", "text": "prevented", "entity_type": "Negative_regulation", "start": 271, "end": 272}, {"id": "T49", "text": "down-regulation", "entity_type": "Negative_regulation", "start": 273, "end": 276}, {"id": "T65", "text": "leukocyte", "entity_type": "Cell", "start": 277, "end": 278}, {"id": "T66", "text": "vessel wall", "entity_type": "Multi-tissue_structure", "start": 279, "end": 281}, {"id": "T64", "text": "interactions", "entity_type": "Binding", "start": 281, "end": 282}, {"id": "T68", "text": "tumor vessels", "entity_type": "Multi-tissue_structure", "start": 284, "end": 286}, {"id": "T55", "text": "nontreated", "entity_type": "Planned_process", "start": 289, "end": 290}, {"id": "T88", "text": "activated", "entity_type": "Positive_regulation", "start": 294, "end": 295}, {"id": "T87", "text": "cell", "entity_type": "Cell", "start": 295, "end": 296}, {"id": "T70", "text": "tumor ECs", "entity_type": "Cell", "start": 301, "end": 303}, {"id": "T56", "text": "suppressed", "entity_type": "Negative_regulation", "start": 304, "end": 305}, {"id": "T71", "text": "intercellular adhesion molecule 1", "entity_type": "Gene_or_gene_product", "start": 307, "end": 311}, {"id": "T72", "text": "ECs", "entity_type": "Cell", "start": 314, "end": 315}, {"id": "T1011", "text": "mouse", "entity_type": "Organism", "start": 317, "end": 318}, {"id": "T75", "text": "tissues", "entity_type": "Tissue", "start": 318, "end": 319}, {"id": "T73", "text": "b.END5 cells", "entity_type": "Cell", "start": 322, "end": 324}, {"id": "T57", "text": "induced", "entity_type": "Positive_regulation", "start": 329, "end": 330}, {"id": "T76", "text": "up-regulation", "entity_type": "Positive_regulation", "start": 330, "end": 333}, {"id": "T77", "text": "intercellular adhesion molecule 1", "entity_type": "Gene_or_gene_product", "start": 334, "end": 338}, {"id": "T78", "text": "vascular cell adhesion molecule 1", "entity_type": "Gene_or_gene_product", "start": 339, "end": 344}, {"id": "T61", "text": "reduced", "entity_type": "Negative_regulation", "start": 345, "end": 346}, {"id": "T79", "text": "ECs", "entity_type": "Cell", "start": 347, "end": 348}, {"id": "T67", "text": "preincubated", "entity_type": "Planned_process", "start": 350, "end": 351}, {"id": "T80", "text": "basic fibroblast growth factor", "entity_type": "Gene_or_gene_product", "start": 352, "end": 356}, {"id": "T81", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 357, "end": 361}], "lang": "en"}
{"doc_id": "PMID-12727857", "wnd_id": "PMID-12727857_1", "text": "The current results may have an impact on the effectiveness of clinical immunotherapeutic treatment protocols, because immune effector cells may not be able to enter tumor tissue.", "tokens": ["The", "current", "results", "may", "have", "an", "impact", "on", "the", "effectiveness", "of", "clinical", "immunotherapeutic", "treatment", "protocols", ",", "because", "immune", "effector", "cells", "may", "not", "be", "able", "to", "enter", "tumor", "tissue", "."], "event_mentions": [{"id": "E31", "event_type": "Localization", "trigger": {"text": "enter", "start": 25, "end": 26}, "arguments": [{"entity_id": "T82", "role": "Theme", "text": "immune effector cells", "start": 17, "end": 20}, {"entity_id": "T83", "role": "ToLoc", "text": "tumor tissue", "start": 26, "end": 28}]}], "relation_mentions": [], "entity_mentions": [{"id": "T82", "text": "immune effector cells", "entity_type": "Cell", "start": 17, "end": 20}, {"id": "T69", "text": "enter", "entity_type": "Localization", "start": 25, "end": 26}, {"id": "T83", "text": "tumor tissue", "entity_type": "Pathological_formation", "start": 26, "end": 28}], "lang": "en"}
{"doc_id": "PMID-12855648", "wnd_id": "PMID-12855648_0", "text": "Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.\n\nPURPOSE: Molecular antagonists of the inhibitor of apoptosis protein survivin have shown promise as novel anticancer strategies for triggering tumor cell apoptosis, dysregulating mitotic progression, and inhibiting tumor growth in preclinical models. However, how survivin couples to the cell death machinery has remained elusive, and the relevant cellular targets of survivin antagonists have not been completely elucidated. Experimental Design: Human umbilical vein and dermal microvascular endothelial cells were infected with replication-deficient adenoviruses encoding survivin (pAd-Survivin), green fluorescent protein (pAd-GFP), or a phosphorylation-defective survivin Thr(34)-->Ala (pAd-T34A) dominant negative mutant. The effect of wild-type or mutant survivin was investigated on capillary network stability, endothelial cell viability, and caspase activation in vitro and on kinetics of tumor growth and development of angiogenesis in a breast cancer xenograft model in vivo. The cell death pathway initiated by survivin targeting was mapped with respect to cytochrome c release, changes in mitochondrial transmembrane potential, and apoptosome requirements using mouse embryonic fibroblasts deficient in Apaf-1 or caspase-9. RESULTS: Adenoviral transduction of endothelial cells with pAd-Survivin inhibited growth factor deprivation- or ceramide-induced apoptosis, reduced caspase-3 and -7 generation, and stabilized three-dimensional capillary networks in vitro. Conversely, expression of pAd-T34A caused apoptosis in umbilical vein and dermal microvascular endothelial cells and resulted in caspase-3 activity. Cell death induced by survivin targeting exhibited the hallmarks of mitochondrial-dependent apoptosis with release of cytochrome c and loss of mitochondrial transmembrane potential and was suppressed in Apaf-1 or caspase-9 knockout mouse embryonic fibroblasts. When injected in human breast cancer xenografts, pAd-T34A inhibited growth of established tumors and triggered tumor cell apoptosis in vivo.", "tokens": ["Therapeutic", "targeting", "of", "the", "survivin", "pathway", "in", "cancer", ":", "initiation", "of", "mitochondrial", "apoptosis", "and", "suppression", "of", "tumor", "-", "associated", "angiogenesis", ".", "PURPOSE", ":", "Molecular", "antagonists", "of", "the", "inhibitor", "of", "apoptosis", "protein", "survivin", "have", "shown", "promise", "as", "novel", "anticancer", "strategies", "for", "triggering", "tumor", "cell", "apoptosis", ",", "dysregulating", "mitotic", "progression", ",", "and", "inhibiting", "tumor", "growth", "in", "preclinical", "models", ".", "However", ",", "how", "survivin", "couples", "to", "the", "cell", "death", "machinery", "has", "remained", "elusive", ",", "and", "the", "relevant", "cellular", "targets", "of", "survivin", "antagonists", "have", "not", "been", "completely", "elucidated", ".", "Experimental", "Design", ":", "Human", "umbilical", "vein", "and", "dermal", "microvascular", "endothelial", "cells", "were", "infected", "with", "replication", "-", "deficient", "adenoviruses", "encoding", "survivin", "(", "pAd-", "Survivin", ")", ",", "green", "fluorescent", "protein", "(", "pAd", "-", "GFP", ")", ",", "or", "a", "phosphorylation", "-", "defective", "survivin", "Thr", "(", "34", ")", "-->", "Ala", "(", "pAd", "-", "T34A", ")", "dominant", "negative", "mutant", ".", "The", "effect", "of", "wild", "-", "type", "or", "mutant", "survivin", "was", "investigated", "on", "capillary", "network", "stability", ",", "endothelial", "cell", "viability", ",", "and", "caspase", "activation", "in", "vitro", "and", "on", "kinetics", "of", "tumor", "growth", "and", "development", "of", "angiogenesis", "in", "a", "breast", "cancer", "xenograft", "model", "in", "vivo", ".", "The", "cell", "death", "pathway", "initiated", "by", "survivin", "targeting", "was", "mapped", "with", "respect", "to", "cytochrome", "c", "release", ",", "changes", "in", "mitochondrial", "transmembrane", "potential", ",", "and", "apoptosome", "requirements", "using", "mouse", "embryonic", "fibroblasts", "deficient", "in", "Apaf", "-", "1", "or", "caspase", "-", "9", ".", "RESULTS", ":", "Adenoviral", "transduction", "of", "endothelial", "cells", "with", "pAd-Survivin", "inhibited", "growth", "factor", "deprivation", "-", "or", "ceramide", "-", "induced", "apoptosis", ",", "reduced", "caspase", "-", "3", "and", "-", "7", "generation", ",", "and", "stabilized", "three", "-", "dimensional", "capillary", "networks", "in", "vitro", ".", "Conversely", ",", "expression", "of", "pAd", "-T34A", "caused", "apoptosis", "in", "umbilical", "vein", "and", "dermal", "microvascular", "endothelial", "cells", "and", "resulted", "in", "caspase", "-", "3", "activity", ".", "Cell", "death", "induced", "by", "survivin", "targeting", "exhibited", "the", "hallmarks", "of", "mitochondrial", "-", "dependent", "apoptosis", "with", "release", "of", "cytochrome", "c", "and", "loss", "of", "mitochondrial", "transmembrane", "potential", "and", "was", "suppressed", "in", "Apaf", "-", "1", "or", "caspase", "-", "9", "knockout", "mouse", "embryonic", "fibroblasts", ".", "When", "injected", "in", "human", "breast", "cancer", "xenografts", ",", "pAd", "-", "T34A", "inhibited", "growth", "of", "established", "tumors", "and", "triggered", "tumor", "cell", "apoptosis", "in", "vivo", "."], "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "targeting", "start": 1, "end": 2}, "arguments": []}, {"id": "E47", "event_type": "Pathway", "trigger": {"text": "pathway", "start": 5, "end": 6}, "arguments": [{"entity_id": "T2", "role": "Participant", "text": "survivin", "start": 4, "end": 5}]}, {"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "suppression", "start": 14, "end": 15}, "arguments": []}, {"id": "E7", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 19, "end": 20}, "arguments": [{"entity_id": "T76", "role": "AtLoc", "text": "tumor", "start": 16, "end": 17}]}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "triggering", "start": 40, "end": 41}, "arguments": []}, {"id": "E4", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 43, "end": 44}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "tumor cell", "start": 41, "end": 43}]}, {"id": "E5", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 50, "end": 51}, "arguments": []}, {"id": "E6", "event_type": "Growth", "trigger": {"text": "growth", "start": 52, "end": 53}, "arguments": [{"entity_id": "T7", "role": "Theme", "text": "tumor", "start": 51, "end": 52}]}, {"id": "E36", "event_type": "Death", "trigger": {"text": "death", "start": 65, "end": 66}, "arguments": [{"entity_id": "T95", "role": "Theme", "text": "cell", "start": 64, "end": 65}]}, {"id": "E8", "event_type": "Planned_process", "trigger": {"text": "infected", "start": 97, "end": 98}, "arguments": [{"entity_id": "T12", "role": "Theme", "text": "dermal microvascular endothelial cells", "start": 92, "end": 96}, {"entity_id": "T79", "role": "Instrument", "text": "adenoviruses", "start": 102, "end": 103}]}, {"id": "E9", "event_type": "Planned_process", "trigger": {"text": "infected", "start": 97, "end": 98}, "arguments": [{"entity_id": "T10", "role": "Theme", "text": "umbilical vein", "start": 89, "end": 91}, {"entity_id": "T79", "role": "Instrument", "text": "adenoviruses", "start": 102, "end": 103}]}, {"id": "E20", "event_type": "Regulation", "trigger": {"text": "effect", "start": 141, "end": 142}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "survivin", "start": 148, "end": 149}, {"entity_id": "T21", "role": "Theme", "text": "capillary network", "start": 152, "end": 154}]}, {"id": "E22", "event_type": "Regulation", "trigger": {"text": "effect", "start": 141, "end": 142}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "survivin", "start": 148, "end": 149}, {"entity_id": "T23", "role": "Theme", "text": "endothelial cell", "start": 156, "end": 158}]}, {"id": "E48", "event_type": "Regulation", "trigger": {"text": "effect", "start": 141, "end": 142}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "survivin", "start": 148, "end": 149}]}, {"id": "E49", "event_type": "Regulation", "trigger": {"text": "effect", "start": 141, "end": 142}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "survivin", "start": 148, "end": 149}]}, {"id": "E50", "event_type": "Regulation", "trigger": {"text": "effect", "start": 141, "end": 142}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "survivin", "start": 148, "end": 149}]}, {"id": "E24", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 162, "end": 163}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "caspase", "start": 161, "end": 162}]}, {"id": "E26", "event_type": "Growth", "trigger": {"text": "growth", "start": 170, "end": 171}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "tumor", "start": 169, "end": 170}]}, {"id": "E44", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 174, "end": 175}, "arguments": [{"entity_id": "T29", "role": "AtLoc", "text": "breast cancer xenograft", "start": 177, "end": 180}]}, {"id": "E37", "event_type": "Death", "trigger": {"text": "death", "start": 186, "end": 187}, "arguments": [{"entity_id": "T97", "role": "Theme", "text": "cell", "start": 185, "end": 186}]}, {"id": "E38", "event_type": "Positive_regulation", "trigger": {"text": "initiated", "start": 188, "end": 189}, "arguments": []}, {"id": "E11", "event_type": "Planned_process", "trigger": {"text": "targeting", "start": 191, "end": 192}, "arguments": [{"entity_id": "T30", "role": "Theme", "text": "survivin", "start": 190, "end": 191}]}, {"id": "E31", "event_type": "Localization", "trigger": {"text": "release", "start": 199, "end": 200}, "arguments": [{"entity_id": "T32", "role": "Theme", "text": "cytochrome c", "start": 197, "end": 199}]}, {"id": "E12", "event_type": "Gene_expression", "trigger": {"text": "deficient", "start": 214, "end": 215}, "arguments": [{"entity_id": "T34", "role": "Theme", "text": "Apaf-1", "start": 216, "end": 219}]}, {"id": "E13", "event_type": "Gene_expression", "trigger": {"text": "deficient", "start": 214, "end": 215}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "caspase-9", "start": 220, "end": 223}]}, {"id": "E14", "event_type": "Planned_process", "trigger": {"text": "transduction", "start": 227, "end": 228}, "arguments": [{"entity_id": "T84", "role": "Instrument", "text": "Adenoviral", "start": 226, "end": 227}, {"entity_id": "T36", "role": "Theme", "text": "endothelial cells", "start": 229, "end": 231}]}, {"id": "E39", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 244, "end": 245}, "arguments": []}, {"id": "E16", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 244, "end": 245}, "arguments": []}, {"id": "E40", "event_type": "Gene_expression", "trigger": {"text": "generation", "start": 251, "end": 252}, "arguments": [{"entity_id": "T85", "role": "Theme", "text": "-7", "start": 249, "end": 251}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "generation", "start": 251, "end": 252}, "arguments": [{"entity_id": "T41", "role": "Theme", "text": "caspase-3", "start": 245, "end": 248}]}, {"id": "E43", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 265, "end": 266}, "arguments": [{"entity_id": "T44", "role": "Theme", "text": "pAd-T34A", "start": 267, "end": 269}]}, {"id": "E18", "event_type": "Positive_regulation", "trigger": {"text": "caused", "start": 269, "end": 270}, "arguments": []}, {"id": "E21", "event_type": "Positive_regulation", "trigger": {"text": "caused", "start": 269, "end": 270}, "arguments": []}, {"id": "E17", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 270, "end": 271}, "arguments": [{"entity_id": "T47", "role": "Theme", "text": "umbilical vein", "start": 272, "end": 274}]}, {"id": "E19", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 270, "end": 271}, "arguments": [{"entity_id": "T49", "role": "Theme", "text": "dermal microvascular endothelial cells", "start": 275, "end": 279}]}, {"id": "E51", "event_type": "Positive_regulation", "trigger": {"text": "resulted", "start": 280, "end": 281}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "caspase-3", "start": 282, "end": 285}]}, {"id": "E41", "event_type": "Death", "trigger": {"text": "death", "start": 288, "end": 289}, "arguments": [{"entity_id": "T100", "role": "Theme", "text": "Cell", "start": 287, "end": 288}]}, {"id": "E42", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 289, "end": 290}, "arguments": []}, {"id": "E23", "event_type": "Planned_process", "trigger": {"text": "targeting", "start": 292, "end": 293}, "arguments": [{"entity_id": "T53", "role": "Theme", "text": "survivin", "start": 291, "end": 292}]}, {"id": "E54", "event_type": "Localization", "trigger": {"text": "release", "start": 302, "end": 303}, "arguments": [{"entity_id": "T55", "role": "Theme", "text": "cytochrome c", "start": 304, "end": 306}]}, {"id": "E56", "event_type": "Planned_process", "trigger": {"text": "knockout", "start": 323, "end": 324}, "arguments": [{"entity_id": "T58", "role": "Theme", "text": "caspase-9", "start": 320, "end": 323}]}, {"id": "E25", "event_type": "Planned_process", "trigger": {"text": "knockout", "start": 323, "end": 324}, "arguments": [{"entity_id": "T57", "role": "Theme", "text": "Apaf-1", "start": 316, "end": 319}]}, {"id": "E27", "event_type": "Planned_process", "trigger": {"text": "injected", "start": 329, "end": 330}, "arguments": [{"entity_id": "T60", "role": "Theme", "text": "breast cancer xenografts", "start": 332, "end": 335}, {"entity_id": "T62", "role": "Instrument", "text": "pAd-T34A", "start": 336, "end": 339}]}, {"id": "E61", "event_type": "Negative_regulation", "trigger": {"text": "inhibited", "start": 339, "end": 340}, "arguments": [{"entity_id": "T62", "role": "Cause", "text": "pAd-T34A", "start": 336, "end": 339}]}, {"id": "E63", "event_type": "Growth", "trigger": {"text": "growth", "start": 340, "end": 341}, "arguments": [{"entity_id": "T64", "role": "Theme", "text": "tumors", "start": 343, "end": 344}]}, {"id": "E28", "event_type": "Positive_regulation", "trigger": {"text": "triggered", "start": 345, "end": 346}, "arguments": [{"entity_id": "T62", "role": "Cause", "text": "pAd-T34A", "start": 336, "end": 339}]}, {"id": "E29", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 348, "end": 349}, "arguments": [{"entity_id": "T65", "role": "Theme", "text": "tumor cell", "start": 346, "end": 348}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T10", "role": "Arg1", "text": "umbilical vein", "start": 89, "end": 91}, {"entity_id": "T10", "role": "Arg1", "text": "umbilical vein", "start": 89, "end": 91}]}, {"id": "R2", "relation_type": "frag", "arguments": [{"entity_id": "T47", "role": "Arg1", "text": "umbilical vein", "start": 272, "end": 274}, {"entity_id": "T47", "role": "Arg1", "text": "umbilical vein", "start": 272, "end": 274}]}, {"id": "R3", "relation_type": "frag", "arguments": [{"entity_id": "T85", "role": "Arg1", "text": "-7", "start": 249, "end": 251}, {"entity_id": "T85", "role": "Arg1", "text": "-7", "start": 249, "end": 251}]}], "entity_mentions": [{"id": "T45", "text": "targeting", "entity_type": "Regulation", "start": 1, "end": 2}, {"id": "T2", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 4, "end": 5}, {"id": "T1", "text": "pathway", "entity_type": "Pathway", "start": 5, "end": 6}, {"id": "T48", "text": "suppression", "entity_type": "Negative_regulation", "start": 14, "end": 15}, {"id": "T76", "text": "tumor", "entity_type": "Pathological_formation", "start": 16, "end": 17}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 19, "end": 20}, {"id": "T4", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 31, "end": 32}, {"id": "T50", "text": "triggering", "entity_type": "Positive_regulation", "start": 40, "end": 41}, {"id": "T11", "text": "tumor cell", "entity_type": "Cell", "start": 41, "end": 43}, {"id": "T66", "text": "apoptosis", "entity_type": "Death", "start": 43, "end": 44}, {"id": "T5", "text": "inhibiting", "entity_type": "Negative_regulation", "start": 50, "end": 51}, {"id": "T7", "text": "tumor", "entity_type": "Pathological_formation", "start": 51, "end": 52}, {"id": "T6", "text": "growth", "entity_type": "Growth", "start": 52, "end": 53}, {"id": "T8", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 60, "end": 61}, {"id": "T95", "text": "cell", "entity_type": "Cell", "start": 64, "end": 65}, {"id": "T96", "text": "death", "entity_type": "Death", "start": 65, "end": 66}, {"id": "T9", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 77, "end": 78}, {"id": "T1000", "text": "Human", "entity_type": "Organism", "start": 88, "end": 89}, {"id": "T10", "text": "umbilical vein", "entity_type": "Cell", "start": 89, "end": 91}, {"id": "T12", "text": "dermal microvascular endothelial cells", "entity_type": "Cell", "start": 92, "end": 96}, {"id": "T77", "text": "infected", "entity_type": "Planned_process", "start": 97, "end": 98}, {"id": "T79", "text": "adenoviruses", "entity_type": "Organism", "start": 102, "end": 103}, {"id": "T14", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 104, "end": 105}, {"id": "T15", "text": "pAd-Survivin", "entity_type": "Gene_or_gene_product", "start": 106, "end": 108}, {"id": "T13", "text": "green fluorescent protein", "entity_type": "Gene_or_gene_product", "start": 110, "end": 113}, {"id": "T16", "text": "pAd-GFP", "entity_type": "Gene_or_gene_product", "start": 114, "end": 117}, {"id": "T17", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 124, "end": 125}, {"id": "T18", "text": "pAd-T34A", "entity_type": "Gene_or_gene_product", "start": 132, "end": 135}, {"id": "T20", "text": "effect", "entity_type": "Regulation", "start": 141, "end": 142}, {"id": "T19", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 148, "end": 149}, {"id": "T21", "text": "capillary network", "entity_type": "Multi-tissue_structure", "start": 152, "end": 154}, {"id": "T23", "text": "endothelial cell", "entity_type": "Cell", "start": 156, "end": 158}, {"id": "T25", "text": "caspase", "entity_type": "Gene_or_gene_product", "start": 161, "end": 162}, {"id": "T24", "text": "activation", "entity_type": "Positive_regulation", "start": 162, "end": 163}, {"id": "T27", "text": "tumor", "entity_type": "Pathological_formation", "start": 169, "end": 170}, {"id": "T26", "text": "growth", "entity_type": "Growth", "start": 170, "end": 171}, {"id": "T28", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 174, "end": 175}, {"id": "T29", "text": "breast cancer xenograft", "entity_type": "Pathological_formation", "start": 177, "end": 180}, {"id": "T97", "text": "cell", "entity_type": "Cell", "start": 185, "end": 186}, {"id": "T98", "text": "death", "entity_type": "Death", "start": 186, "end": 187}, {"id": "T99", "text": "initiated", "entity_type": "Positive_regulation", "start": 188, "end": 189}, {"id": "T30", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 190, "end": 191}, {"id": "T81", "text": "targeting", "entity_type": "Planned_process", "start": 191, "end": 192}, {"id": "T32", "text": "cytochrome c", "entity_type": "Gene_or_gene_product", "start": 197, "end": 199}, {"id": "T31", "text": "release", "entity_type": "Localization", "start": 199, "end": 200}, {"id": "T1001", "text": "mouse", "entity_type": "Organism", "start": 211, "end": 212}, {"id": "T33", "text": "embryonic fibroblasts", "entity_type": "Cell", "start": 212, "end": 214}, {"id": "T82", "text": "deficient", "entity_type": "Gene_expression", "start": 214, "end": 215}, {"id": "T34", "text": "Apaf-1", "entity_type": "Gene_or_gene_product", "start": 216, "end": 219}, {"id": "T35", "text": "caspase-9", "entity_type": "Gene_or_gene_product", "start": 220, "end": 223}, {"id": "T84", "text": "Adenoviral", "entity_type": "Organism", "start": 226, "end": 227}, {"id": "T83", "text": "transduction", "entity_type": "Planned_process", "start": 227, "end": 228}, {"id": "T36", "text": "endothelial cells", "entity_type": "Cell", "start": 229, "end": 231}, {"id": "T37", "text": "pAd-Survivin", "entity_type": "Gene_or_gene_product", "start": 232, "end": 233}, {"id": "T38", "text": "ceramide", "entity_type": "Drug_or_compound", "start": 239, "end": 240}, {"id": "T39", "text": "reduced", "entity_type": "Negative_regulation", "start": 244, "end": 245}, {"id": "T41", "text": "caspase-3", "entity_type": "Gene_or_gene_product", "start": 245, "end": 248}, {"id": "T85", "text": "-7", "entity_type": "Gene_or_gene_product", "start": 249, "end": 251}, {"id": "T40", "text": "generation", "entity_type": "Gene_expression", "start": 251, "end": 252}, {"id": "T42", "text": "capillary networks", "entity_type": "Multi-tissue_structure", "start": 258, "end": 260}, {"id": "T43", "text": "expression", "entity_type": "Gene_expression", "start": 265, "end": 266}, {"id": "T44", "text": "pAd-T34A", "entity_type": "Gene_or_gene_product", "start": 267, "end": 269}, {"id": "T87", "text": "caused", "entity_type": "Positive_regulation", "start": 269, "end": 270}, {"id": "T86", "text": "apoptosis", "entity_type": "Death", "start": 270, "end": 271}, {"id": "T47", "text": "umbilical vein", "entity_type": "Cell", "start": 272, "end": 274}, {"id": "T49", "text": "dermal microvascular endothelial cells", "entity_type": "Cell", "start": 275, "end": 279}, {"id": "T51", "text": "resulted", "entity_type": "Positive_regulation", "start": 280, "end": 281}, {"id": "T52", "text": "caspase-3", "entity_type": "Gene_or_gene_product", "start": 282, "end": 285}, {"id": "T100", "text": "Cell", "entity_type": "Cell", "start": 287, "end": 288}, {"id": "T101", "text": "death", "entity_type": "Death", "start": 288, "end": 289}, {"id": "T102", "text": "induced", "entity_type": "Positive_regulation", "start": 289, "end": 290}, {"id": "T53", "text": "survivin", "entity_type": "Gene_or_gene_product", "start": 291, "end": 292}, {"id": "T88", "text": "targeting", "entity_type": "Planned_process", "start": 292, "end": 293}, {"id": "T54", "text": "release", "entity_type": "Localization", "start": 302, "end": 303}, {"id": "T55", "text": "cytochrome c", "entity_type": "Gene_or_gene_product", "start": 304, "end": 306}, {"id": "T57", "text": "Apaf-1", "entity_type": "Gene_or_gene_product", "start": 316, "end": 319}, {"id": "T58", "text": "caspase-9", "entity_type": "Gene_or_gene_product", "start": 320, "end": 323}, {"id": "T22", "text": "knockout", "entity_type": "Planned_process", "start": 323, "end": 324}, {"id": "T1002", "text": "mouse", "entity_type": "Organism", "start": 324, "end": 325}, {"id": "T59", "text": "embryonic fibroblasts", "entity_type": "Cell", "start": 325, "end": 327}, {"id": "T89", "text": "injected", "entity_type": "Planned_process", "start": 329, "end": 330}, {"id": "T1003", "text": "human", "entity_type": "Organism", "start": 331, "end": 332}, {"id": "T60", "text": "breast cancer xenografts", "entity_type": "Pathological_formation", "start": 332, "end": 335}, {"id": "T62", "text": "pAd-T34A", "entity_type": "Gene_or_gene_product", "start": 336, "end": 339}, {"id": "T61", "text": "inhibited", "entity_type": "Negative_regulation", "start": 339, "end": 340}, {"id": "T63", "text": "growth", "entity_type": "Growth", "start": 340, "end": 341}, {"id": "T64", "text": "tumors", "entity_type": "Pathological_formation", "start": 343, "end": 344}, {"id": "T90", "text": "triggered", "entity_type": "Positive_regulation", "start": 345, "end": 346}, {"id": "T65", "text": "tumor cell", "entity_type": "Cell", "start": 346, "end": 348}, {"id": "T91", "text": "apoptosis", "entity_type": "Death", "start": 348, "end": 349}], "lang": "en"}
{"doc_id": "PMID-12855648", "wnd_id": "PMID-12855648_1", "text": "This was associated with a approximately 60% reduction in tumor-derived blood vessels by quantitative morphometry of CD31-stained tumor areas, and appearance of endothelial cell apoptosis by internucleosomal DNA fragmentation in vivo. CONCLUSIONS: Survivin functions as a novel upstream regulator of mitochondrial-dependent apoptosis, and molecular targeting of this pathway results in anticancer activity via a dual mechanism of induction of tumor cell apoptosis and suppression of angiogenesis.", "tokens": ["This", "was", "associated", "with", "a", "approximately", "60", "%", "reduction", "in", "tumor", "-", "derived", "blood", "vessels", "by", "quantitative", "morphometry", "of", "CD31", "-", "stained", "tumor", "areas", ",", "and", "appearance", "of", "endothelial", "cell", "apoptosis", "by", "internucleosomal", "DNA", "fragmentation", "in", "vivo", ".", "CONCLUSIONS", ":", "Survivin", "functions", "as", "a", "novel", "upstream", "regulator", "of", "mitochondrial", "-", "dependent", "apoptosis", ",", "and", "molecular", "targeting", "of", "this", "pathway", "results", "in", "anticancer", "activity", "via", "a", "dual", "mechanism", "of", "induction", "of", "tumor", "cell", "apoptosis", "and", "suppression", "of", "angiogenesis", "."], "event_mentions": [{"id": "E30", "event_type": "Negative_regulation", "trigger": {"text": "reduction", "start": 8, "end": 9}, "arguments": [{"entity_id": "T68", "role": "Theme", "text": "blood vessels", "start": 13, "end": 15}]}, {"id": "E32", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 30, "end": 31}, "arguments": [{"entity_id": "T71", "role": "Theme", "text": "endothelial cell", "start": 28, "end": 30}]}, {"id": "E33", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 68, "end": 69}, "arguments": []}, {"id": "E34", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 72, "end": 73}, "arguments": [{"entity_id": "T75", "role": "Theme", "text": "tumor cell", "start": 70, "end": 72}]}, {"id": "E35", "event_type": "Negative_regulation", "trigger": {"text": "suppression", "start": 74, "end": 75}, "arguments": []}, {"id": "E45", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 76, "end": 77}, "arguments": []}], "relation_mentions": [], "entity_mentions": [{"id": "T92", "text": "reduction", "entity_type": "Negative_regulation", "start": 8, "end": 9}, {"id": "T67", "text": "tumor", "entity_type": "Pathological_formation", "start": 10, "end": 11}, {"id": "T68", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 13, "end": 15}, {"id": "T69", "text": "CD31", "entity_type": "Gene_or_gene_product", "start": 19, "end": 20}, {"id": "T70", "text": "tumor", "entity_type": "Pathological_formation", "start": 22, "end": 23}, {"id": "T71", "text": "endothelial cell", "entity_type": "Cell", "start": 28, "end": 30}, {"id": "T93", "text": "apoptosis", "entity_type": "Death", "start": 30, "end": 31}, {"id": "T73", "text": "Survivin", "entity_type": "Gene_or_gene_product", "start": 40, "end": 41}, {"id": "T72", "text": "induction", "entity_type": "Positive_regulation", "start": 68, "end": 69}, {"id": "T75", "text": "tumor cell", "entity_type": "Cell", "start": 70, "end": 72}, {"id": "T74", "text": "apoptosis", "entity_type": "Death", "start": 72, "end": 73}, {"id": "T94", "text": "suppression", "entity_type": "Negative_regulation", "start": 74, "end": 75}, {"id": "T78", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 76, "end": 77}], "lang": "en"}
{"doc_id": "PMID-14555793", "wnd_id": "PMID-14555793_0", "text": "Therapeutic angiogenesis: a complex problem requiring a sophisticated approach.\n\nBlood and vascular disorders underlie a plethora of pathologic conditions and are the single most frequent cause of human disease. Ischemia, involving restricted blood flow to tissues is the most common consequence of vessel dysfunction resulting in the disruption of oxygen and nutrient delivery and the accumulation of waste metabolites. Cells cannot survive extended severe ischemia but may be able to adapt to a moderate condition where diffusion to and from bordering nonischemic regions sustains vital functions. Under this condition, the secondary functions of effected cells are likely to be impaired, and a new metabolic equilibrium is established, determined by the level of cross-diffusion and degree of hypoxia. In tissues with a normally high metabolic turnover such as skeletal and cardiac muscle, even mild ischemia causes hypoxia, acidosis, and depressed function (contractility) and eventually threatens myocyte viability and organ function. Ischemic cardiac muscle is additionally vulnerable because reperfusion is essential for survival but reperfusion itself poses additional stress principally from increased production of free radicals during reoxygenation. The latter effect is called reperfusion injury and can cause as much damage as the ischemia. The treatment possibilities for ischemia-related vascular disease are limited. Lipid/cholesterol-lowering agents, diet and antiplatelet adherence (aspirin) therapy may help slow the progression of vessel disease in some instances; but surgical reconstruction may be the only option in advanced stages, and even this is not always an option. An alternative and rather obvious strategy to treat ischemia is to activate endogenous angiogenic or arteriogenic pathways to stimulate revascularization of the tissue. The feasibility of such a strategy has now been established through the results of studies over the past decade, and a new discipline called therapeutic angiogenesis has emerged. This review focuses on the application of therapeutic angiogenesis for treating ischemic muscle disease and includes a critical evaluation of the parameters and limitations of current procedures. The development of this technology has benefited from its application to both peripheral and coronary artery disease and results from both are reviewed here.", "tokens": ["Therapeutic", "angiogenesis", ":", "a", "complex", "problem", "requiring", "a", "sophisticated", "approach", ".", "Blood", "and", "vascular", "disorders", "underlie", "a", "plethora", "of", "pathologic", "conditions", "and", "are", "the", "single", "most", "frequent", "cause", "of", "human", "disease", ".", "Ischemia", ",", "involving", "restricted", "blood", "flow", "to", "tissues", "is", "the", "most", "common", "consequence", "of", "vessel", "dysfunction", "resulting", "in", "the", "disruption", "of", "oxygen", "and", "nutrient", "delivery", "and", "the", "accumulation", "of", "waste", "metabolites", ".", "Cells", "cannot", "survive", "extended", "severe", "ischemia", "but", "may", "be", "able", "to", "adapt", "to", "a", "moderate", "condition", "where", "diffusion", "to", "and", "from", "bordering", "nonischemic", "regions", "sustains", "vital", "functions", ".", "Under", "this", "condition", ",", "the", "secondary", "functions", "of", "effected", "cells", "are", "likely", "to", "be", "impaired", ",", "and", "a", "new", "metabolic", "equilibrium", "is", "established", ",", "determined", "by", "the", "level", "of", "cross-diffusion", "and", "degree", "of", "hypoxia", ".", "In", "tissues", "with", "a", "normally", "high", "metabolic", "turnover", "such", "as", "skeletal", "and", "cardiac", "muscle", ",", "even", "mild", "ischemia", "causes", "hypoxia", ",", "acidosis", ",", "and", "depressed", "function", "(", "contractility", ")", "and", "eventually", "threatens", "myocyte", "viability", "and", "organ", "function", ".", "Ischemic", "cardiac", "muscle", "is", "additionally", "vulnerable", "because", "reperfusion", "is", "essential", "for", "survival", "but", "reperfusion", "itself", "poses", "additional", "stress", "principally", "from", "increased", "production", "of", "free", "radicals", "during", "reoxygenation", ".", "The", "latter", "effect", "is", "called", "reperfusion", "injury", "and", "can", "cause", "as", "much", "damage", "as", "the", "ischemia", ".", "The", "treatment", "possibilities", "for", "ischemia", "-", "related", "vascular", "disease", "are", "limited", ".", "Lipid", "/", "cholesterol", "-", "lowering", "agents", ",", "diet", "and", "antiplatelet", "adherence", "(", "aspirin", ")", "therapy", "may", "help", "slow", "the", "progression", "of", "vessel", "disease", "in", "some", "instances", ";", "but", "surgical", "reconstruction", "may", "be", "the", "only", "option", "in", "advanced", "stages", ",", "and", "even", "this", "is", "not", "always", "an", "option", ".", "An", "alternative", "and", "rather", "obvious", "strategy", "to", "treat", "ischemia", "is", "to", "activate", "endogenous", "angiogenic", "or", "arteriogenic", "pathways", "to", "stimulate", "revascularization", "of", "the", "tissue", ".", "The", "feasibility", "of", "such", "a", "strategy", "has", "now", "been", "established", "through", "the", "results", "of", "studies", "over", "the", "past", "decade", ",", "and", "a", "new", "discipline", "called", "therapeutic", "angiogenesis", "has", "emerged", ".", "This", "review", "focuses", "on", "the", "application", "of", "therapeutic", "angiogenesis", "for", "treating", "ischemic", "muscle", "disease", "and", "includes", "a", "critical", "evaluation", "of", "the", "parameters", "and", "limitations", "of", "current", "procedures", ".", "The", "development", "of", "this", "technology", "has", "benefited", "from", "its", "application", "to", "both", "peripheral", "and", "coronary", "artery", "disease", "and", "results", "from", "both", "are", "reviewed", "here", "."], "event_mentions": [{"id": "E10", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 1, "end": 2}, "arguments": []}, {"id": "E1", "event_type": "Breakdown", "trigger": {"text": "dysfunction", "start": 47, "end": 48}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "vessel", "start": 46, "end": 47}]}, {"id": "E2", "event_type": "Catabolism", "trigger": {"text": "disruption", "start": 51, "end": 52}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "oxygen", "start": 53, "end": 54}]}, {"id": "E9", "event_type": "Death", "trigger": {"text": "survive", "start": 66, "end": 67}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "Cells", "start": 64, "end": 65}]}, {"id": "E8", "event_type": "Regulation", "trigger": {"text": "effected", "start": 100, "end": 101}, "arguments": [{"entity_id": "T33", "role": "Theme", "text": "cells", "start": 101, "end": 102}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "therapy", "start": 236, "end": 237}, "arguments": [{"entity_id": "T12", "role": "Instrument", "text": "aspirin", "start": 234, "end": 235}]}, {"id": "E4", "event_type": "Positive_regulation", "trigger": {"text": "activate", "start": 281, "end": 282}, "arguments": []}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "activate", "start": 281, "end": 282}, "arguments": []}, {"id": "E11", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 283, "end": 284}, "arguments": []}, {"id": "E12", "event_type": "Blood_vessel_development", "trigger": {"text": "arteriogenic pathways", "start": 285, "end": 287}, "arguments": []}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "stimulate", "start": 288, "end": 289}, "arguments": []}, {"id": "E7", "event_type": "Positive_regulation", "trigger": {"text": "stimulate", "start": 288, "end": 289}, "arguments": []}, {"id": "E13", "event_type": "Blood_vessel_development", "trigger": {"text": "revascularization", "start": 289, "end": 290}, "arguments": []}, {"id": "E14", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 320, "end": 321}, "arguments": []}, {"id": "E15", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 332, "end": 333}, "arguments": []}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T7", "role": "Arg1", "text": "skeletal", "start": 137, "end": 138}, {"entity_id": "T7", "role": "Arg1", "text": "skeletal", "start": 137, "end": 138}]}, {"id": "R2", "relation_type": "frag", "arguments": [{"entity_id": "T3", "role": "Arg1", "text": "peripheral", "start": 364, "end": 365}, {"entity_id": "T3", "role": "Arg1", "text": "peripheral", "start": 364, "end": 365}]}], "entity_mentions": [{"id": "T1", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 1, "end": 2}, {"id": "T2", "text": "Blood", "entity_type": "Organism_substance", "start": 11, "end": 12}, {"id": "T28", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 13, "end": 14}, {"id": "T1000", "text": "human", "entity_type": "Organism", "start": 29, "end": 30}, {"id": "T4", "text": "blood", "entity_type": "Organism_substance", "start": 36, "end": 37}, {"id": "T31", "text": "tissues", "entity_type": "Tissue", "start": 39, "end": 40}, {"id": "T5", "text": "vessel", "entity_type": "Multi-tissue_structure", "start": 46, "end": 47}, {"id": "T11", "text": "dysfunction", "entity_type": "Breakdown", "start": 47, "end": 48}, {"id": "T21", "text": "disruption", "entity_type": "Catabolism", "start": 51, "end": 52}, {"id": "T6", "text": "oxygen", "entity_type": "Drug_or_compound", "start": 53, "end": 54}, {"id": "T35", "text": "Cells", "entity_type": "Cell", "start": 64, "end": 65}, {"id": "T36", "text": "survive", "entity_type": "Death", "start": 66, "end": 67}, {"id": "T34", "text": "effected", "entity_type": "Regulation", "start": 100, "end": 101}, {"id": "T33", "text": "cells", "entity_type": "Cell", "start": 101, "end": 102}, {"id": "T32", "text": "tissues", "entity_type": "Tissue", "start": 128, "end": 129}, {"id": "T7", "text": "skeletal", "entity_type": "Tissue", "start": 137, "end": 138}, {"id": "T8", "text": "cardiac muscle", "entity_type": "Tissue", "start": 139, "end": 141}, {"id": "T9", "text": "myocyte", "entity_type": "Cell", "start": 159, "end": 160}, {"id": "T29", "text": "organ", "entity_type": "Organ", "start": 162, "end": 163}, {"id": "T10", "text": "cardiac muscle", "entity_type": "Tissue", "start": 166, "end": 168}, {"id": "T23", "text": "Lipid", "entity_type": "Drug_or_compound", "start": 222, "end": 223}, {"id": "T24", "text": "cholesterol", "entity_type": "Drug_or_compound", "start": 224, "end": 225}, {"id": "T12", "text": "aspirin", "entity_type": "Drug_or_compound", "start": 234, "end": 235}, {"id": "T22", "text": "therapy", "entity_type": "Planned_process", "start": 236, "end": 237}, {"id": "T13", "text": "vessel", "entity_type": "Multi-tissue_structure", "start": 243, "end": 244}, {"id": "T25", "text": "activate", "entity_type": "Positive_regulation", "start": 281, "end": 282}, {"id": "T14", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 283, "end": 284}, {"id": "T15", "text": "arteriogenic pathways", "entity_type": "Blood_vessel_development", "start": 285, "end": 287}, {"id": "T27", "text": "stimulate", "entity_type": "Positive_regulation", "start": 288, "end": 289}, {"id": "T16", "text": "revascularization", "entity_type": "Blood_vessel_development", "start": 289, "end": 290}, {"id": "T30", "text": "tissue", "entity_type": "Tissue", "start": 292, "end": 293}, {"id": "T17", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 320, "end": 321}, {"id": "T18", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 332, "end": 333}, {"id": "T19", "text": "muscle", "entity_type": "Organ", "start": 336, "end": 337}, {"id": "T3", "text": "peripheral", "entity_type": "Multi-tissue_structure", "start": 364, "end": 365}, {"id": "T20", "text": "coronary artery", "entity_type": "Multi-tissue_structure", "start": 366, "end": 368}], "lang": "en"}
{"doc_id": "PMID-14604834", "wnd_id": "PMID-14604834_0", "text": "Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.\n\nThe vascular insulin-like growth factor (IGF)-1 system includes the IGFs, the IGF-1 receptor (IGF-1R), and multiple binding proteins. This growth factor system exerts multiple physiologic effects on the vasculature through both endocrine and autocrine/paracrine mechanisms. The effects of IGF-1 are mediated principally through the IGF-1R but are modulated by complex interactions with multiple IGF binding proteins that themselves are regulated by phosphorylation, proteolysis, polymerization, and cell or matrix association. During the last decade, a significant body of evidence has accumulated, indicating that expression of the components of the IGF system are regulated by multiple factors, including growth factors, cytokines, lipoproteins, reactive oxygen species, and hemodynamic forces. In addition, cross-talk between the IGF system and other growth factors and integrin receptors has been demonstrated. There is accumulating evidence of a role for IGF-1 in multiple vascular pathologies, including atherosclerosis, hypertension, restenosis, angiogenesis, and diabetic vascular disease. This review will discuss the regulation of expression of IGF-1, IGF-1R, and IGF binding proteins in the vasculature and summarize evidence implicating involvement of this system in vascular diseases.", "tokens": ["Expression", ",", "regulation", ",", "and", "function", "of", "IGF", "-", "1", ",", "IGF", "-", "1R", ",", "and", "IGF", "-", "1", "binding", "proteins", "in", "blood", "vessels", ".", "The", "vascular", "insulin", "-", "like", "growth", "factor", "(", "IGF", ")", "-", "1", "system", "includes", "the", "IGFs", ",", "the", "IGF", "-", "1", "receptor", "(", "IGF", "-", "1R", ")", ",", "and", "multiple", "binding", "proteins", ".", "This", "growth", "factor", "system", "exerts", "multiple", "physiologic", "effects", "on", "the", "vasculature", "through", "both", "endocrine", "and", "autocrine", "/", "paracrine", "mechanisms", ".", "The", "effects", "of", "IGF", "-", "1", "are", "mediated", "principally", "through", "the", "IGF", "-", "1", "R", "but", "are", "modulated", "by", "complex", "interactions", "with", "multiple", "IGF", "binding", "proteins", "that", "themselves", "are", "regulated", "by", "phosphorylation", ",", "proteolysis", ",", "polymerization", ",", "and", "cell", "or", "matrix", "association", ".", "During", "the", "last", "decade", ",", "a", "significant", "body", "of", "evidence", "has", "accumulated", ",", "indicating", "that", "expression", "of", "the", "components", "of", "the", "IGF", "system", "are", "regulated", "by", "multiple", "factors", ",", "including", "growth", "factors", ",", "cytokines", ",", "lipoproteins", ",", "reactive", "oxygen", "species", ",", "and", "hemodynamic", "forces", ".", "In", "addition", ",", "cross", "-", "talk", "between", "the", "IGF", "system", "and", "other", "growth", "factors", "and", "integrin", "receptors", "has", "been", "demonstrated", ".", "There", "is", "accumulating", "evidence", "of", "a", "role", "for", "IGF", "-", "1", "in", "multiple", "vascular", "pathologies", ",", "including", "atherosclerosis", ",", "hypertension", ",", "restenosis", ",", "angiogenesis", ",", "and", "diabetic", "vascular", "disease", ".", "This", "review", "will", "discuss", "the", "regulation", "of", "expression", "of", "IGF", "-", "1", ",", "IGF", "-", "1R", ",", "and", "IGF", "binding", "proteins", "in", "the", "vasculature", "and", "summarize", "evidence", "implicating", "involvement", "of", "this", "system", "in", "vascular", "diseases", "."], "event_mentions": [{"id": "E1", "event_type": "Gene_expression", "trigger": {"text": "Expression", "start": 0, "end": 1}, "arguments": [{"entity_id": "T1", "role": "Theme", "text": "IGF-1", "start": 7, "end": 10}]}, {"id": "E5", "event_type": "Gene_expression", "trigger": {"text": "Expression", "start": 0, "end": 1}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "IGF-1R", "start": 11, "end": 14}]}, {"id": "E6", "event_type": "Gene_expression", "trigger": {"text": "Expression", "start": 0, "end": 1}, "arguments": [{"entity_id": "T3", "role": "Theme", "text": "IGF-1 binding proteins", "start": 16, "end": 21}]}, {"id": "E2", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 2, "end": 3}, "arguments": [{"entity_id": "T1", "role": "Theme", "text": "IGF-1", "start": 7, "end": 10}]}, {"id": "E3", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 2, "end": 3}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "IGF-1R", "start": 11, "end": 14}]}, {"id": "E4", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 2, "end": 3}, "arguments": [{"entity_id": "T3", "role": "Theme", "text": "IGF-1 binding proteins", "start": 16, "end": 21}]}, {"id": "E26", "event_type": "Pathway", "trigger": {"text": "system", "start": 37, "end": 38}, "arguments": [{"entity_id": "T6", "role": "Participant", "text": "insulin-like growth factor (IGF)-1", "start": 27, "end": 37}]}, {"id": "E8", "event_type": "Regulation", "trigger": {"text": "mediated", "start": 85, "end": 86}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "IGF-1", "start": 81, "end": 84}]}, {"id": "E7", "event_type": "Binding", "trigger": {"text": "interactions", "start": 98, "end": 99}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "IGF-1", "start": 81, "end": 84}, {"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "regulated", "start": 107, "end": 108}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E14", "event_type": "Regulation", "trigger": {"text": "regulated", "start": 107, "end": 108}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E15", "event_type": "Regulation", "trigger": {"text": "regulated", "start": 107, "end": 108}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E16", "event_type": "Regulation", "trigger": {"text": "regulated", "start": 107, "end": 108}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E27", "event_type": "Regulation", "trigger": {"text": "regulated", "start": 107, "end": 108}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E9", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 109, "end": 110}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E10", "event_type": "Catabolism", "trigger": {"text": "proteolysis", "start": 111, "end": 112}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E11", "event_type": "Binding", "trigger": {"text": "polymerization", "start": 113, "end": 114}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}]}, {"id": "E13", "event_type": "Binding", "trigger": {"text": "association", "start": 119, "end": 120}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}, {"entity_id": "T14", "role": "Theme", "text": "matrix", "start": 118, "end": 119}]}, {"id": "E25", "event_type": "Binding", "trigger": {"text": "association", "start": 119, "end": 120}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "IGF binding proteins", "start": 101, "end": 104}, {"entity_id": "T21", "role": "Theme", "text": "cell", "start": 116, "end": 117}]}, {"id": "E28", "event_type": "Pathway", "trigger": {"text": "system", "start": 143, "end": 144}, "arguments": [{"entity_id": "T23", "role": "Participant", "text": "IGF", "start": 142, "end": 143}]}, {"id": "E29", "event_type": "Pathway", "trigger": {"text": "system", "start": 175, "end": 176}, "arguments": [{"entity_id": "T39", "role": "Participant", "text": "IGF", "start": 174, "end": 175}]}, {"id": "E17", "event_type": "Regulation", "trigger": {"text": "role", "start": 193, "end": 194}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "IGF-1", "start": 195, "end": 198}]}, {"id": "E23", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 210, "end": 211}, "arguments": []}, {"id": "E18", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 222, "end": 223}, "arguments": []}, {"id": "E21", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 222, "end": 223}, "arguments": []}, {"id": "E22", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 222, "end": 223}, "arguments": []}, {"id": "E24", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 224, "end": 225}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "IGF-1", "start": 226, "end": 229}]}, {"id": "E19", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 224, "end": 225}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "IGF-1R", "start": 230, "end": 233}]}, {"id": "E20", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 224, "end": 225}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "IGF binding proteins", "start": 235, "end": 238}]}], "relation_mentions": [], "entity_mentions": [{"id": "T29", "text": "Expression", "entity_type": "Gene_expression", "start": 0, "end": 1}, {"id": "T30", "text": "regulation", "entity_type": "Regulation", "start": 2, "end": 3}, {"id": "T1", "text": "IGF-1", "entity_type": "Gene_or_gene_product", "start": 7, "end": 10}, {"id": "T2", "text": "IGF-1R", "entity_type": "Gene_or_gene_product", "start": 11, "end": 14}, {"id": "T3", "text": "IGF-1 binding proteins", "entity_type": "Gene_or_gene_product", "start": 16, "end": 21}, {"id": "T4", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 22, "end": 24}, {"id": "T6", "text": "insulin-like growth factor (IGF)-1", "entity_type": "Gene_or_gene_product", "start": 27, "end": 37}, {"id": "T5", "text": "system", "entity_type": "Pathway", "start": 37, "end": 38}, {"id": "T7", "text": "IGFs", "entity_type": "Gene_or_gene_product", "start": 40, "end": 41}, {"id": "T8", "text": "IGF-1 receptor", "entity_type": "Gene_or_gene_product", "start": 43, "end": 47}, {"id": "T9", "text": "IGF-1R", "entity_type": "Gene_or_gene_product", "start": 48, "end": 51}, {"id": "T10", "text": "vasculature", "entity_type": "Anatomical_system", "start": 68, "end": 69}, {"id": "T11", "text": "IGF-1", "entity_type": "Gene_or_gene_product", "start": 81, "end": 84}, {"id": "T32", "text": "mediated", "entity_type": "Regulation", "start": 85, "end": 86}, {"id": "T12", "text": "IGF-1R", "entity_type": "Gene_or_gene_product", "start": 89, "end": 93}, {"id": "T31", "text": "interactions", "entity_type": "Binding", "start": 98, "end": 99}, {"id": "T13", "text": "IGF binding proteins", "entity_type": "Gene_or_gene_product", "start": 101, "end": 104}, {"id": "T36", "text": "regulated", "entity_type": "Regulation", "start": 107, "end": 108}, {"id": "T33", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 109, "end": 110}, {"id": "T34", "text": "proteolysis", "entity_type": "Catabolism", "start": 111, "end": 112}, {"id": "T35", "text": "polymerization", "entity_type": "Binding", "start": 113, "end": 114}, {"id": "T21", "text": "cell", "entity_type": "Cell", "start": 116, "end": 117}, {"id": "T14", "text": "matrix", "entity_type": "Cellular_component", "start": 118, "end": 119}, {"id": "T37", "text": "association", "entity_type": "Binding", "start": 119, "end": 120}, {"id": "T23", "text": "IGF", "entity_type": "Gene_or_gene_product", "start": 142, "end": 143}, {"id": "T15", "text": "system", "entity_type": "Pathway", "start": 143, "end": 144}, {"id": "T16", "text": "oxygen", "entity_type": "Drug_or_compound", "start": 159, "end": 160}, {"id": "T39", "text": "IGF", "entity_type": "Gene_or_gene_product", "start": 174, "end": 175}, {"id": "T17", "text": "system", "entity_type": "Pathway", "start": 175, "end": 176}, {"id": "T28", "text": "integrin", "entity_type": "Gene_or_gene_product", "start": 181, "end": 182}, {"id": "T38", "text": "role", "entity_type": "Regulation", "start": 193, "end": 194}, {"id": "T19", "text": "IGF-1", "entity_type": "Gene_or_gene_product", "start": 195, "end": 198}, {"id": "T20", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 210, "end": 211}, {"id": "T22", "text": "regulation", "entity_type": "Regulation", "start": 222, "end": 223}, {"id": "T24", "text": "expression", "entity_type": "Gene_expression", "start": 224, "end": 225}, {"id": "T25", "text": "IGF-1", "entity_type": "Gene_or_gene_product", "start": 226, "end": 229}, {"id": "T26", "text": "IGF-1R", "entity_type": "Gene_or_gene_product", "start": 230, "end": 233}, {"id": "T27", "text": "IGF binding proteins", "entity_type": "Gene_or_gene_product", "start": 235, "end": 238}, {"id": "T18", "text": "vasculature", "entity_type": "Anatomical_system", "start": 240, "end": 241}], "lang": "en"}
{"doc_id": "PMID-14984432", "wnd_id": "PMID-14984432_0", "text": "Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure?\n\nAngiogenic factors, in particular vascular endothelial growth factor (VEGF) and the angiopoietins, Ang-1 and -2, have recently generated significant interest, especially in oncology. The process of angiogenesis is also thought to occur in response to ischaemic conditions, which lie at the core of cardiovascular disease states such as coronary artery disease and congestive heart failure. However, current data do not conclusively show evidence of angiogenesis per se in these conditions, despite (for example) the presence of high levels of VEGF and Ang-2. High levels of these angiogenic factors in heart disease also have not translated into clinically significant new vessel formation, as in accelerated cancer growth or proliferative retinopathy. Indeed, we would hypothesize that these angiogenic markers--especially the angiopoietins--do not necessarily translate into new vessel formation in congestive heart failure (CHF), but may well reflect disturbances of endothelial integrity in CHF.", "tokens": ["Angiopoietin", "/", "tie", "-", "2", "as", "mediators", "of", "angiogenesis", ":", "a", "role", "in", "congestive", "heart", "failure", "?", "Angiogenic", "factors", ",", "in", "particular", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", "and", "the", "angiopoietins", ",", "Ang", "-", "1", "and", "-", "2", ",", "have", "recently", "generated", "significant", "interest", ",", "especially", "in", "oncology", ".", "The", "process", "of", "angiogenesis", "is", "also", "thought", "to", "occur", "in", "response", "to", "ischaemic", "conditions", ",", "which", "lie", "at", "the", "core", "of", "cardiovascular", "disease", "states", "such", "as", "coronary", "artery", "disease", "and", "congestive", "heart", "failure", ".", "However", ",", "current", "data", "do", "not", "conclusively", "show", "evidence", "of", "angiogenesis", "per", "se", "in", "these", "conditions", ",", "despite", "(", "for", "example", ")", "the", "presence", "of", "high", "levels", "of", "VEGF", "and", "Ang", "-", "2", ".", "High", "levels", "of", "these", "angiogenic", "factors", "in", "heart", "disease", "also", "have", "not", "translated", "into", "clinically", "significant", "new", "vessel", "formation", ",", "as", "in", "accelerated", "cancer", "growth", "or", "proliferative", "retinopathy", ".", "Indeed", ",", "we", "would", "hypothesize", "that", "these", "angiogenic", "markers", "--", "especially", "the", "angiopoietins", "--", "do", "not", "necessarily", "translate", "into", "new", "vessel", "formation", "in", "congestive", "heart", "failure", "(", "CHF", ")", ",", "but", "may", "well", "reflect", "disturbances", "of", "endothelial", "integrity", "in", "CHF", "."], "event_mentions": [{"id": "E6", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 8, "end": 9}, "arguments": []}, {"id": "E7", "event_type": "Blood_vessel_development", "trigger": {"text": "Angiogenic", "start": 17, "end": 18}, "arguments": []}, {"id": "E8", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 53, "end": 54}, "arguments": []}, {"id": "E9", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 94, "end": 95}, "arguments": []}, {"id": "E1", "event_type": "Localization", "trigger": {"text": "presence", "start": 107, "end": 108}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "VEGF", "start": 112, "end": 113}]}, {"id": "E2", "event_type": "Localization", "trigger": {"text": "presence", "start": 107, "end": 108}, "arguments": [{"entity_id": "T19", "role": "Theme", "text": "Ang-2", "start": 114, "end": 117}]}, {"id": "E10", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 122, "end": 123}, "arguments": []}, {"id": "E24", "event_type": "Development", "trigger": {"text": "formation", "start": 136, "end": 137}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "vessel", "start": 135, "end": 136}]}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "accelerated", "start": 140, "end": 141}, "arguments": []}, {"id": "E26", "event_type": "Growth", "trigger": {"text": "growth", "start": 142, "end": 143}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "cancer", "start": 141, "end": 142}]}, {"id": "E11", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 154, "end": 155}, "arguments": []}, {"id": "E4", "event_type": "Regulation", "trigger": {"text": "translate", "start": 164, "end": 165}, "arguments": [{"entity_id": "T29", "role": "Cause", "text": "angiopoietins", "start": 159, "end": 160}]}, {"id": "E32", "event_type": "Development", "trigger": {"text": "formation", "start": 168, "end": 169}, "arguments": [{"entity_id": "T33", "role": "Theme", "text": "vessel", "start": 167, "end": 168}]}, {"id": "E5", "event_type": "Regulation", "trigger": {"text": "reflect", "start": 180, "end": 181}, "arguments": [{"entity_id": "T29", "role": "Cause", "text": "angiopoietins", "start": 159, "end": 160}]}, {"id": "E35", "event_type": "Breakdown", "trigger": {"text": "disturbances", "start": 181, "end": 182}, "arguments": [{"entity_id": "T37", "role": "Theme", "text": "endothelial", "start": 183, "end": 184}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T10", "role": "Arg1", "text": "-2", "start": 37, "end": 39}, {"entity_id": "T10", "role": "Arg1", "text": "-2", "start": 37, "end": 39}]}], "entity_mentions": [{"id": "T1", "text": "Angiopoietin", "entity_type": "Gene_or_gene_product", "start": 0, "end": 1}, {"id": "T2", "text": "tie-2", "entity_type": "Gene_or_gene_product", "start": 2, "end": 5}, {"id": "T4", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 8, "end": 9}, {"id": "T5", "text": "heart", "entity_type": "Organ", "start": 14, "end": 15}, {"id": "T6", "text": "Angiogenic", "entity_type": "Blood_vessel_development", "start": 17, "end": 18}, {"id": "T7", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 22, "end": 26}, {"id": "T8", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 27, "end": 28}, {"id": "T9", "text": "angiopoietins", "entity_type": "Gene_or_gene_product", "start": 31, "end": 32}, {"id": "T11", "text": "Ang-1", "entity_type": "Gene_or_gene_product", "start": 33, "end": 36}, {"id": "T10", "text": "-2", "entity_type": "Gene_or_gene_product", "start": 37, "end": 39}, {"id": "T12", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 53, "end": 54}, {"id": "T14", "text": "coronary artery", "entity_type": "Multi-tissue_structure", "start": 76, "end": 78}, {"id": "T15", "text": "heart", "entity_type": "Organ", "start": 81, "end": 82}, {"id": "T17", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 94, "end": 95}, {"id": "T3", "text": "presence", "entity_type": "Localization", "start": 107, "end": 108}, {"id": "T18", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 112, "end": 113}, {"id": "T19", "text": "Ang-2", "entity_type": "Gene_or_gene_product", "start": 114, "end": 117}, {"id": "T20", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 122, "end": 123}, {"id": "T21", "text": "heart", "entity_type": "Organ", "start": 125, "end": 126}, {"id": "T25", "text": "vessel", "entity_type": "Multi-tissue_structure", "start": 135, "end": 136}, {"id": "T24", "text": "formation", "entity_type": "Development", "start": 136, "end": 137}, {"id": "T13", "text": "accelerated", "entity_type": "Positive_regulation", "start": 140, "end": 141}, {"id": "T27", "text": "cancer", "entity_type": "Pathological_formation", "start": 141, "end": 142}, {"id": "T26", "text": "growth", "entity_type": "Growth", "start": 142, "end": 143}, {"id": "T28", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 154, "end": 155}, {"id": "T29", "text": "angiopoietins", "entity_type": "Gene_or_gene_product", "start": 159, "end": 160}, {"id": "T16", "text": "translate", "entity_type": "Regulation", "start": 164, "end": 165}, {"id": "T33", "text": "vessel", "entity_type": "Multi-tissue_structure", "start": 167, "end": 168}, {"id": "T32", "text": "formation", "entity_type": "Development", "start": 168, "end": 169}, {"id": "T34", "text": "heart", "entity_type": "Organ", "start": 171, "end": 172}, {"id": "T22", "text": "reflect", "entity_type": "Regulation", "start": 180, "end": 181}, {"id": "T35", "text": "disturbances", "entity_type": "Breakdown", "start": 181, "end": 182}, {"id": "T37", "text": "endothelial", "entity_type": "Tissue", "start": 183, "end": 184}], "lang": "en"}
{"doc_id": "PMID-15510518", "wnd_id": "PMID-15510518_0", "text": "[Glaucoma and ocular ischemic syndrome--case report]\n\nPURPOSE: Ocular ischemic syndrome (OIS) is often poorly diagnosed and treated as primary open angle glaucoma or later on, as neovascular glaucoma. We present a 54 year old male, treated topical since 23 years for glaucoma and sent to our clinic for trabeculectomy because of rapid worsening of vision on right eye with bilateral total excavation of optic disc. MATERIAL AND METHODS: Observational case report. RESULTS: Because of typical signs of IOS (iris neovascularization, mid-peripheral dot and blot hemorrhages in both eyes, narrowed arterioles in right eye, following examinations were performed: Doppler ultrasonography of carotid arteries, digital subtractional angiography of the carotid vessels and magnetic resonance angiography. The examinations showed occlusion of the right common carotid artery and with 80% stenosis of the left common carotid artery, occlusion of abdominal aorta. After phacoemulsification with implantation of intraocular lens because of rapid intumescence cataract in the right eye, and endarterectomy of left external carotid artery, the neovascularization of the iris regressed in both eyes. CONCLUSION: In case of iris neovascularization or mid-peripheral hemorrhages the Doppler sonography of carotid arteries should be performed. Quick cooperation between ophthalmologist, radiologist and vascular surgeon following endarterectomy seems to stop progressing changes of ocular ischemic syndrome.", "tokens": ["[", "Glaucoma", "and", "ocular", "ischemic", "syndrome", "--", "case", "report", "]", "PURPOSE", ":", "Ocular", "ischemic", "syndrome", "(", "OIS", ")", "is", "often", "poorly", "diagnosed", "and", "treated", "as", "primary", "open", "angle", "glaucoma", "or", "later", "on", ",", "as", "neovascular", "glaucoma", ".", "We", "present", "a", "54", "year", "old", "male", ",", "treated", "topical", "since", "23", "years", "for", "glaucoma", "and", "sent", "to", "our", "clinic", "for", "trabeculectomy", "because", "of", "rapid", "worsening", "of", "vision", "on", "right", "eye", "with", "bilateral", "total", "excavation", "of", "optic", "disc", ".", "MATERIAL", "AND", "METHODS", ":", "Observational", "case", "report", ".", "RESULTS", ":", "Because", "of", "typical", "signs", "of", "IOS", "(", "iris", "neovascularization", ",", "mid-peripheral", "dot", "and", "blot", "hemorrhages", "in", "both", "eyes", ",", "narrowed", "arterioles", "in", "right", "eye", ",", "following", "examinations", "were", "performed", ":", "Doppler", "ultrasonography", "of", "carotid", "arteries", ",", "digital", "subtractional", "angiography", "of", "the", "carotid", "vessels", "and", "magnetic", "resonance", "angiography", ".", "The", "examinations", "showed", "occlusion", "of", "the", "right", "common", "carotid", "artery", "and", "with", "80", "%", "stenosis", "of", "the", "left", "common", "carotid", "artery", ",", "occlusion", "of", "abdominal", "aorta", ".", "After", "phacoemulsification", "with", "implantation", "of", "intraocular", "lens", "because", "of", "rapid", "intumescence", "cataract", "in", "the", "right", "eye", ",", "and", "endarterectomy", "of", "left", "external", "carotid", "artery", ",", "the", "neovascularization", "of", "the", "iris", "regressed", "in", "both", "eyes", ".", "CONCLUSION", ":", "In", "case", "of", "iris", "neovascularization", "or", "mid-peripheral", "hemorrhages", "the", "Doppler", "sonography", "of", "carotid", "arteries", "should", "be", "performed", ".", "Quick", "cooperation", "between", "ophthalmologist", ",", "radiologist", "and", "vascular", "surgeon", "following", "endarterectomy", "seems", "to", "stop", "progressing", "changes", "of", "ocular", "ischemic", "syndrome", "."], "event_mentions": [{"id": "E2", "event_type": "Planned_process", "trigger": {"text": "treated", "start": 45, "end": 46}, "arguments": [{"entity_id": "T21", "role": "Theme", "text": "male", "start": 43, "end": 44}]}, {"id": "E4", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 94, "end": 95}, "arguments": [{"entity_id": "T3", "role": "AtLoc", "text": "iris", "start": 93, "end": 94}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "implantation", "start": 164, "end": 165}, "arguments": [{"entity_id": "T24", "role": "Theme", "text": "lens", "start": 167, "end": 168}]}, {"id": "E5", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 187, "end": 188}, "arguments": [{"entity_id": "T16", "role": "AtLoc", "text": "iris", "start": 190, "end": 191}]}, {"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "regressed", "start": 191, "end": 192}, "arguments": []}, {"id": "E6", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 202, "end": 203}, "arguments": [{"entity_id": "T18", "role": "AtLoc", "text": "iris", "start": 201, "end": 202}]}], "relation_mentions": [], "entity_mentions": [{"id": "T22", "text": "Ocular", "entity_type": "Organ", "start": 12, "end": 13}, {"id": "T21", "text": "male", "entity_type": "Organism", "start": 43, "end": 44}, {"id": "T23", "text": "treated", "entity_type": "Planned_process", "start": 45, "end": 46}, {"id": "T2", "text": "eye", "entity_type": "Organ", "start": 67, "end": 68}, {"id": "T3", "text": "iris", "entity_type": "Multi-tissue_structure", "start": 93, "end": 94}, {"id": "T4", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 94, "end": 95}, {"id": "T5", "text": "eyes", "entity_type": "Organ", "start": 103, "end": 104}, {"id": "T6", "text": "arterioles", "entity_type": "Multi-tissue_structure", "start": 106, "end": 107}, {"id": "T7", "text": "eye", "entity_type": "Organ", "start": 109, "end": 110}, {"id": "T8", "text": "carotid arteries", "entity_type": "Multi-tissue_structure", "start": 119, "end": 121}, {"id": "T9", "text": "carotid vessels", "entity_type": "Multi-tissue_structure", "start": 127, "end": 129}, {"id": "T10", "text": "right common carotid artery", "entity_type": "Multi-tissue_structure", "start": 140, "end": 144}, {"id": "T11", "text": "left common carotid artery", "entity_type": "Multi-tissue_structure", "start": 151, "end": 155}, {"id": "T12", "text": "abdominal aorta", "entity_type": "Multi-tissue_structure", "start": 158, "end": 160}, {"id": "T25", "text": "implantation", "entity_type": "Planned_process", "start": 164, "end": 165}, {"id": "T24", "text": "lens", "entity_type": "Multi-tissue_structure", "start": 167, "end": 168}, {"id": "T13", "text": "eye", "entity_type": "Organ", "start": 176, "end": 177}, {"id": "T14", "text": "left external carotid artery", "entity_type": "Multi-tissue_structure", "start": 181, "end": 185}, {"id": "T15", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 187, "end": 188}, {"id": "T16", "text": "iris", "entity_type": "Multi-tissue_structure", "start": 190, "end": 191}, {"id": "T26", "text": "regressed", "entity_type": "Negative_regulation", "start": 191, "end": 192}, {"id": "T17", "text": "eyes", "entity_type": "Organ", "start": 194, "end": 195}, {"id": "T18", "text": "iris", "entity_type": "Multi-tissue_structure", "start": 201, "end": 202}, {"id": "T19", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 202, "end": 203}, {"id": "T20", "text": "carotid arteries", "entity_type": "Multi-tissue_structure", "start": 210, "end": 212}], "lang": "en"}
{"doc_id": "PMID-15623651", "wnd_id": "PMID-15623651_0", "text": "2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.\n\nPURPOSE: Head and neck squamous cell carcinomas have been reported to overexpress hypoxia-inducible factor (HIF)-1alpha, a transcription factor that promotes expression of angiogenesis factors and resistance to programmed and therapy-induced cell death. 2-Methoxyestradiol (2ME2) is a natural compound with HIF-1alpha inhibitory activity that is currently being evaluated in phase 1 and 2 clinical trials for advanced solid tumors and multiple myeloma. To our knowledge, this is the first study to evaluate the effects of 2ME2 in head and neck squamous cell carcinoma. EXPERIMENTAL DESIGN: In the present study, we investigated the effects of 2ME2 alone and in combination with paclitaxel, an active agent in recurrent or advanced head and neck squamous cell carcinoma. RESULTS: 2ME2 exhibited antiproliferative and cytotoxic effects in a panel of five head and neck squamous cell carcinoma cell lines in the 0.5 to 10 micromol/L range, including induction of G2-M blockade, caspase-3/7 activation, and apoptosis at 48 hours. 2ME2 resulted in decreased nuclear HIF-1alpha-binding activity and affected the expression of downstream genes, such as bid, a proapoptotic bcl-2 family member, and vascular endothelial growth factor, a proangiogenic cytokine. The up-regulation of Bid (57.5% at 12 hours, P  less than  0.0006) and inhibition of vascular endothelial growth factor secretion (57.7% at 24 hours, P  less than  0.015; and 50.3% at 48 hours, P  less than  0.0006) could be partially attributed to the effects on HIF-1alpha, because HIF-1alpha small interfering RNAs produced similar effects.", "tokens": ["2", "-", "methoxyestradiol", "inhibits", "hypoxia", "-", "inducible", "factor", "1", "alpha", ",", "tumor", "growth", ",", "and", "angiogenesis", "and", "augments", "paclitaxel", "efficacy", "in", "head", "and", "neck", "squamous", "cell", "carcinoma", ".", "PURPOSE", ":", "Head", "and", "neck", "squamous", "cell", "carcinomas", "have", "been", "reported", "to", "overexpress", "hypoxia", "-", "inducible", "factor", "(", "HIF", ")", "-", "1", "alpha", ",", "a", "transcription", "factor", "that", "promotes", "expression", "of", "angiogenesis", "factors", "and", "resistance", "to", "programmed", "and", "therapy", "-", "induced", "cell", "death", ".", "2", "-", "Methoxyestradiol", "(", "2ME2", ")", "is", "a", "natural", "compound", "with", "HIF", "-", "1", "alpha", "inhibitory", "activity", "that", "is", "currently", "being", "evaluated", "in", "phase", "1", "and", "2", "clinical", "trials", "for", "advanced", "solid", "tumors", "and", "multiple", "myeloma", ".", "To", "our", "knowledge", ",", "this", "is", "the", "first", "study", "to", "evaluate", "the", "effects", "of", "2ME2", "in", "head", "and", "neck", "squamous", "cell", "carcinoma", ".", "EXPERIMENTAL", "DESIGN", ":", "In", "the", "present", "study", ",", "we", "investigated", "the", "effects", "of", "2ME2", "alone", "and", "in", "combination", "with", "paclitaxel", ",", "an", "active", "agent", "in", "recurrent", "or", "advanced", "head", "and", "neck", "squamous", "cell", "carcinoma", ".", "RESULTS", ":", "2ME2", "exhibited", "antiproliferative", "and", "cytotoxic", "effects", "in", "a", "panel", "of", "five", "head", "and", "neck", "squamous", "cell", "carcinoma", "cell", "lines", "in", "the", "0.5", "to", "10", "micromol", "/", "L", "range", ",", "including", "induction", "of", "G2", "-", "M", "blockade", ",", "caspase", "-", "3/", "7", "activation", ",", "and", "apoptosis", "at", "48", "hours", ".", "2ME2", "resulted", "in", "decreased", "nuclear", "HIF", "-", "1", "alpha", "-", "binding", "activity", "and", "affected", "the", "expression", "of", "downstream", "genes", ",", "such", "as", "bid", ",", "a", "proapoptotic", "bcl", "-", "2", "family", "member", ",", "and", "vascular", "endothelial", "growth", "factor", ",", "a", "proangiogenic", "cytokine", ".", "The", "up", "-", "regulation", "of", "Bid", "(", "57.5", "%", "at", "12", "hours", ",", "P", "less", "than", "0.0006", ")", "and", "inhibition", "of", "vascular", "endothelial", "growth", "factor", "secretion", "(", "57.7", "%", "at", "24", "hours", ",", "P", "less", "than", "0.015", ";", "and", "50.3", "%", "at", "48", "hours", ",", "P", "less", "than", "0.0006", ")", "could", "be", "partially", "attributed", "to", "the", "effects", "on", "HIF", "-", "1", "alpha", ",", "because", "HIF", "-", "1", "alpha", "small", "interfering", "RNAs", "produced", "similar", "effects", "."], "event_mentions": [{"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 3, "end": 4}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "2-methoxyestradiol", "start": 0, "end": 3}, {"entity_id": "T4", "role": "Theme", "text": "hypoxia-inducible factor 1alpha", "start": 4, "end": 10}]}, {"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 3, "end": 4}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "2-methoxyestradiol", "start": 0, "end": 3}]}, {"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 3, "end": 4}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "2-methoxyestradiol", "start": 0, "end": 3}]}, {"id": "E5", "event_type": "Growth", "trigger": {"text": "growth", "start": 12, "end": 13}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "tumor", "start": 11, "end": 12}]}, {"id": "E28", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 15, "end": 16}, "arguments": [{"entity_id": "T11", "role": "AtLoc", "text": "head and neck squamous cell carcinoma", "start": 21, "end": 27}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "overexpress", "start": 40, "end": 41}, "arguments": [{"entity_id": "T16", "role": "Theme", "text": "hypoxia-inducible factor (HIF)-1alpha", "start": 41, "end": 51}]}, {"id": "E29", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 59, "end": 60}, "arguments": []}, {"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 68, "end": 69}, "arguments": []}, {"id": "E25", "event_type": "Death", "trigger": {"text": "death", "start": 70, "end": 71}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "cell", "start": 69, "end": 70}]}, {"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "inhibitory", "start": 87, "end": 88}, "arguments": [{"entity_id": "T20", "role": "Cause", "text": "2-Methoxyestradiol", "start": 72, "end": 75}, {"entity_id": "T21", "role": "Cause", "text": "2ME2", "start": 76, "end": 77}, {"entity_id": "T22", "role": "Theme", "text": "HIF-1alpha", "start": 83, "end": 87}]}, {"id": "E8", "event_type": "Planned_process", "trigger": {"text": "clinical trials", "start": 99, "end": 101}, "arguments": [{"entity_id": "T20", "role": "Instrument", "text": "2-Methoxyestradiol", "start": 72, "end": 75}, {"entity_id": "T21", "role": "Instrument", "text": "2ME2", "start": 76, "end": 77}, {"entity_id": "T23", "role": "Theme", "text": "solid tumors", "start": 103, "end": 105}]}, {"id": "E9", "event_type": "Planned_process", "trigger": {"text": "clinical trials", "start": 99, "end": 101}, "arguments": [{"entity_id": "T20", "role": "Instrument", "text": "2-Methoxyestradiol", "start": 72, "end": 75}, {"entity_id": "T21", "role": "Instrument", "text": "2ME2", "start": 76, "end": 77}, {"entity_id": "T24", "role": "Theme", "text": "myeloma", "start": 107, "end": 108}]}, {"id": "E6", "event_type": "Regulation", "trigger": {"text": "effects", "start": 121, "end": 122}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "2ME2", "start": 123, "end": 124}, {"entity_id": "T28", "role": "Theme", "text": "head and neck squamous cell carcinoma", "start": 125, "end": 131}]}, {"id": "E7", "event_type": "Regulation", "trigger": {"text": "effects", "start": 143, "end": 144}, "arguments": [{"entity_id": "T29", "role": "Cause", "text": "2ME2", "start": 145, "end": 146}, {"entity_id": "T33", "role": "Theme", "text": "head and neck squamous cell carcinoma", "start": 160, "end": 166}]}, {"id": "E27", "event_type": "Regulation", "trigger": {"text": "effects", "start": 143, "end": 144}, "arguments": [{"entity_id": "T30", "role": "Cause", "text": "paclitaxel", "start": 151, "end": 152}, {"entity_id": "T33", "role": "Theme", "text": "head and neck squamous cell carcinoma", "start": 160, "end": 166}]}, {"id": "E11", "event_type": "Regulation", "trigger": {"text": "exhibited", "start": 170, "end": 171}, "arguments": [{"entity_id": "T34", "role": "Cause", "text": "2ME2", "start": 169, "end": 170}, {"entity_id": "T35", "role": "Theme", "text": "head and neck squamous cell carcinoma cell lines", "start": 180, "end": 188}]}, {"id": "E13", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 199, "end": 200}, "arguments": [{"entity_id": "T34", "role": "Cause", "text": "2ME2", "start": 169, "end": 170}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 199, "end": 200}, "arguments": [{"entity_id": "T34", "role": "Cause", "text": "2ME2", "start": 169, "end": 170}]}, {"id": "E16", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 199, "end": 200}, "arguments": [{"entity_id": "T34", "role": "Cause", "text": "2ME2", "start": 169, "end": 170}]}, {"id": "E39", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 210, "end": 211}, "arguments": [{"entity_id": "T34", "role": "Cause", "text": "2ME2", "start": 169, "end": 170}, {"entity_id": "T40", "role": "Theme", "text": "7", "start": 209, "end": 210}]}, {"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 210, "end": 211}, "arguments": [{"entity_id": "T34", "role": "Cause", "text": "2ME2", "start": 169, "end": 170}]}, {"id": "E12", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 213, "end": 214}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "head and neck squamous cell carcinoma cell lines", "start": 180, "end": 188}]}, {"id": "E43", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 221, "end": 222}, "arguments": [{"entity_id": "T42", "role": "Cause", "text": "2ME2", "start": 218, "end": 219}]}, {"id": "E44", "event_type": "Binding", "trigger": {"text": "binding", "start": 228, "end": 229}, "arguments": [{"entity_id": "T45", "role": "Theme", "text": "HIF-1alpha", "start": 223, "end": 227}]}, {"id": "E46", "event_type": "Regulation", "trigger": {"text": "affected", "start": 231, "end": 232}, "arguments": [{"entity_id": "T42", "role": "Cause", "text": "2ME2", "start": 218, "end": 219}]}, {"id": "E19", "event_type": "Regulation", "trigger": {"text": "affected", "start": 231, "end": 232}, "arguments": [{"entity_id": "T42", "role": "Cause", "text": "2ME2", "start": 218, "end": 219}]}, {"id": "E20", "event_type": "Regulation", "trigger": {"text": "affected", "start": 231, "end": 232}, "arguments": [{"entity_id": "T42", "role": "Cause", "text": "2ME2", "start": 218, "end": 219}]}, {"id": "E47", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 233, "end": 234}, "arguments": [{"entity_id": "T48", "role": "Theme", "text": "bid", "start": 240, "end": 241}]}, {"id": "E17", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 233, "end": 234}, "arguments": [{"entity_id": "T49", "role": "Theme", "text": "bcl-2 family", "start": 244, "end": 248}]}, {"id": "E18", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 233, "end": 234}, "arguments": [{"entity_id": "T50", "role": "Theme", "text": "vascular endothelial growth factor", "start": 251, "end": 255}]}, {"id": "E52", "event_type": "Positive_regulation", "trigger": {"text": "up-regulation", "start": 261, "end": 264}, "arguments": [{"entity_id": "T54", "role": "Theme", "text": "Bid", "start": 265, "end": 266}]}, {"id": "E55", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 279, "end": 280}, "arguments": []}, {"id": "E56", "event_type": "Localization", "trigger": {"text": "secretion", "start": 285, "end": 286}, "arguments": [{"entity_id": "T57", "role": "Theme", "text": "vascular endothelial growth factor", "start": 281, "end": 285}]}, {"id": "E21", "event_type": "Regulation", "trigger": {"text": "effects", "start": 316, "end": 317}, "arguments": [{"entity_id": "T58", "role": "Cause", "text": "HIF-1alpha", "start": 318, "end": 322}]}, {"id": "E22", "event_type": "Regulation", "trigger": {"text": "effects", "start": 316, "end": 317}, "arguments": [{"entity_id": "T58", "role": "Cause", "text": "HIF-1alpha", "start": 318, "end": 322}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T40", "role": "Arg1", "text": "7", "start": 209, "end": 210}, {"entity_id": "T40", "role": "Arg1", "text": "7", "start": 209, "end": 210}]}], "entity_mentions": [{"id": "T1", "text": "2-methoxyestradiol", "entity_type": "Drug_or_compound", "start": 0, "end": 3}, {"id": "T2", "text": "inhibits", "entity_type": "Negative_regulation", "start": 3, "end": 4}, {"id": "T4", "text": "hypoxia-inducible factor 1alpha", "entity_type": "Gene_or_gene_product", "start": 4, "end": 10}, {"id": "T6", "text": "tumor", "entity_type": "Pathological_formation", "start": 11, "end": 12}, {"id": "T5", "text": "growth", "entity_type": "Growth", "start": 12, "end": 13}, {"id": "T7", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 15, "end": 16}, {"id": "T8", "text": "paclitaxel", "entity_type": "Drug_or_compound", "start": 18, "end": 19}, {"id": "T11", "text": "head and neck squamous cell carcinoma", "entity_type": "Pathological_formation", "start": 21, "end": 27}, {"id": "T14", "text": "Head and neck squamous cell carcinomas", "entity_type": "Pathological_formation", "start": 30, "end": 36}, {"id": "T15", "text": "overexpress", "entity_type": "Gene_expression", "start": 40, "end": 41}, {"id": "T16", "text": "hypoxia-inducible factor (HIF)-1alpha", "entity_type": "Gene_or_gene_product", "start": 41, "end": 51}, {"id": "T18", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 59, "end": 60}, {"id": "T38", "text": "induced", "entity_type": "Positive_regulation", "start": 68, "end": 69}, {"id": "T36", "text": "cell", "entity_type": "Cell", "start": 69, "end": 70}, {"id": "T37", "text": "death", "entity_type": "Death", "start": 70, "end": 71}, {"id": "T20", "text": "2-Methoxyestradiol", "entity_type": "Drug_or_compound", "start": 72, "end": 75}, {"id": "T21", "text": "2ME2", "entity_type": "Drug_or_compound", "start": 76, "end": 77}, {"id": "T22", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 83, "end": 87}, {"id": "T9", "text": "inhibitory", "entity_type": "Negative_regulation", "start": 87, "end": 88}, {"id": "T13", "text": "clinical trials", "entity_type": "Planned_process", "start": 99, "end": 101}, {"id": "T23", "text": "solid tumors", "entity_type": "Pathological_formation", "start": 103, "end": 105}, {"id": "T24", "text": "myeloma", "entity_type": "Pathological_formation", "start": 107, "end": 108}, {"id": "T10", "text": "effects", "entity_type": "Regulation", "start": 121, "end": 122}, {"id": "T25", "text": "2ME2", "entity_type": "Drug_or_compound", "start": 123, "end": 124}, {"id": "T28", "text": "head and neck squamous cell carcinoma", "entity_type": "Pathological_formation", "start": 125, "end": 131}, {"id": "T12", "text": "effects", "entity_type": "Regulation", "start": 143, "end": 144}, {"id": "T29", "text": "2ME2", "entity_type": "Drug_or_compound", "start": 145, "end": 146}, {"id": "T30", "text": "paclitaxel", "entity_type": "Drug_or_compound", "start": 151, "end": 152}, {"id": "T33", "text": "head and neck squamous cell carcinoma", "entity_type": "Pathological_formation", "start": 160, "end": 166}, {"id": "T34", "text": "2ME2", "entity_type": "Drug_or_compound", "start": 169, "end": 170}, {"id": "T17", "text": "exhibited", "entity_type": "Regulation", "start": 170, "end": 171}, {"id": "T35", "text": "head and neck squamous cell carcinoma cell lines", "entity_type": "Cell", "start": 180, "end": 188}, {"id": "T26", "text": "induction", "entity_type": "Positive_regulation", "start": 199, "end": 200}, {"id": "T40", "text": "7", "entity_type": "Gene_or_gene_product", "start": 209, "end": 210}, {"id": "T39", "text": "activation", "entity_type": "Positive_regulation", "start": 210, "end": 211}, {"id": "T19", "text": "apoptosis", "entity_type": "Death", "start": 213, "end": 214}, {"id": "T42", "text": "2ME2", "entity_type": "Drug_or_compound", "start": 218, "end": 219}, {"id": "T43", "text": "decreased", "entity_type": "Negative_regulation", "start": 221, "end": 222}, {"id": "T45", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 223, "end": 227}, {"id": "T44", "text": "binding", "entity_type": "Binding", "start": 228, "end": 229}, {"id": "T46", "text": "affected", "entity_type": "Regulation", "start": 231, "end": 232}, {"id": "T47", "text": "expression", "entity_type": "Gene_expression", "start": 233, "end": 234}, {"id": "T48", "text": "bid", "entity_type": "Gene_or_gene_product", "start": 240, "end": 241}, {"id": "T49", "text": "bcl-2 family", "entity_type": "Gene_or_gene_product", "start": 244, "end": 248}, {"id": "T50", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 251, "end": 255}, {"id": "T52", "text": "up-regulation", "entity_type": "Positive_regulation", "start": 261, "end": 264}, {"id": "T54", "text": "Bid", "entity_type": "Gene_or_gene_product", "start": 265, "end": 266}, {"id": "T55", "text": "inhibition", "entity_type": "Negative_regulation", "start": 279, "end": 280}, {"id": "T57", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 281, "end": 285}, {"id": "T56", "text": "secretion", "entity_type": "Localization", "start": 285, "end": 286}, {"id": "T27", "text": "effects", "entity_type": "Regulation", "start": 316, "end": 317}, {"id": "T58", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 318, "end": 322}, {"id": "T59", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 324, "end": 328}], "lang": "en"}
{"doc_id": "PMID-15623651", "wnd_id": "PMID-15623651_1", "text": "Finally, in vivo, in a xenograft model of head and neck squamous cell carcinoma using UM-SCC-11A cells, 2ME2 exhibited antitumor and antiangiogenic activity, as measured by CD31 immunostaining. CONCLUSIONS: These results provide support for the use of 2ME2 in combination with paclitaxel for the treatment of recurrent or advanced head and neck squamous cell carcinoma.", "tokens": ["Finally", ",", "in", "vivo", ",", "in", "a", "xenograft", "model", "of", "head", "and", "neck", "squamous", "cell", "carcinoma", "using", "UM", "-", "SCC", "-", "11A", "cells", ",", "2ME2", "exhibited", "antitumor", "and", "antiangiogenic", "activity", ",", "as", "measured", "by", "CD31", "immunostaining", ".", "CONCLUSIONS", ":", "These", "results", "provide", "support", "for", "the", "use", "of", "2ME2", "in", "combination", "with", "paclitaxel", "for", "the", "treatment", "of", "recurrent", "or", "advanced", "head", "and", "neck", "squamous", "cell", "carcinoma", "."], "event_mentions": [{"id": "E23", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 29, "end": 30}, "arguments": [{"entity_id": "T64", "role": "Cause", "text": "2ME2", "start": 24, "end": 25}]}, {"id": "E32", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 29, "end": 30}, "arguments": [{"entity_id": "T64", "role": "Cause", "text": "2ME2", "start": 24, "end": 25}]}, {"id": "E24", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 54, "end": 55}, "arguments": [{"entity_id": "T66", "role": "Instrument", "text": "2ME2", "start": 47, "end": 48}, {"entity_id": "T67", "role": "Instrument", "text": "paclitaxel", "start": 51, "end": 52}, {"entity_id": "T70", "role": "Theme", "text": "head and neck squamous cell carcinoma", "start": 59, "end": 65}]}], "relation_mentions": [], "entity_mentions": [{"id": "T62", "text": "head and neck squamous cell carcinoma", "entity_type": "Pathological_formation", "start": 10, "end": 16}, {"id": "T63", "text": "UM-SCC-11A cells", "entity_type": "Cell", "start": 17, "end": 23}, {"id": "T64", "text": "2ME2", "entity_type": "Drug_or_compound", "start": 24, "end": 25}, {"id": "T31", "text": "activity", "entity_type": "Negative_regulation", "start": 29, "end": 30}, {"id": "T3", "text": "CD31", "entity_type": "Gene_or_gene_product", "start": 34, "end": 35}, {"id": "T66", "text": "2ME2", "entity_type": "Drug_or_compound", "start": 47, "end": 48}, {"id": "T67", "text": "paclitaxel", "entity_type": "Drug_or_compound", "start": 51, "end": 52}, {"id": "T32", "text": "treatment", "entity_type": "Planned_process", "start": 54, "end": 55}, {"id": "T70", "text": "head and neck squamous cell carcinoma", "entity_type": "Pathological_formation", "start": 59, "end": 65}], "lang": "en"}
{"doc_id": "PMID-15774527", "wnd_id": "PMID-15774527_0", "text": "Investigating the causes of low birth weight in contrasting ovine paradigms.\n\nIntrauterine growth restriction (IUGR) still accounts for a large incidence of infant mortality and morbidity worldwide. Many of the circulatory and transport properties of the sheep placenta are similar to those of the human placenta and as such, the pregnant sheep offers an excellent model in which to study the development of IUGR. Two natural models of ovine IUGR are those of hyperthermic exposure during pregnancy, and adolescent overfeeding, also during pregnancy. Both models yield significantly reduced placental weights and an asymmetrically growth-restricted fetus, and display altered maternal hormone concentrations, indicative of an impaired trophoblast capacity. Additionally, impaired placental angiogenesis and uteroplacental blood flow appears to be an early defect in both the hyperthermic and adolescent paradigms. The effects of these alterations in placental functional development appear to be irreversible. IUGR fetuses are both hypoxic and hypoglycaemic, and have reduced insulin and insulin-like growth factor-1 (IGF-1), and elevated concentrations of lactate. However, fetal utilization of oxygen and glucose, on a weight basis, remain constant compared with control pregnancies. Maintained utilization of these substrates, in a substrate-deficient environment, suggests increased sensitivities to metabolic signals, which may play a role in the development of metabolic diseases in later adult life.", "tokens": ["Investigating", "the", "causes", "of", "low", "birth", "weight", "in", "contrasting", "ovine", "paradigms", ".", "Intrauterine", "growth", "restriction", "(", "IUGR", ")", "still", "accounts", "for", "a", "large", "incidence", "of", "infant", "mortality", "and", "morbidity", "worldwide", ".", "Many", "of", "the", "circulatory", "and", "transport", "properties", "of", "the", "sheep", "placenta", "are", "similar", "to", "those", "of", "the", "human", "placenta", "and", "as", "such", ",", "the", "pregnant", "sheep", "offers", "an", "excellent", "model", "in", "which", "to", "study", "the", "development", "of", "IUGR", ".", "Two", "natural", "models", "of", "ovine", "IUGR", "are", "those", "of", "hyperthermic", "exposure", "during", "pregnancy", ",", "and", "adolescent", "overfeeding", ",", "also", "during", "pregnancy", ".", "Both", "models", "yield", "significantly", "reduced", "placental", "weights", "and", "an", "asymmetrically", "growth", "-", "restricted", "fetus", ",", "and", "display", "altered", "maternal", "hormone", "concentrations", ",", "indicative", "of", "an", "impaired", "trophoblast", "capacity", ".", "Additionally", ",", "impaired", "placental", "angiogenesis", "and", "uteroplacental", "blood", "flow", "appears", "to", "be", "an", "early", "defect", "in", "both", "the", "hyperthermic", "and", "adolescent", "paradigms", ".", "The", "effects", "of", "these", "alterations", "in", "placental", "functional", "development", "appear", "to", "be", "irreversible", ".", "IUGR", "fetuses", "are", "both", "hypoxic", "and", "hypoglycaemic", ",", "and", "have", "reduced", "insulin", "and", "insulin", "-", "like", "growth", "factor", "-", "1", "(", "IGF", "-", "1", ")", ",", "and", "elevated", "concentrations", "of", "lactate", ".", "However", ",", "fetal", "utilization", "of", "oxygen", "and", "glucose", ",", "on", "a", "weight", "basis", ",", "remain", "constant", "compared", "with", "control", "pregnancies", ".", "Maintained", "utilization", "of", "these", "substrates", ",", "in", "a", "substrate", "-", "deficient", "environment", ",", "suggests", "increased", "sensitivities", "to", "metabolic", "signals", ",", "which", "may", "play", "a", "role", "in", "the", "development", "of", "metabolic", "diseases", "in", "later", "adult", "life", "."], "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 96, "end": 97}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "placental", "start": 97, "end": 98}]}, {"id": "E2", "event_type": "Growth", "trigger": {"text": "growth", "start": 102, "end": 103}, "arguments": [{"entity_id": "T3", "role": "Theme", "text": "fetus", "start": 105, "end": 106}]}, {"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "restricted", "start": 104, "end": 105}, "arguments": []}, {"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "impaired", "start": 117, "end": 118}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "trophoblast", "start": 118, "end": 119}]}, {"id": "E5", "event_type": "Negative_regulation", "trigger": {"text": "impaired", "start": 123, "end": 124}, "arguments": []}, {"id": "E16", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 125, "end": 126}, "arguments": [{"entity_id": "T28", "role": "AtLoc", "text": "placental", "start": 124, "end": 125}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "effects", "start": 145, "end": 146}, "arguments": []}, {"id": "E11", "event_type": "Regulation", "trigger": {"text": "alterations", "start": 148, "end": 149}, "arguments": []}, {"id": "E8", "event_type": "Development", "trigger": {"text": "development", "start": 152, "end": 153}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "placental", "start": 150, "end": 151}]}, {"id": "E10", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 168, "end": 169}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "insulin", "start": 169, "end": 170}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 168, "end": 169}, "arguments": [{"entity_id": "T12", "role": "Theme", "text": "insulin-like growth factor-1", "start": 171, "end": 178}, {"entity_id": "T13", "role": "Theme", "text": "IGF-1", "start": 179, "end": 182}]}, {"id": "E13", "event_type": "Positive_regulation", "trigger": {"text": "elevated", "start": 185, "end": 186}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "lactate", "start": 188, "end": 189}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1000", "text": "infant", "entity_type": "Organism", "start": 25, "end": 26}, {"id": "T1001", "text": "sheep", "entity_type": "Organism", "start": 40, "end": 41}, {"id": "T1", "text": "placenta", "entity_type": "Organ", "start": 41, "end": 42}, {"id": "T1002", "text": "human", "entity_type": "Organism", "start": 48, "end": 49}, {"id": "T2", "text": "placenta", "entity_type": "Organ", "start": 49, "end": 50}, {"id": "T1003", "text": "sheep", "entity_type": "Organism", "start": 56, "end": 57}, {"id": "T14", "text": "reduced", "entity_type": "Negative_regulation", "start": 96, "end": 97}, {"id": "T18", "text": "placental", "entity_type": "Organ", "start": 97, "end": 98}, {"id": "T19", "text": "growth", "entity_type": "Growth", "start": 102, "end": 103}, {"id": "T20", "text": "restricted", "entity_type": "Negative_regulation", "start": 104, "end": 105}, {"id": "T3", "text": "fetus", "entity_type": "Developing_anatomical_structure", "start": 105, "end": 106}, {"id": "T21", "text": "impaired", "entity_type": "Negative_regulation", "start": 117, "end": 118}, {"id": "T4", "text": "trophoblast", "entity_type": "Cell", "start": 118, "end": 119}, {"id": "T22", "text": "impaired", "entity_type": "Negative_regulation", "start": 123, "end": 124}, {"id": "T28", "text": "placental", "entity_type": "Organ", "start": 124, "end": 125}, {"id": "T5", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 125, "end": 126}, {"id": "T7", "text": "uteroplacental blood", "entity_type": "Organism_substance", "start": 127, "end": 129}, {"id": "T26", "text": "effects", "entity_type": "Regulation", "start": 145, "end": 146}, {"id": "T25", "text": "alterations", "entity_type": "Regulation", "start": 148, "end": 149}, {"id": "T6", "text": "placental", "entity_type": "Organ", "start": 150, "end": 151}, {"id": "T24", "text": "development", "entity_type": "Development", "start": 152, "end": 153}, {"id": "T8", "text": "fetuses", "entity_type": "Developing_anatomical_structure", "start": 159, "end": 160}, {"id": "T10", "text": "reduced", "entity_type": "Negative_regulation", "start": 168, "end": 169}, {"id": "T11", "text": "insulin", "entity_type": "Gene_or_gene_product", "start": 169, "end": 170}, {"id": "T12", "text": "insulin-like growth factor-1", "entity_type": "Gene_or_gene_product", "start": 171, "end": 178}, {"id": "T13", "text": "IGF-1", "entity_type": "Gene_or_gene_product", "start": 179, "end": 182}, {"id": "T9", "text": "elevated", "entity_type": "Positive_regulation", "start": 185, "end": 186}, {"id": "T15", "text": "lactate", "entity_type": "Drug_or_compound", "start": 188, "end": 189}, {"id": "T16", "text": "oxygen", "entity_type": "Drug_or_compound", "start": 195, "end": 196}, {"id": "T17", "text": "glucose", "entity_type": "Drug_or_compound", "start": 197, "end": 198}], "lang": "en"}
{"doc_id": "PMID-15876269", "wnd_id": "PMID-15876269_0", "text": "Rofecoxib as adjunctive therapy for haemophilic arthropathy.\n\nJoint haemorrhage and subsequent haemophilic arthropathy are significant complications in haemophilia. The pathophysiology involves inflammation and angiogenesis. Cyclooxygenase-2 (COX-2) inhibitors are anti-inflammatory agents, which have potent anti-inflammatory, anti-angiogenic and analgesic properties yet do not affect platelet function in the manner of traditional non-steroidal anti-inflammatory drugs. These properties make such agents potentially useful as adjunctive therapy in haemophilia. There is only one prior report describing rofecoxib treatment in a single haemophilia patient. Our objectives were to determine the safety and efficacy of rofecoxib in treating acute haemarthrosis, chronic synovitis, target joints and pain. We conducted a retrospective medical record review of patients treated with rofecoxib for acute haemarthrosis, chronic synovitis, target joint or pain. The safety and efficacy of rofecoxib treatment were determined based on subjective patient reports and physical examinations during follow-up clinic visits. A total of 28 patients between 3 and 37 years of age were treated for a total of 42 courses of rofecoxib treatment. All courses were evaluated for safety and 31 for efficacy. Rofecoxib was used for eight acute haemarthrosis, four target joints, seven cases of synovitis and 12 episodes of pain. Efficacy was demonstrated particularly for chronic synovitis and pain and no serious adverse events occurred. This is the largest study to date evaluating COX-2 inhibitors as adjunctive therapy in haemophilia and suggests that these agents may be an important adjunctive therapy in the management of haemophilia.", "tokens": ["Rofecoxib", "as", "adjunctive", "therapy", "for", "haemophilic", "arthropathy", ".", "Joint", "haemorrhage", "and", "subsequent", "haemophilic", "arthropathy", "are", "significant", "complications", "in", "haemophilia", ".", "The", "pathophysiology", "involves", "inflammation", "and", "angiogenesis", ".", "Cyclooxygenase", "-", "2", "(", "COX", "-", "2", ")", "inhibitors", "are", "anti-inflammatory", "agents", ",", "which", "have", "potent", "anti-inflammatory", ",", "anti-angiogenic", "and", "analgesic", "properties", "yet", "do", "not", "affect", "platelet", "function", "in", "the", "manner", "of", "traditional", "non-steroidal", "anti-inflammatory", "drugs", ".", "These", "properties", "make", "such", "agents", "potentially", "useful", "as", "adjunctive", "therapy", "in", "haemophilia", ".", "There", "is", "only", "one", "prior", "report", "describing", "rofecoxib", "treatment", "in", "a", "single", "haemophilia", "patient", ".", "Our", "objectives", "were", "to", "determine", "the", "safety", "and", "efficacy", "of", "rofecoxib", "in", "treating", "acute", "haemarthrosis", ",", "chronic", "synovitis", ",", "target", "joints", "and", "pain", ".", "We", "conducted", "a", "retrospective", "medical", "record", "review", "of", "patients", "treated", "with", "rofecoxib", "for", "acute", "haemarthrosis", ",", "chronic", "synovitis", ",", "target", "joint", "or", "pain", ".", "The", "safety", "and", "efficacy", "of", "rofecoxib", "treatment", "were", "determined", "based", "on", "subjective", "patient", "reports", "and", "physical", "examinations", "during", "follow", "-", "up", "clinic", "visits", ".", "A", "total", "of", "28", "patients", "between", "3", "and", "37", "years", "of", "age", "were", "treated", "for", "a", "total", "of", "42", "courses", "of", "rofecoxib", "treatment", ".", "All", "courses", "were", "evaluated", "for", "safety", "and", "31", "for", "efficacy", ".", "Rofecoxib", "was", "used", "for", "eight", "acute", "haemarthrosis", ",", "four", "target", "joints", ",", "seven", "cases", "of", "synovitis", "and", "12", "episodes", "of", "pain", ".", "Efficacy", "was", "demonstrated", "particularly", "for", "chronic", "synovitis", "and", "pain", "and", "no", "serious", "adverse", "events", "occurred", ".", "This", "is", "the", "largest", "study", "to", "date", "evaluating", "COX", "-", "2", "inhibitors", "as", "adjunctive", "therapy", "in", "haemophilia", "and", "suggests", "that", "these", "agents", "may", "be", "an", "important", "adjunctive", "therapy", "in", "the", "management", "of", "haemophilia", "."], "event_mentions": [{"id": "E9", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 25, "end": 26}, "arguments": []}, {"id": "E11", "event_type": "Negative_regulation", "trigger": {"text": "properties", "start": 48, "end": 49}, "arguments": []}, {"id": "E1", "event_type": "Regulation", "trigger": {"text": "affect", "start": 52, "end": 53}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "platelet", "start": 53, "end": 54}]}, {"id": "E2", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 85, "end": 86}, "arguments": [{"entity_id": "T11", "role": "Instrument", "text": "rofecoxib", "start": 84, "end": 85}, {"entity_id": "T1000", "role": "Theme", "text": "patient", "start": 90, "end": 91}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "treating", "start": 104, "end": 105}, "arguments": [{"entity_id": "T12", "role": "Instrument", "text": "rofecoxib", "start": 102, "end": 103}, {"entity_id": "T13", "role": "Theme", "text": "joints", "start": 112, "end": 113}]}, {"id": "E4", "event_type": "Planned_process", "trigger": {"text": "treated", "start": 125, "end": 126}, "arguments": [{"entity_id": "T1001", "role": "Theme", "text": "patients", "start": 124, "end": 125}, {"entity_id": "T14", "role": "Instrument", "text": "rofecoxib", "start": 127, "end": 128}]}, {"id": "E5", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 146, "end": 147}, "arguments": [{"entity_id": "T15", "role": "Instrument", "text": "rofecoxib", "start": 145, "end": 146}, {"entity_id": "T1002", "role": "Theme", "text": "patient", "start": 152, "end": 153}]}, {"id": "E6", "event_type": "Planned_process", "trigger": {"text": "treated", "start": 177, "end": 178}, "arguments": [{"entity_id": "T1003", "role": "Theme", "text": "patients", "start": 168, "end": 169}]}, {"id": "E7", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 186, "end": 187}, "arguments": [{"entity_id": "T16", "role": "Instrument", "text": "rofecoxib", "start": 185, "end": 186}]}, {"id": "E8", "event_type": "Planned_process", "trigger": {"text": "used", "start": 201, "end": 202}, "arguments": [{"entity_id": "T17", "role": "Instrument", "text": "Rofecoxib", "start": 199, "end": 200}, {"entity_id": "T18", "role": "Theme", "text": "joints", "start": 209, "end": 210}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "Rofecoxib", "entity_type": "Drug_or_compound", "start": 0, "end": 1}, {"id": "T2", "text": "Joint", "entity_type": "Multi-tissue_structure", "start": 8, "end": 9}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 25, "end": 26}, {"id": "T5", "text": "Cyclooxygenase-2", "entity_type": "Gene_or_gene_product", "start": 27, "end": 30}, {"id": "T6", "text": "COX-2", "entity_type": "Gene_or_gene_product", "start": 31, "end": 34}, {"id": "T29", "text": "properties", "entity_type": "Negative_regulation", "start": 48, "end": 49}, {"id": "T7", "text": "affect", "entity_type": "Regulation", "start": 52, "end": 53}, {"id": "T9", "text": "platelet", "entity_type": "Cell", "start": 53, "end": 54}, {"id": "T10", "text": "non-steroidal anti-inflammatory drugs", "entity_type": "Drug_or_compound", "start": 60, "end": 63}, {"id": "T11", "text": "rofecoxib", "entity_type": "Drug_or_compound", "start": 84, "end": 85}, {"id": "T21", "text": "treatment", "entity_type": "Planned_process", "start": 85, "end": 86}, {"id": "T1000", "text": "patient", "entity_type": "Organism", "start": 90, "end": 91}, {"id": "T12", "text": "rofecoxib", "entity_type": "Drug_or_compound", "start": 102, "end": 103}, {"id": "T22", "text": "treating", "entity_type": "Planned_process", "start": 104, "end": 105}, {"id": "T13", "text": "joints", "entity_type": "Multi-tissue_structure", "start": 112, "end": 113}, {"id": "T1001", "text": "patients", "entity_type": "Organism", "start": 124, "end": 125}, {"id": "T23", "text": "treated", "entity_type": "Planned_process", "start": 125, "end": 126}, {"id": "T14", "text": "rofecoxib", "entity_type": "Drug_or_compound", "start": 127, "end": 128}, {"id": "T24", "text": "joint", "entity_type": "Multi-tissue_structure", "start": 136, "end": 137}, {"id": "T15", "text": "rofecoxib", "entity_type": "Drug_or_compound", "start": 145, "end": 146}, {"id": "T25", "text": "treatment", "entity_type": "Planned_process", "start": 146, "end": 147}, {"id": "T1002", "text": "patient", "entity_type": "Organism", "start": 152, "end": 153}, {"id": "T1003", "text": "patients", "entity_type": "Organism", "start": 168, "end": 169}, {"id": "T26", "text": "treated", "entity_type": "Planned_process", "start": 177, "end": 178}, {"id": "T16", "text": "rofecoxib", "entity_type": "Drug_or_compound", "start": 185, "end": 186}, {"id": "T27", "text": "treatment", "entity_type": "Planned_process", "start": 186, "end": 187}, {"id": "T17", "text": "Rofecoxib", "entity_type": "Drug_or_compound", "start": 199, "end": 200}, {"id": "T28", "text": "used", "entity_type": "Planned_process", "start": 201, "end": 202}, {"id": "T18", "text": "joints", "entity_type": "Multi-tissue_structure", "start": 209, "end": 210}, {"id": "T20", "text": "COX-2", "entity_type": "Gene_or_gene_product", "start": 245, "end": 248}], "lang": "en"}
{"doc_id": "PMID-16221381", "wnd_id": "PMID-16221381_0", "text": "The merits of vascular targeting for gynecologic malignancies.\n\nNeovascularization is an early and critical step in tumor development and progression. Tumor vessels are distinct from their normal counterparts morphologically as well as at a molecular level. Recent studies on factors involved in tumor vascular development have identified new therapeutic targets for inhibiting tumor neovascularization and thus tumor progression. However, the process of tumor blood vessel formation is complex, and each tumor exhibits unique features in its vasculature. An understanding of the relative contribution of various pathways in the development of tumor vasculature is critical for developing effective and selective therapeutic approaches. Several such agents are currently in clinical trials, and many others are under development. In this review, the mechanisms and factors involved in tumor blood vessel formation are discussed. In addition, selected novel classes of antivascular therapies, including those targeting tumor endothelial cells and other components of the tumor vasculature, are summarized.", "tokens": ["The", "merits", "of", "vascular", "targeting", "for", "gynecologic", "malignancies", ".", "Neovascularization", "is", "an", "early", "and", "critical", "step", "in", "tumor", "development", "and", "progression", ".", "Tumor", "vessels", "are", "distinct", "from", "their", "normal", "counterparts", "morphologically", "as", "well", "as", "at", "a", "molecular", "level", ".", "Recent", "studies", "on", "factors", "involved", "in", "tumor", "vascular", "development", "have", "identified", "new", "therapeutic", "targets", "for", "inhibiting", "tumor", "neovascularization", "and", "thus", "tumor", "progression", ".", "However", ",", "the", "process", "of", "tumor", "blood", "vessel", "formation", "is", "complex", ",", "and", "each", "tumor", "exhibits", "unique", "features", "in", "its", "vasculature", ".", "An", "understanding", "of", "the", "relative", "contribution", "of", "various", "pathways", "in", "the", "development", "of", "tumor", "vasculature", "is", "critical", "for", "developing", "effective", "and", "selective", "therapeutic", "approaches", ".", "Several", "such", "agents", "are", "currently", "in", "clinical", "trials", ",", "and", "many", "others", "are", "under", "development", ".", "In", "this", "review", ",", "the", "mechanisms", "and", "factors", "involved", "in", "tumor", "blood", "vessel", "formation", "are", "discussed", ".", "In", "addition", ",", "selected", "novel", "classes", "of", "antivascular", "therapies", ",", "including", "those", "targeting", "tumor", "endothelial", "cells", "and", "other", "components", "of", "the", "tumor", "vasculature", ",", "are", "summarized", "."], "event_mentions": [{"id": "E9", "event_type": "Blood_vessel_development", "trigger": {"text": "Neovascularization", "start": 9, "end": 10}, "arguments": []}, {"id": "E3", "event_type": "Development", "trigger": {"text": "development", "start": 18, "end": 19}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "tumor", "start": 17, "end": 18}]}, {"id": "E2", "event_type": "Development", "trigger": {"text": "progression", "start": 20, "end": 21}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "tumor", "start": 17, "end": 18}]}, {"id": "E8", "event_type": "Development", "trigger": {"text": "development", "start": 47, "end": 48}, "arguments": [{"entity_id": "T10", "role": "Theme", "text": "tumor vascular", "start": 45, "end": 47}]}, {"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 54, "end": 55}, "arguments": []}, {"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 54, "end": 55}, "arguments": []}, {"id": "E6", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 56, "end": 57}, "arguments": [{"entity_id": "T11", "role": "AtLoc", "text": "tumor", "start": 55, "end": 56}]}, {"id": "E13", "event_type": "Development", "trigger": {"text": "progression", "start": 60, "end": 61}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "tumor", "start": 59, "end": 60}]}, {"id": "E16", "event_type": "Development", "trigger": {"text": "formation", "start": 70, "end": 71}, "arguments": [{"entity_id": "T17", "role": "Theme", "text": "tumor blood vessel", "start": 67, "end": 70}]}, {"id": "E22", "event_type": "Development", "trigger": {"text": "development", "start": 95, "end": 96}, "arguments": [{"entity_id": "T23", "role": "Theme", "text": "tumor vasculature", "start": 97, "end": 99}]}, {"id": "E26", "event_type": "Development", "trigger": {"text": "formation", "start": 138, "end": 139}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "tumor blood vessel", "start": 135, "end": 138}]}, {"id": "E5", "event_type": "Planned_process", "trigger": {"text": "targeting", "start": 154, "end": 155}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "tumor endothelial cells", "start": 155, "end": 158}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "Neovascularization", "entity_type": "Blood_vessel_development", "start": 9, "end": 10}, {"id": "T4", "text": "tumor", "entity_type": "Pathological_formation", "start": 17, "end": 18}, {"id": "T3", "text": "development", "entity_type": "Development", "start": 18, "end": 19}, {"id": "T2", "text": "progression", "entity_type": "Development", "start": 20, "end": 21}, {"id": "T5", "text": "Tumor vessels", "entity_type": "Multi-tissue_structure", "start": 22, "end": 24}, {"id": "T10", "text": "tumor vascular", "entity_type": "Multi-tissue_structure", "start": 45, "end": 47}, {"id": "T8", "text": "development", "entity_type": "Development", "start": 47, "end": 48}, {"id": "T6", "text": "inhibiting", "entity_type": "Negative_regulation", "start": 54, "end": 55}, {"id": "T11", "text": "tumor", "entity_type": "Pathological_formation", "start": 55, "end": 56}, {"id": "T12", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 56, "end": 57}, {"id": "T14", "text": "tumor", "entity_type": "Pathological_formation", "start": 59, "end": 60}, {"id": "T13", "text": "progression", "entity_type": "Development", "start": 60, "end": 61}, {"id": "T17", "text": "tumor blood vessel", "entity_type": "Multi-tissue_structure", "start": 67, "end": 70}, {"id": "T16", "text": "formation", "entity_type": "Development", "start": 70, "end": 71}, {"id": "T19", "text": "tumor", "entity_type": "Pathological_formation", "start": 76, "end": 77}, {"id": "T20", "text": "vasculature", "entity_type": "Multi-tissue_structure", "start": 82, "end": 83}, {"id": "T22", "text": "development", "entity_type": "Development", "start": 95, "end": 96}, {"id": "T23", "text": "tumor vasculature", "entity_type": "Multi-tissue_structure", "start": 97, "end": 99}, {"id": "T27", "text": "tumor blood vessel", "entity_type": "Multi-tissue_structure", "start": 135, "end": 138}, {"id": "T26", "text": "formation", "entity_type": "Development", "start": 138, "end": 139}, {"id": "T9", "text": "targeting", "entity_type": "Planned_process", "start": 154, "end": 155}, {"id": "T31", "text": "tumor endothelial cells", "entity_type": "Cell", "start": 155, "end": 158}, {"id": "T33", "text": "tumor vasculature", "entity_type": "Multi-tissue_structure", "start": 163, "end": 165}], "lang": "en"}
{"doc_id": "PMID-16374459", "wnd_id": "PMID-16374459_0", "text": "Regulation of skin microvasculature angiogenesis, cell migration, and permeability by a specific inhibitor of PKCalpha.\n\nActivation of protein kinase C (PKC) induces phenotypic changes in the morphology of microvascular endothelial cells that affect major functions of the microvasculature. These functions include the first stages of sprouting in angiogenesis, cell migration following wounding, and vascular permeability. The specific isoform(s) of PKC responsible for each of these changes has not been previously identified. In this study, we used two inflammatory agents, IL-1beta and phorbol myristic acetate, to activate PKC isozymes and specific inhibitors of PKCalpha (Go6976) and PKCbeta (hispidin) to distinguish how each of these isoform(s) controls angiogenesis, wound healing, and permeability. In all cases, only inhibition of PKCalpha inhibited each of these functions when compared to the inhibition of PKCbeta. Additional analysis of the mechanism of action of Go6976 (RT-PCR, Western blots, and immunohistochemistry) of the changes in the phosphorylated and nonphosphorylated forms of PKCalpha in the cell membrane and cytoplasm confirmed the specificity of PKCalpha inhibition by Go6976. These studies therefore indicate a specific and a regulatory role of the PKCalpha isoform in three major endothelial cell functions that are important in the maintenance of microvascular homeostasis.", "tokens": ["Regulation", "of", "skin", "microvasculature", "angiogenesis", ",", "cell", "migration", ",", "and", "permeability", "by", "a", "specific", "inhibitor", "of", "PKCalpha", ".", "Activation", "of", "protein", "kinase", "C", "(", "PKC", ")", "induces", "phenotypic", "changes", "in", "the", "morphology", "of", "microvascular", "endothelial", "cells", "that", "affect", "major", "functions", "of", "the", "microvasculature", ".", "These", "functions", "include", "the", "first", "stages", "of", "sprouting", "in", "angiogenesis", ",", "cell", "migration", "following", "wounding", ",", "and", "vascular", "permeability", ".", "The", "specific", "isoform", "(s", ")", "of", "PKC", "responsible", "for", "each", "of", "these", "changes", "has", "not", "been", "previously", "identified", ".", "In", "this", "study", ",", "we", "used", "two", "inflammatory", "agents", ",", "IL", "-", "1", "beta", "and", "phorbol", "myristic", "acetate", ",", "to", "activate", "PKC", "isozymes", "and", "specific", "inhibitors", "of", "PKCalpha", "(", "Go6976", ")", "and", "PKCbeta", "(", "hispidin", ")", "to", "distinguish", "how", "each", "of", "these", "isoform", "(s", ")", "controls", "angiogenesis", ",", "wound", "healing", ",", "and", "permeability", ".", "In", "all", "cases", ",", "only", "inhibition", "of", "PKCalpha", "inhibited", "each", "of", "these", "functions", "when", "compared", "to", "the", "inhibition", "of", "PKCbeta", ".", "Additional", "analysis", "of", "the", "mechanism", "of", "action", "of", "Go6976", "(", "RT", "-", "PCR", ",", "Western", "blots", ",", "and", "immunohistochemistry", ")", "of", "the", "changes", "in", "the", "phosphorylated", "and", "nonphosphorylated", "forms", "of", "PKCalpha", "in", "the", "cell", "membrane", "and", "cytoplasm", "confirmed", "the", "specificity", "of", "PKCalpha", "inhibition", "by", "Go6976", ".", "These", "studies", "therefore", "indicate", "a", "specific", "and", "a", "regulatory", "role", "of", "the", "PKCalpha", "isoform", "in", "three", "major", "endothelial", "cell", "functions", "that", "are", "important", "in", "the", "maintenance", "of", "microvascular", "homeostasis", "."], "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "Regulation", "start": 0, "end": 1}, "arguments": []}, {"id": "E2", "event_type": "Regulation", "trigger": {"text": "Regulation", "start": 0, "end": 1}, "arguments": []}, {"id": "E16", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 4, "end": 5}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "skin microvasculature", "start": 2, "end": 4}]}, {"id": "E21", "event_type": "Localization", "trigger": {"text": "migration", "start": 7, "end": 8}, "arguments": [{"entity_id": "T49", "role": "Theme", "text": "cell", "start": 6, "end": 7}]}, {"id": "E9", "event_type": "Positive_regulation", "trigger": {"text": "Activation", "start": 18, "end": 19}, "arguments": [{"entity_id": "T10", "role": "Theme", "text": "protein kinase C", "start": 20, "end": 23}, {"entity_id": "T11", "role": "Theme", "text": "PKC", "start": 24, "end": 25}]}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 26, "end": 27}, "arguments": []}, {"id": "E8", "event_type": "Regulation", "trigger": {"text": "changes", "start": 28, "end": 29}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "microvascular endothelial cells", "start": 33, "end": 36}]}, {"id": "E14", "event_type": "Regulation", "trigger": {"text": "affect", "start": 37, "end": 38}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "microvasculature", "start": 42, "end": 43}]}, {"id": "E18", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 53, "end": 54}, "arguments": []}, {"id": "E20", "event_type": "Localization", "trigger": {"text": "migration", "start": 56, "end": 57}, "arguments": [{"entity_id": "T47", "role": "Theme", "text": "cell", "start": 55, "end": 56}]}, {"id": "E5", "event_type": "Regulation", "trigger": {"text": "responsible", "start": 71, "end": 72}, "arguments": [{"entity_id": "T20", "role": "Theme", "text": "PKC", "start": 70, "end": 71}]}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "activate", "start": 103, "end": 104}, "arguments": [{"entity_id": "T22", "role": "Cause", "text": "phorbol myristic acetate", "start": 98, "end": 101}, {"entity_id": "T25", "role": "Theme", "text": "PKC", "start": 104, "end": 105}]}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "activate", "start": 103, "end": 104}, "arguments": [{"entity_id": "T21", "role": "Cause", "text": "IL-1beta", "start": 93, "end": 97}, {"entity_id": "T25", "role": "Theme", "text": "PKC", "start": 104, "end": 105}]}, {"id": "E7", "event_type": "Regulation", "trigger": {"text": "controls", "start": 128, "end": 129}, "arguments": [{"entity_id": "T26", "role": "Cause", "text": "PKCalpha", "start": 110, "end": 111}]}, {"id": "E10", "event_type": "Regulation", "trigger": {"text": "controls", "start": 128, "end": 129}, "arguments": [{"entity_id": "T28", "role": "Cause", "text": "PKCbeta", "start": 115, "end": 116}]}, {"id": "E19", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 129, "end": 130}, "arguments": []}, {"id": "E31", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 142, "end": 143}, "arguments": [{"entity_id": "T32", "role": "Theme", "text": "PKCalpha", "start": 144, "end": 145}]}, {"id": "E33", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 154, "end": 155}, "arguments": [{"entity_id": "T34", "role": "Theme", "text": "PKCbeta", "start": 156, "end": 157}]}, {"id": "E13", "event_type": "Regulation", "trigger": {"text": "changes", "start": 180, "end": 181}, "arguments": [{"entity_id": "T35", "role": "Cause", "text": "Go6976", "start": 166, "end": 167}]}, {"id": "E15", "event_type": "Regulation", "trigger": {"text": "changes", "start": 180, "end": 181}, "arguments": [{"entity_id": "T35", "role": "Cause", "text": "Go6976", "start": 166, "end": 167}]}, {"id": "E11", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylated", "start": 183, "end": 184}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "PKCalpha", "start": 188, "end": 189}]}, {"id": "E12", "event_type": "Phosphorylation", "trigger": {"text": "nonphosphorylated", "start": 185, "end": 186}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "PKCalpha", "start": 188, "end": 189}]}, {"id": "E39", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 200, "end": 201}, "arguments": [{"entity_id": "T40", "role": "Theme", "text": "PKCalpha", "start": 199, "end": 200}, {"entity_id": "T41", "role": "Cause", "text": "Go6976", "start": 202, "end": 203}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "Regulation", "entity_type": "Regulation", "start": 0, "end": 1}, {"id": "T2", "text": "skin microvasculature", "entity_type": "Tissue", "start": 2, "end": 4}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 4, "end": 5}, {"id": "T49", "text": "cell", "entity_type": "Cell", "start": 6, "end": 7}, {"id": "T50", "text": "migration", "entity_type": "Localization", "start": 7, "end": 8}, {"id": "T6", "text": "PKCalpha", "entity_type": "Gene_or_gene_product", "start": 16, "end": 17}, {"id": "T9", "text": "Activation", "entity_type": "Positive_regulation", "start": 18, "end": 19}, {"id": "T10", "text": "protein kinase C", "entity_type": "Gene_or_gene_product", "start": 20, "end": 23}, {"id": "T11", "text": "PKC", "entity_type": "Gene_or_gene_product", "start": 24, "end": 25}, {"id": "T5", "text": "induces", "entity_type": "Positive_regulation", "start": 26, "end": 27}, {"id": "T8", "text": "changes", "entity_type": "Regulation", "start": 28, "end": 29}, {"id": "T13", "text": "microvascular endothelial cells", "entity_type": "Cell", "start": 33, "end": 36}, {"id": "T14", "text": "affect", "entity_type": "Regulation", "start": 37, "end": 38}, {"id": "T15", "text": "microvasculature", "entity_type": "Tissue", "start": 42, "end": 43}, {"id": "T16", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 53, "end": 54}, {"id": "T47", "text": "cell", "entity_type": "Cell", "start": 55, "end": 56}, {"id": "T48", "text": "migration", "entity_type": "Localization", "start": 56, "end": 57}, {"id": "T19", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 61, "end": 62}, {"id": "T20", "text": "PKC", "entity_type": "Gene_or_gene_product", "start": 70, "end": 71}, {"id": "T7", "text": "responsible", "entity_type": "Regulation", "start": 71, "end": 72}, {"id": "T21", "text": "IL-1beta", "entity_type": "Gene_or_gene_product", "start": 93, "end": 97}, {"id": "T22", "text": "phorbol myristic acetate", "entity_type": "Drug_or_compound", "start": 98, "end": 101}, {"id": "T23", "text": "activate", "entity_type": "Positive_regulation", "start": 103, "end": 104}, {"id": "T25", "text": "PKC", "entity_type": "Gene_or_gene_product", "start": 104, "end": 105}, {"id": "T26", "text": "PKCalpha", "entity_type": "Gene_or_gene_product", "start": 110, "end": 111}, {"id": "T27", "text": "Go6976", "entity_type": "Drug_or_compound", "start": 112, "end": 113}, {"id": "T28", "text": "PKCbeta", "entity_type": "Gene_or_gene_product", "start": 115, "end": 116}, {"id": "T29", "text": "hispidin", "entity_type": "Drug_or_compound", "start": 117, "end": 118}, {"id": "T18", "text": "controls", "entity_type": "Regulation", "start": 128, "end": 129}, {"id": "T30", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 129, "end": 130}, {"id": "T31", "text": "inhibition", "entity_type": "Negative_regulation", "start": 142, "end": 143}, {"id": "T32", "text": "PKCalpha", "entity_type": "Gene_or_gene_product", "start": 144, "end": 145}, {"id": "T33", "text": "inhibition", "entity_type": "Negative_regulation", "start": 154, "end": 155}, {"id": "T34", "text": "PKCbeta", "entity_type": "Gene_or_gene_product", "start": 156, "end": 157}, {"id": "T35", "text": "Go6976", "entity_type": "Drug_or_compound", "start": 166, "end": 167}, {"id": "T46", "text": "changes", "entity_type": "Regulation", "start": 180, "end": 181}, {"id": "T24", "text": "phosphorylated", "entity_type": "Phosphorylation", "start": 183, "end": 184}, {"id": "T45", "text": "nonphosphorylated", "entity_type": "Phosphorylation", "start": 185, "end": 186}, {"id": "T36", "text": "PKCalpha", "entity_type": "Gene_or_gene_product", "start": 188, "end": 189}, {"id": "T37", "text": "cell membrane", "entity_type": "Cellular_component", "start": 191, "end": 193}, {"id": "T38", "text": "cytoplasm", "entity_type": "Cellular_component", "start": 194, "end": 195}, {"id": "T40", "text": "PKCalpha", "entity_type": "Gene_or_gene_product", "start": 199, "end": 200}, {"id": "T39", "text": "inhibition", "entity_type": "Negative_regulation", "start": 200, "end": 201}, {"id": "T41", "text": "Go6976", "entity_type": "Drug_or_compound", "start": 202, "end": 203}, {"id": "T42", "text": "PKCalpha", "entity_type": "Gene_or_gene_product", "start": 216, "end": 217}, {"id": "T43", "text": "endothelial cell", "entity_type": "Cell", "start": 221, "end": 223}, {"id": "T44", "text": "microvascular", "entity_type": "Tissue", "start": 231, "end": 232}], "lang": "en"}
{"doc_id": "PMID-16406506", "wnd_id": "PMID-16406506_0", "text": "Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.\n\nPericytes occur in tumour blood vessels and are critical for the development of a functional vascular network. Targeting tumour pericytes is a promising anti-angiogenic therapy but requires identifying the mechanisms of their recruitment in tumour and addressing whether these mechanisms can be selectively harnessed. Among the pathways involved in pericyte recruitment during embryonic development, the contribution of platelet-derived growth factor B and sphingosine 1-phosphate is confirmed in tumour angiogenesis. The effect of angiopoietin 1 depends on the tumour model. Transforming growth factor-beta1 enhances tumour vascularization and microvessel maturation. Recent reports suggest a participation of matrix metalloproteinases (MMP) in tumour pericyte recruitment that is consistent with the effect of certain MMPs in the development of microvasculature in embryonic development and in in vitro models of vascular remodelling. Here, we discuss the possibility for MMPs to contribute to pericyte recruitment at six levels: (1) direct promotion of pericyte invasion by extracellular matrix degradation; (2) stimulation of pericyte proliferation and protection against apoptosis by modification of the ECM; (3) activation of pericytes through the release of growth factor bound to the ECM; (4) transactivation of angiogenic cell surface receptor; (5) propagation of angiogenic signalling as cofactor; and (6) recruitment of bone marrow-derived stem cells.", "tokens": ["Mechanisms", "of", "pericyte", "recruitment", "in", "tumour", "angiogenesis", ":", "a", "new", "role", "for", "metalloproteinases", ".", "Pericytes", "occur", "in", "tumour", "blood", "vessels", "and", "are", "critical", "for", "the", "development", "of", "a", "functional", "vascular", "network", ".", "Targeting", "tumour", "pericytes", "is", "a", "promising", "anti-angiogenic", "therapy", "but", "requires", "identifying", "the", "mechanisms", "of", "their", "recruitment", "in", "tumour", "and", "addressing", "whether", "these", "mechanisms", "can", "be", "selectively", "harnessed", ".", "Among", "the", "pathways", "involved", "in", "pericyte", "recruitment", "during", "embryonic", "development", ",", "the", "contribution", "of", "platelet", "-", "derived", "growth", "factor", "B", "and", "sphingosine", "1", "-", "phosphate", "is", "confirmed", "in", "tumour", "angiogenesis", ".", "The", "effect", "of", "angiopoietin", "1", "depends", "on", "the", "tumour", "model", ".", "Transforming", "growth", "factor", "-", "bet", "a1", "enhances", "tumour", "vascularization", "and", "microvessel", "maturation", ".", "Recent", "reports", "suggest", "a", "participation", "of", "matrix", "metalloproteinases", "(", "MMP", ")", "in", "tumour", "pericyte", "recruitment", "that", "is", "consistent", "with", "the", "effect", "of", "certain", "MMPs", "in", "the", "development", "of", "microvasculature", "in", "embryonic", "development", "and", "in", "in", "vitro", "models", "of", "vascular", "remodelling", ".", "Here", ",", "we", "discuss", "the", "possibility", "for", "MMPs", "to", "contribute", "to", "pericyte", "recruitment", "at", "six", "levels", ":", "(", "1", ")", "direct", "promotion", "of", "pericyte", "invasion", "by", "extracellular", "matrix", "degradation", ";", "(", "2", ")", "stimulation", "of", "pericyte", "proliferation", "and", "protection", "against", "apoptosis", "by", "modification", "of", "the", "ECM", ";", "(", "3", ")", "activation", "of", "pericytes", "through", "the", "release", "of", "growth", "factor", "bound", "to", "the", "ECM", ";", "(", "4", ")", "transactivation", "of", "angiogenic", "cell", "surface", "receptor", ";", "(", "5", ")", "propagation", "of", "angiogenic", "signalling", "as", "cofactor", ";", "and", "(", "6", ")", "recruitment", "of", "bone", "marrow", "-", "derived", "stem", "cells", "."], "event_mentions": [{"id": "E2", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 3, "end": 4}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "pericyte", "start": 2, "end": 3}, {"entity_id": "T4", "role": "ToLoc", "text": "tumour", "start": 5, "end": 6}]}, {"id": "E18", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 6, "end": 7}, "arguments": [{"entity_id": "T4", "role": "AtLoc", "text": "tumour", "start": 5, "end": 6}]}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "critical", "start": 22, "end": 23}, "arguments": [{"entity_id": "T5", "role": "Cause", "text": "Pericytes", "start": 14, "end": 15}]}, {"id": "E4", "event_type": "Development", "trigger": {"text": "development", "start": 25, "end": 26}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "vascular network", "start": 29, "end": 31}]}, {"id": "E10", "event_type": "Planned_process", "trigger": {"text": "Targeting", "start": 32, "end": 33}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "tumour pericytes", "start": 33, "end": 35}]}, {"id": "E23", "event_type": "Negative_regulation", "trigger": {"text": "therapy", "start": 39, "end": 40}, "arguments": []}, {"id": "E5", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 47, "end": 48}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "tumour pericytes", "start": 33, "end": 35}, {"entity_id": "T13", "role": "ToLoc", "text": "tumour", "start": 49, "end": 50}]}, {"id": "E6", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 66, "end": 67}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "pericyte", "start": 65, "end": 66}]}, {"id": "E7", "event_type": "Regulation", "trigger": {"text": "contribution", "start": 72, "end": 73}, "arguments": [{"entity_id": "T16", "role": "Cause", "text": "platelet-derived growth factor B", "start": 74, "end": 80}]}, {"id": "E9", "event_type": "Regulation", "trigger": {"text": "contribution", "start": 72, "end": 73}, "arguments": [{"entity_id": "T17", "role": "Cause", "text": "sphingosine 1-phosphate", "start": 81, "end": 85}]}, {"id": "E20", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 89, "end": 90}, "arguments": [{"entity_id": "T19", "role": "AtLoc", "text": "tumour", "start": 88, "end": 89}]}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "enhances", "start": 108, "end": 109}, "arguments": [{"entity_id": "T23", "role": "Cause", "text": "Transforming growth factor-beta1", "start": 102, "end": 108}]}, {"id": "E13", "event_type": "Positive_regulation", "trigger": {"text": "enhances", "start": 108, "end": 109}, "arguments": [{"entity_id": "T23", "role": "Cause", "text": "Transforming growth factor-beta1", "start": 102, "end": 108}]}, {"id": "E1", "event_type": "Blood_vessel_development", "trigger": {"text": "vascularization", "start": 110, "end": 111}, "arguments": [{"entity_id": "T26", "role": "AtLoc", "text": "tumour", "start": 109, "end": 110}]}, {"id": "E12", "event_type": "Development", "trigger": {"text": "maturation", "start": 113, "end": 114}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "microvessel", "start": 112, "end": 113}]}, {"id": "E8", "event_type": "Regulation", "trigger": {"text": "participation", "start": 119, "end": 120}, "arguments": [{"entity_id": "T30", "role": "Cause", "text": "matrix metalloproteinases", "start": 121, "end": 123}, {"entity_id": "T31", "role": "Cause", "text": "MMP", "start": 124, "end": 125}]}, {"id": "E33", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 129, "end": 130}, "arguments": [{"entity_id": "T34", "role": "Theme", "text": "tumour pericyte", "start": 127, "end": 129}]}, {"id": "E15", "event_type": "Regulation", "trigger": {"text": "effect", "start": 135, "end": 136}, "arguments": [{"entity_id": "T37", "role": "Cause", "text": "MMPs", "start": 138, "end": 139}]}, {"id": "E39", "event_type": "Development", "trigger": {"text": "development", "start": 141, "end": 142}, "arguments": [{"entity_id": "T40", "role": "Theme", "text": "microvasculature", "start": 143, "end": 144}]}, {"id": "E16", "event_type": "Remodeling", "trigger": {"text": "remodelling", "start": 154, "end": 155}, "arguments": [{"entity_id": "T42", "role": "Theme", "text": "vascular", "start": 153, "end": 154}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "contribute", "start": 165, "end": 166}, "arguments": [{"entity_id": "T43", "role": "Cause", "text": "MMPs", "start": 163, "end": 164}]}, {"id": "E45", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 168, "end": 169}, "arguments": [{"entity_id": "T46", "role": "Theme", "text": "pericyte", "start": 167, "end": 168}]}, {"id": "E47", "event_type": "Positive_regulation", "trigger": {"text": "promotion", "start": 177, "end": 178}, "arguments": []}, {"id": "E49", "event_type": "Localization", "trigger": {"text": "invasion", "start": 180, "end": 181}, "arguments": [{"entity_id": "T50", "role": "Theme", "text": "pericyte", "start": 179, "end": 180}]}, {"id": "E51", "event_type": "Breakdown", "trigger": {"text": "degradation", "start": 184, "end": 185}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "extracellular matrix", "start": 182, "end": 184}]}, {"id": "E53", "event_type": "Positive_regulation", "trigger": {"text": "stimulation", "start": 189, "end": 190}, "arguments": []}, {"id": "E55", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 192, "end": 193}, "arguments": [{"entity_id": "T56", "role": "Theme", "text": "pericyte", "start": 191, "end": 192}]}, {"id": "E59", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 206, "end": 207}, "arguments": [{"entity_id": "T60", "role": "Theme", "text": "pericytes", "start": 208, "end": 209}]}, {"id": "E17", "event_type": "Binding", "trigger": {"text": "bound", "start": 215, "end": 216}, "arguments": [{"entity_id": "T62", "role": "Theme", "text": "ECM", "start": 218, "end": 219}]}, {"id": "E21", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 225, "end": 226}, "arguments": []}, {"id": "E22", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 235, "end": 236}, "arguments": []}, {"id": "E70", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 244, "end": 245}, "arguments": [{"entity_id": "T71", "role": "Theme", "text": "bone marrow-derived stem cells", "start": 246, "end": 252}]}], "relation_mentions": [], "entity_mentions": [{"id": "T2", "text": "pericyte", "entity_type": "Cell", "start": 2, "end": 3}, {"id": "T18", "text": "recruitment", "entity_type": "Localization", "start": 3, "end": 4}, {"id": "T4", "text": "tumour", "entity_type": "Pathological_formation", "start": 5, "end": 6}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 6, "end": 7}, {"id": "T7", "text": "metalloproteinases", "entity_type": "Gene_or_gene_product", "start": 12, "end": 13}, {"id": "T5", "text": "Pericytes", "entity_type": "Cell", "start": 14, "end": 15}, {"id": "T6", "text": "tumour blood vessels", "entity_type": "Multi-tissue_structure", "start": 17, "end": 20}, {"id": "T24", "text": "critical", "entity_type": "Positive_regulation", "start": 22, "end": 23}, {"id": "T29", "text": "development", "entity_type": "Development", "start": 25, "end": 26}, {"id": "T9", "text": "vascular network", "entity_type": "Multi-tissue_structure", "start": 29, "end": 31}, {"id": "T10", "text": "Targeting", "entity_type": "Planned_process", "start": 32, "end": 33}, {"id": "T11", "text": "tumour pericytes", "entity_type": "Cell", "start": 33, "end": 35}, {"id": "T67", "text": "therapy", "entity_type": "Negative_regulation", "start": 39, "end": 40}, {"id": "T35", "text": "recruitment", "entity_type": "Localization", "start": 47, "end": 48}, {"id": "T13", "text": "tumour", "entity_type": "Pathological_formation", "start": 49, "end": 50}, {"id": "T15", "text": "pericyte", "entity_type": "Cell", "start": 65, "end": 66}, {"id": "T36", "text": "recruitment", "entity_type": "Localization", "start": 66, "end": 67}, {"id": "T61", "text": "contribution", "entity_type": "Regulation", "start": 72, "end": 73}, {"id": "T16", "text": "platelet-derived growth factor B", "entity_type": "Gene_or_gene_product", "start": 74, "end": 80}, {"id": "T17", "text": "sphingosine 1-phosphate", "entity_type": "Gene_or_gene_product", "start": 81, "end": 85}, {"id": "T19", "text": "tumour", "entity_type": "Pathological_formation", "start": 88, "end": 89}, {"id": "T20", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 89, "end": 90}, {"id": "T21", "text": "angiopoietin 1", "entity_type": "Gene_or_gene_product", "start": 94, "end": 96}, {"id": "T22", "text": "tumour", "entity_type": "Pathological_formation", "start": 99, "end": 100}, {"id": "T23", "text": "Transforming growth factor-beta1", "entity_type": "Gene_or_gene_product", "start": 102, "end": 108}, {"id": "T64", "text": "enhances", "entity_type": "Positive_regulation", "start": 108, "end": 109}, {"id": "T26", "text": "tumour", "entity_type": "Pathological_formation", "start": 109, "end": 110}, {"id": "T1", "text": "vascularization", "entity_type": "Blood_vessel_development", "start": 110, "end": 111}, {"id": "T28", "text": "microvessel", "entity_type": "Tissue", "start": 112, "end": 113}, {"id": "T72", "text": "maturation", "entity_type": "Development", "start": 113, "end": 114}, {"id": "T8", "text": "participation", "entity_type": "Regulation", "start": 119, "end": 120}, {"id": "T30", "text": "matrix metalloproteinases", "entity_type": "Gene_or_gene_product", "start": 121, "end": 123}, {"id": "T31", "text": "MMP", "entity_type": "Gene_or_gene_product", "start": 124, "end": 125}, {"id": "T34", "text": "tumour pericyte", "entity_type": "Cell", "start": 127, "end": 129}, {"id": "T33", "text": "recruitment", "entity_type": "Localization", "start": 129, "end": 130}, {"id": "T73", "text": "effect", "entity_type": "Regulation", "start": 135, "end": 136}, {"id": "T37", "text": "MMPs", "entity_type": "Gene_or_gene_product", "start": 138, "end": 139}, {"id": "T39", "text": "development", "entity_type": "Development", "start": 141, "end": 142}, {"id": "T40", "text": "microvasculature", "entity_type": "Multi-tissue_structure", "start": 143, "end": 144}, {"id": "T42", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 153, "end": 154}, {"id": "T74", "text": "remodelling", "entity_type": "Remodeling", "start": 154, "end": 155}, {"id": "T43", "text": "MMPs", "entity_type": "Gene_or_gene_product", "start": 163, "end": 164}, {"id": "T14", "text": "contribute", "entity_type": "Positive_regulation", "start": 165, "end": 166}, {"id": "T46", "text": "pericyte", "entity_type": "Cell", "start": 167, "end": 168}, {"id": "T45", "text": "recruitment", "entity_type": "Localization", "start": 168, "end": 169}, {"id": "T47", "text": "promotion", "entity_type": "Positive_regulation", "start": 177, "end": 178}, {"id": "T50", "text": "pericyte", "entity_type": "Cell", "start": 179, "end": 180}, {"id": "T49", "text": "invasion", "entity_type": "Localization", "start": 180, "end": 181}, {"id": "T52", "text": "extracellular matrix", "entity_type": "Cellular_component", "start": 182, "end": 184}, {"id": "T51", "text": "degradation", "entity_type": "Breakdown", "start": 184, "end": 185}, {"id": "T53", "text": "stimulation", "entity_type": "Positive_regulation", "start": 189, "end": 190}, {"id": "T56", "text": "pericyte", "entity_type": "Cell", "start": 191, "end": 192}, {"id": "T55", "text": "proliferation", "entity_type": "Cell_proliferation", "start": 192, "end": 193}, {"id": "T57", "text": "ECM", "entity_type": "Cellular_component", "start": 201, "end": 202}, {"id": "T59", "text": "activation", "entity_type": "Positive_regulation", "start": 206, "end": 207}, {"id": "T60", "text": "pericytes", "entity_type": "Cell", "start": 208, "end": 209}, {"id": "T75", "text": "bound", "entity_type": "Binding", "start": 215, "end": 216}, {"id": "T62", "text": "ECM", "entity_type": "Cellular_component", "start": 218, "end": 219}, {"id": "T65", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 225, "end": 226}, {"id": "T68", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 235, "end": 236}, {"id": "T70", "text": "recruitment", "entity_type": "Localization", "start": 244, "end": 245}, {"id": "T71", "text": "bone marrow-derived stem cells", "entity_type": "Cell", "start": 246, "end": 252}], "lang": "en"}
{"doc_id": "PMID-16907772", "wnd_id": "PMID-16907772_0", "text": "Formation of new bone during vertical distraction osteogenesis of the human mandible is related to the presence of blood vessels.\n\nWe examined the effect of distraction rate on blood vessel growth in intramembraneous ossification after vertical distraction osteogenesis in the human mandible. Six edentulous patients (aged 60+/-9 years) with a severely atrophic mandible underwent bone augmentation with distraction osteogenesis. Two distraction rates (0.5 and 1 mm/day) were compared and for each group three patients were analyzed. Vascular histomorphometry was carried out in two different areas in the distraction gap: (1) in the first and (2) in the second 1 mm area from the osteotomy line, representing the oldest and younger new-bone area, respectively. Correlation analysis was performed between blood vessel parameters and the amount of new bone formed during distraction. Histological analysis demonstrated the presence of blood vessels throughout the soft connective tissue in the distraction gap. The volume density of blood vessels between the two investigated areas was significantly lower in the 1 mm/day groups, suggesting a delay in angiogenesis in this group of patients. A positive correlation between blood vessel volume and bone volume density was found in the younger new-bone area but not in the oldest new-bone area. This correlation was due to a higher number of blood vessels rather than to a larger size of the blood vessels. Our data suggest that the lower blood vessel density found in the patients with 1 mm/day distraction rate may be related to disruption of angiogenesis in the soft connective tissue of the gap or to a less optimal mechanical stimulation of cells involved in angiogenesis. This probably results in the slower rate of osteogenesis seen at the 1 mm/day distraction rate compared with the 0.5 mm/day distraction rate. The data support the concept that a positive relationship exists between the density of blood vessels and the formation of bone. For distraction of the human mandible in elderly patients, a distraction rate of 0.5 mm/day seems beneficial.", "tokens": ["Formation", "of", "new", "bone", "during", "vertical", "distraction", "osteogenesis", "of", "the", "human", "mandible", "is", "related", "to", "the", "presence", "of", "blood", "vessels", ".", "We", "examined", "the", "effect", "of", "distraction", "rate", "on", "blood", "vessel", "growth", "in", "intramembraneous", "ossification", "after", "vertical", "distraction", "osteogenesis", "in", "the", "human", "mandible", ".", "Six", "edentulous", "patients", "(", "aged", "60", "+/-9", "years", ")", "with", "a", "severely", "atrophic", "mandible", "underwent", "bone", "augmentation", "with", "distraction", "osteogenesis", ".", "Two", "distraction", "rates", "(", "0.5", "and", "1", "mm", "/", "day", ")", "were", "compared", "and", "for", "each", "group", "three", "patients", "were", "analyzed", ".", "Vascular", "histomorphometry", "was", "carried", "out", "in", "two", "different", "areas", "in", "the", "distraction", "gap", ":", "(", "1", ")", "in", "the", "first", "and", "(", "2", ")", "in", "the", "second", "1", "mm", "area", "from", "the", "osteotomy", "line", ",", "representing", "the", "oldest", "and", "younger", "new", "-", "bone", "area", ",", "respectively", ".", "Correlation", "analysis", "was", "performed", "between", "blood", "vessel", "parameters", "and", "the", "amount", "of", "new", "bone", "formed", "during", "distraction", ".", "Histological", "analysis", "demonstrated", "the", "presence", "of", "blood", "vessels", "throughout", "the", "soft", "connective", "tissue", "in", "the", "distraction", "gap", ".", "The", "volume", "density", "of", "blood", "vessels", "between", "the", "two", "investigated", "areas", "was", "significantly", "lower", "in", "the", "1", "mm", "/", "day", "groups", ",", "suggesting", "a", "delay", "in", "angiogenesis", "in", "this", "group", "of", "patients", ".", "A", "positive", "correlation", "between", "blood", "vessel", "volume", "and", "bone", "volume", "density", "was", "found", "in", "the", "younger", "new", "-", "bone", "area", "but", "not", "in", "the", "oldest", "new", "-", "bone", "area", ".", "This", "correlation", "was", "due", "to", "a", "higher", "number", "of", "blood", "vessels", "rather", "than", "to", "a", "larger", "size", "of", "the", "blood", "vessels", ".", "Our", "data", "suggest", "that", "the", "lower", "blood", "vessel", "density", "found", "in", "the", "patients", "with", "1", "mm", "/", "day", "distraction", "rate", "may", "be", "related", "to", "disruption", "of", "angiogenesis", "in", "the", "soft", "connective", "tissue", "of", "the", "gap", "or", "to", "a", "less", "optimal", "mechanical", "stimulation", "of", "cells", "involved", "in", "angiogenesis", ".", "This", "probably", "results", "in", "the", "slower", "rate", "of", "osteogenesis", "seen", "at", "the", "1", "mm", "/", "day", "distraction", "rate", "compared", "with", "the", "0.5", "mm", "/", "day", "distraction", "rate", ".", "The", "data", "support", "the", "concept", "that", "a", "positive", "relationship", "exists", "between", "the", "density", "of", "blood", "vessels", "and", "the", "formation", "of", "bone", ".", "For", "distraction", "of", "the", "human", "mandible", "in", "elderly", "patients", ",", "a", "distraction", "rate", "of", "0.5", "mm", "/", "day", "seems", "beneficial", "."], "event_mentions": [{"id": "E1", "event_type": "Development", "trigger": {"text": "Formation", "start": 0, "end": 1}, "arguments": [{"entity_id": "T1", "role": "Theme", "text": "bone", "start": 3, "end": 4}]}, {"id": "E2", "event_type": "Planned_process", "trigger": {"text": "vertical distraction osteogenesis", "start": 5, "end": 8}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "mandible", "start": 11, "end": 12}]}, {"id": "E5", "event_type": "Growth", "trigger": {"text": "growth", "start": 31, "end": 32}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "blood vessel", "start": 29, "end": 31}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "vertical distraction osteogenesis", "start": 36, "end": 39}, "arguments": [{"entity_id": "T7", "role": "Theme", "text": "mandible", "start": 42, "end": 43}]}, {"id": "E6", "event_type": "Development", "trigger": {"text": "formed", "start": 148, "end": 149}, "arguments": [{"entity_id": "T12", "role": "Theme", "text": "bone", "start": 147, "end": 148}]}, {"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "delay", "start": 194, "end": 195}, "arguments": []}, {"id": "E12", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 196, "end": 197}, "arguments": []}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "disruption", "start": 279, "end": 280}, "arguments": []}, {"id": "E13", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 281, "end": 282}, "arguments": [{"entity_id": "T25", "role": "AtLoc", "text": "soft connective tissue", "start": 284, "end": 287}]}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "stimulation", "start": 296, "end": 297}, "arguments": [{"entity_id": "T38", "role": "Theme", "text": "cells", "start": 298, "end": 299}]}, {"id": "E14", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 301, "end": 302}, "arguments": []}, {"id": "E9", "event_type": "Development", "trigger": {"text": "formation", "start": 349, "end": 350}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "bone", "start": 351, "end": 352}]}, {"id": "E10", "event_type": "Planned_process", "trigger": {"text": "distraction", "start": 354, "end": 355}, "arguments": [{"entity_id": "T29", "role": "Theme", "text": "mandible", "start": 358, "end": 359}]}], "relation_mentions": [], "entity_mentions": [{"id": "T30", "text": "Formation", "entity_type": "Development", "start": 0, "end": 1}, {"id": "T1", "text": "bone", "entity_type": "Tissue", "start": 3, "end": 4}, {"id": "T31", "text": "vertical distraction osteogenesis", "entity_type": "Planned_process", "start": 5, "end": 8}, {"id": "T1000", "text": "human", "entity_type": "Organism", "start": 10, "end": 11}, {"id": "T2", "text": "mandible", "entity_type": "Organ", "start": 11, "end": 12}, {"id": "T3", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 18, "end": 20}, {"id": "T6", "text": "blood vessel", "entity_type": "Multi-tissue_structure", "start": 29, "end": 31}, {"id": "T5", "text": "growth", "entity_type": "Growth", "start": 31, "end": 32}, {"id": "T32", "text": "vertical distraction osteogenesis", "entity_type": "Planned_process", "start": 36, "end": 39}, {"id": "T1001", "text": "human", "entity_type": "Organism", "start": 41, "end": 42}, {"id": "T7", "text": "mandible", "entity_type": "Organ", "start": 42, "end": 43}, {"id": "T1002", "text": "patients", "entity_type": "Organism", "start": 46, "end": 47}, {"id": "T8", "text": "mandible", "entity_type": "Organ", "start": 57, "end": 58}, {"id": "T9", "text": "bone", "entity_type": "Tissue", "start": 59, "end": 60}, {"id": "T1003", "text": "patients", "entity_type": "Organism", "start": 83, "end": 84}, {"id": "T10", "text": "bone", "entity_type": "Tissue", "start": 129, "end": 130}, {"id": "T11", "text": "blood vessel", "entity_type": "Multi-tissue_structure", "start": 139, "end": 141}, {"id": "T12", "text": "bone", "entity_type": "Tissue", "start": 147, "end": 148}, {"id": "T33", "text": "formed", "entity_type": "Development", "start": 148, "end": 149}, {"id": "T13", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 158, "end": 160}, {"id": "T14", "text": "soft connective tissue", "entity_type": "Tissue", "start": 162, "end": 165}, {"id": "T15", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 174, "end": 176}, {"id": "T34", "text": "delay", "entity_type": "Negative_regulation", "start": 194, "end": 195}, {"id": "T16", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 196, "end": 197}, {"id": "T1004", "text": "patients", "entity_type": "Organism", "start": 201, "end": 202}, {"id": "T17", "text": "blood vessel", "entity_type": "Multi-tissue_structure", "start": 207, "end": 209}, {"id": "T18", "text": "bone", "entity_type": "Tissue", "start": 211, "end": 212}, {"id": "T19", "text": "bone", "entity_type": "Tissue", "start": 221, "end": 222}, {"id": "T20", "text": "bone", "entity_type": "Tissue", "start": 230, "end": 231}, {"id": "T21", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 242, "end": 244}, {"id": "T22", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 252, "end": 254}, {"id": "T23", "text": "blood vessel", "entity_type": "Multi-tissue_structure", "start": 261, "end": 263}, {"id": "T1005", "text": "patients", "entity_type": "Organism", "start": 267, "end": 268}, {"id": "T35", "text": "disruption", "entity_type": "Negative_regulation", "start": 279, "end": 280}, {"id": "T24", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 281, "end": 282}, {"id": "T25", "text": "soft connective tissue", "entity_type": "Tissue", "start": 284, "end": 287}, {"id": "T39", "text": "stimulation", "entity_type": "Positive_regulation", "start": 296, "end": 297}, {"id": "T38", "text": "cells", "entity_type": "Cell", "start": 298, "end": 299}, {"id": "T26", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 301, "end": 302}, {"id": "T27", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 345, "end": 347}, {"id": "T36", "text": "formation", "entity_type": "Development", "start": 349, "end": 350}, {"id": "T28", "text": "bone", "entity_type": "Tissue", "start": 351, "end": 352}, {"id": "T37", "text": "distraction", "entity_type": "Planned_process", "start": 354, "end": 355}, {"id": "T1006", "text": "human", "entity_type": "Organism", "start": 357, "end": 358}, {"id": "T29", "text": "mandible", "entity_type": "Organ", "start": 358, "end": 359}, {"id": "T1007", "text": "patients", "entity_type": "Organism", "start": 361, "end": 362}], "lang": "en"}
{"doc_id": "PMID-16963846", "wnd_id": "PMID-16963846_0", "text": "Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.\n\nPURPOSE: To assess the safety and effectiveness of photodynamic therapy (PDT) with verteporfin for subfoveal choroidal neovascularization (CNV) secondary to pathologic myopia (PM). METHODS: Sixty-two patients (62 eyes) with PM underwent PDT according to the guidelines of the Verteporfin in Photodynamic Therapy Study. Clinical evaluations performed at all study visits included measurement of best-corrected Snellen visual acuity, slit-lamp biomicroscopy, and fundus fluorescein angiography. Patients were followed up at 1 month and 3 months after treatment and thereafter at 3-month intervals. RESULTS: The final visual acuity of the study patients, after a median follow-up of 31 months, improved by  greater than or=1 Snellen lines in 8 patients (13%), deteriorated in 20 (32%), and remained stable in 34 (55%). The baseline visual acuity was similar in the various study groups. The final mean visual acuity in group A (55 years of age or younger) was 20/80 and significantly (P=0.006) better than that (20/138) in group B (older than 55 years of age). The mean final visual acuity in eyes with higher refractive error at baseline (greater than -17 diopters) was significantly better (P=0.014) than that in eyes with lower refractive error (-6 to -10 diopters). CNV size did not affect visual outcomes. CONCLUSION: PDT preserves vision in patients with CNV associated with PM. Younger patients and eyes with higher refractive error appear more likely to benefit from PDT with verteporfin.", "tokens": ["Photodynamic", "therapy", "with", "verteporfin", "for", "subfoveal", "choroidal", "neovascularization", "secondary", "to", "pathologic", "myopia", ":", "long", "-", "term", "study", ".", "PURPOSE", ":", "To", "assess", "the", "safety", "and", "effectiveness", "of", "photodynamic", "therapy", "(", "PDT", ")", "with", "verteporfin", "for", "subfoveal", "choroidal", "neovascularization", "(", "CNV", ")", "secondary", "to", "pathologic", "myopia", "(", "PM", ")", ".", "METHODS", ":", "Sixty", "-", "two", "patients", "(", "62", "eyes", ")", "with", "PM", "underwent", "PDT", "according", "to", "the", "guidelines", "of", "the", "Verteporfin", "in", "Photodynamic", "Therapy", "Study", ".", "Clinical", "evaluations", "performed", "at", "all", "study", "visits", "included", "measurement", "of", "best", "-", "corrected", "Snellen", "visual", "acuity", ",", "slit", "-", "lamp", "biomicroscopy", ",", "and", "fundus", "fluorescein", "angiography", ".", "Patients", "were", "followed", "up", "at", "1", "month", "and", "3", "months", "after", "treatment", "and", "thereafter", "at", "3", "-", "month", "intervals", ".", "RESULTS", ":", "The", "final", "visual", "acuity", "of", "the", "study", "patients", ",", "after", "a", "median", "follow", "-", "up", "of", "31", "months", ",", "improved", "by", "greater", "than", "or=1", "Snellen", "lines", "in", "8", "patients", "(", "13", "%", ")", ",", "deteriorated", "in", "20", "(", "32", "%", ")", ",", "and", "remained", "stable", "in", "34", "(", "55", "%", ")", ".", "The", "baseline", "visual", "acuity", "was", "similar", "in", "the", "various", "study", "groups", ".", "The", "final", "mean", "visual", "acuity", "in", "group", "A", "(", "55", "years", "of", "age", "or", "younger", ")", "was", "20/80", "and", "significantly", "(", "P=0.006", ")", "better", "than", "that", "(", "20/138", ")", "in", "group", "B", "(", "older", "than", "55", "years", "of", "age", ")", ".", "The", "mean", "final", "visual", "acuity", "in", "eyes", "with", "higher", "refractive", "error", "at", "baseline", "(", "greater", "than", "-", "17", "diopters", ")", "was", "significantly", "better", "(", "P=0.014", ")", "than", "that", "in", "eyes", "with", "lower", "refractive", "error", "(", "-", "6", "to", "-", "10", "diopters", ")", ".", "CNV", "size", "did", "not", "affect", "visual", "outcomes", ".", "CONCLUSION", ":", "PDT", "preserves", "vision", "in", "patients", "with", "CNV", "associated", "with", "PM", ".", "Younger", "patients", "and", "eyes", "with", "higher", "refractive", "error", "appear", "more", "likely", "to", "benefit", "from", "PDT", "with", "verteporfin", "."], "event_mentions": [{"id": "E1", "event_type": "Planned_process", "trigger": {"text": "Photodynamic therapy", "start": 0, "end": 2}, "arguments": [{"entity_id": "T2", "role": "Instrument", "text": "verteporfin", "start": 3, "end": 4}]}, {"id": "E11", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 7, "end": 8}, "arguments": []}, {"id": "E2", "event_type": "Planned_process", "trigger": {"text": "photodynamic therapy", "start": 27, "end": 29}, "arguments": [{"entity_id": "T5", "role": "Instrument", "text": "verteporfin", "start": 33, "end": 34}]}, {"id": "E12", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 37, "end": 38}, "arguments": []}, {"id": "E15", "event_type": "Blood_vessel_development", "trigger": {"text": "CNV", "start": 39, "end": 40}, "arguments": []}, {"id": "E10", "event_type": "Planned_process", "trigger": {"text": "PDT", "start": 62, "end": 63}, "arguments": [{"entity_id": "T1001", "role": "Theme", "text": "patients", "start": 54, "end": 55}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "Photodynamic Therapy", "start": 71, "end": 73}, "arguments": [{"entity_id": "T1001", "role": "Theme", "text": "patients", "start": 54, "end": 55}, {"entity_id": "T10", "role": "Instrument", "text": "Verteporfin", "start": 69, "end": 70}]}, {"id": "E4", "event_type": "Planned_process", "trigger": {"text": "angiography", "start": 100, "end": 101}, "arguments": [{"entity_id": "T1", "role": "Theme", "text": "fundus", "start": 98, "end": 99}, {"entity_id": "T20", "role": "Instrument", "text": "fluorescein", "start": 99, "end": 100}]}, {"id": "E5", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 113, "end": 114}, "arguments": [{"entity_id": "T1002", "role": "Theme", "text": "Patients", "start": 102, "end": 103}]}, {"id": "E13", "event_type": "Blood_vessel_development", "trigger": {"text": "CNV", "start": 272, "end": 273}, "arguments": []}, {"id": "E6", "event_type": "Planned_process", "trigger": {"text": "PDT", "start": 282, "end": 283}, "arguments": [{"entity_id": "T1006", "role": "Theme", "text": "patients", "start": 286, "end": 287}]}, {"id": "E14", "event_type": "Blood_vessel_development", "trigger": {"text": "CNV", "start": 288, "end": 289}, "arguments": []}, {"id": "E7", "event_type": "Planned_process", "trigger": {"text": "PDT", "start": 307, "end": 308}, "arguments": [{"entity_id": "T1008", "role": "Theme", "text": "patients", "start": 294, "end": 295}, {"entity_id": "T16", "role": "Instrument", "text": "verteporfin", "start": 309, "end": 310}]}, {"id": "E8", "event_type": "Planned_process", "trigger": {"text": "PDT", "start": 307, "end": 308}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "eyes", "start": 296, "end": 297}, {"entity_id": "T16", "role": "Instrument", "text": "verteporfin", "start": 309, "end": 310}]}], "relation_mentions": [], "entity_mentions": [{"id": "T6", "text": "Photodynamic therapy", "entity_type": "Planned_process", "start": 0, "end": 2}, {"id": "T2", "text": "verteporfin", "entity_type": "Drug_or_compound", "start": 3, "end": 4}, {"id": "T4", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 7, "end": 8}, {"id": "T8", "text": "photodynamic therapy", "entity_type": "Planned_process", "start": 27, "end": 29}, {"id": "T5", "text": "verteporfin", "entity_type": "Drug_or_compound", "start": 33, "end": 34}, {"id": "T7", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 37, "end": 38}, {"id": "T3", "text": "CNV", "entity_type": "Blood_vessel_development", "start": 39, "end": 40}, {"id": "T1001", "text": "patients", "entity_type": "Organism", "start": 54, "end": 55}, {"id": "T9", "text": "eyes", "entity_type": "Organ", "start": 57, "end": 58}, {"id": "T21", "text": "PDT", "entity_type": "Planned_process", "start": 62, "end": 63}, {"id": "T10", "text": "Verteporfin", "entity_type": "Drug_or_compound", "start": 69, "end": 70}, {"id": "T13", "text": "Photodynamic Therapy", "entity_type": "Planned_process", "start": 71, "end": 73}, {"id": "T1", "text": "fundus", "entity_type": "Multi-tissue_structure", "start": 98, "end": 99}, {"id": "T20", "text": "fluorescein", "entity_type": "Drug_or_compound", "start": 99, "end": 100}, {"id": "T14", "text": "angiography", "entity_type": "Planned_process", "start": 100, "end": 101}, {"id": "T1002", "text": "Patients", "entity_type": "Organism", "start": 102, "end": 103}, {"id": "T17", "text": "treatment", "entity_type": "Planned_process", "start": 113, "end": 114}, {"id": "T1003", "text": "patients", "entity_type": "Organism", "start": 131, "end": 132}, {"id": "T1004", "text": "patients", "entity_type": "Organism", "start": 152, "end": 153}, {"id": "T11", "text": "eyes", "entity_type": "Organ", "start": 235, "end": 236}, {"id": "T12", "text": "eyes", "entity_type": "Organ", "start": 258, "end": 259}, {"id": "T1005", "text": "CNV", "entity_type": "Blood_vessel_development", "start": 272, "end": 273}, {"id": "T18", "text": "PDT", "entity_type": "Planned_process", "start": 282, "end": 283}, {"id": "T1006", "text": "patients", "entity_type": "Organism", "start": 286, "end": 287}, {"id": "T1007", "text": "CNV", "entity_type": "Blood_vessel_development", "start": 288, "end": 289}, {"id": "T1008", "text": "patients", "entity_type": "Organism", "start": 294, "end": 295}, {"id": "T15", "text": "eyes", "entity_type": "Organ", "start": 296, "end": 297}, {"id": "T19", "text": "PDT", "entity_type": "Planned_process", "start": 307, "end": 308}, {"id": "T16", "text": "verteporfin", "entity_type": "Drug_or_compound", "start": 309, "end": 310}], "lang": "en"}
{"doc_id": "PMID-17016553", "wnd_id": "PMID-17016553_0", "text": "Imaging tumor angiogenesis.\n\nSince the discovery of vascular-specific growth factors with angiogenic activity, there has been a significant effort to develop cancer drugs that restrict tumorigenesis by targeting the blood supply. In this issue of the JCI, Mancuso et al. use mouse models to better understand the plasticity of the tumor vasculature in the face of antiangiogenic therapy (see the related article beginning on page 2610). They describe a rapid regrowth of the tumor vasculature following withdrawal of VEGFR inhibitors, emphasizing the importance of fully understanding the function of these and similar treatments used in the clinic at the cellular and molecular level.", "tokens": ["Imaging", "tumor", "angiogenesis", ".", "Since", "the", "discovery", "of", "vascular", "-", "specific", "growth", "factors", "with", "angiogenic", "activity", ",", "there", "has", "been", "a", "significant", "effort", "to", "develop", "cancer", "drugs", "that", "restrict", "tumorigenesis", "by", "targeting", "the", "blood", "supply", ".", "In", "this", "issue", "of", "the", "JCI", ",", "Mancuso", "et", "al", ".", "use", "mouse", "models", "to", "better", "understand", "the", "plasticity", "of", "the", "tumor", "vasculature", "in", "the", "face", "of", "antiangiogenic", "therapy", "(", "see", "the", "related", "article", "beginning", "on", "page", "2610", ")", ".", "They", "describe", "a", "rapid", "regrowth", "of", "the", "tumor", "vasculature", "following", "withdrawal", "of", "VEGFR", "inhibitors", ",", "emphasizing", "the", "importance", "of", "fully", "understanding", "the", "function", "of", "these", "and", "similar", "treatments", "used", "in", "the", "clinic", "at", "the", "cellular", "and", "molecular", "level", "."], "event_mentions": [{"id": "E3", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 2, "end": 3}, "arguments": [{"entity_id": "T1", "role": "AtLoc", "text": "tumor", "start": 1, "end": 2}]}, {"id": "E2", "event_type": "Growth", "trigger": {"text": "regrowth", "start": 80, "end": 81}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "tumor vasculature", "start": 83, "end": 85}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "tumor", "entity_type": "Pathological_formation", "start": 1, "end": 2}, {"id": "T2", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 2, "end": 3}, {"id": "T3", "text": "vascular-specific growth factors", "entity_type": "Gene_or_gene_product", "start": 8, "end": 13}, {"id": "T5", "text": "cancer", "entity_type": "Pathological_formation", "start": 25, "end": 26}, {"id": "T4", "text": "blood", "entity_type": "Organism_substance", "start": 33, "end": 34}, {"id": "T1000", "text": "mouse", "entity_type": "Organism", "start": 48, "end": 49}, {"id": "T6", "text": "tumor vasculature", "entity_type": "Multi-tissue_structure", "start": 57, "end": 59}, {"id": "T13", "text": "regrowth", "entity_type": "Growth", "start": 80, "end": 81}, {"id": "T9", "text": "tumor vasculature", "entity_type": "Multi-tissue_structure", "start": 83, "end": 85}, {"id": "T11", "text": "VEGFR", "entity_type": "Gene_or_gene_product", "start": 88, "end": 89}], "lang": "en"}
{"doc_id": "PMID-17305525", "wnd_id": "PMID-17305525_0", "text": "New vectors and strategies for cardiovascular gene therapy.\n\nCardiovascular diseases are the major cause of morbidity and mortality in both men and women in industrially developed countries. These disorders may result from impaired angiogenesis, particularly in response to hypoxia. Despite many limitations, gene therapy is still emerging as a potential alternative for patients who are not candidates for traditional revascularization procedures, like angioplasty or vein grafts. This review focuses on recent approaches in the development of new gene delivery vectors, with great respect to newly discovered AAV serotypes and their modified forms. Moreover, some new cardiovascular gene therapy strategies have been highlighted, such as combination of different angiogenic growth factors or simultaneous application of genes and progenitor cells in order to obtain stable and functional blood vessels in ischemic tissue.", "tokens": ["New", "vectors", "and", "strategies", "for", "cardiovascular", "gene", "therapy", ".", "Cardiovascular", "diseases", "are", "the", "major", "cause", "of", "morbidity", "and", "mortality", "in", "both", "men", "and", "women", "in", "industrially", "developed", "countries", ".", "These", "disorders", "may", "result", "from", "impaired", "angiogenesis", ",", "particularly", "in", "response", "to", "hypoxia", ".", "Despite", "many", "limitations", ",", "gene", "therapy", "is", "still", "emerging", "as", "a", "potential", "alternative", "for", "patients", "who", "are", "not", "candidates", "for", "traditional", "revascularization", "procedures", ",", "like", "angioplasty", "or", "vein", "grafts", ".", "This", "review", "focuses", "on", "recent", "approaches", "in", "the", "development", "of", "new", "gene", "delivery", "vectors", ",", "with", "great", "respect", "to", "newly", "discovered", "AAV", "serotypes", "and", "their", "modified", "forms", ".", "Moreover", ",", "some", "new", "cardiovascular", "gene", "therapy", "strategies", "have", "been", "highlighted", ",", "such", "as", "combination", "of", "different", "angiogenic", "growth", "factors", "or", "simultaneous", "application", "of", "genes", "and", "progenitor", "cells", "in", "order", "to", "obtain", "stable", "and", "functional", "blood", "vessels", "in", "ischemic", "tissue", "."], "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "impaired", "start": 34, "end": 35}, "arguments": []}, {"id": "E2", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 35, "end": 36}, "arguments": []}, {"id": "E3", "event_type": "Blood_vessel_development", "trigger": {"text": "revascularization", "start": 64, "end": 65}, "arguments": []}, {"id": "E5", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 118, "end": 119}, "arguments": []}, {"id": "E4", "event_type": "Development", "trigger": {"text": "obtain", "start": 132, "end": 133}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "blood vessels", "start": 136, "end": 138}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1000", "text": "men", "entity_type": "Organism", "start": 21, "end": 22}, {"id": "T1001", "text": "women", "entity_type": "Organism", "start": 23, "end": 24}, {"id": "T1", "text": "impaired", "entity_type": "Negative_regulation", "start": 34, "end": 35}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 35, "end": 36}, {"id": "T1002", "text": "patients", "entity_type": "Organism", "start": 57, "end": 58}, {"id": "T7", "text": "revascularization", "entity_type": "Blood_vessel_development", "start": 64, "end": 65}, {"id": "T8", "text": "vein grafts", "entity_type": "Multi-tissue_structure", "start": 70, "end": 72}, {"id": "T9", "text": "AAV serotypes", "entity_type": "Drug_or_compound", "start": 94, "end": 96}, {"id": "T11", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 118, "end": 119}, {"id": "T12", "text": "progenitor cells", "entity_type": "Cell", "start": 127, "end": 129}, {"id": "T2", "text": "obtain", "entity_type": "Development", "start": 132, "end": 133}, {"id": "T14", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 136, "end": 138}, {"id": "T15", "text": "ischemic tissue", "entity_type": "Tissue", "start": 139, "end": 141}], "lang": "en"}
{"doc_id": "PMID-17311993", "wnd_id": "PMID-17311993_0", "text": "Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion.\n\nVascular development is dependent on various growth factors and certain modifiers critical for providing arterial or venous identity, interaction with the surrounding stroma and tissues, hierarchic network formation, and recruitment of pericytes. Notch receptors and ligands (Jagged and Delta-like) play a critical role in this process in addition to VEGF. Dll4 is one of the Notch ligands that regulates arterial specification and maturation events. In the current study, we have shown that loss of function by either targeted allele deletion or use of a soluble form of Dll4 extracellular domain leads to inhibition of Notch signaling, resulting in increased vascular proliferation but defective maturation. Newly forming vessels have thin caliber, a markedly reduced vessel lumen, markedly reduced pericyte recruitment, and deficient vascular perfusion. sDll4 similarly induced defective vascular response in tumor implants leading to reduced tumor growth. Interference with Dll4-Notch signaling may be particularly desirable in tumors that have highly induced Dll4-Notch pathway.", "tokens": ["Inhibition", "of", "Dll4", "-", "mediated", "signaling", "induces", "proliferation", "of", "immature", "vessels", "and", "results", "in", "poor", "tissue", "perfusion", ".", "Vascular", "development", "is", "dependent", "on", "various", "growth", "factors", "and", "certain", "modifiers", "critical", "for", "providing", "arterial", "or", "venous", "identity", ",", "interaction", "with", "the", "surrounding", "stroma", "and", "tissues", ",", "hierarchic", "network", "formation", ",", "and", "recruitment", "of", "pericytes", ".", "Notch", "receptors", "and", "ligands", "(", "Jagged", "and", "Delta", "-", "like", ")", "play", "a", "critical", "role", "in", "this", "process", "in", "addition", "to", "VEGF", ".", "Dll4", "is", "one", "of", "the", "Notch", "ligands", "that", "regulates", "arterial", "specification", "and", "maturation", "events", ".", "In", "the", "current", "study", ",", "we", "have", "shown", "that", "loss", "of", "function", "by", "either", "targeted", "allele", "deletion", "or", "use", "of", "a", "soluble", "form", "of", "Dll4", "extracellular", "domain", "leads", "to", "inhibition", "of", "Notch", "signaling", ",", "resulting", "in", "increased", "vascular", "proliferation", "but", "defective", "maturation", ".", "Newly", "forming", "vessels", "have", "thin", "caliber", ",", "a", "markedly", "reduced", "vessel", "lumen", ",", "markedly", "reduced", "pericyte", "recruitment", ",", "and", "deficient", "vascular", "perfusion", ".", "s", "Dll4", "similarly", "induced", "defective", "vascular", "response", "in", "tumor", "implants", "leading", "to", "reduced", "tumor", "growth", ".", "Interference", "with", "Dll4", "-", "Notch", "signaling", "may", "be", "particularly", "desirable", "in", "tumors", "that", "have", "highly", "induced", "Dll4", "-", "Notch", "pathway", "."], "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "Inhibition", "start": 0, "end": 1}, "arguments": []}, {"id": "E41", "event_type": "Positive_regulation", "trigger": {"text": "mediated", "start": 4, "end": 5}, "arguments": [{"entity_id": "T3", "role": "Cause", "text": "Dll4", "start": 2, "end": 3}]}, {"id": "E34", "event_type": "Pathway", "trigger": {"text": "signaling", "start": 5, "end": 6}, "arguments": []}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 6, "end": 7}, "arguments": []}, {"id": "E6", "event_type": "Growth", "trigger": {"text": "proliferation", "start": 7, "end": 8}, "arguments": [{"entity_id": "T7", "role": "Theme", "text": "vessels", "start": 10, "end": 11}]}, {"id": "E8", "event_type": "Development", "trigger": {"text": "development", "start": 19, "end": 20}, "arguments": [{"entity_id": "T10", "role": "Theme", "text": "Vascular", "start": 18, "end": 19}]}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "dependent", "start": 21, "end": 22}, "arguments": []}, {"id": "E4", "event_type": "Binding", "trigger": {"text": "interaction", "start": 37, "end": 38}, "arguments": [{"entity_id": "T23", "role": "Theme", "text": "stroma", "start": 41, "end": 42}, {"entity_id": "T70", "role": "Theme", "text": "tissues", "start": 43, "end": 44}]}, {"id": "E5", "event_type": "Development", "trigger": {"text": "formation", "start": 47, "end": 48}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "hierarchic network", "start": 45, "end": 47}]}, {"id": "E11", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 50, "end": 51}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "pericytes", "start": 52, "end": 53}]}, {"id": "E9", "event_type": "Regulation", "trigger": {"text": "play a critical role", "start": 65, "end": 69}, "arguments": [{"entity_id": "T60", "role": "Cause", "text": "Jagged", "start": 59, "end": 60}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "play a critical role", "start": 65, "end": 69}, "arguments": [{"entity_id": "T61", "role": "Cause", "text": "Delta", "start": 61, "end": 62}]}, {"id": "E7", "event_type": "Regulation", "trigger": {"text": "regulates", "start": 85, "end": 86}, "arguments": [{"entity_id": "T15", "role": "Cause", "text": "Dll4", "start": 77, "end": 78}]}, {"id": "E31", "event_type": "Regulation", "trigger": {"text": "regulates", "start": 85, "end": 86}, "arguments": [{"entity_id": "T15", "role": "Cause", "text": "Dll4", "start": 77, "end": 78}]}, {"id": "E30", "event_type": "Development", "trigger": {"text": "specification", "start": 87, "end": 88}, "arguments": [{"entity_id": "T66", "role": "Theme", "text": "arterial", "start": 86, "end": 87}]}, {"id": "E27", "event_type": "Development", "trigger": {"text": "maturation", "start": 89, "end": 90}, "arguments": [{"entity_id": "T66", "role": "Theme", "text": "arterial", "start": 86, "end": 87}]}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "leads", "start": 119, "end": 120}, "arguments": [{"entity_id": "T20", "role": "Cause", "text": "Dll4 extracellular domain", "start": 116, "end": 119}]}, {"id": "E21", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 121, "end": 122}, "arguments": []}, {"id": "E36", "event_type": "Pathway", "trigger": {"text": "signaling", "start": 124, "end": 125}, "arguments": [{"entity_id": "T63", "role": "Participant", "text": "Notch", "start": 123, "end": 124}]}, {"id": "E24", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 128, "end": 129}, "arguments": []}, {"id": "E10", "event_type": "Growth", "trigger": {"text": "proliferation", "start": 130, "end": 131}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "vascular", "start": 129, "end": 130}]}, {"id": "E28", "event_type": "Negative_regulation", "trigger": {"text": "defective", "start": 132, "end": 133}, "arguments": []}, {"id": "E13", "event_type": "Development", "trigger": {"text": "maturation", "start": 133, "end": 134}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "vascular", "start": 129, "end": 130}]}, {"id": "E14", "event_type": "Development", "trigger": {"text": "forming", "start": 136, "end": 137}, "arguments": [{"entity_id": "T30", "role": "Theme", "text": "vessels", "start": 137, "end": 138}]}, {"id": "E15", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 144, "end": 145}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "vessel lumen", "start": 145, "end": 147}]}, {"id": "E16", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 149, "end": 150}, "arguments": []}, {"id": "E32", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 151, "end": 152}, "arguments": [{"entity_id": "T34", "role": "Theme", "text": "pericyte", "start": 150, "end": 151}]}, {"id": "E18", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 161, "end": 162}, "arguments": [{"entity_id": "T37", "role": "Cause", "text": "sDll4", "start": 158, "end": 160}]}, {"id": "E39", "event_type": "Negative_regulation", "trigger": {"text": "defective", "start": 162, "end": 163}, "arguments": []}, {"id": "E25", "event_type": "Development", "trigger": {"text": "response", "start": 164, "end": 165}, "arguments": [{"entity_id": "T41", "role": "Theme", "text": "vascular", "start": 163, "end": 164}]}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "leading", "start": 168, "end": 169}, "arguments": []}, {"id": "E20", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 170, "end": 171}, "arguments": []}, {"id": "E43", "event_type": "Growth", "trigger": {"text": "growth", "start": 172, "end": 173}, "arguments": [{"entity_id": "T44", "role": "Theme", "text": "tumor", "start": 171, "end": 172}]}, {"id": "E37", "event_type": "Pathway", "trigger": {"text": "signaling", "start": 179, "end": 180}, "arguments": [{"entity_id": "T46", "role": "Participant", "text": "Dll4", "start": 176, "end": 177}, {"entity_id": "T64", "role": "Participant2", "text": "Notch", "start": 178, "end": 179}]}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 189, "end": 190}, "arguments": []}, {"id": "E38", "event_type": "Pathway", "trigger": {"text": "pathway", "start": 193, "end": 194}, "arguments": [{"entity_id": "T49", "role": "Participant", "text": "Dll4", "start": 190, "end": 191}, {"entity_id": "T65", "role": "Participant2", "text": "Notch", "start": 192, "end": 193}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "Inhibition", "entity_type": "Negative_regulation", "start": 0, "end": 1}, {"id": "T3", "text": "Dll4", "entity_type": "Gene_or_gene_product", "start": 2, "end": 3}, {"id": "T71", "text": "mediated", "entity_type": "Positive_regulation", "start": 4, "end": 5}, {"id": "T2", "text": "signaling", "entity_type": "Pathway", "start": 5, "end": 6}, {"id": "T4", "text": "induces", "entity_type": "Positive_regulation", "start": 6, "end": 7}, {"id": "T6", "text": "proliferation", "entity_type": "Growth", "start": 7, "end": 8}, {"id": "T7", "text": "vessels", "entity_type": "Multi-tissue_structure", "start": 10, "end": 11}, {"id": "T69", "text": "tissue", "entity_type": "Tissue", "start": 15, "end": 16}, {"id": "T10", "text": "Vascular", "entity_type": "Multi-tissue_structure", "start": 18, "end": 19}, {"id": "T8", "text": "development", "entity_type": "Development", "start": 19, "end": 20}, {"id": "T16", "text": "dependent", "entity_type": "Positive_regulation", "start": 21, "end": 22}, {"id": "T18", "text": "interaction", "entity_type": "Binding", "start": 37, "end": 38}, {"id": "T23", "text": "stroma", "entity_type": "Tissue", "start": 41, "end": 42}, {"id": "T70", "text": "tissues", "entity_type": "Tissue", "start": 43, "end": 44}, {"id": "T5", "text": "hierarchic network", "entity_type": "Tissue", "start": 45, "end": 47}, {"id": "T9", "text": "formation", "entity_type": "Development", "start": 47, "end": 48}, {"id": "T11", "text": "recruitment", "entity_type": "Localization", "start": 50, "end": 51}, {"id": "T13", "text": "pericytes", "entity_type": "Cell", "start": 52, "end": 53}, {"id": "T59", "text": "Notch", "entity_type": "Gene_or_gene_product", "start": 54, "end": 55}, {"id": "T60", "text": "Jagged", "entity_type": "Gene_or_gene_product", "start": 59, "end": 60}, {"id": "T61", "text": "Delta", "entity_type": "Gene_or_gene_product", "start": 61, "end": 62}, {"id": "T12", "text": "play a critical role", "entity_type": "Regulation", "start": 65, "end": 69}, {"id": "T14", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 75, "end": 76}, {"id": "T15", "text": "Dll4", "entity_type": "Gene_or_gene_product", "start": 77, "end": 78}, {"id": "T62", "text": "Notch", "entity_type": "Gene_or_gene_product", "start": 82, "end": 83}, {"id": "T38", "text": "regulates", "entity_type": "Regulation", "start": 85, "end": 86}, {"id": "T66", "text": "arterial", "entity_type": "Multi-tissue_structure", "start": 86, "end": 87}, {"id": "T68", "text": "specification", "entity_type": "Development", "start": 87, "end": 88}, {"id": "T67", "text": "maturation", "entity_type": "Development", "start": 89, "end": 90}, {"id": "T20", "text": "Dll4 extracellular domain", "entity_type": "Gene_or_gene_product", "start": 116, "end": 119}, {"id": "T19", "text": "leads", "entity_type": "Positive_regulation", "start": 119, "end": 120}, {"id": "T21", "text": "inhibition", "entity_type": "Negative_regulation", "start": 121, "end": 122}, {"id": "T63", "text": "Notch", "entity_type": "Gene_or_gene_product", "start": 123, "end": 124}, {"id": "T22", "text": "signaling", "entity_type": "Pathway", "start": 124, "end": 125}, {"id": "T24", "text": "increased", "entity_type": "Positive_regulation", "start": 128, "end": 129}, {"id": "T27", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 129, "end": 130}, {"id": "T50", "text": "proliferation", "entity_type": "Growth", "start": 130, "end": 131}, {"id": "T28", "text": "defective", "entity_type": "Negative_regulation", "start": 132, "end": 133}, {"id": "T51", "text": "maturation", "entity_type": "Development", "start": 133, "end": 134}, {"id": "T52", "text": "forming", "entity_type": "Development", "start": 136, "end": 137}, {"id": "T30", "text": "vessels", "entity_type": "Multi-tissue_structure", "start": 137, "end": 138}, {"id": "T53", "text": "reduced", "entity_type": "Negative_regulation", "start": 144, "end": 145}, {"id": "T31", "text": "vessel lumen", "entity_type": "Immaterial_anatomical_entity", "start": 145, "end": 147}, {"id": "T54", "text": "reduced", "entity_type": "Negative_regulation", "start": 149, "end": 150}, {"id": "T34", "text": "pericyte", "entity_type": "Cell", "start": 150, "end": 151}, {"id": "T32", "text": "recruitment", "entity_type": "Localization", "start": 151, "end": 152}, {"id": "T36", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 155, "end": 156}, {"id": "T37", "text": "sDll4", "entity_type": "Gene_or_gene_product", "start": 158, "end": 160}, {"id": "T55", "text": "induced", "entity_type": "Positive_regulation", "start": 161, "end": 162}, {"id": "T39", "text": "defective", "entity_type": "Negative_regulation", "start": 162, "end": 163}, {"id": "T41", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 163, "end": 164}, {"id": "T25", "text": "response", "entity_type": "Development", "start": 164, "end": 165}, {"id": "T42", "text": "tumor", "entity_type": "Pathological_formation", "start": 166, "end": 167}, {"id": "T57", "text": "leading", "entity_type": "Positive_regulation", "start": 168, "end": 169}, {"id": "T56", "text": "reduced", "entity_type": "Negative_regulation", "start": 170, "end": 171}, {"id": "T44", "text": "tumor", "entity_type": "Pathological_formation", "start": 171, "end": 172}, {"id": "T43", "text": "growth", "entity_type": "Growth", "start": 172, "end": 173}, {"id": "T46", "text": "Dll4", "entity_type": "Gene_or_gene_product", "start": 176, "end": 177}, {"id": "T64", "text": "Notch", "entity_type": "Gene_or_gene_product", "start": 178, "end": 179}, {"id": "T45", "text": "signaling", "entity_type": "Pathway", "start": 179, "end": 180}, {"id": "T47", "text": "tumors", "entity_type": "Pathological_formation", "start": 185, "end": 186}, {"id": "T58", "text": "induced", "entity_type": "Positive_regulation", "start": 189, "end": 190}, {"id": "T49", "text": "Dll4", "entity_type": "Gene_or_gene_product", "start": 190, "end": 191}, {"id": "T65", "text": "Notch", "entity_type": "Gene_or_gene_product", "start": 192, "end": 193}, {"id": "T48", "text": "pathway", "entity_type": "Pathway", "start": 193, "end": 194}], "lang": "en"}
{"doc_id": "PMID-17488804", "wnd_id": "PMID-17488804_0", "text": "Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.\n\nFrequent coffee consumption has been associated with a reduced risk of colorectal cancer in a number of case-control studies. Coffee is a leading source of methylxanthines, such as caffeine. The induction of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) is an essential feature of tumor angiogenesis, and the hypoxia-inducible factor-1 (HIF-1) transcription factor is known to be a key regulator of this process. In this study, we investigated the effects of caffeine on HIF-1 protein accumulation and on VEGF and IL-8 expression in the human colon cancer cell line HT29 under hypoxic conditions. Our results show that caffeine significantly inhibits adenosine-induced HIF-1alpha protein accumulation in cancer cells. We show that HIF-1alpha and VEGF are increased through A3 adenosine receptor stimulation, whereas the effects on IL-8 are mediated via the A2B subtype. Pretreatment of cells with caffeine significantly reduces adenosine-induced VEGF promoter activity and VEGF and IL-8 expression. The mechanism of caffeine seems to involve the inhibition of the extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and Akt, leading to a marked decrease in adenosine-induced HIF-1alpha accumulation, VEGF transcriptional activation, and VEGF and IL-8 protein accumulation. From a functional perspective, we observe that caffeine also significantly inhibits the A3 receptor-stimulated cell migration of colon cancer cells. Conditioned media prepared from colon cells treated with an adenosine analog increased human umbilical vein endothelial cell migration. These data provide evidence that adenosine could modulate the migration of colon cancer cells by an HIF-1alpha/VEGF/IL-8-dependent mechanism and that caffeine has the potential to inhibit colon cancer cell growth.", "tokens": ["Caffeine", "inhibits", "adenosine", "-", "induced", "accumulation", "of", "hypoxia", "-", "inducible", "factor", "-", "1", "alpha", ",", "vascular", "endothelial", "growth", "factor", ",", "and", "interleukin", "-", "8", "expression", "in", "hypoxic", "human", "colon", "cancer", "cells", ".", "Frequent", "coffee", "consumption", "has", "been", "associated", "with", "a", "reduced", "risk", "of", "colorectal", "cancer", "in", "a", "number", "of", "case", "-", "control", "studies", ".", "Coffee", "is", "a", "leading", "source", "of", "methylxanthines", ",", "such", "as", "caffeine", ".", "The", "induction", "of", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", "and", "interleukin", "-", "8", "(", "IL", "-", "8", ")", "is", "an", "essential", "feature", "of", "tumor", "angiogenesis", ",", "and", "the", "hypoxia", "-", "inducible", "factor", "-", "1", "(", "HIF", "-", "1", ")", "transcription", "factor", "is", "known", "to", "be", "a", "key", "regulator", "of", "this", "process", ".", "In", "this", "study", ",", "we", "investigated", "the", "effects", "of", "caffeine", "on", "HIF", "-", "1", "protein", "accumulation", "and", "on", "VEGF", "and", "IL", "-", "8", "expression", "in", "the", "human", "colon", "cancer", "cell", "line", "HT29", "under", "hypoxic", "conditions", ".", "Our", "results", "show", "that", "caffeine", "significantly", "inhibits", "adenosine", "-", "induced", "HIF", "-", "1", "alpha", "protein", "accumulation", "in", "cancer", "cells", ".", "We", "show", "that", "HIF", "-", "1", "alpha", "and", "VEGF", "are", "increased", "through", "A3", "adenosine", "receptor", "stimulation", ",", "whereas", "the", "effects", "on", "IL", "-", "8", "are", "mediated", "via", "the", "A2B", "subtype", ".", "Pretreatment", "of", "cells", "with", "caffeine", "significantly", "reduces", "adenosine", "-", "induced", "VEGF", "promoter", "activity", "and", "VEGF", "and", "IL", "-", "8", "expression", ".", "The", "mechanism", "of", "caffeine", "seems", "to", "involve", "the", "inhibition", "of", "the", "extracellular", "signal", "-", "regulated", "kinase", "1/2", "(", "ERK1/2", ")", ",", "p38", ",", "and", "Akt", ",", "leading", "to", "a", "marked", "decrease", "in", "adenosine", "-", "induced", "HIF", "-", "1", "alpha", "accumulation", ",", "VEGF", "transcriptional", "activation", ",", "and", "VEGF", "and", "IL", "-", "8", "protein", "accumulation", ".", "From", "a", "functional", "perspective", ",", "we", "observe", "that", "caffeine", "also", "significantly", "inhibits", "the", "A3", "receptor", "-", "stimulated", "cell", "migration", "of", "colon", "cancer", "cells", ".", "Conditioned", "media", "prepared", "from", "colon", "cells", "treated", "with", "an", "adenosine", "analog", "increased", "human", "umbilical", "vein", "endothelial", "cell", "migration", ".", "These", "data", "provide", "evidence", "that", "adenosine", "could", "modulate", "the", "migration", "of", "colon", "cancer", "cells", "by", "an", "HIF", "-", "1", "alpha", "/", "VEGF", "/", "IL", "-", "8", "-", "dependent", "mechanism", "and", "that", "caffeine", "has", "the", "potential", "to", "inhibit", "colon", "cancer", "cell", "growth", "."], "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 1, "end": 2}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "Caffeine", "start": 0, "end": 1}]}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 1, "end": 2}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "Caffeine", "start": 0, "end": 1}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 1, "end": 2}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "Caffeine", "start": 0, "end": 1}]}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 5, "end": 6}, "arguments": [{"entity_id": "T4", "role": "Cause", "text": "adenosine", "start": 2, "end": 3}]}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 5, "end": 6}, "arguments": [{"entity_id": "T4", "role": "Cause", "text": "adenosine", "start": 2, "end": 3}]}, {"id": "E7", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 5, "end": 6}, "arguments": [{"entity_id": "T4", "role": "Cause", "text": "adenosine", "start": 2, "end": 3}]}, {"id": "E5", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 24, "end": 25}, "arguments": [{"entity_id": "T10", "role": "Theme", "text": "interleukin-8", "start": 21, "end": 24}]}, {"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 24, "end": 25}, "arguments": [{"entity_id": "T8", "role": "Theme", "text": "vascular endothelial growth factor", "start": 15, "end": 19}]}, {"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 24, "end": 25}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "hypoxia-inducible factor-1alpha", "start": 7, "end": 14}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 67, "end": 68}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "vascular endothelial growth factor", "start": 69, "end": 73}, {"entity_id": "T16", "role": "Theme", "text": "VEGF", "start": 74, "end": 75}]}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 67, "end": 68}, "arguments": [{"entity_id": "T17", "role": "Theme", "text": "interleukin-8", "start": 77, "end": 80}, {"entity_id": "T18", "role": "Theme", "text": "IL-8", "start": 81, "end": 84}]}, {"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "essential", "start": 87, "end": 88}, "arguments": []}, {"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "essential", "start": 87, "end": 88}, "arguments": []}, {"id": "E55", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 91, "end": 92}, "arguments": [{"entity_id": "T20", "role": "AtLoc", "text": "tumor", "start": 90, "end": 91}]}, {"id": "E13", "event_type": "Regulation", "trigger": {"text": "effects", "start": 126, "end": 127}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "caffeine", "start": 128, "end": 129}]}, {"id": "E16", "event_type": "Regulation", "trigger": {"text": "effects", "start": 126, "end": 127}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "caffeine", "start": 128, "end": 129}]}, {"id": "E17", "event_type": "Regulation", "trigger": {"text": "effects", "start": 126, "end": 127}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "caffeine", "start": 128, "end": 129}]}, {"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 134, "end": 135}, "arguments": [{"entity_id": "T27", "role": "Theme", "text": "HIF-1", "start": 130, "end": 133}]}, {"id": "E28", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 142, "end": 143}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "IL-8", "start": 139, "end": 142}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 142, "end": 143}, "arguments": [{"entity_id": "T29", "role": "Theme", "text": "VEGF", "start": 137, "end": 138}]}, {"id": "E34", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 161, "end": 162}, "arguments": [{"entity_id": "T33", "role": "Cause", "text": "caffeine", "start": 159, "end": 160}]}, {"id": "E18", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 164, "end": 165}, "arguments": [{"entity_id": "T36", "role": "Cause", "text": "adenosine", "start": 162, "end": 163}]}, {"id": "E35", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 170, "end": 171}, "arguments": [{"entity_id": "T37", "role": "Theme", "text": "HIF-1alpha", "start": 165, "end": 169}]}, {"id": "E39", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 185, "end": 186}, "arguments": [{"entity_id": "T41", "role": "Theme", "text": "VEGF", "start": 183, "end": 184}]}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 185, "end": 186}, "arguments": [{"entity_id": "T40", "role": "Theme", "text": "HIF-1alpha", "start": 178, "end": 182}]}, {"id": "E42", "event_type": "Positive_regulation", "trigger": {"text": "stimulation", "start": 190, "end": 191}, "arguments": [{"entity_id": "T43", "role": "Theme", "text": "A3 adenosine receptor", "start": 187, "end": 190}]}, {"id": "E20", "event_type": "Regulation", "trigger": {"text": "effects", "start": 194, "end": 195}, "arguments": [{"entity_id": "T45", "role": "Theme", "text": "IL-8", "start": 196, "end": 199}]}, {"id": "E44", "event_type": "Regulation", "trigger": {"text": "mediated", "start": 200, "end": 201}, "arguments": [{"entity_id": "T46", "role": "Cause", "text": "A2B", "start": 203, "end": 204}]}, {"id": "E21", "event_type": "Planned_process", "trigger": {"text": "Pretreatment", "start": 206, "end": 207}, "arguments": [{"entity_id": "T105", "role": "Theme", "text": "cells", "start": 208, "end": 209}, {"entity_id": "T47", "role": "Instrument", "text": "caffeine", "start": 210, "end": 211}]}, {"id": "E48", "event_type": "Negative_regulation", "trigger": {"text": "reduces", "start": 212, "end": 213}, "arguments": []}, {"id": "E23", "event_type": "Negative_regulation", "trigger": {"text": "reduces", "start": 212, "end": 213}, "arguments": []}, {"id": "E24", "event_type": "Negative_regulation", "trigger": {"text": "reduces", "start": 212, "end": 213}, "arguments": []}, {"id": "E49", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 215, "end": 216}, "arguments": [{"entity_id": "T50", "role": "Cause", "text": "adenosine", "start": 213, "end": 214}, {"entity_id": "T51", "role": "Theme", "text": "VEGF", "start": 216, "end": 217}, {"entity_id": "T87", "role": "Site", "text": "promoter", "start": 217, "end": 218}]}, {"id": "E54", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 225, "end": 226}, "arguments": [{"entity_id": "T55", "role": "Theme", "text": "IL-8", "start": 222, "end": 225}]}, {"id": "E22", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 225, "end": 226}, "arguments": [{"entity_id": "T53", "role": "Theme", "text": "VEGF", "start": 220, "end": 221}]}, {"id": "E25", "event_type": "Regulation", "trigger": {"text": "involve", "start": 233, "end": 234}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E32", "event_type": "Regulation", "trigger": {"text": "involve", "start": 233, "end": 234}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E33", "event_type": "Regulation", "trigger": {"text": "involve", "start": 233, "end": 234}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E36", "event_type": "Regulation", "trigger": {"text": "involve", "start": 233, "end": 234}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E59", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 235, "end": 236}, "arguments": []}, {"id": "E27", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 235, "end": 236}, "arguments": [{"entity_id": "T62", "role": "Theme", "text": "p38", "start": 248, "end": 249}]}, {"id": "E29", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 235, "end": 236}, "arguments": []}, {"id": "E30", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 235, "end": 236}, "arguments": [{"entity_id": "T63", "role": "Theme", "text": "Akt", "start": 251, "end": 252}]}, {"id": "E31", "event_type": "Positive_regulation", "trigger": {"text": "leading", "start": 253, "end": 254}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E46", "event_type": "Positive_regulation", "trigger": {"text": "leading", "start": 253, "end": 254}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E47", "event_type": "Positive_regulation", "trigger": {"text": "leading", "start": 253, "end": 254}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E50", "event_type": "Positive_regulation", "trigger": {"text": "leading", "start": 253, "end": 254}, "arguments": [{"entity_id": "T56", "role": "Cause", "text": "caffeine", "start": 230, "end": 231}]}, {"id": "E66", "event_type": "Negative_regulation", "trigger": {"text": "decrease", "start": 257, "end": 258}, "arguments": []}, {"id": "E41", "event_type": "Negative_regulation", "trigger": {"text": "decrease", "start": 257, "end": 258}, "arguments": []}, {"id": "E43", "event_type": "Negative_regulation", "trigger": {"text": "decrease", "start": 257, "end": 258}, "arguments": []}, {"id": "E45", "event_type": "Negative_regulation", "trigger": {"text": "decrease", "start": 257, "end": 258}, "arguments": []}, {"id": "E37", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 261, "end": 262}, "arguments": [{"entity_id": "T68", "role": "Cause", "text": "adenosine", "start": 259, "end": 260}]}, {"id": "E67", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 266, "end": 267}, "arguments": [{"entity_id": "T69", "role": "Theme", "text": "HIF-1alpha", "start": 262, "end": 266}]}, {"id": "E38", "event_type": "Transcription", "trigger": {"text": "transcriptional", "start": 269, "end": 270}, "arguments": [{"entity_id": "T71", "role": "Theme", "text": "VEGF", "start": 268, "end": 269}]}, {"id": "E70", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 270, "end": 271}, "arguments": []}, {"id": "E72", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 279, "end": 280}, "arguments": [{"entity_id": "T74", "role": "Theme", "text": "IL-8", "start": 275, "end": 278}]}, {"id": "E40", "event_type": "Positive_regulation", "trigger": {"text": "accumulation", "start": 279, "end": 280}, "arguments": [{"entity_id": "T73", "role": "Theme", "text": "VEGF", "start": 273, "end": 274}]}, {"id": "E75", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 292, "end": 293}, "arguments": [{"entity_id": "T76", "role": "Cause", "text": "caffeine", "start": 289, "end": 290}]}, {"id": "E77", "event_type": "Positive_regulation", "trigger": {"text": "stimulated", "start": 297, "end": 298}, "arguments": [{"entity_id": "T78", "role": "Cause", "text": "A3 receptor", "start": 294, "end": 296}]}, {"id": "E79", "event_type": "Localization", "trigger": {"text": "migration", "start": 299, "end": 300}, "arguments": [{"entity_id": "T80", "role": "Theme", "text": "colon cancer cells", "start": 301, "end": 304}]}, {"id": "E51", "event_type": "Planned_process", "trigger": {"text": "treated", "start": 311, "end": 312}, "arguments": [{"entity_id": "T81", "role": "Theme", "text": "colon cells", "start": 309, "end": 311}, {"entity_id": "T83", "role": "Instrument", "text": "adenosine", "start": 314, "end": 315}]}, {"id": "E53", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 316, "end": 317}, "arguments": []}, {"id": "E52", "event_type": "Localization", "trigger": {"text": "migration", "start": 322, "end": 323}, "arguments": [{"entity_id": "T86", "role": "Theme", "text": "human umbilical vein endothelial cell", "start": 317, "end": 322}]}, {"id": "E89", "event_type": "Regulation", "trigger": {"text": "modulate", "start": 331, "end": 332}, "arguments": [{"entity_id": "T88", "role": "Cause", "text": "adenosine", "start": 329, "end": 330}]}, {"id": "E90", "event_type": "Localization", "trigger": {"text": "migration", "start": 333, "end": 334}, "arguments": [{"entity_id": "T91", "role": "Theme", "text": "colon cancer cells", "start": 335, "end": 338}]}, {"id": "E57", "event_type": "Positive_regulation", "trigger": {"text": "dependent", "start": 351, "end": 352}, "arguments": [{"entity_id": "T95", "role": "Cause", "text": "IL-8", "start": 347, "end": 350}]}, {"id": "E58", "event_type": "Positive_regulation", "trigger": {"text": "dependent", "start": 351, "end": 352}, "arguments": [{"entity_id": "T94", "role": "Cause", "text": "VEGF", "start": 345, "end": 346}]}, {"id": "E60", "event_type": "Positive_regulation", "trigger": {"text": "dependent", "start": 351, "end": 352}, "arguments": [{"entity_id": "T93", "role": "Cause", "text": "HIF-1alpha", "start": 340, "end": 344}]}, {"id": "E56", "event_type": "Pathway", "trigger": {"text": "mechanism", "start": 352, "end": 353}, "arguments": []}, {"id": "E96", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 360, "end": 361}, "arguments": [{"entity_id": "T97", "role": "Cause", "text": "caffeine", "start": 355, "end": 356}]}, {"id": "E98", "event_type": "Cell_proliferation", "trigger": {"text": "growth", "start": 364, "end": 365}, "arguments": [{"entity_id": "T99", "role": "Theme", "text": "colon cancer cell", "start": 361, "end": 364}]}], "relation_mentions": [], "entity_mentions": [{"id": "T2", "text": "Caffeine", "entity_type": "Drug_or_compound", "start": 0, "end": 1}, {"id": "T1", "text": "inhibits", "entity_type": "Negative_regulation", "start": 1, "end": 2}, {"id": "T4", "text": "adenosine", "entity_type": "Drug_or_compound", "start": 2, "end": 3}, {"id": "T3", "text": "accumulation", "entity_type": "Positive_regulation", "start": 5, "end": 6}, {"id": "T6", "text": "hypoxia-inducible factor-1alpha", "entity_type": "Gene_or_gene_product", "start": 7, "end": 14}, {"id": "T8", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 15, "end": 19}, {"id": "T10", "text": "interleukin-8", "entity_type": "Gene_or_gene_product", "start": 21, "end": 24}, {"id": "T5", "text": "expression", "entity_type": "Gene_expression", "start": 24, "end": 25}, {"id": "T1000", "text": "human", "entity_type": "Organism", "start": 27, "end": 28}, {"id": "T11", "text": "colon cancer cells", "entity_type": "Cell", "start": 28, "end": 31}, {"id": "T19", "text": "colorectal cancer", "entity_type": "Pathological_formation", "start": 43, "end": 45}, {"id": "T12", "text": "methylxanthines", "entity_type": "Drug_or_compound", "start": 60, "end": 61}, {"id": "T13", "text": "caffeine", "entity_type": "Drug_or_compound", "start": 64, "end": 65}, {"id": "T14", "text": "induction", "entity_type": "Positive_regulation", "start": 67, "end": 68}, {"id": "T15", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 69, "end": 73}, {"id": "T16", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 74, "end": 75}, {"id": "T17", "text": "interleukin-8", "entity_type": "Gene_or_gene_product", "start": 77, "end": 80}, {"id": "T18", "text": "IL-8", "entity_type": "Gene_or_gene_product", "start": 81, "end": 84}, {"id": "T7", "text": "essential", "entity_type": "Positive_regulation", "start": 87, "end": 88}, {"id": "T20", "text": "tumor", "entity_type": "Pathological_formation", "start": 90, "end": 91}, {"id": "T21", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 91, "end": 92}, {"id": "T22", "text": "hypoxia-inducible factor-1", "entity_type": "Gene_or_gene_product", "start": 95, "end": 101}, {"id": "T23", "text": "HIF-1", "entity_type": "Gene_or_gene_product", "start": 102, "end": 105}, {"id": "T9", "text": "effects", "entity_type": "Regulation", "start": 126, "end": 127}, {"id": "T25", "text": "caffeine", "entity_type": "Drug_or_compound", "start": 128, "end": 129}, {"id": "T27", "text": "HIF-1", "entity_type": "Gene_or_gene_product", "start": 130, "end": 133}, {"id": "T26", "text": "accumulation", "entity_type": "Positive_regulation", "start": 134, "end": 135}, {"id": "T29", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 137, "end": 138}, {"id": "T31", "text": "IL-8", "entity_type": "Gene_or_gene_product", "start": 139, "end": 142}, {"id": "T28", "text": "expression", "entity_type": "Gene_expression", "start": 142, "end": 143}, {"id": "T1003", "text": "human", "entity_type": "Organism", "start": 145, "end": 146}, {"id": "T32", "text": "colon cancer cell line HT29", "entity_type": "Cell", "start": 146, "end": 151}, {"id": "T33", "text": "caffeine", "entity_type": "Drug_or_compound", "start": 159, "end": 160}, {"id": "T34", "text": "inhibits", "entity_type": "Negative_regulation", "start": 161, "end": 162}, {"id": "T36", "text": "adenosine", "entity_type": "Drug_or_compound", "start": 162, "end": 163}, {"id": "T24", "text": "induced", "entity_type": "Positive_regulation", "start": 164, "end": 165}, {"id": "T37", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 165, "end": 169}, {"id": "T35", "text": "accumulation", "entity_type": "Positive_regulation", "start": 170, "end": 171}, {"id": "T38", "text": "cancer cells", "entity_type": "Cell", "start": 172, "end": 174}, {"id": "T40", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 178, "end": 182}, {"id": "T41", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 183, "end": 184}, {"id": "T39", "text": "increased", "entity_type": "Positive_regulation", "start": 185, "end": 186}, {"id": "T43", "text": "A3 adenosine receptor", "entity_type": "Gene_or_gene_product", "start": 187, "end": 190}, {"id": "T42", "text": "stimulation", "entity_type": "Positive_regulation", "start": 190, "end": 191}, {"id": "T30", "text": "effects", "entity_type": "Regulation", "start": 194, "end": 195}, {"id": "T45", "text": "IL-8", "entity_type": "Gene_or_gene_product", "start": 196, "end": 199}, {"id": "T44", "text": "mediated", "entity_type": "Regulation", "start": 200, "end": 201}, {"id": "T46", "text": "A2B", "entity_type": "Gene_or_gene_product", "start": 203, "end": 204}, {"id": "T84", "text": "Pretreatment", "entity_type": "Planned_process", "start": 206, "end": 207}, {"id": "T105", "text": "cells", "entity_type": "Cell", "start": 208, "end": 209}, {"id": "T47", "text": "caffeine", "entity_type": "Drug_or_compound", "start": 210, "end": 211}, {"id": "T48", "text": "reduces", "entity_type": "Negative_regulation", "start": 212, "end": 213}, {"id": "T50", "text": "adenosine", "entity_type": "Drug_or_compound", "start": 213, "end": 214}, {"id": "T49", "text": "induced", "entity_type": "Positive_regulation", "start": 215, "end": 216}, {"id": "T51", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 216, "end": 217}, {"id": "T87", "text": "promoter", "entity_type": "DNA_domain_or_region", "start": 217, "end": 218}, {"id": "T53", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 220, "end": 221}, {"id": "T55", "text": "IL-8", "entity_type": "Gene_or_gene_product", "start": 222, "end": 225}, {"id": "T54", "text": "expression", "entity_type": "Gene_expression", "start": 225, "end": 226}, {"id": "T56", "text": "caffeine", "entity_type": "Drug_or_compound", "start": 230, "end": 231}, {"id": "T52", "text": "involve", "entity_type": "Regulation", "start": 233, "end": 234}, {"id": "T59", "text": "inhibition", "entity_type": "Negative_regulation", "start": 235, "end": 236}, {"id": "T62", "text": "p38", "entity_type": "Gene_or_gene_product", "start": 248, "end": 249}, {"id": "T63", "text": "Akt", "entity_type": "Gene_or_gene_product", "start": 251, "end": 252}, {"id": "T100", "text": "leading", "entity_type": "Positive_regulation", "start": 253, "end": 254}, {"id": "T66", "text": "decrease", "entity_type": "Negative_regulation", "start": 257, "end": 258}, {"id": "T68", "text": "adenosine", "entity_type": "Drug_or_compound", "start": 259, "end": 260}, {"id": "T101", "text": "induced", "entity_type": "Positive_regulation", "start": 261, "end": 262}, {"id": "T69", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 262, "end": 266}, {"id": "T67", "text": "accumulation", "entity_type": "Positive_regulation", "start": 266, "end": 267}, {"id": "T71", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 268, "end": 269}, {"id": "T102", "text": "transcriptional", "entity_type": "Transcription", "start": 269, "end": 270}, {"id": "T70", "text": "activation", "entity_type": "Positive_regulation", "start": 270, "end": 271}, {"id": "T73", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 273, "end": 274}, {"id": "T74", "text": "IL-8", "entity_type": "Gene_or_gene_product", "start": 275, "end": 278}, {"id": "T72", "text": "accumulation", "entity_type": "Positive_regulation", "start": 279, "end": 280}, {"id": "T76", "text": "caffeine", "entity_type": "Drug_or_compound", "start": 289, "end": 290}, {"id": "T75", "text": "inhibits", "entity_type": "Negative_regulation", "start": 292, "end": 293}, {"id": "T78", "text": "A3 receptor", "entity_type": "Gene_or_gene_product", "start": 294, "end": 296}, {"id": "T77", "text": "stimulated", "entity_type": "Positive_regulation", "start": 297, "end": 298}, {"id": "T104", "text": "cell", "entity_type": "Cell", "start": 298, "end": 299}, {"id": "T79", "text": "migration", "entity_type": "Localization", "start": 299, "end": 300}, {"id": "T80", "text": "colon cancer cells", "entity_type": "Cell", "start": 301, "end": 304}, {"id": "T81", "text": "colon cells", "entity_type": "Cell", "start": 309, "end": 311}, {"id": "T64", "text": "treated", "entity_type": "Planned_process", "start": 311, "end": 312}, {"id": "T83", "text": "adenosine", "entity_type": "Drug_or_compound", "start": 314, "end": 315}, {"id": "T103", "text": "increased", "entity_type": "Positive_regulation", "start": 316, "end": 317}, {"id": "T86", "text": "human umbilical vein endothelial cell", "entity_type": "Cell", "start": 317, "end": 322}, {"id": "T65", "text": "migration", "entity_type": "Localization", "start": 322, "end": 323}, {"id": "T88", "text": "adenosine", "entity_type": "Drug_or_compound", "start": 329, "end": 330}, {"id": "T89", "text": "modulate", "entity_type": "Regulation", "start": 331, "end": 332}, {"id": "T90", "text": "migration", "entity_type": "Localization", "start": 333, "end": 334}, {"id": "T91", "text": "colon cancer cells", "entity_type": "Cell", "start": 335, "end": 338}, {"id": "T93", "text": "HIF-1alpha", "entity_type": "Gene_or_gene_product", "start": 340, "end": 344}, {"id": "T94", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 345, "end": 346}, {"id": "T95", "text": "IL-8", "entity_type": "Gene_or_gene_product", "start": 347, "end": 350}, {"id": "T106", "text": "dependent", "entity_type": "Positive_regulation", "start": 351, "end": 352}, {"id": "T92", "text": "mechanism", "entity_type": "Pathway", "start": 352, "end": 353}, {"id": "T97", "text": "caffeine", "entity_type": "Drug_or_compound", "start": 355, "end": 356}, {"id": "T96", "text": "inhibit", "entity_type": "Negative_regulation", "start": 360, "end": 361}, {"id": "T99", "text": "colon cancer cell", "entity_type": "Cell", "start": 361, "end": 364}, {"id": "T98", "text": "growth", "entity_type": "Cell_proliferation", "start": 364, "end": 365}], "lang": "en"}
{"doc_id": "PMID-18559522", "wnd_id": "PMID-18559522_0", "text": "The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.\n\nSolid tumors express a range of factors required to sustain their growth and promote their dissemination. Among these are vascular endothelial growth factor-A (VEGF-A), the key angiogenic stimulant, and VEGF-C, a primary mediator of lymphangiogenesis. Small molecule tyrosine kinase inhibitors offer the potential to inhibit more than one kinase and impede tumor growth by multiple mechanisms. However, their potency toward individual targets can vary. Cediranib (RECENTIN; AZD2171) is an inhibitor of VEGF signaling that has been shown in experimental models to prevent VEGF-A-induced angiogenesis and primary tumor growth, yet the effects of cediranib on VEGF receptor (VEGFR)-3-mediated endothelial cell function and lymphangiogenesis are unknown. To better understand the activity of cediranib against VEGFR-3 and its associated signaling events compared with its activity against VEGFR-2, we used the receptor-specific ligands VEGF-E and VEGF-C156S. In human endothelial cells, cediranib inhibited VEGF-E-induced phosphorylation of VEGFR-2 and VEGF-C156S-induced phosphorylation of VEGFR-3 at concentrations of  less than /=1nmol/L and inhibited activation of downstream signaling molecules. Additionally, cediranib blocked VEGF-C156S-induced and VEGF-E-induced proliferation, survival, and migration of lymphatic and blood vascular endothelial cells. In vivo, cediranib (6 mg/kg/d) prevented angiogenesis and lymphangiogenesis induced by VEGF-E-expressing and VEGF-C156S-expressing adenoviruses, respectively.", "tokens": ["The", "tyrosine", "kinase", "inhibitor", "cediranib", "blocks", "ligand", "-", "induced", "vascular", "endothelial", "growth", "factor", "receptor", "-", "3", "activity", "and", "lymphangiogenesis", ".", "Solid", "tumors", "express", "a", "range", "of", "factors", "required", "to", "sustain", "their", "growth", "and", "promote", "their", "dissemination", ".", "Among", "these", "are", "vascular", "endothelial", "growth", "factor", "-", "A", "(", "VEGF", "-", "A", ")", ",", "the", "key", "angiogenic", "stimulant", ",", "and", "VEGF", "-C", ",", "a", "primary", "mediator", "of", "lymphangiogenesis", ".", "Small", "molecule", "tyrosine", "kinase", "inhibitors", "offer", "the", "potential", "to", "inhibit", "more", "than", "one", "kinase", "and", "impede", "tumor", "growth", "by", "multiple", "mechanisms", ".", "However", ",", "their", "potency", "toward", "individual", "targets", "can", "vary", ".", "Cediranib", "(", "RECENTIN", ";", "AZD2171", ")", "is", "an", "inhibitor", "of", "VEGF", "signaling", "that", "has", "been", "shown", "in", "experimental", "models", "to", "prevent", "VEGF", "-", "A", "-", "induced", "angiogenesis", "and", "primary", "tumor", "growth", ",", "yet", "the", "effects", "of", "cediranib", "on", "VEGF", "receptor", "(", "VEGFR", ")", "-", "3", "-", "mediated", "endothelial", "cell", "function", "and", "lymphangiogenesis", "are", "unknown", ".", "To", "better", "understand", "the", "activity", "of", "cediranib", "against", "VEGFR", "-", "3", "and", "its", "associated", "signaling", "events", "compared", "with", "its", "activity", "against", "VEGFR", "-", "2", ",", "we", "used", "the", "receptor", "-", "specific", "ligands", "VEGF", "-E", "and", "VEGF", "-", "C156S", ".", "In", "human", "endothelial", "cells", ",", "cediranib", "inhibited", "VEGF", "-", "E-", "induced", "phosphorylation", "of", "VEGFR", "-", "2", "and", "VEGF", "-", "C156S", "-", "induced", "phosphorylation", "of", "VEGFR", "-", "3", "at", "concentrations", "of", "less", "than", "/", "=1nmol", "/", "L", "and", "inhibited", "activation", "of", "downstream", "signaling", "molecules", ".", "Additionally", ",", "cediranib", "blocked", "VEGF", "-", "C156S", "-", "induced", "and", "VEGF", "-", "E-", "induced", "proliferation", ",", "survival", ",", "and", "migration", "of", "lymphatic", "and", "blood", "vascular", "endothelial", "cells", ".", "In", "vivo", ",", "cediranib", "(", "6", "mg", "/", "kg/d", ")", "prevented", "angiogenesis", "and", "lymphangiogenesis", "induced", "by", "VEGF", "-", "E-", "expressing", "and", "VEGF", "-", "C156S", "-", "expressing", "adenoviruses", ",", "respectively", "."], "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "blocks", "start": 5, "end": 6}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "cediranib", "start": 4, "end": 5}, {"entity_id": "T4", "role": "Theme", "text": "vascular endothelial growth factor receptor-3", "start": 9, "end": 16}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 8, "end": 9}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "vascular endothelial growth factor receptor-3", "start": 9, "end": 16}]}, {"id": "E48", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 54, "end": 55}, "arguments": []}, {"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "impede", "start": 82, "end": 83}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "tyrosine kinase inhibitors", "start": 69, "end": 72}]}, {"id": "E15", "event_type": "Growth", "trigger": {"text": "growth", "start": 84, "end": 85}, "arguments": [{"entity_id": "T16", "role": "Theme", "text": "tumor", "start": 83, "end": 84}]}, {"id": "E54", "event_type": "Pathway", "trigger": {"text": "signaling", "start": 110, "end": 111}, "arguments": [{"entity_id": "T21", "role": "Participant", "text": "VEGF", "start": 109, "end": 110}]}, {"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "prevent", "start": 119, "end": 120}, "arguments": [{"entity_id": "T17", "role": "Cause", "text": "Cediranib", "start": 99, "end": 100}, {"entity_id": "T18", "role": "Cause", "text": "RECENTIN", "start": 101, "end": 102}, {"entity_id": "T19", "role": "Cause", "text": "AZD2171", "start": 103, "end": 104}]}, {"id": "E6", "event_type": "Negative_regulation", "trigger": {"text": "prevent", "start": 119, "end": 120}, "arguments": [{"entity_id": "T17", "role": "Cause", "text": "Cediranib", "start": 99, "end": 100}, {"entity_id": "T18", "role": "Cause", "text": "RECENTIN", "start": 101, "end": 102}, {"entity_id": "T19", "role": "Cause", "text": "AZD2171", "start": 103, "end": 104}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 124, "end": 125}, "arguments": [{"entity_id": "T23", "role": "Cause", "text": "VEGF-A", "start": 120, "end": 123}]}, {"id": "E49", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 125, "end": 126}, "arguments": []}, {"id": "E25", "event_type": "Growth", "trigger": {"text": "growth", "start": 129, "end": 130}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "tumor", "start": 128, "end": 129}]}, {"id": "E8", "event_type": "Regulation", "trigger": {"text": "effects", "start": 133, "end": 134}, "arguments": [{"entity_id": "T27", "role": "Cause", "text": "cediranib", "start": 135, "end": 136}, {"entity_id": "T31", "role": "Theme", "text": "endothelial cell", "start": 146, "end": 148}]}, {"id": "E7", "event_type": "Regulation", "trigger": {"text": "mediated", "start": 145, "end": 146}, "arguments": [{"entity_id": "T28", "role": "Cause", "text": "VEGF receptor (VEGFR)-3", "start": 137, "end": 144}, {"entity_id": "T31", "role": "Theme", "text": "endothelial cell", "start": 146, "end": 148}]}, {"id": "E40", "event_type": "Negative_regulation", "trigger": {"text": "inhibited", "start": 199, "end": 200}, "arguments": [{"entity_id": "T41", "role": "Cause", "text": "cediranib", "start": 198, "end": 199}]}, {"id": "E11", "event_type": "Negative_regulation", "trigger": {"text": "inhibited", "start": 199, "end": 200}, "arguments": [{"entity_id": "T41", "role": "Cause", "text": "cediranib", "start": 198, "end": 199}]}, {"id": "E9", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 203, "end": 204}, "arguments": []}, {"id": "E42", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 204, "end": 205}, "arguments": [{"entity_id": "T44", "role": "Theme", "text": "VEGFR-2", "start": 206, "end": 209}]}, {"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 214, "end": 215}, "arguments": [{"entity_id": "T30", "role": "Cause", "text": "VEGF-C156S", "start": 210, "end": 213}]}, {"id": "E45", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 215, "end": 216}, "arguments": [{"entity_id": "T46", "role": "Theme", "text": "VEGFR-3", "start": 217, "end": 220}]}, {"id": "E12", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 240, "end": 241}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "cediranib", "start": 239, "end": 240}]}, {"id": "E33", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 240, "end": 241}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "cediranib", "start": 239, "end": 240}]}, {"id": "E34", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 240, "end": 241}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "cediranib", "start": 239, "end": 240}]}, {"id": "E35", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 240, "end": 241}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "cediranib", "start": 239, "end": 240}]}, {"id": "E36", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 240, "end": 241}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "cediranib", "start": 239, "end": 240}]}, {"id": "E37", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 240, "end": 241}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "cediranib", "start": 239, "end": 240}]}, {"id": "E13", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 245, "end": 246}, "arguments": [{"entity_id": "T49", "role": "Cause", "text": "VEGF-C156S", "start": 241, "end": 244}]}, {"id": "E28", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 245, "end": 246}, "arguments": [{"entity_id": "T49", "role": "Cause", "text": "VEGF-C156S", "start": 241, "end": 244}]}, {"id": "E29", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 245, "end": 246}, "arguments": [{"entity_id": "T49", "role": "Cause", "text": "VEGF-C156S", "start": 241, "end": 244}]}, {"id": "E30", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 245, "end": 246}, "arguments": [{"entity_id": "T49", "role": "Cause", "text": "VEGF-C156S", "start": 241, "end": 244}]}, {"id": "E31", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 245, "end": 246}, "arguments": [{"entity_id": "T49", "role": "Cause", "text": "VEGF-C156S", "start": 241, "end": 244}]}, {"id": "E32", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 245, "end": 246}, "arguments": [{"entity_id": "T49", "role": "Cause", "text": "VEGF-C156S", "start": 241, "end": 244}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 250, "end": 251}, "arguments": []}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 250, "end": 251}, "arguments": []}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 250, "end": 251}, "arguments": []}, {"id": "E24", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 250, "end": 251}, "arguments": []}, {"id": "E26", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 250, "end": 251}, "arguments": []}, {"id": "E27", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 250, "end": 251}, "arguments": []}, {"id": "E16", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 251, "end": 252}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "lymphatic", "start": 258, "end": 259}]}, {"id": "E21", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 251, "end": 252}, "arguments": [{"entity_id": "T53", "role": "Theme", "text": "blood vascular endothelial cells", "start": 260, "end": 264}]}, {"id": "E17", "event_type": "Death", "trigger": {"text": "survival", "start": 253, "end": 254}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "lymphatic", "start": 258, "end": 259}]}, {"id": "E20", "event_type": "Death", "trigger": {"text": "survival", "start": 253, "end": 254}, "arguments": [{"entity_id": "T53", "role": "Theme", "text": "blood vascular endothelial cells", "start": 260, "end": 264}]}, {"id": "E18", "event_type": "Localization", "trigger": {"text": "migration", "start": 256, "end": 257}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "lymphatic", "start": 258, "end": 259}]}, {"id": "E19", "event_type": "Localization", "trigger": {"text": "migration", "start": 256, "end": 257}, "arguments": [{"entity_id": "T53", "role": "Theme", "text": "blood vascular endothelial cells", "start": 260, "end": 264}]}, {"id": "E38", "event_type": "Negative_regulation", "trigger": {"text": "prevented", "start": 275, "end": 276}, "arguments": [{"entity_id": "T54", "role": "Cause", "text": "cediranib", "start": 268, "end": 269}]}, {"id": "E50", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 276, "end": 277}, "arguments": []}, {"id": "E39", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 279, "end": 280}, "arguments": [{"entity_id": "T82", "role": "Cause", "text": "adenoviruses", "start": 291, "end": 292}]}, {"id": "E59", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 284, "end": 285}, "arguments": []}, {"id": "E61", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 290, "end": 291}, "arguments": [{"entity_id": "T62", "role": "Theme", "text": "VEGF-C156S", "start": 286, "end": 289}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T52", "role": "Arg1", "text": "lymphatic", "start": 258, "end": 259}, {"entity_id": "T52", "role": "Arg1", "text": "lymphatic", "start": 258, "end": 259}]}], "entity_mentions": [{"id": "T2", "text": "cediranib", "entity_type": "Drug_or_compound", "start": 4, "end": 5}, {"id": "T3", "text": "blocks", "entity_type": "Negative_regulation", "start": 5, "end": 6}, {"id": "T5", "text": "induced", "entity_type": "Positive_regulation", "start": 8, "end": 9}, {"id": "T4", "text": "vascular endothelial growth factor receptor-3", "entity_type": "Gene_or_gene_product", "start": 9, "end": 16}, {"id": "T6", "text": "Solid tumors", "entity_type": "Pathological_formation", "start": 20, "end": 22}, {"id": "T7", "text": "vascular endothelial growth factor-A", "entity_type": "Gene_or_gene_product", "start": 40, "end": 46}, {"id": "T8", "text": "VEGF-A", "entity_type": "Gene_or_gene_product", "start": 47, "end": 50}, {"id": "T9", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 54, "end": 55}, {"id": "T11", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 58, "end": 60}, {"id": "T1", "text": "tyrosine kinase inhibitors", "entity_type": "Drug_or_compound", "start": 69, "end": 72}, {"id": "T10", "text": "impede", "entity_type": "Negative_regulation", "start": 82, "end": 83}, {"id": "T16", "text": "tumor", "entity_type": "Pathological_formation", "start": 83, "end": 84}, {"id": "T15", "text": "growth", "entity_type": "Growth", "start": 84, "end": 85}, {"id": "T17", "text": "Cediranib", "entity_type": "Drug_or_compound", "start": 99, "end": 100}, {"id": "T18", "text": "RECENTIN", "entity_type": "Drug_or_compound", "start": 101, "end": 102}, {"id": "T19", "text": "AZD2171", "entity_type": "Drug_or_compound", "start": 103, "end": 104}, {"id": "T21", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 109, "end": 110}, {"id": "T20", "text": "signaling", "entity_type": "Pathway", "start": 110, "end": 111}, {"id": "T12", "text": "prevent", "entity_type": "Negative_regulation", "start": 119, "end": 120}, {"id": "T23", "text": "VEGF-A", "entity_type": "Gene_or_gene_product", "start": 120, "end": 123}, {"id": "T13", "text": "induced", "entity_type": "Positive_regulation", "start": 124, "end": 125}, {"id": "T24", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 125, "end": 126}, {"id": "T26", "text": "tumor", "entity_type": "Pathological_formation", "start": 128, "end": 129}, {"id": "T25", "text": "growth", "entity_type": "Growth", "start": 129, "end": 130}, {"id": "T22", "text": "effects", "entity_type": "Regulation", "start": 133, "end": 134}, {"id": "T27", "text": "cediranib", "entity_type": "Drug_or_compound", "start": 135, "end": 136}, {"id": "T28", "text": "VEGF receptor (VEGFR)-3", "entity_type": "Gene_or_gene_product", "start": 137, "end": 144}, {"id": "T14", "text": "mediated", "entity_type": "Regulation", "start": 145, "end": 146}, {"id": "T31", "text": "endothelial cell", "entity_type": "Cell", "start": 146, "end": 148}, {"id": "T33", "text": "cediranib", "entity_type": "Drug_or_compound", "start": 160, "end": 161}, {"id": "T34", "text": "VEGFR-3", "entity_type": "Gene_or_gene_product", "start": 162, "end": 165}, {"id": "T35", "text": "VEGFR-2", "entity_type": "Gene_or_gene_product", "start": 175, "end": 178}, {"id": "T36", "text": "VEGF-E", "entity_type": "Gene_or_gene_product", "start": 186, "end": 188}, {"id": "T37", "text": "VEGF-C156S", "entity_type": "Gene_or_gene_product", "start": 189, "end": 192}, {"id": "T1000", "text": "human", "entity_type": "Organism", "start": 194, "end": 195}, {"id": "T38", "text": "endothelial cells", "entity_type": "Cell", "start": 195, "end": 197}, {"id": "T41", "text": "cediranib", "entity_type": "Drug_or_compound", "start": 198, "end": 199}, {"id": "T40", "text": "inhibited", "entity_type": "Negative_regulation", "start": 199, "end": 200}, {"id": "T29", "text": "induced", "entity_type": "Positive_regulation", "start": 203, "end": 204}, {"id": "T42", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 204, "end": 205}, {"id": "T44", "text": "VEGFR-2", "entity_type": "Gene_or_gene_product", "start": 206, "end": 209}, {"id": "T30", "text": "VEGF-C156S", "entity_type": "Gene_or_gene_product", "start": 210, "end": 213}, {"id": "T32", "text": "induced", "entity_type": "Positive_regulation", "start": 214, "end": 215}, {"id": "T45", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 215, "end": 216}, {"id": "T46", "text": "VEGFR-3", "entity_type": "Gene_or_gene_product", "start": 217, "end": 220}, {"id": "T47", "text": "cediranib", "entity_type": "Drug_or_compound", "start": 239, "end": 240}, {"id": "T39", "text": "blocked", "entity_type": "Negative_regulation", "start": 240, "end": 241}, {"id": "T49", "text": "VEGF-C156S", "entity_type": "Gene_or_gene_product", "start": 241, "end": 244}, {"id": "T48", "text": "induced", "entity_type": "Positive_regulation", "start": 245, "end": 246}, {"id": "T55", "text": "induced", "entity_type": "Positive_regulation", "start": 250, "end": 251}, {"id": "T57", "text": "proliferation", "entity_type": "Cell_proliferation", "start": 251, "end": 252}, {"id": "T58", "text": "survival", "entity_type": "Death", "start": 253, "end": 254}, {"id": "T64", "text": "migration", "entity_type": "Localization", "start": 256, "end": 257}, {"id": "T52", "text": "lymphatic", "entity_type": "Cell", "start": 258, "end": 259}, {"id": "T53", "text": "blood vascular endothelial cells", "entity_type": "Cell", "start": 260, "end": 264}, {"id": "T54", "text": "cediranib", "entity_type": "Drug_or_compound", "start": 268, "end": 269}, {"id": "T66", "text": "prevented", "entity_type": "Negative_regulation", "start": 275, "end": 276}, {"id": "T56", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 276, "end": 277}, {"id": "T76", "text": "induced", "entity_type": "Positive_regulation", "start": 279, "end": 280}, {"id": "T59", "text": "expressing", "entity_type": "Gene_expression", "start": 284, "end": 285}, {"id": "T62", "text": "VEGF-C156S", "entity_type": "Gene_or_gene_product", "start": 286, "end": 289}, {"id": "T61", "text": "expressing", "entity_type": "Gene_expression", "start": 290, "end": 291}, {"id": "T82", "text": "adenoviruses", "entity_type": "Organism", "start": 291, "end": 292}], "lang": "en"}
{"doc_id": "PMID-18559522", "wnd_id": "PMID-18559522_1", "text": "Cediranib (6 mg/kg/day) also blocked angiogenesis and lymphangiogenesis induced by adenoviruses expressing VEGF-A or VEGF-C and compromised the blood and lymphatic vasculatures of VEGF-C-expressing tumors. Cediranib may, therefore, be an effective means of preventing tumor progression, not only by inhibiting VEGFR-2 activity and angiogenesis, but also by concomitantly inhibiting VEGFR-3 activity and lymphangiogenesis.", "tokens": ["Cediranib", "(", "6", "mg/kg/day", ")", "also", "blocked", "angiogenesis", "and", "lymphangiogenesis", "induced", "by", "adenoviruses", "expressing", "VEGF", "-", "A", "or", "VEGF", "-C", "and", "compromised", "the", "blood", "and", "lymphatic", "vasculatures", "of", "VEGF", "-", "C", "-", "expressing", "tumors", ".", "Cediranib", "may", ",", "therefore", ",", "be", "an", "effective", "means", "of", "preventing", "tumor", "progression", ",", "not", "only", "by", "inhibiting", "VEGFR", "-", "2", "activity", "and", "angiogenesis", ",", "but", "also", "by", "concomitantly", "inhibiting", "VEGFR", "-", "3", "activity", "and", "lymphangiogenesis", "."], "event_mentions": [{"id": "E41", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 6, "end": 7}, "arguments": [{"entity_id": "T63", "role": "Cause", "text": "Cediranib", "start": 0, "end": 1}]}, {"id": "E52", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 7, "end": 8}, "arguments": []}, {"id": "E68", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 13, "end": 14}, "arguments": [{"entity_id": "T69", "role": "Theme", "text": "VEGF-A", "start": 14, "end": 17}]}, {"id": "E43", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 13, "end": 14}, "arguments": [{"entity_id": "T70", "role": "Theme", "text": "VEGF-C", "start": 18, "end": 20}]}, {"id": "E74", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 32, "end": 33}, "arguments": [{"entity_id": "T75", "role": "Theme", "text": "VEGF-C", "start": 28, "end": 31}]}, {"id": "E78", "event_type": "Negative_regulation", "trigger": {"text": "preventing", "start": 45, "end": 46}, "arguments": []}, {"id": "E46", "event_type": "Negative_regulation", "trigger": {"text": "preventing", "start": 45, "end": 46}, "arguments": []}, {"id": "E47", "event_type": "Negative_regulation", "trigger": {"text": "preventing", "start": 45, "end": 46}, "arguments": []}, {"id": "E79", "event_type": "Development", "trigger": {"text": "progression", "start": 47, "end": 48}, "arguments": [{"entity_id": "T80", "role": "Theme", "text": "tumor", "start": 46, "end": 47}]}, {"id": "E81", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 52, "end": 53}, "arguments": [{"entity_id": "T77", "role": "Cause", "text": "Cediranib", "start": 35, "end": 36}, {"entity_id": "T83", "role": "Theme", "text": "VEGFR-2", "start": 53, "end": 56}]}, {"id": "E44", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 52, "end": 53}, "arguments": [{"entity_id": "T77", "role": "Cause", "text": "Cediranib", "start": 35, "end": 36}]}, {"id": "E53", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 58, "end": 59}, "arguments": []}, {"id": "E85", "event_type": "Negative_regulation", "trigger": {"text": "inhibiting", "start": 64, "end": 65}, "arguments": [{"entity_id": "T86", "role": "Theme", "text": "VEGFR-3", "start": 65, "end": 68}]}], "relation_mentions": [], "entity_mentions": [{"id": "T63", "text": "Cediranib", "entity_type": "Drug_or_compound", "start": 0, "end": 1}, {"id": "T87", "text": "blocked", "entity_type": "Negative_regulation", "start": 6, "end": 7}, {"id": "T65", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 7, "end": 8}, {"id": "T89", "text": "adenoviruses", "entity_type": "Organism", "start": 12, "end": 13}, {"id": "T68", "text": "expressing", "entity_type": "Gene_expression", "start": 13, "end": 14}, {"id": "T69", "text": "VEGF-A", "entity_type": "Gene_or_gene_product", "start": 14, "end": 17}, {"id": "T70", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 18, "end": 20}, {"id": "T71", "text": "blood", "entity_type": "Organism_substance", "start": 23, "end": 24}, {"id": "T72", "text": "lymphatic vasculatures", "entity_type": "Multi-tissue_structure", "start": 25, "end": 27}, {"id": "T75", "text": "VEGF-C", "entity_type": "Gene_or_gene_product", "start": 28, "end": 31}, {"id": "T74", "text": "expressing", "entity_type": "Gene_expression", "start": 32, "end": 33}, {"id": "T73", "text": "tumors", "entity_type": "Pathological_formation", "start": 33, "end": 34}, {"id": "T77", "text": "Cediranib", "entity_type": "Drug_or_compound", "start": 35, "end": 36}, {"id": "T78", "text": "preventing", "entity_type": "Negative_regulation", "start": 45, "end": 46}, {"id": "T80", "text": "tumor", "entity_type": "Pathological_formation", "start": 46, "end": 47}, {"id": "T79", "text": "progression", "entity_type": "Development", "start": 47, "end": 48}, {"id": "T81", "text": "inhibiting", "entity_type": "Negative_regulation", "start": 52, "end": 53}, {"id": "T83", "text": "VEGFR-2", "entity_type": "Gene_or_gene_product", "start": 53, "end": 56}, {"id": "T84", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 58, "end": 59}, {"id": "T85", "text": "inhibiting", "entity_type": "Negative_regulation", "start": 64, "end": 65}, {"id": "T86", "text": "VEGFR-3", "entity_type": "Gene_or_gene_product", "start": 65, "end": 68}], "lang": "en"}
{"doc_id": "PMID-1869637", "wnd_id": "PMID-1869637_0", "text": "Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum: an assessment of graft size and ultrastructure.\n\nTo identify a suitable donor cell population for gene therapy applications to the central nervous system, primary fibroblasts isolated from skin biopsies and maintained in culture are employed as autologous cells for intracerebral grafting within the adult rat striatum. Results from the present investigation reveal that cultured primary skin fibroblasts cease to proliferate once they reach confluence; these cells are thus contact inhibited in vitro. Following implantation within the striatum, the volume of the primary fibroblast grafts, stained immunohistochemically for fibronectin, does not differ significantly at 3 and 8 weeks. The graft size is dependent on the density of the cell suspension, but not dependent on either the number of passages the cells are taken through in culture prior to grafting or on the postoperative survival period. Ultrastructural evidence reveals that at 8 weeks the grafts are composed primarily of collagen and fibroblasts with rough endoplasmic reticulum and vesicles. Reactive astrocytic processes and phagocytic cells are also present in the grafts. The grafts are extensively vascularized with capillaries composed of nonfenestrated endothelium; intercellular junctions are evident at sites of apposition between endothelial cells. It is concluded that primary skin fibroblasts are able to survive for at least 8 weeks following intracerebral implantation and continue to synthesize collagen and fibronectin in vivo. Also, the grafts maintain a constant volume between 3 and 8 weeks, thereby indicating that primary skin fibroblasts do not produce tumors. Finally, dynamic host-to-graft interactions--including phagocytic migration, astrocytic hypertrophy and infiltration within the grafts, and angiogenesis--are features that constitute the structural integration of primary skin fibroblasts grafted within the adult rat central nervous system.", "tokens": ["Intracerebral", "grafting", "of", "cultured", "autologous", "skin", "fibroblasts", "into", "the", "rat", "striatum", ":", "an", "assessment", "of", "graft", "size", "and", "ultrastructure", ".", "To", "identify", "a", "suitable", "donor", "cell", "population", "for", "gene", "therapy", "applications", "to", "the", "central", "nervous", "system", ",", "primary", "fibroblasts", "isolated", "from", "skin", "biopsies", "and", "maintained", "in", "culture", "are", "employed", "as", "autologous", "cells", "for", "intracerebral", "grafting", "within", "the", "adult", "rat", "striatum", ".", "Results", "from", "the", "present", "investigation", "reveal", "that", "cultured", "primary", "skin", "fibroblasts", "cease", "to", "proliferate", "once", "they", "reach", "confluence", ";", "these", "cells", "are", "thus", "contact", "inhibited", "in", "vitro", ".", "Following", "implantation", "within", "the", "striatum", ",", "the", "volume", "of", "the", "primary", "fibroblast", "grafts", ",", "stained", "immunohistochemically", "for", "fibronectin", ",", "does", "not", "differ", "significantly", "at", "3", "and", "8", "weeks", ".", "The", "graft", "size", "is", "dependent", "on", "the", "density", "of", "the", "cell", "suspension", ",", "but", "not", "dependent", "on", "either", "the", "number", "of", "passages", "the", "cells", "are", "taken", "through", "in", "culture", "prior", "to", "grafting", "or", "on", "the", "postoperative", "survival", "period", ".", "Ultrastructural", "evidence", "reveals", "that", "at", "8", "weeks", "the", "grafts", "are", "composed", "primarily", "of", "collagen", "and", "fibroblasts", "with", "rough", "endoplasmic", "reticulum", "and", "vesicles", ".", "Reactive", "astrocytic", "processes", "and", "phagocytic", "cells", "are", "also", "present", "in", "the", "grafts", ".", "The", "grafts", "are", "extensively", "vascularized", "with", "capillaries", "composed", "of", "nonfenestrated", "endothelium", ";", "intercellular", "junctions", "are", "evident", "at", "sites", "of", "apposition", "between", "endothelial", "cells", ".", "It", "is", "concluded", "that", "primary", "skin", "fibroblasts", "are", "able", "to", "survive", "for", "at", "least", "8", "weeks", "following", "intracerebral", "implantation", "and", "continue", "to", "synthesize", "collagen", "and", "fibronectin", "in", "vivo", ".", "Also", ",", "the", "grafts", "maintain", "a", "constant", "volume", "between", "3", "and", "8", "weeks", ",", "thereby", "indicating", "that", "primary", "skin", "fibroblasts", "do", "not", "produce", "tumors", ".", "Finally", ",", "dynamic", "host", "-", "to", "-", "graft", "interactions", "--", "including", "phagocytic", "migration", ",", "astrocytic", "hypertrophy", "and", "infiltration", "within", "the", "grafts", ",", "and", "angiogenesis", "--", "are", "features", "that", "constitute", "the", "structural", "integration", "of", "primary", "skin", "fibroblasts", "grafted", "within", "the", "adult", "rat", "central", "nervous", "system", "."], "event_mentions": [{"id": "E1", "event_type": "Planned_process", "trigger": {"text": "Intracerebral grafting", "start": 0, "end": 2}, "arguments": [{"entity_id": "T2", "role": "Instrument", "text": "skin fibroblasts", "start": 5, "end": 7}, {"entity_id": "T3", "role": "Theme", "text": "striatum", "start": 10, "end": 11}]}, {"id": "E4", "event_type": "Planned_process", "trigger": {"text": "isolated", "start": 39, "end": 40}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "fibroblasts", "start": 38, "end": 39}]}, {"id": "E2", "event_type": "Planned_process", "trigger": {"text": "intracerebral grafting", "start": 53, "end": 55}, "arguments": [{"entity_id": "T48", "role": "Instrument", "text": "cells", "start": 51, "end": 52}, {"entity_id": "T7", "role": "Theme", "text": "striatum", "start": 59, "end": 60}]}, {"id": "E5", "event_type": "Planned_process", "trigger": {"text": "cultured", "start": 68, "end": 69}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "skin fibroblasts", "start": 70, "end": 72}]}, {"id": "E6", "event_type": "Cell_proliferation", "trigger": {"text": "proliferate", "start": 74, "end": 75}, "arguments": [{"entity_id": "T9", "role": "Theme", "text": "skin fibroblasts", "start": 70, "end": 72}]}, {"id": "E3", "event_type": "Binding", "trigger": {"text": "contact", "start": 84, "end": 85}, "arguments": [{"entity_id": "T49", "role": "Theme", "text": "cells", "start": 81, "end": 82}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "inhibited", "start": 85, "end": 86}, "arguments": []}, {"id": "E7", "event_type": "Planned_process", "trigger": {"text": "implantation", "start": 90, "end": 91}, "arguments": [{"entity_id": "T10", "role": "Theme", "text": "striatum", "start": 93, "end": 94}, {"entity_id": "T11", "role": "Instrument", "text": "fibroblast grafts", "start": 100, "end": 102}]}, {"id": "E14", "event_type": "Planned_process", "trigger": {"text": "passages", "start": 139, "end": 140}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "cells", "start": 141, "end": 142}]}, {"id": "E15", "event_type": "Planned_process", "trigger": {"text": "culture", "start": 146, "end": 147}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "cells", "start": 141, "end": 142}]}, {"id": "E16", "event_type": "Planned_process", "trigger": {"text": "grafting", "start": 149, "end": 150}, "arguments": [{"entity_id": "T52", "role": "Instrument", "text": "cells", "start": 141, "end": 142}]}, {"id": "E8", "event_type": "Death", "trigger": {"text": "survive", "start": 227, "end": 228}, "arguments": [{"entity_id": "T21", "role": "Theme", "text": "skin fibroblasts", "start": 222, "end": 224}]}, {"id": "E9", "event_type": "Gene_expression", "trigger": {"text": "synthesize", "start": 239, "end": 240}, "arguments": [{"entity_id": "T22", "role": "Theme", "text": "collagen", "start": 240, "end": 241}]}, {"id": "E10", "event_type": "Gene_expression", "trigger": {"text": "synthesize", "start": 239, "end": 240}, "arguments": [{"entity_id": "T23", "role": "Theme", "text": "fibronectin", "start": 242, "end": 243}]}, {"id": "E11", "event_type": "Development", "trigger": {"text": "produce", "start": 268, "end": 269}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "tumors", "start": 269, "end": 270}]}, {"id": "E17", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 294, "end": 295}, "arguments": []}, {"id": "E12", "event_type": "Planned_process", "trigger": {"text": "grafted", "start": 307, "end": 308}, "arguments": [{"entity_id": "T29", "role": "Instrument", "text": "skin fibroblasts", "start": 305, "end": 307}, {"entity_id": "T30", "role": "Theme", "text": "central nervous system", "start": 312, "end": 315}]}], "relation_mentions": [], "entity_mentions": [{"id": "T20", "text": "Intracerebral grafting", "entity_type": "Planned_process", "start": 0, "end": 2}, {"id": "T2", "text": "skin fibroblasts", "entity_type": "Cell", "start": 5, "end": 7}, {"id": "T1000", "text": "rat", "entity_type": "Organism", "start": 9, "end": 10}, {"id": "T3", "text": "striatum", "entity_type": "Multi-tissue_structure", "start": 10, "end": 11}, {"id": "T1", "text": "graft", "entity_type": "Tissue", "start": 15, "end": 16}, {"id": "T28", "text": "cell", "entity_type": "Cell", "start": 25, "end": 26}, {"id": "T4", "text": "central nervous system", "entity_type": "Anatomical_system", "start": 33, "end": 36}, {"id": "T5", "text": "fibroblasts", "entity_type": "Cell", "start": 38, "end": 39}, {"id": "T31", "text": "isolated", "entity_type": "Planned_process", "start": 39, "end": 40}, {"id": "T6", "text": "skin biopsies", "entity_type": "Multi-tissue_structure", "start": 41, "end": 43}, {"id": "T48", "text": "cells", "entity_type": "Cell", "start": 51, "end": 52}, {"id": "T24", "text": "intracerebral grafting", "entity_type": "Planned_process", "start": 53, "end": 55}, {"id": "T1001", "text": "rat", "entity_type": "Organism", "start": 58, "end": 59}, {"id": "T7", "text": "striatum", "entity_type": "Multi-tissue_structure", "start": 59, "end": 60}, {"id": "T32", "text": "cultured", "entity_type": "Planned_process", "start": 68, "end": 69}, {"id": "T9", "text": "skin fibroblasts", "entity_type": "Cell", "start": 70, "end": 72}, {"id": "T33", "text": "proliferate", "entity_type": "Cell_proliferation", "start": 74, "end": 75}, {"id": "T49", "text": "cells", "entity_type": "Cell", "start": 81, "end": 82}, {"id": "T50", "text": "contact", "entity_type": "Binding", "start": 84, "end": 85}, {"id": "T51", "text": "inhibited", "entity_type": "Negative_regulation", "start": 85, "end": 86}, {"id": "T34", "text": "implantation", "entity_type": "Planned_process", "start": 90, "end": 91}, {"id": "T10", "text": "striatum", "entity_type": "Multi-tissue_structure", "start": 93, "end": 94}, {"id": "T11", "text": "fibroblast grafts", "entity_type": "Tissue", "start": 100, "end": 102}, {"id": "T12", "text": "fibronectin", "entity_type": "Gene_or_gene_product", "start": 106, "end": 107}, {"id": "T8", "text": "graft", "entity_type": "Tissue", "start": 119, "end": 120}, {"id": "T47", "text": "cell", "entity_type": "Cell", "start": 128, "end": 129}, {"id": "T53", "text": "passages", "entity_type": "Planned_process", "start": 139, "end": 140}, {"id": "T52", "text": "cells", "entity_type": "Cell", "start": 141, "end": 142}, {"id": "T54", "text": "culture", "entity_type": "Planned_process", "start": 146, "end": 147}, {"id": "T55", "text": "grafting", "entity_type": "Planned_process", "start": 149, "end": 150}, {"id": "T35", "text": "grafts", "entity_type": "Tissue", "start": 165, "end": 166}, {"id": "T13", "text": "collagen", "entity_type": "Gene_or_gene_product", "start": 170, "end": 171}, {"id": "T14", "text": "fibroblasts", "entity_type": "Cell", "start": 172, "end": 173}, {"id": "T45", "text": "endoplasmic reticulum", "entity_type": "Cellular_component", "start": 175, "end": 177}, {"id": "T46", "text": "vesicles", "entity_type": "Cellular_component", "start": 178, "end": 179}, {"id": "T15", "text": "astrocytic processes", "entity_type": "Cellular_component", "start": 181, "end": 183}, {"id": "T16", "text": "phagocytic cells", "entity_type": "Cell", "start": 184, "end": 186}, {"id": "T36", "text": "grafts", "entity_type": "Tissue", "start": 191, "end": 192}, {"id": "T37", "text": "grafts", "entity_type": "Tissue", "start": 194, "end": 195}, {"id": "T17", "text": "capillaries", "entity_type": "Tissue", "start": 199, "end": 200}, {"id": "T18", "text": "endothelium", "entity_type": "Tissue", "start": 203, "end": 204}, {"id": "T19", "text": "endothelial cells", "entity_type": "Cell", "start": 214, "end": 216}, {"id": "T21", "text": "skin fibroblasts", "entity_type": "Cell", "start": 222, "end": 224}, {"id": "T38", "text": "survive", "entity_type": "Death", "start": 227, "end": 228}, {"id": "T39", "text": "synthesize", "entity_type": "Gene_expression", "start": 239, "end": 240}, {"id": "T22", "text": "collagen", "entity_type": "Gene_or_gene_product", "start": 240, "end": 241}, {"id": "T23", "text": "fibronectin", "entity_type": "Gene_or_gene_product", "start": 242, "end": 243}, {"id": "T40", "text": "grafts", "entity_type": "Tissue", "start": 249, "end": 250}, {"id": "T25", "text": "skin fibroblasts", "entity_type": "Cell", "start": 264, "end": 266}, {"id": "T41", "text": "produce", "entity_type": "Development", "start": 268, "end": 269}, {"id": "T26", "text": "tumors", "entity_type": "Pathological_formation", "start": 269, "end": 270}, {"id": "T42", "text": "graft", "entity_type": "Tissue", "start": 278, "end": 279}, {"id": "T43", "text": "grafts", "entity_type": "Tissue", "start": 291, "end": 292}, {"id": "T27", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 294, "end": 295}, {"id": "T29", "text": "skin fibroblasts", "entity_type": "Cell", "start": 305, "end": 307}, {"id": "T44", "text": "grafted", "entity_type": "Planned_process", "start": 307, "end": 308}, {"id": "T1002", "text": "rat", "entity_type": "Organism", "start": 311, "end": 312}, {"id": "T30", "text": "central nervous system", "entity_type": "Anatomical_system", "start": 312, "end": 315}], "lang": "en"}
{"doc_id": "PMID-18835936", "wnd_id": "PMID-18835936_0", "text": "Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity.\n\nOBJECTIVE: The expansion of adipose tissue is linked to the development of its vasculature. However, the regulation of adipose tissue angiogenesis in humans has not been extensively studied. Our aim was to compare the angiogenesis associated with subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) from the same obese patients in an in vivo model. RESEARCH DESIGN AND METHODS: Adipose tissue samples from visceral (VAT) and subcutaneous (SAT) sites, obtained from 36 obese patients (mean BMI 46.5 kg/m(2)) during bariatric surgery, were layered on chick chorioallantoic membrane (CAM). RESULTS: Both SAT and VAT expressed angiogenic factors without significant difference for vascular endothelial growth factor (VEGF) expression. Adipose tissue layered on CAM stimulated angiogenesis. Angiogenic stimulation was macroscopically detectable, with engulfment of the samples, in 39% and was evidenced by angiography in 59% of the samples. A connection between CAM and adipose tissue vessels was evidenced by immunohistochemistry, with recruitment of both avian and human endothelial cells. The angiogenic potency of adipose tissue was not related to its localization (with an angiogenic stimulation in 60% of SAT samples and 61% of VAT samples) or to adipocyte size or inflammatory infiltrate assessed in adipose samples before the graft on CAM. Stimulation of angiogenesis by adipose tissue was nearly abolished by bevacizumab, which specifically targets human VEGF. CONCLUSIONS: We have established a model to study the regulation of angiogenesis by human adipose tissue. This model highlighted the role of VEGF in angiogenesis in both SAT and VAT.", "tokens": ["Angiogenesis", "associated", "with", "visceral", "and", "subcutaneous", "adipose", "tissue", "in", "severe", "human", "obesity", ".", "OBJECTIVE", ":", "The", "expansion", "of", "adipose", "tissue", "is", "linked", "to", "the", "development", "of", "its", "vasculature", ".", "However", ",", "the", "regulation", "of", "adipose", "tissue", "angiogenesis", "in", "humans", "has", "not", "been", "extensively", "studied", ".", "Our", "aim", "was", "to", "compare", "the", "angiogenesis", "associated", "with", "subcutaneous", "adipose", "tissue", "(", "SAT", ")", "and", "visceral", "adipose", "tissue", "(", "VAT", ")", "from", "the", "same", "obese", "patients", "in", "an", "in", "vivo", "model", ".", "RESEARCH", "DESIGN", "AND", "METHODS", ":", "Adipose", "tissue", "samples", "from", "visceral", "(", "VAT", ")", "and", "subcutaneous", "(", "SAT", ")", "sites", ",", "obtained", "from", "36", "obese", "patients", "(", "mean", "BMI", "46.5", "kg", "/", "m", "(", "2", ")", ")", "during", "bariatric", "surgery", ",", "were", "layered", "on", "chick", "chorioallantoic", "membrane", "(", "CAM", ")", ".", "RESULTS", ":", "Both", "SAT", "and", "VAT", "expressed", "angiogenic", "factors", "without", "significant", "difference", "for", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", "expression", ".", "Adipose", "tissue", "layered", "on", "CAM", "stimulated", "angiogenesis", ".", "Angiogenic", "stimulation", "was", "macroscopically", "detectable", ",", "with", "engulfment", "of", "the", "samples", ",", "in", "39", "%", "and", "was", "evidenced", "by", "angiography", "in", "59", "%", "of", "the", "samples", ".", "A", "connection", "between", "CAM", "and", "adipose", "tissue", "vessels", "was", "evidenced", "by", "immunohistochemistry", ",", "with", "recruitment", "of", "both", "avian", "and", "human", "endothelial", "cells", ".", "The", "angiogenic", "potency", "of", "adipose", "tissue", "was", "not", "related", "to", "its", "localization", "(", "with", "an", "angiogenic", "stimulation", "in", "60", "%", "of", "SAT", "samples", "and", "61", "%", "of", "VAT", "samples", ")", "or", "to", "adipocyte", "size", "or", "inflammatory", "infiltrate", "assessed", "in", "adipose", "samples", "before", "the", "graft", "on", "CAM", ".", "Stimulation", "of", "angiogenesis", "by", "adipose", "tissue", "was", "nearly", "abolished", "by", "bevacizumab", ",", "which", "specifically", "targets", "human", "VEGF", ".", "CONCLUSIONS", ":", "We", "have", "established", "a", "model", "to", "study", "the", "regulation", "of", "angiogenesis", "by", "human", "adipose", "tissue", ".", "This", "model", "highlighted", "the", "role", "of", "VEGF", "in", "angiogenesis", "in", "both", "SAT", "and", "VAT", "."], "event_mentions": [{"id": "E22", "event_type": "Blood_vessel_development", "trigger": {"text": "Angiogenesis", "start": 0, "end": 1}, "arguments": [{"entity_id": "T2", "role": "AtLoc", "text": "visceral", "start": 3, "end": 4}]}, {"id": "E33", "event_type": "Blood_vessel_development", "trigger": {"text": "Angiogenesis", "start": 0, "end": 1}, "arguments": [{"entity_id": "T3", "role": "AtLoc", "text": "subcutaneous adipose tissue", "start": 5, "end": 8}]}, {"id": "E1", "event_type": "Development", "trigger": {"text": "expansion", "start": 16, "end": 17}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "adipose tissue", "start": 18, "end": 20}]}, {"id": "E21", "event_type": "Regulation", "trigger": {"text": "linked", "start": 21, "end": 22}, "arguments": []}, {"id": "E2", "event_type": "Development", "trigger": {"text": "development", "start": 24, "end": 25}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "vasculature", "start": 27, "end": 28}]}, {"id": "E3", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 32, "end": 33}, "arguments": []}, {"id": "E23", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 36, "end": 37}, "arguments": [{"entity_id": "T6", "role": "AtLoc", "text": "adipose tissue", "start": 34, "end": 36}]}, {"id": "E24", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 51, "end": 52}, "arguments": [{"entity_id": "T9", "role": "AtLoc", "text": "subcutaneous adipose tissue", "start": 54, "end": 57}, {"entity_id": "T10", "role": "AtLoc", "text": "SAT", "start": 58, "end": 59}]}, {"id": "E34", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 51, "end": 52}, "arguments": [{"entity_id": "T11", "role": "AtLoc", "text": "visceral adipose tissue", "start": 61, "end": 64}, {"entity_id": "T12", "role": "AtLoc", "text": "VAT", "start": 65, "end": 66}]}, {"id": "E4", "event_type": "Planned_process", "trigger": {"text": "obtained", "start": 98, "end": 99}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "SAT", "start": 94, "end": 95}]}, {"id": "E5", "event_type": "Planned_process", "trigger": {"text": "obtained", "start": 98, "end": 99}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "VAT", "start": 89, "end": 90}]}, {"id": "E6", "event_type": "Planned_process", "trigger": {"text": "layered", "start": 119, "end": 120}, "arguments": [{"entity_id": "T15", "role": "Theme", "text": "SAT", "start": 94, "end": 95}]}, {"id": "E7", "event_type": "Planned_process", "trigger": {"text": "layered", "start": 119, "end": 120}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "VAT", "start": 89, "end": 90}]}, {"id": "E25", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 135, "end": 136}, "arguments": []}, {"id": "E8", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 148, "end": 149}, "arguments": [{"entity_id": "T19", "role": "Theme", "text": "vascular endothelial growth factor", "start": 141, "end": 145}, {"entity_id": "T20", "role": "Theme", "text": "VEGF", "start": 146, "end": 147}]}, {"id": "E9", "event_type": "Planned_process", "trigger": {"text": "layered", "start": 152, "end": 153}, "arguments": [{"entity_id": "T47", "role": "Theme", "text": "Adipose tissue", "start": 150, "end": 152}]}, {"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "stimulated", "start": 155, "end": 156}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "Adipose tissue", "start": 150, "end": 152}]}, {"id": "E26", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 156, "end": 157}, "arguments": []}, {"id": "E27", "event_type": "Blood_vessel_development", "trigger": {"text": "Angiogenic", "start": 158, "end": 159}, "arguments": []}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "stimulation", "start": 159, "end": 160}, "arguments": []}, {"id": "E12", "event_type": "Binding", "trigger": {"text": "connection", "start": 186, "end": 187}, "arguments": [{"entity_id": "T24", "role": "Theme", "text": "CAM", "start": 188, "end": 189}, {"entity_id": "T25", "role": "Theme", "text": "adipose tissue vessels", "start": 190, "end": 193}]}, {"id": "E13", "event_type": "Localization", "trigger": {"text": "recruitment", "start": 199, "end": 200}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "endothelial cells", "start": 205, "end": 207}]}, {"id": "E28", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 209, "end": 210}, "arguments": [{"entity_id": "T28", "role": "AtLoc", "text": "adipose tissue", "start": 212, "end": 214}]}, {"id": "E14", "event_type": "Localization", "trigger": {"text": "localization", "start": 219, "end": 220}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "adipose tissue", "start": 212, "end": 214}]}, {"id": "E29", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenic", "start": 223, "end": 224}, "arguments": []}, {"id": "E15", "event_type": "Positive_regulation", "trigger": {"text": "stimulation", "start": 224, "end": 225}, "arguments": []}, {"id": "E16", "event_type": "Positive_regulation", "trigger": {"text": "Stimulation", "start": 255, "end": 256}, "arguments": [{"entity_id": "T35", "role": "Cause", "text": "adipose tissue", "start": 259, "end": 261}]}, {"id": "E30", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 257, "end": 258}, "arguments": []}, {"id": "E17", "event_type": "Negative_regulation", "trigger": {"text": "abolished", "start": 263, "end": 264}, "arguments": [{"entity_id": "T37", "role": "Cause", "text": "bevacizumab", "start": 265, "end": 266}]}, {"id": "E18", "event_type": "Regulation", "trigger": {"text": "targets", "start": 269, "end": 270}, "arguments": [{"entity_id": "T37", "role": "Cause", "text": "bevacizumab", "start": 265, "end": 266}, {"entity_id": "T38", "role": "Theme", "text": "VEGF", "start": 271, "end": 272}]}, {"id": "E19", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 283, "end": 284}, "arguments": [{"entity_id": "T40", "role": "Cause", "text": "adipose tissue", "start": 288, "end": 290}]}, {"id": "E31", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 285, "end": 286}, "arguments": []}, {"id": "E20", "event_type": "Regulation", "trigger": {"text": "role", "start": 295, "end": 296}, "arguments": [{"entity_id": "T42", "role": "Cause", "text": "VEGF", "start": 297, "end": 298}]}, {"id": "E36", "event_type": "Regulation", "trigger": {"text": "role", "start": 295, "end": 296}, "arguments": [{"entity_id": "T42", "role": "Cause", "text": "VEGF", "start": 297, "end": 298}]}, {"id": "E32", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 299, "end": 300}, "arguments": [{"entity_id": "T44", "role": "AtLoc", "text": "SAT", "start": 302, "end": 303}]}, {"id": "E35", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 299, "end": 300}, "arguments": [{"entity_id": "T45", "role": "AtLoc", "text": "VAT", "start": 304, "end": 305}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T2", "role": "Arg1", "text": "visceral", "start": 3, "end": 4}, {"entity_id": "T2", "role": "Arg1", "text": "visceral", "start": 3, "end": 4}]}], "entity_mentions": [{"id": "T1", "text": "Angiogenesis", "entity_type": "Blood_vessel_development", "start": 0, "end": 1}, {"id": "T2", "text": "visceral", "entity_type": "Tissue", "start": 3, "end": 4}, {"id": "T3", "text": "subcutaneous adipose tissue", "entity_type": "Tissue", "start": 5, "end": 8}, {"id": "T1000", "text": "human", "entity_type": "Organism", "start": 10, "end": 11}, {"id": "T49", "text": "expansion", "entity_type": "Development", "start": 16, "end": 17}, {"id": "T4", "text": "adipose tissue", "entity_type": "Tissue", "start": 18, "end": 20}, {"id": "T68", "text": "linked", "entity_type": "Regulation", "start": 21, "end": 22}, {"id": "T50", "text": "development", "entity_type": "Development", "start": 24, "end": 25}, {"id": "T5", "text": "vasculature", "entity_type": "Multi-tissue_structure", "start": 27, "end": 28}, {"id": "T51", "text": "regulation", "entity_type": "Regulation", "start": 32, "end": 33}, {"id": "T6", "text": "adipose tissue", "entity_type": "Tissue", "start": 34, "end": 36}, {"id": "T7", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 36, "end": 37}, {"id": "T1001", "text": "humans", "entity_type": "Organism", "start": 38, "end": 39}, {"id": "T8", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 51, "end": 52}, {"id": "T9", "text": "subcutaneous adipose tissue", "entity_type": "Tissue", "start": 54, "end": 57}, {"id": "T10", "text": "SAT", "entity_type": "Tissue", "start": 58, "end": 59}, {"id": "T11", "text": "visceral adipose tissue", "entity_type": "Tissue", "start": 61, "end": 64}, {"id": "T12", "text": "VAT", "entity_type": "Tissue", "start": 65, "end": 66}, {"id": "T1002", "text": "patients", "entity_type": "Organism", "start": 71, "end": 72}, {"id": "T13", "text": "Adipose tissue samples", "entity_type": "Tissue", "start": 83, "end": 86}, {"id": "T14", "text": "VAT", "entity_type": "Tissue", "start": 89, "end": 90}, {"id": "T15", "text": "SAT", "entity_type": "Tissue", "start": 94, "end": 95}, {"id": "T52", "text": "obtained", "entity_type": "Planned_process", "start": 98, "end": 99}, {"id": "T1003", "text": "patients", "entity_type": "Organism", "start": 102, "end": 103}, {"id": "T53", "text": "layered", "entity_type": "Planned_process", "start": 119, "end": 120}, {"id": "T1004", "text": "chick", "entity_type": "Organism", "start": 121, "end": 122}, {"id": "T16", "text": "chorioallantoic membrane", "entity_type": "Multi-tissue_structure", "start": 122, "end": 124}, {"id": "T17", "text": "CAM", "entity_type": "Multi-tissue_structure", "start": 125, "end": 126}, {"id": "T41", "text": "SAT", "entity_type": "Tissue", "start": 131, "end": 132}, {"id": "T46", "text": "VAT", "entity_type": "Tissue", "start": 133, "end": 134}, {"id": "T18", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 135, "end": 136}, {"id": "T19", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 141, "end": 145}, {"id": "T20", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 146, "end": 147}, {"id": "T36", "text": "expression", "entity_type": "Gene_expression", "start": 148, "end": 149}, {"id": "T47", "text": "Adipose tissue", "entity_type": "Tissue", "start": 150, "end": 152}, {"id": "T54", "text": "layered", "entity_type": "Planned_process", "start": 152, "end": 153}, {"id": "T21", "text": "CAM", "entity_type": "Multi-tissue_structure", "start": 154, "end": 155}, {"id": "T55", "text": "stimulated", "entity_type": "Positive_regulation", "start": 155, "end": 156}, {"id": "T22", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 156, "end": 157}, {"id": "T23", "text": "Angiogenic", "entity_type": "Blood_vessel_development", "start": 158, "end": 159}, {"id": "T56", "text": "stimulation", "entity_type": "Positive_regulation", "start": 159, "end": 160}, {"id": "T57", "text": "connection", "entity_type": "Binding", "start": 186, "end": 187}, {"id": "T24", "text": "CAM", "entity_type": "Multi-tissue_structure", "start": 188, "end": 189}, {"id": "T25", "text": "adipose tissue vessels", "entity_type": "Tissue", "start": 190, "end": 193}, {"id": "T58", "text": "recruitment", "entity_type": "Localization", "start": 199, "end": 200}, {"id": "T59", "text": "avian", "entity_type": "Organism", "start": 202, "end": 203}, {"id": "T1005", "text": "human", "entity_type": "Organism", "start": 204, "end": 205}, {"id": "T26", "text": "endothelial cells", "entity_type": "Cell", "start": 205, "end": 207}, {"id": "T27", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 209, "end": 210}, {"id": "T28", "text": "adipose tissue", "entity_type": "Tissue", "start": 212, "end": 214}, {"id": "T60", "text": "localization", "entity_type": "Localization", "start": 219, "end": 220}, {"id": "T29", "text": "angiogenic", "entity_type": "Blood_vessel_development", "start": 223, "end": 224}, {"id": "T61", "text": "stimulation", "entity_type": "Positive_regulation", "start": 224, "end": 225}, {"id": "T30", "text": "SAT samples", "entity_type": "Tissue", "start": 229, "end": 231}, {"id": "T31", "text": "VAT samples", "entity_type": "Tissue", "start": 235, "end": 237}, {"id": "T32", "text": "adipocyte", "entity_type": "Cell", "start": 240, "end": 241}, {"id": "T62", "text": "adipose samples", "entity_type": "Tissue", "start": 247, "end": 249}, {"id": "T48", "text": "graft", "entity_type": "Tissue", "start": 251, "end": 252}, {"id": "T33", "text": "CAM", "entity_type": "Multi-tissue_structure", "start": 253, "end": 254}, {"id": "T63", "text": "Stimulation", "entity_type": "Positive_regulation", "start": 255, "end": 256}, {"id": "T34", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 257, "end": 258}, {"id": "T35", "text": "adipose tissue", "entity_type": "Tissue", "start": 259, "end": 261}, {"id": "T64", "text": "abolished", "entity_type": "Negative_regulation", "start": 263, "end": 264}, {"id": "T37", "text": "bevacizumab", "entity_type": "Drug_or_compound", "start": 265, "end": 266}, {"id": "T65", "text": "targets", "entity_type": "Regulation", "start": 269, "end": 270}, {"id": "T1006", "text": "human", "entity_type": "Organism", "start": 270, "end": 271}, {"id": "T38", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 271, "end": 272}, {"id": "T66", "text": "regulation", "entity_type": "Regulation", "start": 283, "end": 284}, {"id": "T39", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 285, "end": 286}, {"id": "T1007", "text": "human", "entity_type": "Organism", "start": 287, "end": 288}, {"id": "T40", "text": "adipose tissue", "entity_type": "Tissue", "start": 288, "end": 290}, {"id": "T67", "text": "role", "entity_type": "Regulation", "start": 295, "end": 296}, {"id": "T42", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 297, "end": 298}, {"id": "T43", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 299, "end": 300}, {"id": "T44", "text": "SAT", "entity_type": "Tissue", "start": 302, "end": 303}, {"id": "T45", "text": "VAT", "entity_type": "Tissue", "start": 304, "end": 305}], "lang": "en"}
{"doc_id": "PMID-19080335", "wnd_id": "PMID-19080335_0", "text": "Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.\n\nBACKGROUND: Mesenchymal stem cells (MSCs) transplantation is of therapeutic potential after ischemic injury in both experimental and clinical studies. Clinically, elderly patients are more vulnerable to acute myocardial infarction (AMI). But little is known about the characteristics of young donor-derived MSCs transplanted to old patients with AMI. The present study was designed to investigate the effect of transplanted MSCs from rats of different ages on the improvement of heart function after AMI. METHODS: MSCs from Sprague-Dawley (SD) rats were isolated and cultured in vitro. The apoptosis characteristics of MSCs were observed under conditions of ischemia and anoxia. SD rats underwent MI received intramyocardial injection of MSCs from young donor rats (n = 8), old donor rats (n = 8), respectively. AMI control group received equal volume physiological saline. Immunofluorescence was used to observe the differentiation of the grafted cells into cardiomyocytes. Four weeks after cell transplantation, reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry for vascular endothelial growth factor (VEGF), VIII-factor immunohistochemistry for vessel density, TUNEL, caspase-3 for cardiomyocyte apoptosis, echocardiography and hemodynamic detection for heart function were performed. RESULTS: The apoptosis rate of the old donor-derived MSCs group was significantly higher than that of the young donor-derived MSCs group under conditions of ischemia and anoxia (P  less than  0.05). Engrafted MSCs survived, proliferated and differentiated into myocardium-like cells. VEGF gene expression and capillary density in the old donor-derived group were lower than those in the young donor-derived group but higher than those in the control group (P  less than  0.05).", "tokens": ["Effect", "of", "transplanted", "mesenchymal", "stem", "cells", "from", "rats", "of", "different", "ages", "on", "the", "improvement", "of", "heart", "function", "after", "acute", "myocardial", "infarction", ".", "BACKGROUND", ":", "Mesenchymal", "stem", "cells", "(", "MSCs", ")", "transplantation", "is", "of", "therapeutic", "potential", "after", "ischemic", "injury", "in", "both", "experimental", "and", "clinical", "studies", ".", "Clinically", ",", "elderly", "patients", "are", "more", "vulnerable", "to", "acute", "myocardial", "infarction", "(", "AMI", ")", ".", "But", "little", "is", "known", "about", "the", "characteristics", "of", "young", "donor", "-", "derived", "MSCs", "transplanted", "to", "old", "patients", "with", "AMI", ".", "The", "present", "study", "was", "designed", "to", "investigate", "the", "effect", "of", "transplanted", "MSCs", "from", "rats", "of", "different", "ages", "on", "the", "improvement", "of", "heart", "function", "after", "AMI", ".", "METHODS", ":", "MSCs", "from", "Sprague", "-", "Dawley", "(", "SD", ")", "rats", "were", "isolated", "and", "cultured", "in", "vitro", ".", "The", "apoptosis", "characteristics", "of", "MSCs", "were", "observed", "under", "conditions", "of", "ischemia", "and", "anoxia", ".", "SD", "rats", "underwent", "MI", "received", "intramyocardial", "injection", "of", "MSCs", "from", "young", "donor", "rats", "(", "n", "=", "8", ")", ",", "old", "donor", "rats", "(", "n", "=", "8", ")", ",", "respectively", ".", "AMI", "control", "group", "received", "equal", "volume", "physiological", "saline", ".", "Immunofluorescence", "was", "used", "to", "observe", "the", "differentiation", "of", "the", "grafted", "cells", "into", "cardiomyocytes", ".", "Four", "weeks", "after", "cell", "transplantation", ",", "reverse", "transcriptase", "-", "polymerase", "chain", "reaction", "(", "RT", "-", "PCR", ")", "and", "immunohistochemistry", "for", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", ",", "VIII", "-", "factor", "immunohistochemistry", "for", "vessel", "density", ",", "TUNEL", ",", "caspase", "-", "3", "for", "cardiomyocyte", "apoptosis", ",", "echocardiography", "and", "hemodynamic", "detection", "for", "heart", "function", "were", "performed", ".", "RESULTS", ":", "The", "apoptosis", "rate", "of", "the", "old", "donor", "-", "derived", "MSCs", "group", "was", "significantly", "higher", "than", "that", "of", "the", "young", "donor", "-", "derived", "MSCs", "group", "under", "conditions", "of", "ischemia", "and", "anoxia", "(", "P", "less", "than", "0.05", ")", ".", "Engrafted", "MSCs", "survived", ",", "proliferated", "and", "differentiated", "into", "myocardium", "-", "like", "cells", ".", "VEGF", "gene", "expression", "and", "capillary", "density", "in", "the", "old", "donor", "-", "derived", "group", "were", "lower", "than", "those", "in", "the", "young", "donor", "-", "derived", "group", "but", "higher", "than", "those", "in", "the", "control", "group", "(", "P", "less", "than", "0.05", ")", "."], "event_mentions": [{"id": "E1", "event_type": "Planned_process", "trigger": {"text": "transplanted", "start": 2, "end": 3}, "arguments": [{"entity_id": "T2", "role": "Instrument", "text": "mesenchymal stem cells", "start": 3, "end": 6}]}, {"id": "E4", "event_type": "Planned_process", "trigger": {"text": "transplantation", "start": 30, "end": 31}, "arguments": [{"entity_id": "T5", "role": "Instrument", "text": "Mesenchymal stem cells", "start": 24, "end": 27}, {"entity_id": "T6", "role": "Instrument", "text": "MSCs", "start": 28, "end": 29}]}, {"id": "E7", "event_type": "Planned_process", "trigger": {"text": "transplanted", "start": 73, "end": 74}, "arguments": [{"entity_id": "T8", "role": "Instrument", "text": "MSCs", "start": 72, "end": 73}, {"entity_id": "T1002", "role": "Theme", "text": "patients", "start": 76, "end": 77}]}, {"id": "E9", "event_type": "Planned_process", "trigger": {"text": "transplanted", "start": 90, "end": 91}, "arguments": [{"entity_id": "T10", "role": "Instrument", "text": "MSCs", "start": 91, "end": 92}]}, {"id": "E2", "event_type": "Planned_process", "trigger": {"text": "isolated", "start": 118, "end": 119}, "arguments": [{"entity_id": "T12", "role": "Instrument", "text": "MSCs", "start": 108, "end": 109}, {"entity_id": "T1004", "role": "Theme", "text": "Sprague-Dawley (SD) rats", "start": 110, "end": 117}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "cultured", "start": 120, "end": 121}, "arguments": [{"entity_id": "T12", "role": "Theme", "text": "MSCs", "start": 108, "end": 109}]}, {"id": "E5", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 125, "end": 126}, "arguments": [{"entity_id": "T13", "role": "Theme", "text": "MSCs", "start": 128, "end": 129}]}, {"id": "E14", "event_type": "Planned_process", "trigger": {"text": "injection", "start": 144, "end": 145}, "arguments": [{"entity_id": "T1005", "role": "Theme", "text": "SD rats", "start": 138, "end": 140}, {"entity_id": "T15", "role": "Instrument", "text": "MSCs", "start": 146, "end": 147}]}, {"id": "E6", "event_type": "Development", "trigger": {"text": "differentiation", "start": 183, "end": 184}, "arguments": [{"entity_id": "T68", "role": "Theme", "text": "cells", "start": 187, "end": 188}]}, {"id": "E25", "event_type": "Planned_process", "trigger": {"text": "grafted", "start": 186, "end": 187}, "arguments": [{"entity_id": "T68", "role": "Instrument", "text": "cells", "start": 187, "end": 188}]}, {"id": "E24", "event_type": "Planned_process", "trigger": {"text": "transplantation", "start": 195, "end": 196}, "arguments": [{"entity_id": "T66", "role": "Instrument", "text": "cell", "start": 194, "end": 195}]}, {"id": "E22", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 234, "end": 235}, "arguments": [{"entity_id": "T23", "role": "Theme", "text": "cardiomyocyte", "start": 233, "end": 234}]}, {"id": "E8", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 249, "end": 250}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "MSCs", "start": 257, "end": 258}]}, {"id": "E10", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 249, "end": 250}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "MSCs", "start": 270, "end": 271}]}, {"id": "E27", "event_type": "Planned_process", "trigger": {"text": "Engrafted", "start": 285, "end": 286}, "arguments": [{"entity_id": "T28", "role": "Instrument", "text": "MSCs", "start": 286, "end": 287}]}, {"id": "E15", "event_type": "Death", "trigger": {"text": "survived", "start": 287, "end": 288}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "MSCs", "start": 286, "end": 287}]}, {"id": "E11", "event_type": "Cell_proliferation", "trigger": {"text": "proliferated", "start": 289, "end": 290}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "MSCs", "start": 286, "end": 287}]}, {"id": "E12", "event_type": "Development", "trigger": {"text": "differentiated", "start": 291, "end": 292}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "MSCs", "start": 286, "end": 287}]}, {"id": "E30", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 300, "end": 301}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "VEGF", "start": 298, "end": 299}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "transplanted", "entity_type": "Planned_process", "start": 2, "end": 3}, {"id": "T2", "text": "mesenchymal stem cells", "entity_type": "Cell", "start": 3, "end": 6}, {"id": "T1000", "text": "rats", "entity_type": "Organism", "start": 7, "end": 8}, {"id": "T3", "text": "heart", "entity_type": "Organ", "start": 15, "end": 16}, {"id": "T5", "text": "Mesenchymal stem cells", "entity_type": "Cell", "start": 24, "end": 27}, {"id": "T6", "text": "MSCs", "entity_type": "Cell", "start": 28, "end": 29}, {"id": "T4", "text": "transplantation", "entity_type": "Planned_process", "start": 30, "end": 31}, {"id": "T1001", "text": "patients", "entity_type": "Organism", "start": 48, "end": 49}, {"id": "T8", "text": "MSCs", "entity_type": "Cell", "start": 72, "end": 73}, {"id": "T7", "text": "transplanted", "entity_type": "Planned_process", "start": 73, "end": 74}, {"id": "T1002", "text": "patients", "entity_type": "Organism", "start": 76, "end": 77}, {"id": "T9", "text": "transplanted", "entity_type": "Planned_process", "start": 90, "end": 91}, {"id": "T10", "text": "MSCs", "entity_type": "Cell", "start": 91, "end": 92}, {"id": "T1003", "text": "rats", "entity_type": "Organism", "start": 93, "end": 94}, {"id": "T11", "text": "heart", "entity_type": "Organ", "start": 101, "end": 102}, {"id": "T12", "text": "MSCs", "entity_type": "Cell", "start": 108, "end": 109}, {"id": "T1004", "text": "Sprague-Dawley (SD) rats", "entity_type": "Organism", "start": 110, "end": 117}, {"id": "T46", "text": "isolated", "entity_type": "Planned_process", "start": 118, "end": 119}, {"id": "T51", "text": "cultured", "entity_type": "Planned_process", "start": 120, "end": 121}, {"id": "T52", "text": "apoptosis", "entity_type": "Death", "start": 125, "end": 126}, {"id": "T13", "text": "MSCs", "entity_type": "Cell", "start": 128, "end": 129}, {"id": "T1005", "text": "SD rats", "entity_type": "Organism", "start": 138, "end": 140}, {"id": "T14", "text": "injection", "entity_type": "Planned_process", "start": 144, "end": 145}, {"id": "T15", "text": "MSCs", "entity_type": "Cell", "start": 146, "end": 147}, {"id": "T1006", "text": "rats", "entity_type": "Organism", "start": 150, "end": 151}, {"id": "T1007", "text": "rats", "entity_type": "Organism", "start": 159, "end": 160}, {"id": "T53", "text": "differentiation", "entity_type": "Development", "start": 183, "end": 184}, {"id": "T69", "text": "grafted", "entity_type": "Planned_process", "start": 186, "end": 187}, {"id": "T68", "text": "cells", "entity_type": "Cell", "start": 187, "end": 188}, {"id": "T16", "text": "cardiomyocytes", "entity_type": "Cell", "start": 189, "end": 190}, {"id": "T66", "text": "cell", "entity_type": "Cell", "start": 194, "end": 195}, {"id": "T67", "text": "transplantation", "entity_type": "Planned_process", "start": 195, "end": 196}, {"id": "T17", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 211, "end": 215}, {"id": "T18", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 216, "end": 217}, {"id": "T19", "text": "VIII-factor", "entity_type": "Gene_or_gene_product", "start": 219, "end": 222}, {"id": "T20", "text": "vessel", "entity_type": "Multi-tissue_structure", "start": 224, "end": 225}, {"id": "T21", "text": "caspase-3", "entity_type": "Gene_or_gene_product", "start": 229, "end": 232}, {"id": "T23", "text": "cardiomyocyte", "entity_type": "Cell", "start": 233, "end": 234}, {"id": "T22", "text": "apoptosis", "entity_type": "Death", "start": 234, "end": 235}, {"id": "T24", "text": "heart", "entity_type": "Organ", "start": 241, "end": 242}, {"id": "T54", "text": "apoptosis", "entity_type": "Death", "start": 249, "end": 250}, {"id": "T25", "text": "MSCs", "entity_type": "Cell", "start": 257, "end": 258}, {"id": "T26", "text": "MSCs", "entity_type": "Cell", "start": 270, "end": 271}, {"id": "T27", "text": "Engrafted", "entity_type": "Planned_process", "start": 285, "end": 286}, {"id": "T28", "text": "MSCs", "entity_type": "Cell", "start": 286, "end": 287}, {"id": "T58", "text": "survived", "entity_type": "Death", "start": 287, "end": 288}, {"id": "T55", "text": "proliferated", "entity_type": "Cell_proliferation", "start": 289, "end": 290}, {"id": "T56", "text": "differentiated", "entity_type": "Development", "start": 291, "end": 292}, {"id": "T29", "text": "myocardium-like cells", "entity_type": "Cell", "start": 293, "end": 297}, {"id": "T31", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 298, "end": 299}, {"id": "T30", "text": "expression", "entity_type": "Gene_expression", "start": 300, "end": 301}, {"id": "T32", "text": "capillary", "entity_type": "Tissue", "start": 302, "end": 303}], "lang": "en"}
{"doc_id": "PMID-19080335", "wnd_id": "PMID-19080335_1", "text": "The transplantation of old donor-derived MSCs attenuated apoptosis of cardiomyocytes in the peri-infarct region compared with the control group and the effect was elevated in young donor-derived MSCs (P  less than  0.05). The heart functions (left ventricle ejection fraction (LVEF), left ventricle fractional shortening (LVFS)) were improved more significantly in the old donor-derived MSCs group than in the control group and the heart function in the young donor-derived MSCs group further improved (P  less than  0.05). CONCLUSIONS: Young donor-derived MSCs can improve heart function significantly through angiogenesis and decreasing cardiomyocyte apoptosis when transplanted to the infarcted area.", "tokens": ["The", "transplantation", "of", "old", "donor", "-", "derived", "MSCs", "attenuated", "apoptosis", "of", "cardiomyocytes", "in", "the", "peri-infarct", "region", "compared", "with", "the", "control", "group", "and", "the", "effect", "was", "elevated", "in", "young", "donor", "-", "derived", "MSCs", "(", "P", "less", "than", "0.05", ")", ".", "The", "heart", "functions", "(", "left", "ventricle", "ejection", "fraction", "(", "LVEF", ")", ",", "left", "ventricle", "fractional", "shortening", "(", "LVFS", ")", ")", "were", "improved", "more", "significantly", "in", "the", "old", "donor", "-", "derived", "MSCs", "group", "than", "in", "the", "control", "group", "and", "the", "heart", "function", "in", "the", "young", "donor", "-", "derived", "MSCs", "group", "further", "improved", "(", "P", "less", "than", "0.05", ")", ".", "CONCLUSIONS", ":", "Young", "donor", "-", "derived", "MSCs", "can", "improve", "heart", "function", "significantly", "through", "angiogenesis", "and", "decreasing", "cardiomyocyte", "apoptosis", "when", "transplanted", "to", "the", "infarcted", "area", "."], "event_mentions": [{"id": "E33", "event_type": "Planned_process", "trigger": {"text": "transplantation", "start": 1, "end": 2}, "arguments": [{"entity_id": "T34", "role": "Instrument", "text": "MSCs", "start": 7, "end": 8}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "attenuated", "start": 8, "end": 9}, "arguments": []}, {"id": "E35", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 9, "end": 10}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "cardiomyocytes", "start": 11, "end": 12}]}, {"id": "E16", "event_type": "Regulation", "trigger": {"text": "effect", "start": 23, "end": 24}, "arguments": [{"entity_id": "T37", "role": "Theme", "text": "MSCs", "start": 31, "end": 32}]}, {"id": "E17", "event_type": "Positive_regulation", "trigger": {"text": "elevated", "start": 25, "end": 26}, "arguments": []}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "improved", "start": 89, "end": 90}, "arguments": [{"entity_id": "T42", "role": "Theme", "text": "heart", "start": 78, "end": 79}]}, {"id": "E20", "event_type": "Positive_regulation", "trigger": {"text": "improve", "start": 105, "end": 106}, "arguments": [{"entity_id": "T45", "role": "Theme", "text": "heart", "start": 106, "end": 107}]}, {"id": "E21", "event_type": "Regulation", "trigger": {"text": "improve", "start": 105, "end": 106}, "arguments": [{"entity_id": "T44", "role": "Cause", "text": "MSCs", "start": 103, "end": 104}]}, {"id": "E26", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 110, "end": 111}, "arguments": []}, {"id": "E48", "event_type": "Negative_regulation", "trigger": {"text": "decreasing", "start": 112, "end": 113}, "arguments": [{"entity_id": "T44", "role": "Cause", "text": "MSCs", "start": 103, "end": 104}]}, {"id": "E49", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 114, "end": 115}, "arguments": [{"entity_id": "T50", "role": "Theme", "text": "cardiomyocyte", "start": 113, "end": 114}]}, {"id": "E23", "event_type": "Planned_process", "trigger": {"text": "transplanted", "start": 116, "end": 117}, "arguments": [{"entity_id": "T44", "role": "Instrument", "text": "MSCs", "start": 103, "end": 104}]}], "relation_mentions": [], "entity_mentions": [{"id": "T33", "text": "transplantation", "entity_type": "Planned_process", "start": 1, "end": 2}, {"id": "T34", "text": "MSCs", "entity_type": "Cell", "start": 7, "end": 8}, {"id": "T57", "text": "attenuated", "entity_type": "Negative_regulation", "start": 8, "end": 9}, {"id": "T35", "text": "apoptosis", "entity_type": "Death", "start": 9, "end": 10}, {"id": "T36", "text": "cardiomyocytes", "entity_type": "Cell", "start": 11, "end": 12}, {"id": "T59", "text": "effect", "entity_type": "Regulation", "start": 23, "end": 24}, {"id": "T60", "text": "elevated", "entity_type": "Positive_regulation", "start": 25, "end": 26}, {"id": "T37", "text": "MSCs", "entity_type": "Cell", "start": 31, "end": 32}, {"id": "T38", "text": "heart", "entity_type": "Organ", "start": 40, "end": 41}, {"id": "T39", "text": "ventricle", "entity_type": "Multi-tissue_structure", "start": 44, "end": 45}, {"id": "T40", "text": "ventricle", "entity_type": "Multi-tissue_structure", "start": 52, "end": 53}, {"id": "T41", "text": "MSCs", "entity_type": "Cell", "start": 69, "end": 70}, {"id": "T42", "text": "heart", "entity_type": "Organ", "start": 78, "end": 79}, {"id": "T43", "text": "MSCs", "entity_type": "Cell", "start": 86, "end": 87}, {"id": "T62", "text": "improved", "entity_type": "Positive_regulation", "start": 89, "end": 90}, {"id": "T44", "text": "MSCs", "entity_type": "Cell", "start": 103, "end": 104}, {"id": "T63", "text": "improve", "entity_type": "Positive_regulation", "start": 105, "end": 106}, {"id": "T64", "text": "improve", "entity_type": "Regulation", "start": 105, "end": 106}, {"id": "T45", "text": "heart", "entity_type": "Organ", "start": 106, "end": 107}, {"id": "T47", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 110, "end": 111}, {"id": "T48", "text": "decreasing", "entity_type": "Negative_regulation", "start": 112, "end": 113}, {"id": "T50", "text": "cardiomyocyte", "entity_type": "Cell", "start": 113, "end": 114}, {"id": "T49", "text": "apoptosis", "entity_type": "Death", "start": 114, "end": 115}, {"id": "T65", "text": "transplanted", "entity_type": "Planned_process", "start": 116, "end": 117}], "lang": "en"}
{"doc_id": "PMID-19152650", "wnd_id": "PMID-19152650_0", "text": "Effect of estrogen and progesterone on macrophage activation during wound healing.\n\nAge-related impaired wound healing leads to substantial morbidity and mortality along with a large financial burden to health services. There is accumulating evidence that the tissue damage associated with chronic wounds is initiated and propagated by an inappropriately excessive inflammatory response. Research on age-related impaired wound healing suggests that the decline in sex steroid hormones with age may have a substantial influence on the inflammatory response in vivo. Topical and systemic estrogen treatments have shown an increased rate of healing by reducing inflammation, however the underlying mechanisms are little understood. In vitro studies also suggest progesterone may play a role in modulating inflammation. Macrophages are essential mediators of inflammation and wound healing. Macrophages can be activated in a classical or alternative manner in parallel with the T(H)1/T(H)2 dichotomy, respectively. Using a murine incisional wound healing model this study was carried out to investigate the roles of estrogen and progesterone on macrophage activation during the wound healing response. Our findings suggest with a reduction of steroid hormones following ovariectomy, alternatively activated macrophage markers (Fizz1 and Ym1) were reduced, with this effect being reversed with the administration of estrogen or progesterone; suggesting that with the reduction of steroid hormones macrophages are activated in a classical manner, promoting inflammation, whereas estrogen or progesterone are contributing toward macrophage activation in an alternative manner, driving wound repair, angiogenesis, and remodeling.", "tokens": ["Effect", "of", "estrogen", "and", "progesterone", "on", "macrophage", "activation", "during", "wound", "healing", ".", "Age", "-", "related", "impaired", "wound", "healing", "leads", "to", "substantial", "morbidity", "and", "mortality", "along", "with", "a", "large", "financial", "burden", "to", "health", "services", ".", "There", "is", "accumulating", "evidence", "that", "the", "tissue", "damage", "associated", "with", "chronic", "wounds", "is", "initiated", "and", "propagated", "by", "an", "inappropriately", "excessive", "inflammatory", "response", ".", "Research", "on", "age", "-", "related", "impaired", "wound", "healing", "suggests", "that", "the", "decline", "in", "sex", "steroid", "hormones", "with", "age", "may", "have", "a", "substantial", "influence", "on", "the", "inflammatory", "response", "in", "vivo", ".", "Topical", "and", "systemic", "estrogen", "treatments", "have", "shown", "an", "increased", "rate", "of", "healing", "by", "reducing", "inflammation", ",", "however", "the", "underlying", "mechanisms", "are", "little", "understood", ".", "In", "vitro", "studies", "also", "suggest", "progesterone", "may", "play", "a", "role", "in", "modulating", "inflammation", ".", "Macrophages", "are", "essential", "mediators", "of", "inflammation", "and", "wound", "healing", ".", "Macrophages", "can", "be", "activated", "in", "a", "classical", "or", "alternative", "manner", "in", "parallel", "with", "the", "T", "(", "H", ")", "1", "/", "T(", "H", ")", "2", "dichotomy", ",", "respectively", ".", "Using", "a", "murine", "incisional", "wound", "healing", "model", "this", "study", "was", "carried", "out", "to", "investigate", "the", "roles", "of", "estrogen", "and", "progesterone", "on", "macrophage", "activation", "during", "the", "wound", "healing", "response", ".", "Our", "findings", "suggest", "with", "a", "reduction", "of", "steroid", "hormones", "following", "ovariectomy", ",", "alternatively", "activated", "macrophage", "markers", "(", "Fizz1", "and", "Ym1", ")", "were", "reduced", ",", "with", "this", "effect", "being", "reversed", "with", "the", "administration", "of", "estrogen", "or", "progesterone", ";", "suggesting", "that", "with", "the", "reduction", "of", "steroid", "hormones", "macrophages", "are", "activated", "in", "a", "classical", "manner", ",", "promoting", "inflammation", ",", "whereas", "estrogen", "or", "progesterone", "are", "contributing", "toward", "macrophage", "activation", "in", "an", "alternative", "manner", ",", "driving", "wound", "repair", ",", "angiogenesis", ",", "and", "remodeling", "."], "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "Effect", "start": 0, "end": 1}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "estrogen", "start": 2, "end": 3}]}, {"id": "E2", "event_type": "Regulation", "trigger": {"text": "Effect", "start": 0, "end": 1}, "arguments": [{"entity_id": "T3", "role": "Cause", "text": "progesterone", "start": 4, "end": 5}]}, {"id": "E4", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 7, "end": 8}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "macrophage", "start": 6, "end": 7}]}, {"id": "E16", "event_type": "Breakdown", "trigger": {"text": "damage", "start": 41, "end": 42}, "arguments": [{"entity_id": "T43", "role": "Theme", "text": "tissue", "start": 40, "end": 41}]}, {"id": "E18", "event_type": "Positive_regulation", "trigger": {"text": "initiated", "start": 47, "end": 48}, "arguments": []}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "treatments", "start": 91, "end": 92}, "arguments": [{"entity_id": "T7", "role": "Instrument", "text": "estrogen", "start": 90, "end": 91}]}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 138, "end": 139}, "arguments": [{"entity_id": "T12", "role": "Theme", "text": "Macrophages", "start": 135, "end": 136}]}, {"id": "E5", "event_type": "Regulation", "trigger": {"text": "the roles of", "start": 177, "end": 180}, "arguments": [{"entity_id": "T15", "role": "Cause", "text": "estrogen", "start": 180, "end": 181}]}, {"id": "E6", "event_type": "Regulation", "trigger": {"text": "the roles of", "start": 177, "end": 180}, "arguments": [{"entity_id": "T16", "role": "Cause", "text": "progesterone", "start": 182, "end": 183}]}, {"id": "E17", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 185, "end": 186}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "macrophage", "start": 184, "end": 185}]}, {"id": "E19", "event_type": "Negative_regulation", "trigger": {"text": "reduction", "start": 197, "end": 198}, "arguments": [{"entity_id": "T20", "role": "Theme", "text": "steroid hormones", "start": 199, "end": 201}]}, {"id": "E7", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 205, "end": 206}, "arguments": [{"entity_id": "T22", "role": "Theme", "text": "Fizz1", "start": 209, "end": 210}]}, {"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 205, "end": 206}, "arguments": [{"entity_id": "T23", "role": "Theme", "text": "Ym1", "start": 211, "end": 212}]}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 214, "end": 215}, "arguments": [{"entity_id": "T23", "role": "Theme", "text": "Ym1", "start": 211, "end": 212}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 214, "end": 215}, "arguments": [{"entity_id": "T22", "role": "Theme", "text": "Fizz1", "start": 209, "end": 210}]}, {"id": "E14", "event_type": "Negative_regulation", "trigger": {"text": "reversed", "start": 220, "end": 221}, "arguments": []}, {"id": "E21", "event_type": "Negative_regulation", "trigger": {"text": "reversed", "start": 220, "end": 221}, "arguments": []}, {"id": "E22", "event_type": "Negative_regulation", "trigger": {"text": "reversed", "start": 220, "end": 221}, "arguments": []}, {"id": "E23", "event_type": "Negative_regulation", "trigger": {"text": "reversed", "start": 220, "end": 221}, "arguments": []}, {"id": "E25", "event_type": "Planned_process", "trigger": {"text": "administration", "start": 223, "end": 224}, "arguments": [{"entity_id": "T26", "role": "Instrument", "text": "estrogen", "start": 225, "end": 226}]}, {"id": "E20", "event_type": "Planned_process", "trigger": {"text": "administration", "start": 223, "end": 224}, "arguments": [{"entity_id": "T27", "role": "Instrument", "text": "progesterone", "start": 227, "end": 228}]}, {"id": "E28", "event_type": "Negative_regulation", "trigger": {"text": "reduction", "start": 233, "end": 234}, "arguments": [{"entity_id": "T29", "role": "Theme", "text": "steroid hormones", "start": 235, "end": 237}]}, {"id": "E30", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 239, "end": 240}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "macrophages", "start": 237, "end": 238}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "contributing", "start": 253, "end": 254}, "arguments": [{"entity_id": "T33", "role": "Cause", "text": "progesterone", "start": 251, "end": 252}]}, {"id": "E13", "event_type": "Regulation", "trigger": {"text": "contributing", "start": 253, "end": 254}, "arguments": [{"entity_id": "T32", "role": "Cause", "text": "estrogen", "start": 249, "end": 250}]}, {"id": "E34", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 256, "end": 257}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "macrophage", "start": 255, "end": 256}]}, {"id": "E15", "event_type": "Positive_regulation", "trigger": {"text": "driving", "start": 262, "end": 263}, "arguments": [{"entity_id": "T33", "role": "Cause", "text": "progesterone", "start": 251, "end": 252}]}, {"id": "E24", "event_type": "Positive_regulation", "trigger": {"text": "driving", "start": 262, "end": 263}, "arguments": [{"entity_id": "T32", "role": "Cause", "text": "estrogen", "start": 249, "end": 250}]}, {"id": "E26", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 266, "end": 267}, "arguments": []}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "Effect", "entity_type": "Regulation", "start": 0, "end": 1}, {"id": "T2", "text": "estrogen", "entity_type": "Drug_or_compound", "start": 2, "end": 3}, {"id": "T3", "text": "progesterone", "entity_type": "Drug_or_compound", "start": 4, "end": 5}, {"id": "T5", "text": "macrophage", "entity_type": "Cell", "start": 6, "end": 7}, {"id": "T4", "text": "activation", "entity_type": "Positive_regulation", "start": 7, "end": 8}, {"id": "T43", "text": "tissue", "entity_type": "Tissue", "start": 40, "end": 41}, {"id": "T44", "text": "damage", "entity_type": "Breakdown", "start": 41, "end": 42}, {"id": "T45", "text": "initiated", "entity_type": "Positive_regulation", "start": 47, "end": 48}, {"id": "T6", "text": "sex steroid hormones", "entity_type": "Drug_or_compound", "start": 70, "end": 73}, {"id": "T7", "text": "estrogen", "entity_type": "Drug_or_compound", "start": 90, "end": 91}, {"id": "T10", "text": "treatments", "entity_type": "Planned_process", "start": 91, "end": 92}, {"id": "T8", "text": "progesterone", "entity_type": "Drug_or_compound", "start": 116, "end": 117}, {"id": "T9", "text": "Macrophages", "entity_type": "Cell", "start": 125, "end": 126}, {"id": "T12", "text": "Macrophages", "entity_type": "Cell", "start": 135, "end": 136}, {"id": "T11", "text": "activated", "entity_type": "Positive_regulation", "start": 138, "end": 139}, {"id": "T13", "text": "T(H)1", "entity_type": "Cell", "start": 149, "end": 154}, {"id": "T14", "text": "T(H)2", "entity_type": "Cell", "start": 155, "end": 159}, {"id": "T1000", "text": "murine", "entity_type": "Organism", "start": 165, "end": 166}, {"id": "T36", "text": "the roles of", "entity_type": "Regulation", "start": 177, "end": 180}, {"id": "T15", "text": "estrogen", "entity_type": "Drug_or_compound", "start": 180, "end": 181}, {"id": "T16", "text": "progesterone", "entity_type": "Drug_or_compound", "start": 182, "end": 183}, {"id": "T18", "text": "macrophage", "entity_type": "Cell", "start": 184, "end": 185}, {"id": "T17", "text": "activation", "entity_type": "Positive_regulation", "start": 185, "end": 186}, {"id": "T19", "text": "reduction", "entity_type": "Negative_regulation", "start": 197, "end": 198}, {"id": "T20", "text": "steroid hormones", "entity_type": "Drug_or_compound", "start": 199, "end": 201}, {"id": "T38", "text": "activated", "entity_type": "Positive_regulation", "start": 205, "end": 206}, {"id": "T21", "text": "macrophage", "entity_type": "Cell", "start": 206, "end": 207}, {"id": "T22", "text": "Fizz1", "entity_type": "Gene_or_gene_product", "start": 209, "end": 210}, {"id": "T23", "text": "Ym1", "entity_type": "Gene_or_gene_product", "start": 211, "end": 212}, {"id": "T39", "text": "reduced", "entity_type": "Negative_regulation", "start": 214, "end": 215}, {"id": "T41", "text": "reversed", "entity_type": "Negative_regulation", "start": 220, "end": 221}, {"id": "T25", "text": "administration", "entity_type": "Planned_process", "start": 223, "end": 224}, {"id": "T26", "text": "estrogen", "entity_type": "Drug_or_compound", "start": 225, "end": 226}, {"id": "T27", "text": "progesterone", "entity_type": "Drug_or_compound", "start": 227, "end": 228}, {"id": "T28", "text": "reduction", "entity_type": "Negative_regulation", "start": 233, "end": 234}, {"id": "T29", "text": "steroid hormones", "entity_type": "Drug_or_compound", "start": 235, "end": 237}, {"id": "T31", "text": "macrophages", "entity_type": "Cell", "start": 237, "end": 238}, {"id": "T30", "text": "activated", "entity_type": "Positive_regulation", "start": 239, "end": 240}, {"id": "T32", "text": "estrogen", "entity_type": "Drug_or_compound", "start": 249, "end": 250}, {"id": "T33", "text": "progesterone", "entity_type": "Drug_or_compound", "start": 251, "end": 252}, {"id": "T40", "text": "contributing", "entity_type": "Regulation", "start": 253, "end": 254}, {"id": "T35", "text": "macrophage", "entity_type": "Cell", "start": 255, "end": 256}, {"id": "T34", "text": "activation", "entity_type": "Positive_regulation", "start": 256, "end": 257}, {"id": "T42", "text": "driving", "entity_type": "Positive_regulation", "start": 262, "end": 263}, {"id": "T24", "text": "wound", "entity_type": "Pathological_formation", "start": 263, "end": 264}, {"id": "T37", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 266, "end": 267}], "lang": "en"}
{"doc_id": "PMID-19164985", "wnd_id": "PMID-19164985_0", "text": "Effect of platelet-rich plasma and fibrin glue on healing of critical-size calvarial bone defects.\n\nDespite the insufficient number of experimental studies, platelet-rich plasma (PRP) including high amounts of growth factors is introduced to clinical use rapidly. The aim of this study was to compare the effects of PRP and platelet-poor plasma (PPP) on healing of critical-size bone defects.Bilateral full-thickness, critical-size bone defects were created in the parietal bones of 32 rabbits, which had been studied in 4 groups. Saline, thrombin solution, PPP, and PRP were applied to the created defects before closure. Radiologic defect area measurement results at 0, 4, and 16 weeks were compared between the groups. In addition, densities of the newly formed bones at 16th week were studied. Histologic parameters (primary and secondary bone trabecula, neovascularization, and bone marrow and connective tissue formation) were compared between 4- and 16-week groups.More rapid decrease in defect size was observed in groups 3 and 4 than in groups 1 and 2, both in the 4th and 16th weeks. Newly formed bone densities were also found to be higher in these 2 groups. New bone formation was detected to be more rapid considering histologic parameters, in groups 3 and 4 at 4th and 16th weeks.Study demonstrates that PRP and PPP might have favorable effects on bone healing. Although we cannot reveal any statistical difference between these 2 substances considering osteoinductive potential, PRP group has demonstrated superior results compared with fibrin glue group. Higher platelet concentrations may expose beneficial effects of PRP.", "tokens": ["Effect", "of", "platelet", "-", "rich", "plasma", "and", "fibrin", "glue", "on", "healing", "of", "critical", "-", "size", "calvarial", "bone", "defects", ".", "Despite", "the", "insufficient", "number", "of", "experimental", "studies", ",", "platelet", "-", "rich", "plasma", "(", "PRP", ")", "including", "high", "amounts", "of", "growth", "factors", "is", "introduced", "to", "clinical", "use", "rapidly", ".", "The", "aim", "of", "this", "study", "was", "to", "compare", "the", "effects", "of", "PRP", "and", "platelet", "-", "poor", "plasma", "(", "PPP", ")", "on", "healing", "of", "critical", "-", "size", "bone", "defects", ".", "Bilateral", "full", "-", "thickness", ",", "critical", "-", "size", "bone", "defects", "were", "created", "in", "the", "parietal", "bones", "of", "32", "rabbits", ",", "which", "had", "been", "studied", "in", "4", "groups", ".", "Saline", ",", "thrombin", "solution", ",", "PPP", ",", "and", "PRP", "were", "applied", "to", "the", "created", "defects", "before", "closure", ".", "Radiologic", "defect", "area", "measurement", "results", "at", "0", ",", "4", ",", "and", "16", "weeks", "were", "compared", "between", "the", "groups", ".", "In", "addition", ",", "densities", "of", "the", "newly", "formed", "bones", "at", "16th", "week", "were", "studied", ".", "Histologic", "parameters", "(", "primary", "and", "secondary", "bone", "trabecula", ",", "neovascularization", ",", "and", "bone", "marrow", "and", "connective", "tissue", "formation", ")", "were", "compared", "between", "4", "-", "and", "16", "-", "week", "groups", ".", "More", "rapid", "decrease", "in", "defect", "size", "was", "observed", "in", "groups", "3", "and", "4", "than", "in", "groups", "1", "and", "2", ",", "both", "in", "the", "4th", "and", "16th", "weeks", ".", "Newly", "formed", "bone", "densities", "were", "also", "found", "to", "be", "higher", "in", "these", "2", "groups", ".", "New", "bone", "formation", "was", "detected", "to", "be", "more", "rapid", "considering", "histologic", "parameters", ",", "in", "groups", "3", "and", "4", "at", "4th", "and", "16th", "weeks", ".", "Study", "demonstrates", "that", "PRP", "and", "PPP", "might", "have", "favorable", "effects", "on", "bone", "healing", ".", "Although", "we", "cannot", "reveal", "any", "statistical", "difference", "between", "these", "2", "substances", "considering", "osteoinductive", "potential", ",", "PRP", "group", "has", "demonstrated", "superior", "results", "compared", "with", "fibrin", "glue", "group", ".", "Higher", "platelet", "concentrations", "may", "expose", "beneficial", "effects", "of", "PRP", "."], "event_mentions": [{"id": "E2", "event_type": "Regulation", "trigger": {"text": "effects", "start": 56, "end": 57}, "arguments": [{"entity_id": "T10", "role": "Cause", "text": "PRP", "start": 58, "end": 59}, {"entity_id": "T15", "role": "Theme", "text": "bone", "start": 73, "end": 74}]}, {"id": "E3", "event_type": "Regulation", "trigger": {"text": "effects", "start": 56, "end": 57}, "arguments": [{"entity_id": "T11", "role": "Cause", "text": "platelet-poor plasma", "start": 60, "end": 64}, {"entity_id": "T14", "role": "Cause", "text": "PPP", "start": 65, "end": 66}, {"entity_id": "T15", "role": "Theme", "text": "bone", "start": 73, "end": 74}]}, {"id": "E1", "event_type": "Planned_process", "trigger": {"text": "applied", "start": 114, "end": 115}, "arguments": [{"entity_id": "T20", "role": "Instrument", "text": "PRP", "start": 112, "end": 113}]}, {"id": "E4", "event_type": "Planned_process", "trigger": {"text": "applied", "start": 114, "end": 115}, "arguments": [{"entity_id": "T19", "role": "Instrument", "text": "PPP", "start": 109, "end": 110}]}, {"id": "E5", "event_type": "Planned_process", "trigger": {"text": "applied", "start": 114, "end": 115}, "arguments": [{"entity_id": "T18", "role": "Instrument", "text": "thrombin", "start": 106, "end": 107}]}, {"id": "E6", "event_type": "Planned_process", "trigger": {"text": "applied", "start": 114, "end": 115}, "arguments": [{"entity_id": "T2", "role": "Instrument", "text": "Saline", "start": 104, "end": 105}]}, {"id": "E7", "event_type": "Development", "trigger": {"text": "formed", "start": 148, "end": 149}, "arguments": [{"entity_id": "T21", "role": "Theme", "text": "bones", "start": 149, "end": 150}]}, {"id": "E13", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 165, "end": 166}, "arguments": []}, {"id": "E8", "event_type": "Development", "trigger": {"text": "formation", "start": 173, "end": 174}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "connective tissue", "start": 171, "end": 173}]}, {"id": "E9", "event_type": "Development", "trigger": {"text": "formation", "start": 173, "end": 174}, "arguments": [{"entity_id": "T24", "role": "Theme", "text": "bone marrow", "start": 168, "end": 170}]}, {"id": "E10", "event_type": "Development", "trigger": {"text": "formed", "start": 215, "end": 216}, "arguments": [{"entity_id": "T26", "role": "Theme", "text": "bone", "start": 216, "end": 217}]}, {"id": "E27", "event_type": "Development", "trigger": {"text": "formation", "start": 231, "end": 232}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "bone", "start": 230, "end": 231}]}, {"id": "E11", "event_type": "Regulation", "trigger": {"text": "effects", "start": 262, "end": 263}, "arguments": [{"entity_id": "T30", "role": "Cause", "text": "PPP", "start": 258, "end": 259}, {"entity_id": "T31", "role": "Theme", "text": "bone", "start": 264, "end": 265}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "effects", "start": 262, "end": 263}, "arguments": [{"entity_id": "T29", "role": "Cause", "text": "PRP", "start": 256, "end": 257}, {"entity_id": "T31", "role": "Theme", "text": "bone", "start": 264, "end": 265}]}], "relation_mentions": [], "entity_mentions": [{"id": "T37", "text": "Effect", "entity_type": "Gene_or_gene_product", "start": 0, "end": 1}, {"id": "T1", "text": "platelet-rich plasma", "entity_type": "Organism_substance", "start": 2, "end": 6}, {"id": "T4", "text": "fibrin", "entity_type": "Gene_or_gene_product", "start": 7, "end": 8}, {"id": "T5", "text": "calvarial bone", "entity_type": "Organ", "start": 15, "end": 17}, {"id": "T6", "text": "platelet-rich plasma", "entity_type": "Organism_substance", "start": 27, "end": 31}, {"id": "T9", "text": "PRP", "entity_type": "Organism_substance", "start": 32, "end": 33}, {"id": "T3", "text": "effects", "entity_type": "Regulation", "start": 56, "end": 57}, {"id": "T10", "text": "PRP", "entity_type": "Organism_substance", "start": 58, "end": 59}, {"id": "T11", "text": "platelet-poor plasma", "entity_type": "Organism_substance", "start": 60, "end": 64}, {"id": "T14", "text": "PPP", "entity_type": "Organism_substance", "start": 65, "end": 66}, {"id": "T15", "text": "bone", "entity_type": "Organ", "start": 73, "end": 74}, {"id": "T16", "text": "bone", "entity_type": "Organ", "start": 84, "end": 85}, {"id": "T17", "text": "parietal bones", "entity_type": "Organ", "start": 90, "end": 92}, {"id": "T1000", "text": "rabbits", "entity_type": "Organism", "start": 94, "end": 95}, {"id": "T2", "text": "Saline", "entity_type": "Drug_or_compound", "start": 104, "end": 105}, {"id": "T18", "text": "thrombin", "entity_type": "Gene_or_gene_product", "start": 106, "end": 107}, {"id": "T19", "text": "PPP", "entity_type": "Organism_substance", "start": 109, "end": 110}, {"id": "T20", "text": "PRP", "entity_type": "Organism_substance", "start": 112, "end": 113}, {"id": "T7", "text": "applied", "entity_type": "Planned_process", "start": 114, "end": 115}, {"id": "T8", "text": "formed", "entity_type": "Development", "start": 148, "end": 149}, {"id": "T21", "text": "bones", "entity_type": "Organ", "start": 149, "end": 150}, {"id": "T22", "text": "bone trabecula", "entity_type": "Tissue", "start": 162, "end": 164}, {"id": "T23", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 165, "end": 166}, {"id": "T24", "text": "bone marrow", "entity_type": "Multi-tissue_structure", "start": 168, "end": 170}, {"id": "T25", "text": "connective tissue", "entity_type": "Tissue", "start": 171, "end": 173}, {"id": "T12", "text": "formation", "entity_type": "Development", "start": 173, "end": 174}, {"id": "T13", "text": "formed", "entity_type": "Development", "start": 215, "end": 216}, {"id": "T26", "text": "bone", "entity_type": "Organ", "start": 216, "end": 217}, {"id": "T28", "text": "bone", "entity_type": "Organ", "start": 230, "end": 231}, {"id": "T27", "text": "formation", "entity_type": "Development", "start": 231, "end": 232}, {"id": "T29", "text": "PRP", "entity_type": "Organism_substance", "start": 256, "end": 257}, {"id": "T30", "text": "PPP", "entity_type": "Organism_substance", "start": 258, "end": 259}, {"id": "T34", "text": "effects", "entity_type": "Regulation", "start": 262, "end": 263}, {"id": "T31", "text": "bone", "entity_type": "Organ", "start": 264, "end": 265}, {"id": "T32", "text": "PRP", "entity_type": "Organism_substance", "start": 282, "end": 283}, {"id": "T33", "text": "fibrin", "entity_type": "Gene_or_gene_product", "start": 290, "end": 291}, {"id": "T35", "text": "platelet", "entity_type": "Cell", "start": 295, "end": 296}, {"id": "T36", "text": "PRP", "entity_type": "Organism_substance", "start": 302, "end": 303}], "lang": "en"}
{"doc_id": "PMID-19223494", "wnd_id": "PMID-19223494_0", "text": "Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.\n\nPURPOSE: Pigment epithelial-derived factor (PEDF) is a potent angiogenesis inhibitor with multiple other functions, some of which enhance tumor growth. Our previous studies mapped PEDF antiangiogenic and prosurvival activities to distinct epitopes. This study was aimed to determine the minimal fragment of PEDF, which maintains antiangiogenic and antitumor efficacy. EXPERIMENTAL DESIGN: We analyzed antigenicity, hydrophilicity, and charge distribution of the angioinhibitory epitope (the 34-mer) and designed three peptides covering its COOH terminus, P14, P18, and P23. We analyzed their ability to block endothelial cell chemotaxis and induce apoptosis in vitro and their antiangiogenic activity in vivo. The selected peptide was tested for the antitumor activity against mildly aggressive xenografted prostate carcinoma and highly aggressive renal cell carcinoma. To verify that P18 acts in the same manner as PEDF, we used immunohistochemistry to measure PEDF targets, vascular endothelial growth factor receptor 2, and CD95 ligand expression in P18-treated vasculature. RESULTS: P14 and P18 blocked endothelial cell chemotaxis; P18 and P23 induced apoptosis. P18 showed the highest IC50 and blocked angiogenesis in vivo: P23 was inactive and P14 was proangiogenic. P18 increased the production of CD95 ligand and reduced the expression of vascular endothelial growth factor receptor 2 by the endothelial cells in vivo. In tumor studies, P18 was more effective in blocking the angiogenesis and growth of the prostate cancer than parental 34-mer; in the renal cell carcinoma, P18 strongly decreased angiogenesis and halted the progression of established tumors. CONCLUSIONS: P18 is a novel and potent antiangiogenic biotherapeutic agent that has potential to be developed for the treatment of prostate and renal cancer.", "tokens": ["Short", "pigment", "epithelial", "-", "derived", "factor", "-", "derived", "peptide", "inhibits", "angiogenesis", "and", "tumor", "growth", ".", "PURPOSE", ":", "Pigment", "epithelial", "-", "derived", "factor", "(", "PEDF", ")", "is", "a", "potent", "angiogenesis", "inhibitor", "with", "multiple", "other", "functions", ",", "some", "of", "which", "enhance", "tumor", "growth", ".", "Our", "previous", "studies", "mapped", "PEDF", "antiangiogenic", "and", "prosurvival", "activities", "to", "distinct", "epitopes", ".", "This", "study", "was", "aimed", "to", "determine", "the", "minimal", "fragment", "of", "PEDF", ",", "which", "maintains", "antiangiogenic", "and", "antitumor", "efficacy", ".", "EXPERIMENTAL", "DESIGN", ":", "We", "analyzed", "antigenicity", ",", "hydrophilicity", ",", "and", "charge", "distribution", "of", "the", "angioinhibitory", "epitope", "(", "the", "34", "-", "mer", ")", "and", "designed", "three", "peptides", "covering", "its", "COOH", "terminus", ",", "P14", ",", "P18", ",", "and", "P23", ".", "We", "analyzed", "their", "ability", "to", "block", "endothelial", "cell", "chemotaxis", "and", "induce", "apoptosis", "in", "vitro", "and", "their", "antiangiogenic", "activity", "in", "vivo", ".", "The", "selected", "peptide", "was", "tested", "for", "the", "antitumor", "activity", "against", "mildly", "aggressive", "xenografted", "prostate", "carcinoma", "and", "highly", "aggressive", "renal", "cell", "carcinoma", ".", "To", "verify", "that", "P18", "acts", "in", "the", "same", "manner", "as", "PEDF", ",", "we", "used", "immunohistochemistry", "to", "measure", "PEDF", "targets", ",", "vascular", "endothelial", "growth", "factor", "receptor", "2", ",", "and", "CD95", "ligand", "expression", "in", "P18", "-", "treated", "vasculature", ".", "RESULTS", ":", "P14", "and", "P18", "blocked", "endothelial", "cell", "chemotaxis", ";", "P18", "and", "P23", "induced", "apoptosis", ".", "P18", "showed", "the", "highest", "IC50", "and", "blocked", "angiogenesis", "in", "vivo", ":", "P23", "was", "inactive", "and", "P14", "was", "proangiogenic", ".", "P18", "increased", "the", "production", "of", "CD95", "ligand", "and", "reduced", "the", "expression", "of", "vascular", "endothelial", "growth", "factor", "receptor", "2", "by", "the", "endothelial", "cells", "in", "vivo", ".", "In", "tumor", "studies", ",", "P18", "was", "more", "effective", "in", "blocking", "the", "angiogenesis", "and", "growth", "of", "the", "prostate", "cancer", "than", "parental", "34", "-", "mer", ";", "in", "the", "renal", "cell", "carcinoma", ",", "P18", "strongly", "decreased", "angiogenesis", "and", "halted", "the", "progression", "of", "established", "tumors", ".", "CONCLUSIONS", ":", "P18", "is", "a", "novel", "and", "potent", "antiangiogenic", "biotherapeutic", "agent", "that", "has", "potential", "to", "be", "developed", "for", "the", "treatment", "of", "prostate", "and", "renal", "cancer", "."], "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 9, "end": 10}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "Short pigment epithelial-derived factor-derived peptide", "start": 0, "end": 9}]}, {"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 9, "end": 10}, "arguments": [{"entity_id": "T1", "role": "Cause", "text": "Short pigment epithelial-derived factor-derived peptide", "start": 0, "end": 9}]}, {"id": "E27", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 10, "end": 11}, "arguments": []}, {"id": "E4", "event_type": "Growth", "trigger": {"text": "growth", "start": 13, "end": 14}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "tumor", "start": 12, "end": 13}]}, {"id": "E28", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 28, "end": 29}, "arguments": []}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "enhance", "start": 38, "end": 39}, "arguments": []}, {"id": "E10", "event_type": "Growth", "trigger": {"text": "growth", "start": 40, "end": 41}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "tumor", "start": 39, "end": 40}]}, {"id": "E44", "event_type": "Negative_regulation", "trigger": {"text": "activities", "start": 50, "end": 51}, "arguments": [{"entity_id": "T12", "role": "Cause", "text": "PEDF", "start": 46, "end": 47}]}, {"id": "E45", "event_type": "Negative_regulation", "trigger": {"text": "efficacy", "start": 72, "end": 73}, "arguments": [{"entity_id": "T15", "role": "Cause", "text": "PEDF", "start": 65, "end": 66}]}, {"id": "E49", "event_type": "Negative_regulation", "trigger": {"text": "efficacy", "start": 72, "end": 73}, "arguments": [{"entity_id": "T15", "role": "Cause", "text": "PEDF", "start": 65, "end": 66}]}, {"id": "E31", "event_type": "Blood_vessel_development", "trigger": {"text": "angioinhibitory", "start": 88, "end": 89}, "arguments": []}, {"id": "E22", "event_type": "Negative_regulation", "trigger": {"text": "block", "start": 117, "end": 118}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "P14", "start": 105, "end": 106}]}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "block", "start": 117, "end": 118}, "arguments": [{"entity_id": "T20", "role": "Cause", "text": "P18", "start": 107, "end": 108}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "block", "start": 117, "end": 118}, "arguments": [{"entity_id": "T21", "role": "Cause", "text": "P23", "start": 110, "end": 111}]}, {"id": "E5", "event_type": "Localization", "trigger": {"text": "chemotaxis", "start": 120, "end": 121}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "endothelial cell", "start": 118, "end": 120}]}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "induce", "start": 122, "end": 123}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "P14", "start": 105, "end": 106}]}, {"id": "E11", "event_type": "Positive_regulation", "trigger": {"text": "induce", "start": 122, "end": 123}, "arguments": [{"entity_id": "T20", "role": "Cause", "text": "P18", "start": 107, "end": 108}]}, {"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "induce", "start": 122, "end": 123}, "arguments": [{"entity_id": "T21", "role": "Cause", "text": "P23", "start": 110, "end": 111}]}, {"id": "E7", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 123, "end": 124}, "arguments": [{"entity_id": "T25", "role": "Theme", "text": "endothelial cell", "start": 118, "end": 120}]}, {"id": "E46", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 129, "end": 130}, "arguments": [{"entity_id": "T19", "role": "Cause", "text": "P14", "start": 105, "end": 106}]}, {"id": "E47", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 129, "end": 130}, "arguments": [{"entity_id": "T20", "role": "Cause", "text": "P18", "start": 107, "end": 108}]}, {"id": "E48", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 129, "end": 130}, "arguments": [{"entity_id": "T21", "role": "Cause", "text": "P23", "start": 110, "end": 111}]}, {"id": "E50", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 141, "end": 142}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "prostate carcinoma", "start": 146, "end": 148}]}, {"id": "E51", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 141, "end": 142}, "arguments": [{"entity_id": "T29", "role": "Theme", "text": "renal cell carcinoma", "start": 151, "end": 154}]}, {"id": "E13", "event_type": "Planned_process", "trigger": {"text": "xenografted", "start": 145, "end": 146}, "arguments": [{"entity_id": "T28", "role": "Instrument", "text": "prostate carcinoma", "start": 146, "end": 148}]}, {"id": "E34", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 185, "end": 186}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "CD95 ligand", "start": 183, "end": 185}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 185, "end": 186}, "arguments": [{"entity_id": "T33", "role": "Theme", "text": "vascular endothelial growth factor receptor 2", "start": 175, "end": 181}]}, {"id": "E16", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 185, "end": 186}, "arguments": [{"entity_id": "T32", "role": "Theme", "text": "PEDF targets", "start": 172, "end": 174}]}, {"id": "E14", "event_type": "Planned_process", "trigger": {"text": "treated", "start": 189, "end": 190}, "arguments": [{"entity_id": "T36", "role": "Instrument", "text": "P18", "start": 187, "end": 188}, {"entity_id": "T37", "role": "Theme", "text": "vasculature", "start": 190, "end": 191}]}, {"id": "E17", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 197, "end": 198}, "arguments": [{"entity_id": "T39", "role": "Cause", "text": "P18", "start": 196, "end": 197}]}, {"id": "E21", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 197, "end": 198}, "arguments": [{"entity_id": "T38", "role": "Cause", "text": "P14", "start": 194, "end": 195}]}, {"id": "E18", "event_type": "Localization", "trigger": {"text": "chemotaxis", "start": 200, "end": 201}, "arguments": [{"entity_id": "T42", "role": "Theme", "text": "endothelial cell", "start": 198, "end": 200}]}, {"id": "E41", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 205, "end": 206}, "arguments": [{"entity_id": "T44", "role": "Cause", "text": "P23", "start": 204, "end": 205}]}, {"id": "E52", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 205, "end": 206}, "arguments": [{"entity_id": "T43", "role": "Cause", "text": "P18", "start": 202, "end": 203}]}, {"id": "E24", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 206, "end": 207}, "arguments": [{"entity_id": "T42", "role": "Theme", "text": "endothelial cell", "start": 198, "end": 200}]}, {"id": "E20", "event_type": "Negative_regulation", "trigger": {"text": "blocked", "start": 214, "end": 215}, "arguments": [{"entity_id": "T45", "role": "Cause", "text": "P18", "start": 208, "end": 209}]}, {"id": "E33", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 215, "end": 216}, "arguments": []}, {"id": "E19", "event_type": "Negative_regulation", "trigger": {"text": "inactive", "start": 221, "end": 222}, "arguments": [{"entity_id": "T48", "role": "Theme", "text": "P23", "start": 219, "end": 220}]}, {"id": "E53", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 228, "end": 229}, "arguments": [{"entity_id": "T52", "role": "Cause", "text": "P18", "start": 227, "end": 228}]}, {"id": "E54", "event_type": "Gene_expression", "trigger": {"text": "production", "start": 230, "end": 231}, "arguments": [{"entity_id": "T55", "role": "Theme", "text": "CD95 ligand", "start": 232, "end": 234}]}, {"id": "E56", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 235, "end": 236}, "arguments": [{"entity_id": "T52", "role": "Cause", "text": "P18", "start": 227, "end": 228}]}, {"id": "E58", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 237, "end": 238}, "arguments": [{"entity_id": "T59", "role": "Theme", "text": "vascular endothelial growth factor receptor 2", "start": 239, "end": 245}]}, {"id": "E63", "event_type": "Negative_regulation", "trigger": {"text": "blocking", "start": 261, "end": 262}, "arguments": [{"entity_id": "T62", "role": "Cause", "text": "P18", "start": 256, "end": 257}]}, {"id": "E23", "event_type": "Negative_regulation", "trigger": {"text": "blocking", "start": 261, "end": 262}, "arguments": [{"entity_id": "T62", "role": "Cause", "text": "P18", "start": 256, "end": 257}]}, {"id": "E42", "event_type": "Negative_regulation", "trigger": {"text": "blocking", "start": 261, "end": 262}, "arguments": [{"entity_id": "T62", "role": "Cause", "text": "P18", "start": 256, "end": 257}]}, {"id": "E43", "event_type": "Negative_regulation", "trigger": {"text": "blocking", "start": 261, "end": 262}, "arguments": [{"entity_id": "T62", "role": "Cause", "text": "P18", "start": 256, "end": 257}]}, {"id": "E36", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 263, "end": 264}, "arguments": [{"entity_id": "T67", "role": "AtLoc", "text": "prostate cancer", "start": 268, "end": 270}]}, {"id": "E40", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 263, "end": 264}, "arguments": [{"entity_id": "T69", "role": "AtLoc", "text": "renal cell carcinoma", "start": 278, "end": 281}]}, {"id": "E66", "event_type": "Growth", "trigger": {"text": "growth", "start": 265, "end": 266}, "arguments": [{"entity_id": "T67", "role": "Theme", "text": "prostate cancer", "start": 268, "end": 270}]}, {"id": "E39", "event_type": "Growth", "trigger": {"text": "growth", "start": 265, "end": 266}, "arguments": [{"entity_id": "T69", "role": "Theme", "text": "renal cell carcinoma", "start": 278, "end": 281}]}, {"id": "E25", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 284, "end": 285}, "arguments": [{"entity_id": "T70", "role": "Cause", "text": "P18", "start": 282, "end": 283}]}, {"id": "E37", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 285, "end": 286}, "arguments": [{"entity_id": "T75", "role": "AtLoc", "text": "tumors", "start": 292, "end": 293}]}, {"id": "E73", "event_type": "Negative_regulation", "trigger": {"text": "halted", "start": 287, "end": 288}, "arguments": [{"entity_id": "T70", "role": "Cause", "text": "P18", "start": 282, "end": 283}]}, {"id": "E74", "event_type": "Positive_regulation", "trigger": {"text": "progression", "start": 289, "end": 290}, "arguments": [{"entity_id": "T75", "role": "Theme", "text": "tumors", "start": 292, "end": 293}]}, {"id": "E79", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 313, "end": 314}, "arguments": [{"entity_id": "T80", "role": "Theme", "text": "prostate", "start": 315, "end": 316}]}, {"id": "E26", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 313, "end": 314}, "arguments": [{"entity_id": "T81", "role": "Theme", "text": "renal cancer", "start": 317, "end": 319}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T80", "role": "Arg1", "text": "prostate", "start": 315, "end": 316}, {"entity_id": "T80", "role": "Arg1", "text": "prostate", "start": 315, "end": 316}]}], "entity_mentions": [{"id": "T1", "text": "Short pigment epithelial-derived factor-derived peptide", "entity_type": "Gene_or_gene_product", "start": 0, "end": 9}, {"id": "T2", "text": "inhibits", "entity_type": "Negative_regulation", "start": 9, "end": 10}, {"id": "T3", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 10, "end": 11}, {"id": "T5", "text": "tumor", "entity_type": "Pathological_formation", "start": 12, "end": 13}, {"id": "T4", "text": "growth", "entity_type": "Growth", "start": 13, "end": 14}, {"id": "T6", "text": "Pigment epithelial-derived factor", "entity_type": "Gene_or_gene_product", "start": 17, "end": 22}, {"id": "T7", "text": "PEDF", "entity_type": "Gene_or_gene_product", "start": 23, "end": 24}, {"id": "T8", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 28, "end": 29}, {"id": "T9", "text": "enhance", "entity_type": "Positive_regulation", "start": 38, "end": 39}, {"id": "T11", "text": "tumor", "entity_type": "Pathological_formation", "start": 39, "end": 40}, {"id": "T10", "text": "growth", "entity_type": "Growth", "start": 40, "end": 41}, {"id": "T12", "text": "PEDF", "entity_type": "Gene_or_gene_product", "start": 46, "end": 47}, {"id": "T77", "text": "activities", "entity_type": "Negative_regulation", "start": 50, "end": 51}, {"id": "T15", "text": "PEDF", "entity_type": "Gene_or_gene_product", "start": 65, "end": 66}, {"id": "T82", "text": "efficacy", "entity_type": "Negative_regulation", "start": 72, "end": 73}, {"id": "T18", "text": "angioinhibitory", "entity_type": "Blood_vessel_development", "start": 88, "end": 89}, {"id": "T19", "text": "P14", "entity_type": "Gene_or_gene_product", "start": 105, "end": 106}, {"id": "T20", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 107, "end": 108}, {"id": "T21", "text": "P23", "entity_type": "Gene_or_gene_product", "start": 110, "end": 111}, {"id": "T22", "text": "block", "entity_type": "Negative_regulation", "start": 117, "end": 118}, {"id": "T25", "text": "endothelial cell", "entity_type": "Cell", "start": 118, "end": 120}, {"id": "T14", "text": "chemotaxis", "entity_type": "Localization", "start": 120, "end": 121}, {"id": "T17", "text": "induce", "entity_type": "Positive_regulation", "start": 122, "end": 123}, {"id": "T23", "text": "apoptosis", "entity_type": "Death", "start": 123, "end": 124}, {"id": "T83", "text": "activity", "entity_type": "Negative_regulation", "start": 129, "end": 130}, {"id": "T86", "text": "activity", "entity_type": "Negative_regulation", "start": 141, "end": 142}, {"id": "T27", "text": "xenografted", "entity_type": "Planned_process", "start": 145, "end": 146}, {"id": "T28", "text": "prostate carcinoma", "entity_type": "Pathological_formation", "start": 146, "end": 148}, {"id": "T29", "text": "renal cell carcinoma", "entity_type": "Pathological_formation", "start": 151, "end": 154}, {"id": "T30", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 158, "end": 159}, {"id": "T31", "text": "PEDF", "entity_type": "Gene_or_gene_product", "start": 165, "end": 166}, {"id": "T32", "text": "PEDF targets", "entity_type": "Gene_or_gene_product", "start": 172, "end": 174}, {"id": "T33", "text": "vascular endothelial growth factor receptor 2", "entity_type": "Gene_or_gene_product", "start": 175, "end": 181}, {"id": "T35", "text": "CD95 ligand", "entity_type": "Gene_or_gene_product", "start": 183, "end": 185}, {"id": "T34", "text": "expression", "entity_type": "Gene_expression", "start": 185, "end": 186}, {"id": "T36", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 187, "end": 188}, {"id": "T40", "text": "treated", "entity_type": "Planned_process", "start": 189, "end": 190}, {"id": "T37", "text": "vasculature", "entity_type": "Multi-tissue_structure", "start": 190, "end": 191}, {"id": "T38", "text": "P14", "entity_type": "Gene_or_gene_product", "start": 194, "end": 195}, {"id": "T39", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 196, "end": 197}, {"id": "T46", "text": "blocked", "entity_type": "Negative_regulation", "start": 197, "end": 198}, {"id": "T42", "text": "endothelial cell", "entity_type": "Cell", "start": 198, "end": 200}, {"id": "T50", "text": "chemotaxis", "entity_type": "Localization", "start": 200, "end": 201}, {"id": "T43", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 202, "end": 203}, {"id": "T44", "text": "P23", "entity_type": "Gene_or_gene_product", "start": 204, "end": 205}, {"id": "T41", "text": "induced", "entity_type": "Positive_regulation", "start": 205, "end": 206}, {"id": "T24", "text": "apoptosis", "entity_type": "Death", "start": 206, "end": 207}, {"id": "T45", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 208, "end": 209}, {"id": "T64", "text": "blocked", "entity_type": "Negative_regulation", "start": 214, "end": 215}, {"id": "T47", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 215, "end": 216}, {"id": "T48", "text": "P23", "entity_type": "Gene_or_gene_product", "start": 219, "end": 220}, {"id": "T57", "text": "inactive", "entity_type": "Negative_regulation", "start": 221, "end": 222}, {"id": "T49", "text": "P14", "entity_type": "Gene_or_gene_product", "start": 223, "end": 224}, {"id": "T52", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 227, "end": 228}, {"id": "T53", "text": "increased", "entity_type": "Positive_regulation", "start": 228, "end": 229}, {"id": "T54", "text": "production", "entity_type": "Gene_expression", "start": 230, "end": 231}, {"id": "T55", "text": "CD95 ligand", "entity_type": "Gene_or_gene_product", "start": 232, "end": 234}, {"id": "T56", "text": "reduced", "entity_type": "Negative_regulation", "start": 235, "end": 236}, {"id": "T58", "text": "expression", "entity_type": "Gene_expression", "start": 237, "end": 238}, {"id": "T59", "text": "vascular endothelial growth factor receptor 2", "entity_type": "Gene_or_gene_product", "start": 239, "end": 245}, {"id": "T60", "text": "endothelial cells", "entity_type": "Cell", "start": 247, "end": 249}, {"id": "T61", "text": "tumor", "entity_type": "Pathological_formation", "start": 253, "end": 254}, {"id": "T62", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 256, "end": 257}, {"id": "T63", "text": "blocking", "entity_type": "Negative_regulation", "start": 261, "end": 262}, {"id": "T65", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 263, "end": 264}, {"id": "T66", "text": "growth", "entity_type": "Growth", "start": 265, "end": 266}, {"id": "T67", "text": "prostate cancer", "entity_type": "Pathological_formation", "start": 268, "end": 270}, {"id": "T68", "text": "parental 34-mer", "entity_type": "Gene_or_gene_product", "start": 271, "end": 275}, {"id": "T69", "text": "renal cell carcinoma", "entity_type": "Pathological_formation", "start": 278, "end": 281}, {"id": "T70", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 282, "end": 283}, {"id": "T71", "text": "decreased", "entity_type": "Negative_regulation", "start": 284, "end": 285}, {"id": "T72", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 285, "end": 286}, {"id": "T73", "text": "halted", "entity_type": "Negative_regulation", "start": 287, "end": 288}, {"id": "T74", "text": "progression", "entity_type": "Positive_regulation", "start": 289, "end": 290}, {"id": "T75", "text": "tumors", "entity_type": "Pathological_formation", "start": 292, "end": 293}, {"id": "T76", "text": "P18", "entity_type": "Gene_or_gene_product", "start": 296, "end": 297}, {"id": "T79", "text": "treatment", "entity_type": "Planned_process", "start": 313, "end": 314}, {"id": "T80", "text": "prostate", "entity_type": "Pathological_formation", "start": 315, "end": 316}, {"id": "T81", "text": "renal cancer", "entity_type": "Pathological_formation", "start": 317, "end": 319}], "lang": "en"}
{"doc_id": "PMID-19295129", "wnd_id": "PMID-19295129_0", "text": "Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting.\n\nEndothelial cell proliferation and migration is essential to angiogenesis. Typically, proliferation and chemotaxis of endothelial cells is driven by growth factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). VEGF activates phospholipases (PLCs) - specifically PLCgamma1 - that are important for tubulogenesis, differentiation and DNA synthesis. However, we show here that VEGF, specifically through VEGFR2, induces phosphorylation of two serine residues on PLCbeta3, and this was confirmed in an ex vivo embryoid body model. Knockdown of PLCbeta3 in HUVEC cells affects IP3 production, actin reorganization, migration and proliferation; whereas migration is inhibited, proliferation is enhanced. Our data suggest that enhanced proliferation is precipitated by an accelerated cell cycle, and decreased migration by an inability to activate CDC42. Given that PLCbeta3 is typically known as an effector of heterotrimeric G-proteins, our data demonstrate a unique crosstalk between the G-protein and receptor tyrosine kinase (RTK) axes and reveal a novel molecular mechanism of VEGF signaling and, thus, angiogenesis.", "tokens": ["Distinct", "role", "of", "PLCbeta3", "in", "VEGF", "-", "mediated", "directional", "migration", "and", "vascular", "sprouting", ".", "Endothelial", "cell", "proliferation", "and", "migration", "is", "essential", "to", "angiogenesis", ".", "Typically", ",", "proliferation", "and", "chemotaxis", "of", "endothelial", "cells", "is", "driven", "by", "growth", "factors", "such", "as", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", "and", "basic", "fibroblast", "growth", "factor", "(", "bFGF", ")", ".", "VEGF", "activates", "phospholipases", "(", "PLCs", ")", "-", "specifically", "PLCgamma1", "-", "that", "are", "important", "for", "tubulogenesis", ",", "differentiation", "and", "DNA", "synthesis", ".", "However", ",", "we", "show", "here", "that", "VEGF", ",", "specifically", "through", "VEGFR2", ",", "induces", "phosphorylation", "of", "two", "serine", "residues", "on", "PLCbeta3", ",", "and", "this", "was", "confirmed", "in", "an", "ex", "vivo", "embryoid", "body", "model", ".", "Knockdown", "of", "PLCbeta3", "in", "HUVEC", "cells", "affects", "IP3", "production", ",", "actin", "reorganization", ",", "migration", "and", "proliferation", ";", "whereas", "migration", "is", "inhibited", ",", "proliferation", "is", "enhanced", ".", "Our", "data", "suggest", "that", "enhanced", "proliferation", "is", "precipitated", "by", "an", "accelerated", "cell", "cycle", ",", "and", "decreased", "migration", "by", "an", "inability", "to", "activate", "CDC42", ".", "Given", "that", "PLCbeta3", "is", "typically", "known", "as", "an", "effector", "of", "heterotrimeric", "G", "-", "proteins", ",", "our", "data", "demonstrate", "a", "unique", "crosstalk", "between", "the", "G", "-", "protein", "and", "receptor", "tyrosine", "kinase", "(", "RTK", ")", "axes", "and", "reveal", "a", "novel", "molecular", "mechanism", "of", "VEGF", "signaling", "and", ",", "thus", ",", "angiogenesis", "."], "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "mediated", "start": 7, "end": 8}, "arguments": [{"entity_id": "T3", "role": "Cause", "text": "VEGF", "start": 5, "end": 6}]}, {"id": "E4", "event_type": "Development", "trigger": {"text": "sprouting", "start": 12, "end": 13}, "arguments": [{"entity_id": "T6", "role": "Theme", "text": "vascular", "start": 11, "end": 12}]}, {"id": "E9", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 16, "end": 17}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "Endothelial cell", "start": 14, "end": 16}]}, {"id": "E7", "event_type": "Localization", "trigger": {"text": "migration", "start": 18, "end": 19}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "Endothelial cell", "start": 14, "end": 16}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "essential", "start": 20, "end": 21}, "arguments": []}, {"id": "E3", "event_type": "Positive_regulation", "trigger": {"text": "essential", "start": 20, "end": 21}, "arguments": []}, {"id": "E35", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 22, "end": 23}, "arguments": []}, {"id": "E14", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 26, "end": 27}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "endothelial cells", "start": 30, "end": 32}]}, {"id": "E17", "event_type": "Localization", "trigger": {"text": "chemotaxis", "start": 28, "end": 29}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "endothelial cells", "start": 30, "end": 32}]}, {"id": "E6", "event_type": "Regulation", "trigger": {"text": "driven", "start": 33, "end": 34}, "arguments": [{"entity_id": "T20", "role": "Cause", "text": "vascular endothelial growth factor", "start": 39, "end": 43}, {"entity_id": "T21", "role": "Cause", "text": "VEGF", "start": 44, "end": 45}]}, {"id": "E11", "event_type": "Regulation", "trigger": {"text": "driven", "start": 33, "end": 34}, "arguments": [{"entity_id": "T20", "role": "Cause", "text": "vascular endothelial growth factor", "start": 39, "end": 43}, {"entity_id": "T21", "role": "Cause", "text": "VEGF", "start": 44, "end": 45}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "driven", "start": 33, "end": 34}, "arguments": [{"entity_id": "T22", "role": "Cause", "text": "basic fibroblast growth factor", "start": 47, "end": 51}, {"entity_id": "T23", "role": "Cause", "text": "bFGF", "start": 52, "end": 53}]}, {"id": "E13", "event_type": "Regulation", "trigger": {"text": "driven", "start": 33, "end": 34}, "arguments": [{"entity_id": "T22", "role": "Cause", "text": "basic fibroblast growth factor", "start": 47, "end": 51}, {"entity_id": "T23", "role": "Cause", "text": "bFGF", "start": 52, "end": 53}]}, {"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "activates", "start": 56, "end": 57}, "arguments": [{"entity_id": "T24", "role": "Cause", "text": "VEGF", "start": 55, "end": 56}, {"entity_id": "T27", "role": "Theme", "text": "PLCgamma1", "start": 63, "end": 64}]}, {"id": "E18", "event_type": "Positive_regulation", "trigger": {"text": "important", "start": 67, "end": 68}, "arguments": []}, {"id": "E36", "event_type": "Blood_vessel_development", "trigger": {"text": "tubulogenesis", "start": 69, "end": 70}, "arguments": []}, {"id": "E20", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 88, "end": 89}, "arguments": []}, {"id": "E21", "event_type": "Regulation", "trigger": {"text": "induces", "start": 88, "end": 89}, "arguments": [{"entity_id": "T30", "role": "Cause", "text": "VEGF", "start": 82, "end": 83}, {"entity_id": "T31", "role": "Theme", "text": "VEGFR2", "start": 86, "end": 87}]}, {"id": "E32", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 89, "end": 90}, "arguments": [{"entity_id": "T51", "role": "Site", "text": "two serine residues", "start": 91, "end": 94}, {"entity_id": "T33", "role": "Theme", "text": "PLCbeta3", "start": 95, "end": 96}]}, {"id": "E34", "event_type": "Planned_process", "trigger": {"text": "Knockdown", "start": 109, "end": 110}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "PLCbeta3", "start": 111, "end": 112}]}, {"id": "E22", "event_type": "Regulation", "trigger": {"text": "affects", "start": 115, "end": 116}, "arguments": []}, {"id": "E25", "event_type": "Regulation", "trigger": {"text": "affects", "start": 115, "end": 116}, "arguments": []}, {"id": "E26", "event_type": "Regulation", "trigger": {"text": "affects", "start": 115, "end": 116}, "arguments": []}, {"id": "E27", "event_type": "Regulation", "trigger": {"text": "affects", "start": 115, "end": 116}, "arguments": []}, {"id": "E37", "event_type": "Gene_expression", "trigger": {"text": "production", "start": 117, "end": 118}, "arguments": [{"entity_id": "T38", "role": "Theme", "text": "IP3", "start": 116, "end": 117}]}, {"id": "E39", "event_type": "Regulation", "trigger": {"text": "reorganization", "start": 120, "end": 121}, "arguments": [{"entity_id": "T40", "role": "Theme", "text": "actin", "start": 119, "end": 120}]}, {"id": "E23", "event_type": "Localization", "trigger": {"text": "migration", "start": 122, "end": 123}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "HUVEC cells", "start": 113, "end": 115}]}, {"id": "E24", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 124, "end": 125}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "HUVEC cells", "start": 113, "end": 115}]}, {"id": "E28", "event_type": "Localization", "trigger": {"text": "migration", "start": 127, "end": 128}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "HUVEC cells", "start": 113, "end": 115}]}, {"id": "E30", "event_type": "Negative_regulation", "trigger": {"text": "inhibited", "start": 129, "end": 130}, "arguments": []}, {"id": "E29", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 131, "end": 132}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "HUVEC cells", "start": 113, "end": 115}]}, {"id": "E31", "event_type": "Positive_regulation", "trigger": {"text": "enhanced", "start": 133, "end": 134}, "arguments": []}, {"id": "E33", "event_type": "Positive_regulation", "trigger": {"text": "activate", "start": 156, "end": 157}, "arguments": [{"entity_id": "T41", "role": "Theme", "text": "CDC42", "start": 157, "end": 158}]}, {"id": "E40", "event_type": "Pathway", "trigger": {"text": "signaling", "start": 201, "end": 202}, "arguments": [{"entity_id": "T48", "role": "Participant", "text": "VEGF", "start": 200, "end": 201}]}, {"id": "E38", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 206, "end": 207}, "arguments": []}], "relation_mentions": [], "entity_mentions": [{"id": "T2", "text": "PLCbeta3", "entity_type": "Gene_or_gene_product", "start": 3, "end": 4}, {"id": "T3", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 5, "end": 6}, {"id": "T1", "text": "mediated", "entity_type": "Regulation", "start": 7, "end": 8}, {"id": "T6", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 11, "end": 12}, {"id": "T4", "text": "sprouting", "entity_type": "Development", "start": 12, "end": 13}, {"id": "T11", "text": "Endothelial cell", "entity_type": "Cell", "start": 14, "end": 16}, {"id": "T9", "text": "proliferation", "entity_type": "Cell_proliferation", "start": 16, "end": 17}, {"id": "T7", "text": "migration", "entity_type": "Localization", "start": 18, "end": 19}, {"id": "T12", "text": "essential", "entity_type": "Positive_regulation", "start": 20, "end": 21}, {"id": "T13", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 22, "end": 23}, {"id": "T14", "text": "proliferation", "entity_type": "Cell_proliferation", "start": 26, "end": 27}, {"id": "T17", "text": "chemotaxis", "entity_type": "Localization", "start": 28, "end": 29}, {"id": "T18", "text": "endothelial cells", "entity_type": "Cell", "start": 30, "end": 32}, {"id": "T19", "text": "driven", "entity_type": "Regulation", "start": 33, "end": 34}, {"id": "T20", "text": "vascular endothelial growth factor", "entity_type": "Gene_or_gene_product", "start": 39, "end": 43}, {"id": "T21", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 44, "end": 45}, {"id": "T22", "text": "basic fibroblast growth factor", "entity_type": "Gene_or_gene_product", "start": 47, "end": 51}, {"id": "T23", "text": "bFGF", "entity_type": "Gene_or_gene_product", "start": 52, "end": 53}, {"id": "T24", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 55, "end": 56}, {"id": "T28", "text": "activates", "entity_type": "Positive_regulation", "start": 56, "end": 57}, {"id": "T25", "text": "phospholipases", "entity_type": "Gene_or_gene_product", "start": 57, "end": 58}, {"id": "T26", "text": "PLCs", "entity_type": "Gene_or_gene_product", "start": 59, "end": 60}, {"id": "T27", "text": "PLCgamma1", "entity_type": "Gene_or_gene_product", "start": 63, "end": 64}, {"id": "T45", "text": "important", "entity_type": "Positive_regulation", "start": 67, "end": 68}, {"id": "T29", "text": "tubulogenesis", "entity_type": "Blood_vessel_development", "start": 69, "end": 70}, {"id": "T30", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 82, "end": 83}, {"id": "T31", "text": "VEGFR2", "entity_type": "Gene_or_gene_product", "start": 86, "end": 87}, {"id": "T46", "text": "induces", "entity_type": "Positive_regulation", "start": 88, "end": 89}, {"id": "T50", "text": "induces", "entity_type": "Regulation", "start": 88, "end": 89}, {"id": "T32", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 89, "end": 90}, {"id": "T51", "text": "two serine residues", "entity_type": "Protein_domain_or_region", "start": 91, "end": 94}, {"id": "T33", "text": "PLCbeta3", "entity_type": "Gene_or_gene_product", "start": 95, "end": 96}, {"id": "T34", "text": "Knockdown", "entity_type": "Planned_process", "start": 109, "end": 110}, {"id": "T35", "text": "PLCbeta3", "entity_type": "Gene_or_gene_product", "start": 111, "end": 112}, {"id": "T36", "text": "HUVEC cells", "entity_type": "Cell", "start": 113, "end": 115}, {"id": "T52", "text": "affects", "entity_type": "Regulation", "start": 115, "end": 116}, {"id": "T38", "text": "IP3", "entity_type": "Gene_or_gene_product", "start": 116, "end": 117}, {"id": "T37", "text": "production", "entity_type": "Gene_expression", "start": 117, "end": 118}, {"id": "T40", "text": "actin", "entity_type": "Gene_or_gene_product", "start": 119, "end": 120}, {"id": "T39", "text": "reorganization", "entity_type": "Regulation", "start": 120, "end": 121}, {"id": "T53", "text": "migration", "entity_type": "Localization", "start": 122, "end": 123}, {"id": "T54", "text": "proliferation", "entity_type": "Cell_proliferation", "start": 124, "end": 125}, {"id": "T55", "text": "migration", "entity_type": "Localization", "start": 127, "end": 128}, {"id": "T57", "text": "inhibited", "entity_type": "Negative_regulation", "start": 129, "end": 130}, {"id": "T56", "text": "proliferation", "entity_type": "Cell_proliferation", "start": 131, "end": 132}, {"id": "T58", "text": "enhanced", "entity_type": "Positive_regulation", "start": 133, "end": 134}, {"id": "T60", "text": "cell", "entity_type": "Cell", "start": 146, "end": 147}, {"id": "T59", "text": "activate", "entity_type": "Positive_regulation", "start": 156, "end": 157}, {"id": "T41", "text": "CDC42", "entity_type": "Gene_or_gene_product", "start": 157, "end": 158}, {"id": "T42", "text": "PLCbeta3", "entity_type": "Gene_or_gene_product", "start": 161, "end": 162}, {"id": "T43", "text": "heterotrimeric G-proteins", "entity_type": "Gene_or_gene_product", "start": 169, "end": 173}, {"id": "T44", "text": "G-protein", "entity_type": "Gene_or_gene_product", "start": 182, "end": 185}, {"id": "T48", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 200, "end": 201}, {"id": "T47", "text": "signaling", "entity_type": "Pathway", "start": 201, "end": 202}, {"id": "T49", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 206, "end": 207}], "lang": "en"}
{"doc_id": "PMID-19446450", "wnd_id": "PMID-19446450_0", "text": "AngiomiRs--key regulators of angiogenesis.\n\nThe formation of new blood vessels through the process of angiogenesis is critical in vascular development and homeostasis. Aberrant angiogenesis leads to a variety of diseases, such as ischemia and cancer. Recent studies have revealed important roles for miRNAs in regulating endothelial cell (EC) function, especially angiogenesis. Mice with EC-specific deletion of Dicer, a key enzyme for generating miRNAs, display defective postnatal angiogenesis. Specific miRNAs (angiomiRs) have recently been shown to regulate angiogenesis in vivo. miRNA-126, an EC-restricted miRNA, regulates vascular integrity and developmental angiogenesis. miR-378, miR-296, and the miR-17-92 cluster contribute to tumor angiogenesis. Manipulating angiomiRs in the settings of pathological vascularization represents a new therapeutic approach.", "tokens": ["AngiomiRs", "--", "key", "regulators", "of", "angiogenesis", ".", "The", "formation", "of", "new", "blood", "vessels", "through", "the", "process", "of", "angiogenesis", "is", "critical", "in", "vascular", "development", "and", "homeostasis", ".", "Aberrant", "angiogenesis", "leads", "to", "a", "variety", "of", "diseases", ",", "such", "as", "ischemia", "and", "cancer", ".", "Recent", "studies", "have", "revealed", "important", "roles", "for", "miRNAs", "in", "regulating", "endothelial", "cell", "(", "EC", ")", "function", ",", "especially", "angiogenesis", ".", "Mice", "with", "EC", "-", "specific", "deletion", "of", "Dicer", ",", "a", "key", "enzyme", "for", "generating", "miRNAs", ",", "display", "defective", "postnatal", "angiogenesis", ".", "Specific", "miRNAs", "(", "angiomiRs", ")", "have", "recently", "been", "shown", "to", "regulate", "angiogenesis", "in", "vivo", ".", "miRNA", "-126", ",", "an", "EC", "-", "restricted", "miRNA", ",", "regulates", "vascular", "integrity", "and", "developmental", "angiogenesis", ".", "miR-378", ",", "miR-296", ",", "and", "the", "miR", "-17", "-", "92", "cluster", "contribute", "to", "tumor", "angiogenesis", ".", "Manipulating", "angiomiRs", "in", "the", "settings", "of", "pathological", "vascularization", "represents", "a", "new", "therapeutic", "approach", "."], "event_mentions": [{"id": "E17", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 5, "end": 6}, "arguments": []}, {"id": "E1", "event_type": "Development", "trigger": {"text": "formation", "start": 8, "end": 9}, "arguments": [{"entity_id": "T4", "role": "Theme", "text": "blood vessels", "start": 11, "end": 13}]}, {"id": "E18", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 17, "end": 18}, "arguments": []}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "critical", "start": 19, "end": 20}, "arguments": []}, {"id": "E8", "event_type": "Development", "trigger": {"text": "development", "start": 22, "end": 23}, "arguments": [{"entity_id": "T10", "role": "Theme", "text": "vascular", "start": 21, "end": 22}]}, {"id": "E4", "event_type": "Regulation", "trigger": {"text": "Aberrant", "start": 26, "end": 27}, "arguments": []}, {"id": "E19", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 27, "end": 28}, "arguments": []}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "leads", "start": 28, "end": 29}, "arguments": [{"entity_id": "T31", "role": "Theme", "text": "cancer", "start": 39, "end": 40}]}, {"id": "E7", "event_type": "Regulation", "trigger": {"text": "regulating", "start": 50, "end": 51}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "endothelial cell", "start": 51, "end": 53}, {"entity_id": "T15", "role": "Theme", "text": "EC", "start": 54, "end": 55}]}, {"id": "E10", "event_type": "Regulation", "trigger": {"text": "regulating", "start": 50, "end": 51}, "arguments": []}, {"id": "E20", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 59, "end": 60}, "arguments": []}, {"id": "E11", "event_type": "Negative_regulation", "trigger": {"text": "deletion", "start": 66, "end": 67}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "Dicer", "start": 68, "end": 69}]}, {"id": "E21", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 80, "end": 81}, "arguments": []}, {"id": "E13", "event_type": "Regulation", "trigger": {"text": "regulate", "start": 92, "end": 93}, "arguments": [{"entity_id": "T22", "role": "Cause", "text": "angiomiRs", "start": 85, "end": 86}]}, {"id": "E22", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 93, "end": 94}, "arguments": []}, {"id": "E29", "event_type": "Regulation", "trigger": {"text": "regulates", "start": 106, "end": 107}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "miRNA-126", "start": 97, "end": 99}]}, {"id": "E3", "event_type": "Regulation", "trigger": {"text": "regulates", "start": 106, "end": 107}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "miRNA-126", "start": 97, "end": 99}, {"entity_id": "T3", "role": "Theme", "text": "vascular", "start": 107, "end": 108}]}, {"id": "E23", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 111, "end": 112}, "arguments": []}, {"id": "E14", "event_type": "Regulation", "trigger": {"text": "contribute", "start": 124, "end": 125}, "arguments": [{"entity_id": "T35", "role": "Cause", "text": "miR-17-", "start": 119, "end": 122}]}, {"id": "E15", "event_type": "Regulation", "trigger": {"text": "contribute", "start": 124, "end": 125}, "arguments": [{"entity_id": "T34", "role": "Cause", "text": "miR-296", "start": 115, "end": 116}]}, {"id": "E16", "event_type": "Regulation", "trigger": {"text": "contribute", "start": 124, "end": 125}, "arguments": [{"entity_id": "T33", "role": "Cause", "text": "miR-378", "start": 113, "end": 114}]}, {"id": "E6", "event_type": "Regulation", "trigger": {"text": "contribute", "start": 124, "end": 125}, "arguments": [{"entity_id": "T6", "role": "Cause", "text": "92", "start": 122, "end": 123}]}, {"id": "E24", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 127, "end": 128}, "arguments": [{"entity_id": "T13", "role": "AtLoc", "text": "tumor", "start": 126, "end": 127}]}, {"id": "E25", "event_type": "Blood_vessel_development", "trigger": {"text": "vascularization", "start": 136, "end": 137}, "arguments": []}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T6", "role": "Arg1", "text": "92", "start": 122, "end": 123}, {"entity_id": "T6", "role": "Arg1", "text": "92", "start": 122, "end": 123}]}], "entity_mentions": [{"id": "T1", "text": "AngiomiRs", "entity_type": "Gene_or_gene_product", "start": 0, "end": 1}, {"id": "T2", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 5, "end": 6}, {"id": "T23", "text": "formation", "entity_type": "Development", "start": 8, "end": 9}, {"id": "T4", "text": "blood vessels", "entity_type": "Multi-tissue_structure", "start": 11, "end": 13}, {"id": "T5", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 17, "end": 18}, {"id": "T30", "text": "critical", "entity_type": "Positive_regulation", "start": 19, "end": 20}, {"id": "T10", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 21, "end": 22}, {"id": "T8", "text": "development", "entity_type": "Development", "start": 22, "end": 23}, {"id": "T7", "text": "Aberrant", "entity_type": "Regulation", "start": 26, "end": 27}, {"id": "T11", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 27, "end": 28}, {"id": "T36", "text": "leads", "entity_type": "Positive_regulation", "start": 28, "end": 29}, {"id": "T31", "text": "cancer", "entity_type": "Pathological_formation", "start": 39, "end": 40}, {"id": "T38", "text": "regulating", "entity_type": "Regulation", "start": 50, "end": 51}, {"id": "T14", "text": "endothelial cell", "entity_type": "Cell", "start": 51, "end": 53}, {"id": "T15", "text": "EC", "entity_type": "Cell", "start": 54, "end": 55}, {"id": "T16", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 59, "end": 60}, {"id": "T1000", "text": "Mice", "entity_type": "Organism", "start": 61, "end": 62}, {"id": "T17", "text": "EC", "entity_type": "Cell", "start": 63, "end": 64}, {"id": "T41", "text": "deletion", "entity_type": "Negative_regulation", "start": 66, "end": 67}, {"id": "T18", "text": "Dicer", "entity_type": "Gene_or_gene_product", "start": 68, "end": 69}, {"id": "T20", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 80, "end": 81}, {"id": "T22", "text": "angiomiRs", "entity_type": "Gene_or_gene_product", "start": 85, "end": 86}, {"id": "T43", "text": "regulate", "entity_type": "Regulation", "start": 92, "end": 93}, {"id": "T24", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 93, "end": 94}, {"id": "T25", "text": "miRNA-126", "entity_type": "Gene_or_gene_product", "start": 97, "end": 99}, {"id": "T26", "text": "EC", "entity_type": "Cell", "start": 101, "end": 102}, {"id": "T29", "text": "regulates", "entity_type": "Regulation", "start": 106, "end": 107}, {"id": "T3", "text": "vascular", "entity_type": "Multi-tissue_structure", "start": 107, "end": 108}, {"id": "T32", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 111, "end": 112}, {"id": "T33", "text": "miR-378", "entity_type": "Gene_or_gene_product", "start": 113, "end": 114}, {"id": "T34", "text": "miR-296", "entity_type": "Gene_or_gene_product", "start": 115, "end": 116}, {"id": "T35", "text": "miR-17-", "entity_type": "Gene_or_gene_product", "start": 119, "end": 122}, {"id": "T6", "text": "92", "entity_type": "Gene_or_gene_product", "start": 122, "end": 123}, {"id": "T44", "text": "contribute", "entity_type": "Regulation", "start": 124, "end": 125}, {"id": "T13", "text": "tumor", "entity_type": "Pathological_formation", "start": 126, "end": 127}, {"id": "T37", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 127, "end": 128}, {"id": "T39", "text": "angiomiRs", "entity_type": "Gene_or_gene_product", "start": 130, "end": 131}, {"id": "T40", "text": "vascularization", "entity_type": "Blood_vessel_development", "start": 136, "end": 137}], "lang": "en"}
{"doc_id": "PMID-19514363", "wnd_id": "PMID-19514363_0", "text": "[Role of the tumor suppressor ARF in oncogenesis]\n\nThe paper reviews the data available in the literature on a role of the tumor suppressor ARF in oncogenesis and considers the structure of a gene encoding ARF protein. The p53-dependent and p-53-independent functions of this protein are under many studies. There is evidence for the implication of ARF in angiogenesis. There is more and more information on the role of ARF in the regulation of a cell cycle, apoptosis, and autophagy. The importance of this tumor suppressor in the mechanisms of carcinogenesis is beyond question as the inactivation of ARF suppressor activity leads to the rapid growth of neoplasia. However, the exact mechanisms of ARF action yet remain unclear and require further studies by different specialists at both the molecular genetic and other levels of investigation.", "tokens": ["[", "Role", "of", "the", "tumor", "suppressor", "ARF", "in", "oncogenesis", "]", "The", "paper", "reviews", "the", "data", "available", "in", "the", "literature", "on", "a", "role", "of", "the", "tumor", "suppressor", "ARF", "in", "oncogenesis", "and", "considers", "the", "structure", "of", "a", "gene", "encoding", "ARF", "protein", ".", "The", "p53", "-", "dependent", "and", "p-53", "-", "independent", "functions", "of", "this", "protein", "are", "under", "many", "studies", ".", "There", "is", "evidence", "for", "the", "implication", "of", "ARF", "in", "angiogenesis", ".", "There", "is", "more", "and", "more", "information", "on", "the", "role", "of", "ARF", "in", "the", "regulation", "of", "a", "cell", "cycle", ",", "apoptosis", ",", "and", "autophagy", ".", "The", "importance", "of", "this", "tumor", "suppressor", "in", "the", "mechanisms", "of", "carcinogenesis", "is", "beyond", "question", "as", "the", "inactivation", "of", "ARF", "suppressor", "activity", "leads", "to", "the", "rapid", "growth", "of", "neoplasia", ".", "However", ",", "the", "exact", "mechanisms", "of", "ARF", "action", "yet", "remain", "unclear", "and", "require", "further", "studies", "by", "different", "specialists", "at", "both", "the", "molecular", "genetic", "and", "other", "levels", "of", "investigation", "."], "event_mentions": [{"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "dependent", "start": 43, "end": 44}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "ARF", "start": 37, "end": 38}, {"entity_id": "T6", "role": "Cause", "text": "p53", "start": 41, "end": 42}]}, {"id": "E1", "event_type": "Regulation", "trigger": {"text": "independent", "start": 47, "end": 48}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "ARF", "start": 37, "end": 38}, {"entity_id": "T7", "role": "Cause", "text": "p-53", "start": 45, "end": 46}]}, {"id": "E3", "event_type": "Regulation", "trigger": {"text": "implication", "start": 62, "end": 63}, "arguments": [{"entity_id": "T9", "role": "Cause", "text": "ARF", "start": 64, "end": 65}]}, {"id": "E8", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 66, "end": 67}, "arguments": []}, {"id": "E6", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 81, "end": 82}, "arguments": []}, {"id": "E7", "event_type": "Death", "trigger": {"text": "apoptosis", "start": 87, "end": 88}, "arguments": [{"entity_id": "T21", "role": "Theme", "text": "cell", "start": 84, "end": 85}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "inactivation", "start": 108, "end": 109}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "ARF", "start": 110, "end": 111}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "leads", "start": 113, "end": 114}, "arguments": []}, {"id": "E4", "event_type": "Growth", "trigger": {"text": "growth", "start": 117, "end": 118}, "arguments": [{"entity_id": "T18", "role": "Theme", "text": "neoplasia", "start": 119, "end": 120}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "tumor", "entity_type": "Pathological_formation", "start": 4, "end": 5}, {"id": "T2", "text": "ARF", "entity_type": "Gene_or_gene_product", "start": 6, "end": 7}, {"id": "T3", "text": "tumor", "entity_type": "Pathological_formation", "start": 24, "end": 25}, {"id": "T4", "text": "ARF", "entity_type": "Gene_or_gene_product", "start": 26, "end": 27}, {"id": "T5", "text": "ARF", "entity_type": "Gene_or_gene_product", "start": 37, "end": 38}, {"id": "T6", "text": "p53", "entity_type": "Gene_or_gene_product", "start": 41, "end": 42}, {"id": "T16", "text": "dependent", "entity_type": "Positive_regulation", "start": 43, "end": 44}, {"id": "T7", "text": "p-53", "entity_type": "Gene_or_gene_product", "start": 45, "end": 46}, {"id": "T8", "text": "independent", "entity_type": "Regulation", "start": 47, "end": 48}, {"id": "T17", "text": "implication", "entity_type": "Regulation", "start": 62, "end": 63}, {"id": "T9", "text": "ARF", "entity_type": "Gene_or_gene_product", "start": 64, "end": 65}, {"id": "T10", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 66, "end": 67}, {"id": "T11", "text": "ARF", "entity_type": "Gene_or_gene_product", "start": 78, "end": 79}, {"id": "T22", "text": "regulation", "entity_type": "Regulation", "start": 81, "end": 82}, {"id": "T21", "text": "cell", "entity_type": "Cell", "start": 84, "end": 85}, {"id": "T23", "text": "apoptosis", "entity_type": "Death", "start": 87, "end": 88}, {"id": "T12", "text": "tumor", "entity_type": "Pathological_formation", "start": 96, "end": 97}, {"id": "T13", "text": "inactivation", "entity_type": "Negative_regulation", "start": 108, "end": 109}, {"id": "T14", "text": "ARF", "entity_type": "Gene_or_gene_product", "start": 110, "end": 111}, {"id": "T20", "text": "leads", "entity_type": "Positive_regulation", "start": 113, "end": 114}, {"id": "T19", "text": "growth", "entity_type": "Growth", "start": 117, "end": 118}, {"id": "T18", "text": "neoplasia", "entity_type": "Pathological_formation", "start": 119, "end": 120}, {"id": "T15", "text": "ARF", "entity_type": "Gene_or_gene_product", "start": 127, "end": 128}], "lang": "en"}
{"doc_id": "PMID-19528456", "wnd_id": "PMID-19528456_0", "text": "Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).\n\nVEGF is the key player in tumor angiogenesis. In the current study, the impact of VEGF expression on the response of tumors to the VEGFR2 associated tyrosine kinase inhibitor vandetanib was evaluated. MATERIALS AND METHODS: Human colon carcinoma (HT29) and murine squamous carcinoma (SCCVII) clonal cell lines expressing varying levels of VEGF were established and their response to vandetanib was assessed in tissue culture and as solid tumors. RESULTS: Vandetanib treatment had no effect on tumor cell clonogenic cell survival in vitro but doses >or=10 nM significantly reduced endothelial cell migration. In vivo, tumors derived from cell clones expressing high levels of VEGF displayed significantly enhanced angiogenesis and more aggressive growth. An intradermal angiogenesis assay was used to demonstrate that a 4-day treatment with vandetanib (50 mg/kg/day) was able to significantly inhibit blood vessel growth induced by both parental and high VEGF-expressing tumor cell clones. In the HT29 tumor model, treatment response to vandetanib (50 mg/kg/day, Monday-Friday for 2 weeks) was greatest in xenografts derived from the highest VEGF-expressing cell clones. A similar trend was noted in the SCCVII tumor model. The present findings indicate that vandetanib therapy effectively counteracted the aggressive feature of tumor growth resulting from VEGF over-expressing tumor cells and suggest that such tumors may be particularly well suited for anti-VEGF interventions.", "tokens": ["Impact", "of", "tumor", "cell", "VEGF", "expression", "on", "the", "in", "vivo", "efficacy", "of", "vandetanib", "(", "ZACTIMA", ";", "ZD6474", ")", ".", "VEGF", "is", "the", "key", "player", "in", "tumor", "angiogenesis", ".", "In", "the", "current", "study", ",", "the", "impact", "of", "VEGF", "expression", "on", "the", "response", "of", "tumors", "to", "the", "VEGFR2", "associated", "tyrosine", "kinase", "inhibitor", "vandetanib", "was", "evaluated", ".", "MATERIALS", "AND", "METHODS", ":", "Human", "colon", "carcinoma", "(", "HT29", ")", "and", "murine", "squamous", "carcinoma", "(", "SCCVII", ")", "clonal", "cell", "lines", "expressing", "varying", "levels", "of", "VEGF", "were", "established", "and", "their", "response", "to", "vandetanib", "was", "assessed", "in", "tissue", "culture", "and", "as", "solid", "tumors", ".", "RESULTS", ":", "Vandetanib", "treatment", "had", "no", "effect", "on", "tumor", "cell", "clonogenic", "cell", "survival", "in", "vitro", "but", "doses", ">", "or=10", "nM", "significantly", "reduced", "endothelial", "cell", "migration", ".", "In", "vivo", ",", "tumors", "derived", "from", "cell", "clones", "expressing", "high", "levels", "of", "VEGF", "displayed", "significantly", "enhanced", "angiogenesis", "and", "more", "aggressive", "growth", ".", "An", "intradermal", "angiogenesis", "assay", "was", "used", "to", "demonstrate", "that", "a", "4", "-", "day", "treatment", "with", "vandetanib", "(", "50", "mg", "/", "kg/day", ")", "was", "able", "to", "significantly", "inhibit", "blood", "vessel", "growth", "induced", "by", "both", "parental", "and", "high", "VEGF", "-", "expressing", "tumor", "cell", "clones", ".", "In", "the", "HT29", "tumor", "model", ",", "treatment", "response", "to", "vandetanib", "(", "50", "mg", "/", "kg/day", ",", "Monday", "-", "Friday", "for", "2", "weeks", ")", "was", "greatest", "in", "xenografts", "derived", "from", "the", "highest", "VEGF", "-", "expressing", "cell", "clones", ".", "A", "similar", "trend", "was", "noted", "in", "the", "SCCVII", "tumor", "model", ".", "The", "present", "findings", "indicate", "that", "vandetanib", "therapy", "effectively", "counteracted", "the", "aggressive", "feature", "of", "tumor", "growth", "resulting", "from", "VEGF", "over", "-", "expressing", "tumor", "cells", "and", "suggest", "that", "such", "tumors", "may", "be", "particularly", "well", "suited", "for", "anti-VEGF", "interventions", "."], "event_mentions": [{"id": "E1", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 5, "end": 6}, "arguments": [{"entity_id": "T3", "role": "Theme", "text": "VEGF", "start": 4, "end": 5}]}, {"id": "E16", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 26, "end": 27}, "arguments": [{"entity_id": "T9", "role": "AtLoc", "text": "tumor", "start": 25, "end": 26}]}, {"id": "E11", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 37, "end": 38}, "arguments": [{"entity_id": "T12", "role": "Theme", "text": "VEGF", "start": 36, "end": 37}]}, {"id": "E13", "event_type": "Regulation", "trigger": {"text": "response", "start": 40, "end": 41}, "arguments": [{"entity_id": "T14", "role": "Theme", "text": "tumors", "start": 42, "end": 43}, {"entity_id": "T17", "role": "Cause", "text": "vandetanib", "start": 50, "end": 51}]}, {"id": "E2", "event_type": "Binding", "trigger": {"text": "associated", "start": 46, "end": 47}, "arguments": [{"entity_id": "T16", "role": "Theme", "text": "VEGFR2", "start": 45, "end": 46}, {"entity_id": "T17", "role": "Theme", "text": "vandetanib", "start": 50, "end": 51}]}, {"id": "E21", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 74, "end": 75}, "arguments": [{"entity_id": "T24", "role": "Theme", "text": "VEGF", "start": 78, "end": 79}]}, {"id": "E25", "event_type": "Regulation", "trigger": {"text": "response", "start": 83, "end": 84}, "arguments": [{"entity_id": "T26", "role": "Cause", "text": "vandetanib", "start": 85, "end": 86}]}, {"id": "E28", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 99, "end": 100}, "arguments": [{"entity_id": "T29", "role": "Instrument", "text": "Vandetanib", "start": 98, "end": 99}, {"entity_id": "T30", "role": "Theme", "text": "tumor cell", "start": 104, "end": 106}]}, {"id": "E3", "event_type": "Regulation", "trigger": {"text": "effect", "start": 102, "end": 103}, "arguments": []}, {"id": "E4", "event_type": "Death", "trigger": {"text": "survival", "start": 108, "end": 109}, "arguments": [{"entity_id": "T73", "role": "Theme", "text": "cell", "start": 107, "end": 108}]}, {"id": "E5", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 117, "end": 118}, "arguments": []}, {"id": "E33", "event_type": "Localization", "trigger": {"text": "migration", "start": 120, "end": 121}, "arguments": [{"entity_id": "T34", "role": "Theme", "text": "endothelial cell", "start": 118, "end": 120}]}, {"id": "E36", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 130, "end": 131}, "arguments": [{"entity_id": "T37", "role": "Theme", "text": "VEGF", "start": 134, "end": 135}]}, {"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "enhanced", "start": 137, "end": 138}, "arguments": [{"entity_id": "T35", "role": "Cause", "text": "tumors", "start": 125, "end": 126}]}, {"id": "E8", "event_type": "Positive_regulation", "trigger": {"text": "enhanced", "start": 137, "end": 138}, "arguments": [{"entity_id": "T35", "role": "Cause", "text": "tumors", "start": 125, "end": 126}]}, {"id": "E17", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 138, "end": 139}, "arguments": [{"entity_id": "T35", "role": "AtLoc", "text": "tumors", "start": 125, "end": 126}]}, {"id": "E7", "event_type": "Growth", "trigger": {"text": "growth", "start": 142, "end": 143}, "arguments": [{"entity_id": "T35", "role": "Theme", "text": "tumors", "start": 125, "end": 126}]}, {"id": "E18", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 146, "end": 147}, "arguments": [{"entity_id": "T40", "role": "AtLoc", "text": "intradermal", "start": 145, "end": 146}]}, {"id": "E42", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 157, "end": 158}, "arguments": [{"entity_id": "T43", "role": "Instrument", "text": "vandetanib", "start": 159, "end": 160}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 170, "end": 171}, "arguments": []}, {"id": "E46", "event_type": "Growth", "trigger": {"text": "growth", "start": 173, "end": 174}, "arguments": [{"entity_id": "T47", "role": "Theme", "text": "blood vessel", "start": 171, "end": 173}]}, {"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 174, "end": 175}, "arguments": [{"entity_id": "T50", "role": "Cause", "text": "tumor cell", "start": 183, "end": 185}]}, {"id": "E48", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 182, "end": 183}, "arguments": [{"entity_id": "T49", "role": "Theme", "text": "VEGF", "start": 180, "end": 181}]}, {"id": "E14", "event_type": "Planned_process", "trigger": {"text": "treatment", "start": 193, "end": 194}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "HT29 tumor", "start": 189, "end": 191}]}, {"id": "E12", "event_type": "Regulation", "trigger": {"text": "response", "start": 194, "end": 195}, "arguments": [{"entity_id": "T52", "role": "Theme", "text": "HT29 tumor", "start": 189, "end": 191}, {"entity_id": "T53", "role": "Cause", "text": "vandetanib", "start": 196, "end": 197}]}, {"id": "E54", "event_type": "Gene_expression", "trigger": {"text": "expressing", "start": 220, "end": 221}, "arguments": [{"entity_id": "T55", "role": "Theme", "text": "VEGF", "start": 218, "end": 219}]}, {"id": "E58", "event_type": "Planned_process", "trigger": {"text": "therapy", "start": 241, "end": 242}, "arguments": [{"entity_id": "T59", "role": "Instrument", "text": "vandetanib", "start": 240, "end": 241}]}, {"id": "E15", "event_type": "Negative_regulation", "trigger": {"text": "counteracted", "start": 243, "end": 244}, "arguments": []}, {"id": "E60", "event_type": "Growth", "trigger": {"text": "growth", "start": 249, "end": 250}, "arguments": [{"entity_id": "T61", "role": "Theme", "text": "tumor", "start": 248, "end": 249}]}, {"id": "E62", "event_type": "Gene_expression", "trigger": {"text": "over-expressing", "start": 253, "end": 256}, "arguments": [{"entity_id": "T63", "role": "Theme", "text": "VEGF", "start": 252, "end": 253}]}, {"id": "E67", "event_type": "Negative_regulation", "trigger": {"text": "interventions", "start": 270, "end": 271}, "arguments": []}], "relation_mentions": [], "entity_mentions": [{"id": "T2", "text": "tumor cell", "entity_type": "Cell", "start": 2, "end": 4}, {"id": "T3", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 4, "end": 5}, {"id": "T1", "text": "expression", "entity_type": "Gene_expression", "start": 5, "end": 6}, {"id": "T4", "text": "vandetanib", "entity_type": "Drug_or_compound", "start": 12, "end": 13}, {"id": "T5", "text": "ZACTIMA", "entity_type": "Drug_or_compound", "start": 14, "end": 15}, {"id": "T6", "text": "ZD6474", "entity_type": "Drug_or_compound", "start": 16, "end": 17}, {"id": "T7", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 19, "end": 20}, {"id": "T9", "text": "tumor", "entity_type": "Pathological_formation", "start": 25, "end": 26}, {"id": "T10", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 26, "end": 27}, {"id": "T12", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 36, "end": 37}, {"id": "T11", "text": "expression", "entity_type": "Gene_expression", "start": 37, "end": 38}, {"id": "T13", "text": "response", "entity_type": "Regulation", "start": 40, "end": 41}, {"id": "T14", "text": "tumors", "entity_type": "Pathological_formation", "start": 42, "end": 43}, {"id": "T16", "text": "VEGFR2", "entity_type": "Gene_or_gene_product", "start": 45, "end": 46}, {"id": "T8", "text": "associated", "entity_type": "Binding", "start": 46, "end": 47}, {"id": "T17", "text": "vandetanib", "entity_type": "Drug_or_compound", "start": 50, "end": 51}, {"id": "T1000", "text": "Human", "entity_type": "Organism", "start": 58, "end": 59}, {"id": "T19", "text": "colon carcinoma", "entity_type": "Pathological_formation", "start": 59, "end": 61}, {"id": "T20", "text": "HT29", "entity_type": "Cell", "start": 62, "end": 63}, {"id": "T1001", "text": "murine", "entity_type": "Organism", "start": 65, "end": 66}, {"id": "T22", "text": "squamous carcinoma", "entity_type": "Pathological_formation", "start": 66, "end": 68}, {"id": "T23", "text": "SCCVII", "entity_type": "Cell", "start": 69, "end": 70}, {"id": "T72", "text": "cell lines", "entity_type": "Cell", "start": 72, "end": 74}, {"id": "T21", "text": "expressing", "entity_type": "Gene_expression", "start": 74, "end": 75}, {"id": "T24", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 78, "end": 79}, {"id": "T25", "text": "response", "entity_type": "Regulation", "start": 83, "end": 84}, {"id": "T26", "text": "vandetanib", "entity_type": "Drug_or_compound", "start": 85, "end": 86}, {"id": "T71", "text": "tissue", "entity_type": "Tissue", "start": 89, "end": 90}, {"id": "T27", "text": "solid tumors", "entity_type": "Pathological_formation", "start": 93, "end": 95}, {"id": "T29", "text": "Vandetanib", "entity_type": "Drug_or_compound", "start": 98, "end": 99}, {"id": "T28", "text": "treatment", "entity_type": "Planned_process", "start": 99, "end": 100}, {"id": "T15", "text": "effect", "entity_type": "Regulation", "start": 102, "end": 103}, {"id": "T30", "text": "tumor cell", "entity_type": "Cell", "start": 104, "end": 106}, {"id": "T73", "text": "cell", "entity_type": "Cell", "start": 107, "end": 108}, {"id": "T18", "text": "survival", "entity_type": "Death", "start": 108, "end": 109}, {"id": "T31", "text": "reduced", "entity_type": "Negative_regulation", "start": 117, "end": 118}, {"id": "T34", "text": "endothelial cell", "entity_type": "Cell", "start": 118, "end": 120}, {"id": "T33", "text": "migration", "entity_type": "Localization", "start": 120, "end": 121}, {"id": "T35", "text": "tumors", "entity_type": "Pathological_formation", "start": 125, "end": 126}, {"id": "T74", "text": "cell clones", "entity_type": "Cell", "start": 128, "end": 130}, {"id": "T36", "text": "expressing", "entity_type": "Gene_expression", "start": 130, "end": 131}, {"id": "T37", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 134, "end": 135}, {"id": "T38", "text": "enhanced", "entity_type": "Positive_regulation", "start": 137, "end": 138}, {"id": "T39", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 138, "end": 139}, {"id": "T44", "text": "growth", "entity_type": "Growth", "start": 142, "end": 143}, {"id": "T40", "text": "intradermal", "entity_type": "Multi-tissue_structure", "start": 145, "end": 146}, {"id": "T41", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 146, "end": 147}, {"id": "T42", "text": "treatment", "entity_type": "Planned_process", "start": 157, "end": 158}, {"id": "T43", "text": "vandetanib", "entity_type": "Drug_or_compound", "start": 159, "end": 160}, {"id": "T65", "text": "inhibit", "entity_type": "Negative_regulation", "start": 170, "end": 171}, {"id": "T47", "text": "blood vessel", "entity_type": "Multi-tissue_structure", "start": 171, "end": 173}, {"id": "T46", "text": "growth", "entity_type": "Growth", "start": 173, "end": 174}, {"id": "T69", "text": "induced", "entity_type": "Positive_regulation", "start": 174, "end": 175}, {"id": "T49", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 180, "end": 181}, {"id": "T48", "text": "expressing", "entity_type": "Gene_expression", "start": 182, "end": 183}, {"id": "T50", "text": "tumor cell", "entity_type": "Cell", "start": 183, "end": 185}, {"id": "T52", "text": "HT29 tumor", "entity_type": "Pathological_formation", "start": 189, "end": 191}, {"id": "T70", "text": "treatment", "entity_type": "Planned_process", "start": 193, "end": 194}, {"id": "T51", "text": "response", "entity_type": "Regulation", "start": 194, "end": 195}, {"id": "T53", "text": "vandetanib", "entity_type": "Drug_or_compound", "start": 196, "end": 197}, {"id": "T55", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 218, "end": 219}, {"id": "T54", "text": "expressing", "entity_type": "Gene_expression", "start": 220, "end": 221}, {"id": "T75", "text": "cell clones", "entity_type": "Cell", "start": 221, "end": 223}, {"id": "T57", "text": "SCCVII tumor", "entity_type": "Pathological_formation", "start": 231, "end": 233}, {"id": "T59", "text": "vandetanib", "entity_type": "Drug_or_compound", "start": 240, "end": 241}, {"id": "T58", "text": "therapy", "entity_type": "Planned_process", "start": 241, "end": 242}, {"id": "T56", "text": "counteracted", "entity_type": "Negative_regulation", "start": 243, "end": 244}, {"id": "T61", "text": "tumor", "entity_type": "Pathological_formation", "start": 248, "end": 249}, {"id": "T60", "text": "growth", "entity_type": "Growth", "start": 249, "end": 250}, {"id": "T63", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 252, "end": 253}, {"id": "T62", "text": "over-expressing", "entity_type": "Gene_expression", "start": 253, "end": 256}, {"id": "T64", "text": "tumor cells", "entity_type": "Cell", "start": 256, "end": 258}, {"id": "T66", "text": "tumors", "entity_type": "Pathological_formation", "start": 262, "end": 263}, {"id": "T67", "text": "interventions", "entity_type": "Negative_regulation", "start": 270, "end": 271}], "lang": "en"}
{"doc_id": "PMID-19625706", "wnd_id": "PMID-19625706_0", "text": "Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property.\n\nAngiostatin was first discovered as a plasminogen fragment with antitumor/antiangiogenic property. One of the angiostatin isoforms, that is, angiostatin 4.5 (AS4.5), consisting of plasminogen kringle 1 to 4 and a most part of kringle 5, is produced by autoproteolysis and present in human plasma. beta2-glycoprotein I (beta2GPI) is proteolytically cleaved by plasmin in its domain V (nicked beta2GPI), resulting in binding to plasminogen. Antiangiogenic properties have been recently reported in nicked beta2GPI as well as in intact beta2GPI at higher concentrations. In the present study, we found significant binding of nicked beta2GPI to AS4.5 (K(D) = 3.27 x 10(6) M(-1)). Via this binding, nicked beta2GPI attenuates the antiangiogenic functions of AS4.5 in the proliferation of arterial/venous endothelial cells, in the extracellular matrix invasion and the tube formation of venous endothelial cells, and in vivo angiogenesis. In contrast, intact beta2GPI does not bind to AS4.5 or inhibit its antiangiogenic activity. Thus, nicked beta2GPI exerts dual effects on angiogenesis, that is, nicked beta2GPI promotes angiogenesis in the presence of AS4.5, whereas nicked beta2GPI inhibits angiogenesis at concentrations high enough to neutralize AS4.5. Our data suggest that plasmin-nicked beta2GPI promotes angiogenesis by interacting with plasmin-generated AS4.5 in sites of increased fibrinolysis such as thrombus.", "tokens": ["Nicked", "{", "beta}2-glycoprotein", "I", "binds", "angiostatin", "4.5", "(", "plasminogen", "kringle", "1", "-", "5", ")", "and", "attenuates", "its", "antiangiogenic", "property", ".", "Angiostatin", "was", "first", "discovered", "as", "a", "plasminogen", "fragment", "with", "antitumor", "/", "antiangiogenic", "property", ".", "One", "of", "the", "angiostatin", "isoforms", ",", "that", "is", ",", "angiostatin", "4.5", "(", "AS4.5", ")", ",", "consisting", "of", "plasminogen", "kringle", "1", "to", "4", "and", "a", "most", "part", "of", "kringle", "5", ",", "is", "produced", "by", "autoproteolysis", "and", "present", "in", "human", "plasma", ".", "beta2-glycoprotein", "I", "(", "beta2GPI", ")", "is", "proteolytically", "cleaved", "by", "plasmin", "in", "its", "domain", "V", "(", "nicked", "beta2GPI", ")", ",", "resulting", "in", "binding", "to", "plasminogen", ".", "Antiangiogenic", "properties", "have", "been", "recently", "reported", "in", "nicked", "beta2GPI", "as", "well", "as", "in", "intact", "beta2GPI", "at", "higher", "concentrations", ".", "In", "the", "present", "study", ",", "we", "found", "significant", "binding", "of", "nicked", "beta2GPI", "to", "AS4.5", "(", "K(", "D", ")", "=", "3.27", "x", "10", "(", "6", ")", "M", "(", "-", "1", ")", ")", ".", "Via", "this", "binding", ",", "nicked", "beta2GPI", "attenuates", "the", "antiangiogenic", "functions", "of", "AS4.5", "in", "the", "proliferation", "of", "arterial", "/", "venous", "endothelial", "cells", ",", "in", "the", "extracellular", "matrix", "invasion", "and", "the", "tube", "formation", "of", "venous", "endothelial", "cells", ",", "and", "in", "vivo", "angiogenesis", ".", "In", "contrast", ",", "intact", "beta2GPI", "does", "not", "bind", "to", "AS4.5", "or", "inhibit", "its", "antiangiogenic", "activity", ".", "Thus", ",", "nicked", "beta2GPI", "exerts", "dual", "effects", "on", "angiogenesis", ",", "that", "is", ",", "nicked", "beta2GPI", "promotes", "angiogenesis", "in", "the", "presence", "of", "AS4.5", ",", "whereas", "nicked", "beta2GPI", "inhibits", "angiogenesis", "at", "concentrations", "high", "enough", "to", "neutralize", "AS4.5", ".", "Our", "data", "suggest", "that", "plasmin", "-", "nicked", "beta2GPI", "promotes", "angiogenesis", "by", "interacting", "with", "plasmin", "-", "generated", "AS4.5", "in", "sites", "of", "increased", "fibrinolysis", "such", "as", "thrombus", "."], "event_mentions": [{"id": "E1", "event_type": "Binding", "trigger": {"text": "binds", "start": 4, "end": 5}, "arguments": [{"entity_id": "T2", "role": "Theme", "text": "Nicked {beta}2-glycoprotein I", "start": 0, "end": 4}, {"entity_id": "T3", "role": "Theme", "text": "angiostatin 4.5", "start": 5, "end": 7}]}, {"id": "E2", "event_type": "Negative_regulation", "trigger": {"text": "attenuates", "start": 15, "end": 16}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "Nicked {beta}2-glycoprotein I", "start": 0, "end": 4}]}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "property", "start": 18, "end": 19}, "arguments": [{"entity_id": "T2", "role": "Cause", "text": "Nicked {beta}2-glycoprotein I", "start": 0, "end": 4}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "property", "start": 32, "end": 33}, "arguments": [{"entity_id": "T8", "role": "Cause", "text": "plasminogen fragment", "start": 26, "end": 28}]}, {"id": "E10", "event_type": "Negative_regulation", "trigger": {"text": "property", "start": 32, "end": 33}, "arguments": [{"entity_id": "T8", "role": "Cause", "text": "plasminogen fragment", "start": 26, "end": 28}]}, {"id": "E3", "event_type": "Protein_processing", "trigger": {"text": "autoproteolysis", "start": 67, "end": 68}, "arguments": [{"entity_id": "T11", "role": "Theme", "text": "angiostatin 4.5", "start": 43, "end": 45}, {"entity_id": "T12", "role": "Theme", "text": "AS4.5", "start": 46, "end": 47}]}, {"id": "E15", "event_type": "Protein_processing", "trigger": {"text": "cleaved", "start": 81, "end": 82}, "arguments": [{"entity_id": "T16", "role": "Theme", "text": "beta2-glycoprotein I", "start": 74, "end": 76}, {"entity_id": "T17", "role": "Theme", "text": "beta2GPI", "start": 77, "end": 78}]}, {"id": "E4", "event_type": "Positive_regulation", "trigger": {"text": "cleaved", "start": 81, "end": 82}, "arguments": [{"entity_id": "T18", "role": "Cause", "text": "plasmin", "start": 83, "end": 84}, {"entity_id": "T19", "role": "Site", "text": "domain V", "start": 86, "end": 88}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "resulting", "start": 93, "end": 94}, "arguments": []}, {"id": "E21", "event_type": "Binding", "trigger": {"text": "binding", "start": 95, "end": 96}, "arguments": [{"entity_id": "T20", "role": "Theme", "text": "nicked beta2GPI", "start": 89, "end": 91}, {"entity_id": "T22", "role": "Theme", "text": "plasminogen", "start": 97, "end": 98}]}, {"id": "E6", "event_type": "Negative_regulation", "trigger": {"text": "properties", "start": 100, "end": 101}, "arguments": [{"entity_id": "T25", "role": "Cause", "text": "nicked beta2GPI", "start": 106, "end": 108}]}, {"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "properties", "start": 100, "end": 101}, "arguments": [{"entity_id": "T26", "role": "Cause", "text": "beta2GPI", "start": 113, "end": 114}]}, {"id": "E27", "event_type": "Binding", "trigger": {"text": "binding", "start": 126, "end": 127}, "arguments": [{"entity_id": "T28", "role": "Theme", "text": "nicked beta2GPI", "start": 128, "end": 130}, {"entity_id": "T29", "role": "Theme", "text": "AS4.5", "start": 131, "end": 132}]}, {"id": "E11", "event_type": "Binding", "trigger": {"text": "binding", "start": 152, "end": 153}, "arguments": [{"entity_id": "T30", "role": "Theme", "text": "nicked beta2GPI", "start": 154, "end": 156}, {"entity_id": "T33", "role": "Theme", "text": "AS4.5", "start": 161, "end": 162}]}, {"id": "E12", "event_type": "Negative_regulation", "trigger": {"text": "attenuates", "start": 156, "end": 157}, "arguments": [{"entity_id": "T30", "role": "Cause", "text": "nicked beta2GPI", "start": 154, "end": 156}]}, {"id": "E13", "event_type": "Negative_regulation", "trigger": {"text": "functions", "start": 159, "end": 160}, "arguments": [{"entity_id": "T33", "role": "Cause", "text": "AS4.5", "start": 161, "end": 162}]}, {"id": "E35", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 164, "end": 165}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "arterial", "start": 166, "end": 167}]}, {"id": "E14", "event_type": "Cell_proliferation", "trigger": {"text": "proliferation", "start": 164, "end": 165}, "arguments": [{"entity_id": "T38", "role": "Theme", "text": "venous endothelial cells", "start": 168, "end": 171}]}, {"id": "E16", "event_type": "Localization", "trigger": {"text": "invasion", "start": 176, "end": 177}, "arguments": [{"entity_id": "T38", "role": "Theme", "text": "venous endothelial cells", "start": 168, "end": 171}, {"entity_id": "T41", "role": "ToLoc", "text": "extracellular matrix", "start": 174, "end": 176}]}, {"id": "E17", "event_type": "Localization", "trigger": {"text": "invasion", "start": 176, "end": 177}, "arguments": [{"entity_id": "T36", "role": "Theme", "text": "arterial", "start": 166, "end": 167}, {"entity_id": "T41", "role": "ToLoc", "text": "extracellular matrix", "start": 174, "end": 176}]}, {"id": "E18", "event_type": "Development", "trigger": {"text": "formation", "start": 180, "end": 181}, "arguments": [{"entity_id": "T43", "role": "Theme", "text": "tube", "start": 179, "end": 180}]}, {"id": "E31", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 189, "end": 190}, "arguments": []}, {"id": "E19", "event_type": "Binding", "trigger": {"text": "bind", "start": 198, "end": 199}, "arguments": [{"entity_id": "T47", "role": "Theme", "text": "beta2GPI", "start": 195, "end": 196}, {"entity_id": "T48", "role": "Theme", "text": "AS4.5", "start": 200, "end": 201}]}, {"id": "E20", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 202, "end": 203}, "arguments": [{"entity_id": "T47", "role": "Cause", "text": "beta2GPI", "start": 195, "end": 196}]}, {"id": "E22", "event_type": "Negative_regulation", "trigger": {"text": "activity", "start": 205, "end": 206}, "arguments": [{"entity_id": "T48", "role": "Cause", "text": "AS4.5", "start": 200, "end": 201}]}, {"id": "E33", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 215, "end": 216}, "arguments": []}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "promotes", "start": 222, "end": 223}, "arguments": [{"entity_id": "T53", "role": "Cause", "text": "nicked beta2GPI", "start": 220, "end": 222}]}, {"id": "E36", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 223, "end": 224}, "arguments": []}, {"id": "E24", "event_type": "Negative_regulation", "trigger": {"text": "inhibits", "start": 233, "end": 234}, "arguments": [{"entity_id": "T57", "role": "Cause", "text": "nicked beta2GPI", "start": 231, "end": 233}]}, {"id": "E37", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 234, "end": 235}, "arguments": []}, {"id": "E25", "event_type": "Regulation", "trigger": {"text": "promotes", "start": 251, "end": 252}, "arguments": []}, {"id": "E38", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 252, "end": 253}, "arguments": []}, {"id": "E64", "event_type": "Binding", "trigger": {"text": "interacting", "start": 254, "end": 255}, "arguments": [{"entity_id": "T61", "role": "Theme", "text": "plasmin-nicked beta2GPI", "start": 247, "end": 251}, {"entity_id": "T65", "role": "Theme", "text": "plasmin-generated AS4.5", "start": 256, "end": 260}]}], "relation_mentions": [{"id": "R1", "relation_type": "frag", "arguments": [{"entity_id": "T36", "role": "Arg1", "text": "arterial", "start": 166, "end": 167}, {"entity_id": "T36", "role": "Arg1", "text": "arterial", "start": 166, "end": 167}]}, {"id": "R2", "relation_type": "frag", "arguments": [{"entity_id": "T24", "role": "Arg1", "text": "4", "start": 55, "end": 56}, {"entity_id": "T24", "role": "Arg1", "text": "4", "start": 55, "end": 56}]}, {"id": "R3", "relation_type": "frag", "arguments": [{"entity_id": "T31", "role": "Arg1", "text": "kringle 5", "start": 61, "end": 63}, {"entity_id": "T31", "role": "Arg1", "text": "kringle 5", "start": 61, "end": 63}]}, {"id": "R4", "relation_type": "frag", "arguments": [{"entity_id": "T37", "role": "Arg1", "text": "5", "start": 12, "end": 13}, {"entity_id": "T37", "role": "Arg1", "text": "5", "start": 12, "end": 13}]}], "entity_mentions": [{"id": "T2", "text": "Nicked {beta}2-glycoprotein I", "entity_type": "Gene_or_gene_product", "start": 0, "end": 4}, {"id": "T1", "text": "binds", "entity_type": "Binding", "start": 4, "end": 5}, {"id": "T3", "text": "angiostatin 4.5", "entity_type": "Gene_or_gene_product", "start": 5, "end": 7}, {"id": "T4", "text": "plasminogen kringle 1", "entity_type": "Protein_domain_or_region", "start": 8, "end": 11}, {"id": "T37", "text": "5", "entity_type": "Protein_domain_or_region", "start": 12, "end": 13}, {"id": "T5", "text": "attenuates", "entity_type": "Negative_regulation", "start": 15, "end": 16}, {"id": "T58", "text": "property", "entity_type": "Negative_regulation", "start": 18, "end": 19}, {"id": "T7", "text": "Angiostatin", "entity_type": "Gene_or_gene_product", "start": 20, "end": 21}, {"id": "T8", "text": "plasminogen fragment", "entity_type": "Gene_or_gene_product", "start": 26, "end": 28}, {"id": "T66", "text": "property", "entity_type": "Negative_regulation", "start": 32, "end": 33}, {"id": "T10", "text": "angiostatin", "entity_type": "Gene_or_gene_product", "start": 37, "end": 38}, {"id": "T11", "text": "angiostatin 4.5", "entity_type": "Gene_or_gene_product", "start": 43, "end": 45}, {"id": "T12", "text": "AS4.5", "entity_type": "Gene_or_gene_product", "start": 46, "end": 47}, {"id": "T13", "text": "plasminogen kringle 1", "entity_type": "Protein_domain_or_region", "start": 51, "end": 54}, {"id": "T24", "text": "4", "entity_type": "Protein_domain_or_region", "start": 55, "end": 56}, {"id": "T31", "text": "kringle 5", "entity_type": "Protein_domain_or_region", "start": 61, "end": 63}, {"id": "T39", "text": "autoproteolysis", "entity_type": "Protein_processing", "start": 67, "end": 68}, {"id": "T1000", "text": "human", "entity_type": "Organism", "start": 71, "end": 72}, {"id": "T14", "text": "plasma", "entity_type": "Organism_substance", "start": 72, "end": 73}, {"id": "T16", "text": "beta2-glycoprotein I", "entity_type": "Gene_or_gene_product", "start": 74, "end": 76}, {"id": "T17", "text": "beta2GPI", "entity_type": "Gene_or_gene_product", "start": 77, "end": 78}, {"id": "T15", "text": "cleaved", "entity_type": "Protein_processing", "start": 81, "end": 82}, {"id": "T45", "text": "cleaved", "entity_type": "Positive_regulation", "start": 81, "end": 82}, {"id": "T18", "text": "plasmin", "entity_type": "Gene_or_gene_product", "start": 83, "end": 84}, {"id": "T19", "text": "domain V", "entity_type": "Protein_domain_or_region", "start": 86, "end": 88}, {"id": "T20", "text": "nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 89, "end": 91}, {"id": "T51", "text": "resulting", "entity_type": "Positive_regulation", "start": 93, "end": 94}, {"id": "T21", "text": "binding", "entity_type": "Binding", "start": 95, "end": 96}, {"id": "T22", "text": "plasminogen", "entity_type": "Gene_or_gene_product", "start": 97, "end": 98}, {"id": "T54", "text": "properties", "entity_type": "Negative_regulation", "start": 100, "end": 101}, {"id": "T25", "text": "nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 106, "end": 108}, {"id": "T26", "text": "beta2GPI", "entity_type": "Gene_or_gene_product", "start": 113, "end": 114}, {"id": "T27", "text": "binding", "entity_type": "Binding", "start": 126, "end": 127}, {"id": "T28", "text": "nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 128, "end": 130}, {"id": "T29", "text": "AS4.5", "entity_type": "Gene_or_gene_product", "start": 131, "end": 132}, {"id": "T67", "text": "binding", "entity_type": "Binding", "start": 152, "end": 153}, {"id": "T30", "text": "nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 154, "end": 156}, {"id": "T68", "text": "attenuates", "entity_type": "Negative_regulation", "start": 156, "end": 157}, {"id": "T69", "text": "functions", "entity_type": "Negative_regulation", "start": 159, "end": 160}, {"id": "T33", "text": "AS4.5", "entity_type": "Gene_or_gene_product", "start": 161, "end": 162}, {"id": "T35", "text": "proliferation", "entity_type": "Cell_proliferation", "start": 164, "end": 165}, {"id": "T36", "text": "arterial", "entity_type": "Cell", "start": 166, "end": 167}, {"id": "T38", "text": "venous endothelial cells", "entity_type": "Cell", "start": 168, "end": 171}, {"id": "T41", "text": "extracellular matrix", "entity_type": "Cellular_component", "start": 174, "end": 176}, {"id": "T70", "text": "invasion", "entity_type": "Localization", "start": 176, "end": 177}, {"id": "T43", "text": "tube", "entity_type": "Tissue", "start": 179, "end": 180}, {"id": "T71", "text": "formation", "entity_type": "Development", "start": 180, "end": 181}, {"id": "T44", "text": "venous endothelial cells", "entity_type": "Cell", "start": 182, "end": 185}, {"id": "T46", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 189, "end": 190}, {"id": "T47", "text": "beta2GPI", "entity_type": "Gene_or_gene_product", "start": 195, "end": 196}, {"id": "T72", "text": "bind", "entity_type": "Binding", "start": 198, "end": 199}, {"id": "T48", "text": "AS4.5", "entity_type": "Gene_or_gene_product", "start": 200, "end": 201}, {"id": "T73", "text": "inhibit", "entity_type": "Negative_regulation", "start": 202, "end": 203}, {"id": "T74", "text": "activity", "entity_type": "Negative_regulation", "start": 205, "end": 206}, {"id": "T50", "text": "nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 209, "end": 211}, {"id": "T52", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 215, "end": 216}, {"id": "T53", "text": "nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 220, "end": 222}, {"id": "T75", "text": "promotes", "entity_type": "Positive_regulation", "start": 222, "end": 223}, {"id": "T55", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 223, "end": 224}, {"id": "T56", "text": "AS4.5", "entity_type": "Gene_or_gene_product", "start": 228, "end": 229}, {"id": "T57", "text": "nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 231, "end": 233}, {"id": "T76", "text": "inhibits", "entity_type": "Negative_regulation", "start": 233, "end": 234}, {"id": "T59", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 234, "end": 235}, {"id": "T60", "text": "AS4.5", "entity_type": "Gene_or_gene_product", "start": 241, "end": 242}, {"id": "T61", "text": "plasmin-nicked beta2GPI", "entity_type": "Gene_or_gene_product", "start": 247, "end": 251}, {"id": "T77", "text": "promotes", "entity_type": "Regulation", "start": 251, "end": 252}, {"id": "T63", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 252, "end": 253}, {"id": "T64", "text": "interacting", "entity_type": "Binding", "start": 254, "end": 255}, {"id": "T65", "text": "plasmin-generated AS4.5", "entity_type": "Gene_or_gene_product", "start": 256, "end": 260}, {"id": "T78", "text": "thrombus", "entity_type": "Pathological_formation", "start": 267, "end": 268}], "lang": "en"}
{"doc_id": "PMID-19636328", "wnd_id": "PMID-19636328_0", "text": "Targeting angiogenesis: progress with anti-VEGF treatment with large molecules.\n\nAngiogenesis--one of the hallmarks of cancer--has emerged as a valid therapeutic target in oncology. The VEGF system represents a key mediator of tumor-initiated angiogenesis and the first target of antiangiogenesis agents introduced in clinical practice. Although anti-VEGF therapies have clearly demonstrated antitumor efficacy in various malignancies, especially when combined with conventional cytotoxic chemotherapy, their mechanism of action is not fully understood. This Review will discuss the rationale for using antiangiogenic compounds and will focus on large molecules, such as antibodies, that target the VEGF system. Clinical data on bevacizumab is discussed in detail. Predictive markers for anti-VEGF agents have not yet been identified and questions regarding the usefulness of bevacizumab in the adjuvant setting as well as its continued use beyond progression remain unanswered, in spite of negative data on bevacizumab in treating patients with adjuvant colon cancer. Nonetheless, anti-VEGF therapy has enhanced the arsenal of anticancer therapies and has provided new insights into the biology of malignancy.", "tokens": ["Targeting", "angiogenesis", ":", "progress", "with", "anti-VEGF", "treatment", "with", "large", "molecules", ".", "Angiogenesis", "--", "one", "of", "the", "hallmarks", "of", "cancer", "--", "has", "emerged", "as", "a", "valid", "therapeutic", "target", "in", "oncology", ".", "The", "VEGF", "system", "represents", "a", "key", "mediator", "of", "tumor", "-", "initiated", "angiogenesis", "and", "the", "first", "target", "of", "antiangiogenesis", "agents", "introduced", "in", "clinical", "practice", ".", "Although", "anti-VEGF", "therapies", "have", "clearly", "demonstrated", "antitumor", "efficacy", "in", "various", "malignancies", ",", "especially", "when", "combined", "with", "conventional", "cytotoxic", "chemotherapy", ",", "their", "mechanism", "of", "action", "is", "not", "fully", "understood", ".", "This", "Review", "will", "discuss", "the", "rationale", "for", "using", "antiangiogenic", "compounds", "and", "will", "focus", "on", "large", "molecules", ",", "such", "as", "antibodies", ",", "that", "target", "the", "VEGF", "system", ".", "Clinical", "data", "on", "bevacizumab", "is", "discussed", "in", "detail", ".", "Predictive", "markers", "for", "anti-VEGF", "agents", "have", "not", "yet", "been", "identified", "and", "questions", "regarding", "the", "usefulness", "of", "bevacizumab", "in", "the", "adjuvant", "setting", "as", "well", "as", "its", "continued", "use", "beyond", "progression", "remain", "unanswered", ",", "in", "spite", "of", "negative", "data", "on", "bevacizumab", "in", "treating", "patients", "with", "adjuvant", "colon", "cancer", ".", "Nonetheless", ",", "anti-VEGF", "therapy", "has", "enhanced", "the", "arsenal", "of", "anticancer", "therapies", "and", "has", "provided", "new", "insights", "into", "the", "biology", "of", "malignancy", "."], "event_mentions": [{"id": "E2", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 1, "end": 2}, "arguments": []}, {"id": "E3", "event_type": "Blood_vessel_development", "trigger": {"text": "Angiogenesis", "start": 11, "end": 12}, "arguments": []}, {"id": "E10", "event_type": "Pathway", "trigger": {"text": "system", "start": 32, "end": 33}, "arguments": [{"entity_id": "T5", "role": "Participant", "text": "VEGF", "start": 31, "end": 32}]}, {"id": "E7", "event_type": "Positive_regulation", "trigger": {"text": "initiated", "start": 40, "end": 41}, "arguments": [{"entity_id": "T7", "role": "Cause", "text": "tumor", "start": 38, "end": 39}]}, {"id": "E4", "event_type": "Blood_vessel_development", "trigger": {"text": "angiogenesis", "start": 41, "end": 42}, "arguments": []}, {"id": "E9", "event_type": "Planned_process", "trigger": {"text": "therapies", "start": 56, "end": 57}, "arguments": [{"entity_id": "T24", "role": "Instrument", "text": "anti-VEGF", "start": 55, "end": 56}]}, {"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "efficacy", "start": 61, "end": 62}, "arguments": []}, {"id": "E11", "event_type": "Pathway", "trigger": {"text": "system", "start": 108, "end": 109}, "arguments": [{"entity_id": "T13", "role": "Participant", "text": "VEGF", "start": 107, "end": 108}]}, {"id": "E1", "event_type": "Planned_process", "trigger": {"text": "treating", "start": 159, "end": 160}, "arguments": [{"entity_id": "T17", "role": "Instrument", "text": "bevacizumab", "start": 157, "end": 158}, {"entity_id": "T1000", "role": "Theme", "text": "patients", "start": 160, "end": 161}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 1, "end": 2}, {"id": "T3", "text": "Angiogenesis", "entity_type": "Blood_vessel_development", "start": 11, "end": 12}, {"id": "T5", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 31, "end": 32}, {"id": "T4", "text": "system", "entity_type": "Pathway", "start": 32, "end": 33}, {"id": "T7", "text": "tumor", "entity_type": "Pathological_formation", "start": 38, "end": 39}, {"id": "T20", "text": "initiated", "entity_type": "Positive_regulation", "start": 40, "end": 41}, {"id": "T8", "text": "angiogenesis", "entity_type": "Blood_vessel_development", "start": 41, "end": 42}, {"id": "T24", "text": "anti-VEGF", "entity_type": "Gene_or_gene_product", "start": 55, "end": 56}, {"id": "T23", "text": "therapies", "entity_type": "Planned_process", "start": 56, "end": 57}, {"id": "T22", "text": "efficacy", "entity_type": "Negative_regulation", "start": 61, "end": 62}, {"id": "T13", "text": "VEGF", "entity_type": "Gene_or_gene_product", "start": 107, "end": 108}, {"id": "T12", "text": "system", "entity_type": "Pathway", "start": 108, "end": 109}, {"id": "T14", "text": "bevacizumab", "entity_type": "Drug_or_compound", "start": 113, "end": 114}, {"id": "T16", "text": "bevacizumab", "entity_type": "Drug_or_compound", "start": 135, "end": 136}, {"id": "T17", "text": "bevacizumab", "entity_type": "Drug_or_compound", "start": 157, "end": 158}, {"id": "T6", "text": "treating", "entity_type": "Planned_process", "start": 159, "end": 160}, {"id": "T1000", "text": "patients", "entity_type": "Organism", "start": 160, "end": 161}, {"id": "T18", "text": "colon cancer", "entity_type": "Pathological_formation", "start": 163, "end": 165}], "lang": "en"}
{"doc_id": "PMID-6246863", "wnd_id": "PMID-6246863_0", "text": "Protection from experimental ocular herpetic keratitis by a heat-killed virus vaccine.\n\nNew Zealand white rabbits were given limbal inoculations of a heat-killed suspension of herpes simplex virus (HSV) in a lysate of human embryonic kidney cells. At intervals of four to 14 days, the animals were challenged by intrastromal inoculation with 10,000 plaque-forming units of viable HSV. Epithelial keratitis, disciform edema, and necrotizing keratitis with neovascularization of the cornea developed in control animals. Epithelial keratitis and corneal edema also developed in the immunized animals during the first week after virus challenge, but these symptoms rapidly resolved during the following weeks. The absence of iritis, neovascularization, and necrotizing keratitis in the corneas of the immunized animals was particularly striking.", "tokens": ["Protection", "from", "experimental", "ocular", "herpetic", "keratitis", "by", "a", "heat", "-", "killed", "virus", "vaccine", ".", "New", "Zealand", "white", "rabbits", "were", "given", "limbal", "inoculations", "of", "a", "heat", "-", "killed", "suspension", "of", "herpes", "simplex", "virus", "(", "HSV", ")", "in", "a", "lysate", "of", "human", "embryonic", "kidney", "cells", ".", "At", "intervals", "of", "four", "to", "14", "days", ",", "the", "animals", "were", "challenged", "by", "intrastromal", "inoculation", "with", "10,000", "plaque", "-", "forming", "units", "of", "viable", "HSV", ".", "Epithelial", "keratitis", ",", "disciform", "edema", ",", "and", "necrotizing", "keratitis", "with", "neovascularization", "of", "the", "cornea", "developed", "in", "control", "animals", ".", "Epithelial", "keratitis", "and", "corneal", "edema", "also", "developed", "in", "the", "immunized", "animals", "during", "the", "first", "week", "after", "virus", "challenge", ",", "but", "these", "symptoms", "rapidly", "resolved", "during", "the", "following", "weeks", ".", "The", "absence", "of", "iritis", ",", "neovascularization", ",", "and", "necrotizing", "keratitis", "in", "the", "corneas", "of", "the", "immunized", "animals", "was", "particularly", "striking", "."], "event_mentions": [{"id": "E2", "event_type": "Planned_process", "trigger": {"text": "inoculations", "start": 21, "end": 22}, "arguments": [{"entity_id": "T1000", "role": "Theme", "text": "New Zealand white rabbits", "start": 14, "end": 18}, {"entity_id": "T12", "role": "Instrument", "text": "herpes simplex virus", "start": 29, "end": 32}, {"entity_id": "T13", "role": "Instrument", "text": "HSV", "start": 33, "end": 34}]}, {"id": "E3", "event_type": "Planned_process", "trigger": {"text": "inoculation", "start": 58, "end": 59}, "arguments": [{"entity_id": "T14", "role": "Instrument", "text": "HSV", "start": 67, "end": 68}]}, {"id": "E5", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 79, "end": 80}, "arguments": [{"entity_id": "T5", "role": "AtLoc", "text": "cornea", "start": 82, "end": 83}]}, {"id": "E1", "event_type": "Development", "trigger": {"text": "developed", "start": 83, "end": 84}, "arguments": [{"entity_id": "T5", "role": "Theme", "text": "cornea", "start": 82, "end": 83}]}, {"id": "E4", "event_type": "Development", "trigger": {"text": "developed", "start": 94, "end": 95}, "arguments": [{"entity_id": "T7", "role": "Theme", "text": "corneal edema", "start": 91, "end": 93}]}, {"id": "E6", "event_type": "Blood_vessel_development", "trigger": {"text": "neovascularization", "start": 122, "end": 123}, "arguments": [{"entity_id": "T9", "role": "AtLoc", "text": "corneas", "start": 129, "end": 130}]}], "relation_mentions": [], "entity_mentions": [{"id": "T1000", "text": "New Zealand white rabbits", "entity_type": "Organism", "start": 14, "end": 18}, {"id": "T11", "text": "inoculations", "entity_type": "Planned_process", "start": 21, "end": 22}, {"id": "T12", "text": "herpes simplex virus", "entity_type": "Organism", "start": 29, "end": 32}, {"id": "T13", "text": "HSV", "entity_type": "Organism", "start": 33, "end": 34}, {"id": "T1001", "text": "human", "entity_type": "Organism", "start": 39, "end": 40}, {"id": "T2", "text": "embryonic kidney cells", "entity_type": "Cell", "start": 40, "end": 43}, {"id": "T15", "text": "inoculation", "entity_type": "Planned_process", "start": 58, "end": 59}, {"id": "T14", "text": "HSV", "entity_type": "Organism", "start": 67, "end": 68}, {"id": "T3", "text": "Epithelial", "entity_type": "Tissue", "start": 69, "end": 70}, {"id": "T1", "text": "disciform edema", "entity_type": "Pathological_formation", "start": 72, "end": 74}, {"id": "T4", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 79, "end": 80}, {"id": "T5", "text": "cornea", "entity_type": "Multi-tissue_structure", "start": 82, "end": 83}, {"id": "T10", "text": "developed", "entity_type": "Development", "start": 83, "end": 84}, {"id": "T6", "text": "Epithelial", "entity_type": "Tissue", "start": 88, "end": 89}, {"id": "T7", "text": "corneal edema", "entity_type": "Pathological_formation", "start": 91, "end": 93}, {"id": "T16", "text": "developed", "entity_type": "Development", "start": 94, "end": 95}, {"id": "T8", "text": "neovascularization", "entity_type": "Blood_vessel_development", "start": 122, "end": 123}, {"id": "T9", "text": "corneas", "entity_type": "Multi-tissue_structure", "start": 129, "end": 130}], "lang": "en"}
